Program Book PDF Version - EAS 2014, Madrid

82nd EAS Congress MAY 31st JUNE 3rd 2014 MADRID SPAIN

PROGRAMME BOOK www.kenes.com/eas

83 EAS CONGRESS RD

March 22 - 25, 2015 Glasgow, UK

W O G S A L G

Abstract Submission and online Registration opens: Monday, September 8, 2014 Abstract Submission Deadline: Monday, October 27, 2014 Early Bird Registration Deadline: Monday, January 12, 2015

www.kenes.com/eas

82 EAS Congress nd

MAY 31st JUNE 3rd 2014 MADRID SPAIN

PROGRAMME BOOK

Organised by 1-3 Rue de Chantepoulet, PO Box 1726, CH-1211, Geneva 1, Switzerland Tel: +41 22 908 0488 | Fax: +41 22 906 9140 | Email: [email protected] | Website:eas.kenes.com

CONTENTS Welcoming Words Committees Committee of Honour Faculty List The European Atherosclerosis Society The Anitschkow Prize Young Investigator Awards General Information CME Accreditation Disclosure and Resolution of Personal Conflicts of Interest About Madrid Information for Presenters Poster Presentations Moderated Poster Session Poster Overview Hall Name Eulogy of Distinguished Scientists Congress Floor Plan Programme at a Glance

3 4 5 6 7 8 9 10 12 14 15 16 17 18 19 20 22 23

SCIENTIFIC PROGRAMME Saturday, May 31, 2014 Sunday, June 1, 2014 Monday, June 2, 2014 Tuesday, June 3, 2014

27 31 41 53

moderated poster sessions

59

poster presentations

85

index of authors

189

Recognition, Acknowledgements and Commercial Support

241 243 247 253

Acknowledgements Industry Supported Sessions Exhibition Floor Plan 2

WELCOMING WORDS Dear Friends and Colleagues, Welcome to Madrid! On behalf of the European Atherosclerosis Society (EAS) and the Spanish Society of Atherosclerosis it is our great pleasure to welcome you to Madrid and the 82nd Congress of EAS. The Spanish Society of Atherosclerosis (SEA) is particularly pleased to welcome colleagues from more than 70 countries, especially Latin American countries and the Iberolatinamerican Atherosclerosis Society (SILAT). EAS Congress brings together scientists and health care professionals from around the world - all involved in many different aspects of atherosclerosis. As an acknowledged leader in the field, EAS promotes the highest standards in academic and scientific knowledge, clinical practice and continuing education for its members. EAS Congress provides a unique opportunity for interaction - both interdisciplinary and multidisciplinary. The Scientific Programme, through plenary lectures, workshops, and educational symposia, features recent research findings in all areas of atherosclerosis. Make sure to take part also in the poster exhibition and moderated poster sessions – the heart of the meeting, where new connections are made, and new collaborations formed. The city of Madrid provides an unforgettable backdrop for the Congress. Despite its cosmopolitan nature, the citizens of Madrid are warm and friendly - and passionately proud to share with you their cultural heritage. The contribution that EAS has made to scientific knowledge over the past 50 years (1964-2014) is of paramount relevance to the field. We hope you will join us in celebrating the Society’s 50th anniversary, as we acknowledge the achievements of the past and look towards the future challenges.

Alberico L. Catapano EAS President

Arnold von Eckardstein Scientific Programme Committee Chair

Jesús Millán Núñez-Cortés Congress Chair

Juan Pedro-Botet Montoya Congress Co-Chair

3

COMMITTEES CONGRESS CHAIRPERSON

SCIENTIFIC PROGRAMME COMMITTEE

Jesús Millán Núñez-Cortés, Spain

Arnold von Eckardstein, Zurich, Scientific Programme Committee Chair Alberico L. Catapano, Milan Philippe Moulin, Lyon Jesús Millán Núñez-Cortés, Madrid Bart Staels, Lille Petri Kovanen, Helsinki Ruth Frikke-Schmidt, Copenhagen Giuseppe Danilo Norata, Milan Chris Packard, Glasgow Juan Pedro-Botet, Barcelona Miranda van Eck, Leiden

EAS EXECUTIVE COMMITTEE Alberico L. Catapano, Italy, President Olov Wiklund, Sweden, Vice President M. John Chapman, France, Past President Petri Kovanen, Finland, Secretary & Award Committee Chair Jan Borén, Sweden, Treasurer Geesje Dallinga-Thie, Netherlands Børge Nordestgaard, Denmark Arnold von Eckardstein, Switzerland Michal Vrablík, Czech Republic

LOCAL ORGANISING COMMITTEE Jesús Millán Núñez-Cortés, Madrid, Chair Juan Pedro-Botet, Barcelona, Co-Chair Lina Badimón, Barcelona Rafael Carmena, Valencia Fernando Civeira, Zaragoza Jesús Egido, Madrid Pedro Gonzalez Santos, Málaga Vicente Lahera, Madrid Luis Masana, Reus Jose Antonio Páramo, Pamplona Francisco Pérez Jimenez, Córdoba Fernando Rodriguez Artalejo, Madrid Emilio Ros, Barcelona Teresa Tejerina, Madrid

4

CONGRESS COMMITTEE Marja-Ritta Taskinen, Finland, Chair Chris Packard, UK Jan Borén, Sweden Jesús Millán Núñez-Cortés, Spain Philippe Moulin, France Giuseppe Danilo Norata, Italy Juan Pedro-Botet, Spain

COMMITTEE OF HONOUR President HM Queen Sofia of Spain

Members HE Mrs Ana Mato Adrover Minister of Health, Social Services and Equality HE Mr Ignacio Gonzalez Gonzalez President of the Community of Madrid HE F. Rodríguez Rodríguez Health Counsellor of the Regional Government of Madrid HE Mrs Ana Botella Serrano Mayoress of Madrid HE Mr Joaquin Poch Broto President of the Royal Academy of Medicine Mr Juan Jose Rodriguez Sendin President of the General Council of Colleges of Physicians of Spain Prof. Dr. José Carrillo Menendez Magfco Rector of the University Complutense of Madrid Prof. Dr. Jose Luis Alvarez-Sala Walther Dean of School of Medicine. University Complutense of Madrid Prof. Dr. Juan Ascaso Gimilio Elected President of the Spanish Society of Atherosclerosis 5

FACULTY LIST Angelin Bo, Sweden Arca Marcello, Italy Armitage Jane M., UK Arner Peter, Sweden Bäckhed Fredrik, Sweden Badimón Lina, Spain Binder Christoph, Austria Borén Jan, Sweden Cariou Bertrand, France Carmena Rafael, Spain Catapano Alberico, Italy Chapman John, France Civeira Fernando, Spain Corsini Alberto, Italy Dallinga-Thie Geesje, Netherlands de Backer Guy, Belgium de Geest Bart, Belgium Després Jean Pierre, Canada Detmar Michael, Switzerland Dieplinger Hans, Austria Ehnholm Christian, Finland Fernández-Hernando Carlos, USA Francque Sven, Belgium Frikke-Schmidt Ruth, Denmark Fruchart Jean-Charles, France Goldberg Ira J., USA Gonzalez Santos Pedro, Spain Gotto Jr. Antonio M., USA Graham Mark, USA Graham Ian, Ireland

Groen Bert, Netherlands Gylling Helena, Finland Heeren Jörg, Germany Hu Frank B., USA Humphries Steve, UK Ikonen Elina, Finland Kivimäki Mika, UK Kontush Anatol, France Kostner Gert, Austria Kovanen Petri, Finland Kronenberg Florian, Austria Kuiper Johan, Netherlands Lahera Vicente, Spain Malik Asrar B., USA Mangas Alipio, Spain Masana Luis, Spain Millan Nuñez-Cortes Jesús, Spain Moulin Philippe, France Nestel Paul, Australia Newby Andrew, UK Newsome Philip, UK Nieuwdorp Max, Netherlands Nofer Roch, Germany Norata Giuseppe Danilo, Italy Nordestgaard Børge, Denmark O’Leary Dan, USA Olsson Anders, Sweden Packard Chris, UK Páramo Jose Antonio, Spain Pedro-Botet Juan, Spain

Pérez Jimenez Francisco, Spain Pinto Xavier, Spain Pocovi Miguel, Spain Randolph Gwendalyn, USA Rauramaa Rainer, Finland Riccardi Gabrielle, Italy Rodríguez-Artalejo Fernando, Spain Ros Emilio, Spain Sattar Naveed, UK Shepherd James, UK Smith Ulf, Sweden Staels Bart, France Stroes Erik, Netherlands Tabas Ira, USA Taskinen Marja-Riitta, Finland Tejerina Teresa, Spain Thompson Gilbert, UK Thum Thomas, Germany Tokgözoglu Lale, Turkey Tybjaerg-Hansen Anne, Denmark Valdivielso Pedro, Spain van Eck Miranada, Netherlands von Eckardstein Arnold, Switzerland Vrablik Michal, Czech Republic Wellington Cheryl, Canada Wiegman Albert, Netherlands Wiklund Olov, Sweden Zernecke Alma, Germany

APPRECIATION AND THANKS We would like to thank the reviewers of the submitted abstracts and the Young Investigator Award Jury for their valuable assistance. 6

The European Atherosclerosis Society Our aim is to provide a framework for the scientific and clinical discussion of new developments in basic research, diagnosis and therapy of atherosclerosis.

What we do • Publications • Guidelines and Consensus Position Papers and related Handbooks • The Society’s official journal, Atherosclerosis • Educational activities • Annual Congress • Advanced Courses for both basic scientists and clinicians • On-line education • EAS Academy includes webcasts, learning quizzes, technical videos and more • Educational Apps for iPads and other devices

Membership Membership is open to individuals working or studying in basic and clinical research in the field of atherosclerosis or related areas. • Member benefits include: • Full access to all EAS Academy content, including Premium content • Full access to the Journal Atherosclerosis • Save of up to 30% on Congress registration fee the following year • Apply to attend Advanced Courses • Apply for Grants and Awards

For more information Visit www.eas-society.org to find out more about the Society’s activities and an on-line membership application form.

CONTACT DETAILS European Atherosclerosis Society Administrative Office, Kronhusgatan 11 SE 411 05, Gothenburg, SWEDEN Tel: +46 31 724 27 95 Fax: +46 31 724 27 01 Email: [email protected]

7

THE ANITSCHKOW PRIZE THE ANITSCHKOW PRIZE IN ATHEROSCLEROSIS RESEARCH, 2014 IN RECOGNITION OF OUTSTANDING NOVEL CONTRIBUTIONS AND AN EXCELLENT TRACK RECORD OF PUBLICATIONS, AND THE IMPACT THEY HAVE HAD ON RESEARCH IN THE AREA OF ATHEROSCLEROSIS AND LINKED METABOLIC DISTURBANCES

PROFESSOR JOHN KASTELEIN Professor Kastelein is a recognized world leader in the studies focusing on the significance of lipoprotein metabolism in the development of atherosclerotic vascular disease. His current research interests focus on the etiology, diagnosis, prevention and treatment of hypertriglyceridemia, hypercholesterolaemia and low HDL cholesterol, all conditions associated with atherosclerosis and cardiovascular disease. He has published over 740 research papers in peer reviewed journals, including Nature Genetics, Lancet, New England Journal of Medicine, JAMA and Circulation, and his Hirsch index is 82 and his total citations are more than 23.000. His position in the AMC and the department of Vascular Medicine allows him to devote the majority of his time to science and in particular to scientific guidance of his large number of PhD students. Most of these young scientists are destined to become medical specialists in an academic environment and carry the torch of scientific research with a focus on human clinical relevance. The most important concept in Prof. Kastelein’s research career, developed initially by his mentor Dr. Hayden at the University of British Columbia and subsequently transformed into practice in Amsterdam at the University of Amsterdam, is the “extreme genetics” approach. This approach has been very successful, Familial Hypercholesterolemia is now internationally recognized as the paradigm for the relationship between LDL-C and heart disease, a relationship substantiated by at least 50 peer reviewed manuscripts and 10 postdoctoral theses in his curriculum vitae. The same “extreme genetics” concept was applied to disorders of HDL-C and elevated triglycerides, and led to the discovery of the cholesterol efflux protein ABCA1 and later to gene therapy for lipoprotein lipase deficiency, both in close collaboration with Dr. Hayden. These two contributions have led to important breakthroughs in the field of drug development for the prevention of cardiovascular disease (development of ABCA1 agonists) and in the area of gene therapy for hereditary disorders such as haemophilia, LCAT deficiency and others.

8

YOUNG INVESTIGATOR AWARDS THESE ANNUAL AWARDS ARE PRESENTED BY EAS FOR OUTSTANDING PUBLICATIONS BY YOUNG SCIENTISTS IN THE FIELD OF ATHEROSCLEROSIS

ANA CATARINA ALVES Dr. Ana Catarina Alves won the Award in Clinical Research for her publication Novel functional APOB mutations outside LDLbinding region causing familial hypercholesterolaemia, published in Human Molecular Genetics. Ana Catarina Alves (ACA) (dob 25/03/1980) is currently a final year PhD student in Biochemistry at the Faculty of Science, University of Lisbon, Portugal. ACA developed all scientific activity in genetic dyslipidemias, particularly in Familial Hypercholesterolemia (FH), an area in which she has a great interest. ACA started her scientific career in 2004 as a researcher assistant at the Cardiovascular Research Group, National Institute of Health, in Lisbon, on a project about the identification of mutations in genes involved in FH phenotype (LDLR and APOB) in patients with clinical diagnosis of FH. In 2008 ACA received a scholarship from the Science and Technology Foundation, to do her PhD in biochemistry, with a thesis entitled “Basis Genetic of Familial Hypercholesterolemia”. Meanwhile ACA has also participated in several projects developed by the Cardiovascular Research Group such as” Young Heart – a study of cardiovascular prevention in schools”, “Clinical and molecular study of familial dyslipidaemias with increased cardiovascular risk”, “Prevalence of familial hypercholesterolemia and analysis of cardiovascular risk factors in the Portuguese population” and “Novel genes causing Familial Hypercholesterolaemia”. ACA was a co-author of the 1st prize of the Pfizer award in clinical investigation 2009 given by the Medical Sciences Society entitled “Familial hypercholesterolemia – an opportunity for preventive medicine” and has won 2 prizes at national congresses. ACA has published 10 international research papers and presented her work at more than 50 national and international scientific conferences.

JAMES SOH Dr. James Soh won the Award in Basic Research for his publication MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion, published in Nature Medicine. James Soh is from Anaheim, California, and was raised there for most of his life until undergraduate college at University of California, Berkeley. In college, he majored in molecular cell biology and applied to medical school afterward. He enrolled at State University of New York (SUNY), Downstate Medical Center in 2006 in the MD/PhD program. After completing the first two years of medical school, he entered the graduate program and joined the laboratory of Dr. Mahmood Hussain, working on the role of microsomal triglyceride transfer protein (MTP) in the synthesis and secretion of apolipoprotein B. During his graduate thesis, they investigated the role of microRNAs in lipid synthesis and secretion. Ultimately, they came across a potential microRNA (miR-30c) that could regulate the expression of MTP and thus apolipoprotein B secretion. Given that miRs were known to regulate gene pathways rather than individual genes, we also found that miR-30c could also regulate lipid synthesis genes. After defending my thesis, he re-joined the medical school and started medical clerkships. His background and training gives him the opportunity to not only practice medicine but also participate in basic science research. His goal is to become a physician who can bridge the divide between clinical side of medicine and the basic science in developing new therapies.

9

GENERAL INFORMATION VENUE

CONGRESS NAME BADGE

IFEMA - Feria de Madrid Madrid, North Convention Centre Parque Ferial Juan Carlos I. Campo de las Naciones, 28042 Phone: 34 902 22 15 15 www.ifema.es

Upon registration you will receive your name badge. You are kindly requested to wear your badge during all sessions and events.

The official language of the Congress is English. All presentations will be made in English.

Coffee and refreshments will be served to Congress participants on the 1st floor on May 31st and in the Exhibition Area from June 1st –3rd, as indicated in the Programme. Lunch boxes will be served to participants.

CLOTHING

CYBER CENTRE

Clothing is informal for all occasions.

Free internet facilities will be available for participants’ use in the Exhibition Area during exhibition hours.

OFFICIAL LANGUAGE

REGISTRATION DESK HOURS The Registration Desk will be situated at the North Entrance, ground level of the convention center, as follows: Saturday, May 31st 10:30 – 20:30 Sunday, June 1st 07:30 – 18:30 Monday, June 2nd 08:00 – 18:30 Tuesday, June 3rd 08:00 – 12:30

EXHIBITION OPENING HOURS Saturday, May 31st 17:30 – end of Welcome Reception Sunday, June 1st 10:00 – 17:30 Monday, June 2nd 10:00 – 17:30 Tuesday, June 3rd 10:00 – 12:30

10

REFRESHMENTS

CONGRESS ABSTRACTS The congress abstracts will be published online in the Atherosclerosis Journal following the Congress.

MOBILE PHONES AND PHOTOGRAPHY Participants are kindly requested to keep their mobile phones switched off in session halls and refrain from taking pictures during sessions.

SMOKING POLICY The 82nd EAS Congress is a non-smoking event and participants are requested to refrain from smoking in the venue.

LIABILITY AND INSURANCE

CONGRESS ORGANISERS

The Congress Secretariat and Organisers cannot accept liability for personal accidents or loss of or damage to private property of participants. Participants are advised to take out their own personal travel and health insurance for their trip.

82nd EAS Congress

SAFETY AND SECURITY Please do not leave bags or suitcases unattended at any time, whether inside or outside the session halls. Hotels strongly recommend that you use their safety deposit boxes for your valuables.

1-3, Rue de Chantepoulet P.O. Box 1726 CH-1211 Geneva 1, Switzerland Tel: +41 22 908 0488 Fax: +41 22 906 9140 E-mail: [email protected] Website: eas.kenes.com

PRESS ROOM A press room is available to registered journalists. Journalists must register at the Registration Desk. Upon registration, journalists will receive a press kit including the detailded press briefing schedule. Press releases related to the press briefings will be available to the journalists in the Press Room.

PRESS ROOM HOURS Saturday, May 31st 10:30 – 20:30 Sunday, June 1st 07:30 – 18:30 Monday, June 2nd 08:00 – 18:30 Tuesday, June 3rd 08:00 – 12:30

WEBCASTING A selection of sessions will be webcast and will be available on the Society website after the Congress.

11

CME ACCREDITATION EDUCATIONAL OBJECTIVES • Address individual needs in compliance with their Continuous Professional Development (CPD) plan • Exchange ideas and knowledge in the field of atherosclerosis and related cardiovascular conditions across continents, institutions, and individuals • Discuss the latest scientific advantages in the field of atherosclerosis and related cardiovascular conditions • Identify possible programmatic collaborations to more effectively address regional, national and local responses to atherosclerosis around the world and overcome barriers that limit access to prevention, care and services • Summarize the latest research outcomes in the field of atherosclerosis and related cardiovascular conditions

TARGET AUDIENCE Specialists in the field of clinical chemistry, diabetes, endocrinology, primary care and more.

ACCREDITATION STATEMENT AND CREDIT DESIGNATION European Board for Accreditation in Cardiology (EBAC) The 82nd Congress of the European Atherosclerosis Society (EAS 2014) is accredited by the European Board for Accreditation in Cardiology (EBAC) for 13 hours of External CME credits.

12

Additionally, the Educational Programme “Mixed hyperlipidemi and triglycerides in cardiovascular prevention” is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of External CME credits. Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

American Medical Association (AMA) Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.

Royal College of Physicians and Surgeons of Canada Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada. For more information, visit: www.royalcollege.ca.

CREDIT BREAKDOWN Day

Maximum Credits

Saturday May 31, 2014

0

Sunday June 1, 2014

5

Monday June 2, 2014

5

Tuesday June 3, 2014

3

Total Credits:

13

TO RECEIVE YOUR CME/CPD CERTIFICATE Your CME/CPD certificate will be delivered electronically after completing the educational evaluation and credit claiming procedure. The process will take 5 minutes. We thank you for your feedback as it is an important part of the CME/CPD accreditation process and helps improve future educational offerings.

Before July 1, 2014 1. Follow the link in the email notification sent at the end of the congress, or visit the CME/CPD Accreditation page under the scientific information menu at eas.kenes.com 2. Complete the anonymous online evaluation 3. You will be automatically directed to the credit claim system 4. Login with your unique User ID (included in your registration package, on your badge, or in the email sent after the event) 5. Indicate the number of hours you attended 6. Your CME/CPD certificate will be available for download and also emailed to the address provided 7. Retain the certificate for your personal records

13

DISCLOSURE AND RESOLUTION OF PERSONAL CONFLICTS OF INTEREST In accordance with CME/CPD accreditation criteria and standards for commercial support to ensure balance, independence, objectivity, and scientific rigor, those in control of the educational content must disclose potential or actual conflicts of interest. Disclosure information is evaluated and conflicts of interest resolved. Disclosure is made to participants prior to the activity. Participants will be asked on the evaluation to assess the objectivity and independence of the event. This applies equally to oral and poster presentations.

INDUSTRY SUPPORT DISCLOSURE This event is supported in part by funding from industry. All support is managed in strict accordance with CME/ CPD accreditation criteria and standards for commercial support. Appropriate acknowledgement of all supporting organizations is made in the Programme guide, on the event website, and with signage during the event. Disclosure is made to participants prior to the activity. Aegerion AHA Amgen AstraZeneca BASF Chiesi Danone Denka Seiken diaDexus

14

EAS Fresenius Medical Care Deutschland Itamar Kowa Mabtech Mercodia MSD Pfizer Raisio

Regeneron Rottapharm Sanofi Spanish Atherosclerosis Society Synageva Unilever Wisepress

ABOUT MADRID Madrid is located on the Manzanares river in the centre of the country. As the capital city of Spain, seat of government, and residence of the Spanish monarch, Madrid is the political, economic and cultural centre of Spain. Voted one of the world’s best cities in which to live, the city of Madrid represents perfect harmony between efficiency and quality of life, at a price which is hard to beat anywhere else in the world. With 144 museums, almost 3.000 hours of sunshine per year, 59.000 hotel beds, 6 public and 7 private universities, more than 350 metro stations and almost 300 km of underground lines, and more than 5.000 restaurants Madrid is a city to enjoy and share. The city’s many parks make Madrid the greenest city in Europe. While Madrid possesses a modern infrastructure, it has preserved the look and feel of many of its historic neighbourhoods and streets. Its landmarks include the Royal Palace of Madrid; the Teatro Real (Royal theatre) with its restored 1850 Opera House; the Buen Retiro Park, founded in 1631; the 19thcentury National Library building (founded in 1712) containing some of Spain’s historical

archives; a large number of National museums. Cibeles Palace and Fountain have become the monument symbol of the city. Madrid offers visitors an incomparable tour: the Art Walk (Prado Museum, Reina Sofia National Museum and Thyssen-Bornemisza Museum), a unique itinerary in the world in the most emblematic area in the city: Paseo del Prado. Madrid’s cultural and historical legacy can be felt in the streets: Habsburg Madrid, Borbón Madrid, Medieval Madrid, 19th century Madrid, Goya’s Madrid or Velazquez’s Madrid, among others. City center walking is an exclusive experience: Plaza Mayor, Puerta del Sol, Plaza de Cibeles, Madrid offers visitors a unique gastronomy with Spanish and local cuisine (“cocido madrileño,” “chocolate con churros”) shopping for every taste and every pocket, and shops from the most avant to the traditional. Madrid is the only city in the world which is surrounded by six sites considered World Heritage by UNESCO, less than an hour’s drive away: Toledo, Ávila, Segovia, Alaclá de Henares, El Escorial and Aranjuez. The Madrid Convention Bureau (MCB) welcomes you to Madrid and the 82nd EAS Congress.

15

INFORMATION FOR PRESENTERS ORAL PRESENTATIONS A speakers’ ready room will be available throughout the Congress for speakers. The room is located on the first floor, in the North Halls. If using a PowerPoint presentation (or any other PC based application), please note you need to bring it on a USB Memory stick or CD/DVD and load it on one of the Congress computers in the Speakers’ Ready Room at least 1 hour before the start of the session. You may supply your own laptop computer as a back-up. If combining video films with the Power Point, please make sure to check it in the session hall where your lecture is taking place during a coffee or lunch break prior to your session, at least 30 minutes before the session begins – even after checking it in the Speakers’ Ready Room. Please note that the Congress computers in the session halls are powered by Windows 7 and Office 2010.

16

Important note for Macintosh Users In order to use Mac Presentations on a PC compatible computer, please note that you need to prepare it according to the instructions below, before bringing it to the Speakers’ Ready Room: 1. Use a common font, such as Ariel, Times New Roman, Verdana, etc. (Special fonts might be changes to default font on a Power Point based PC). 2. Insert pictures as JPEG files (and not TIF, PNG, or PICT – these images will not be visible on a Power Point based PC). 3. Use a common movie format, such as AVI, MPG and WMV (MOV files from QuickTime will not be available on a Power Point based PC). You may bring your own Macintosh laptop computer as back-up. In such a case, please confirm that it has a VGA socket for external signal and come to check it in the Speakers’ Ready Room as soon as you arrive and later in the session hall where your lecture is taking place during the coffee or lunch break prior to your session, at least 30 minutes before the beginning of the session. Please note that VHS Video projection, 35 mm’ slide projection and overhead projection (projection of transparencies) will not be available.

POSTER PRESENTATIONS Posters will be on display for the entire Congress. Please check the Scientific Programme to see the exact poster board number, date, and time of the poster discussion groups. Posters may be mounted from 15:30 on Saturday, May 31st, 2014 and should remain on display until the end of sessions on Tuesday, June 3rd, 2014. Authors are asked to actively participate in both poster sessions which will take place on Sunday, June 1st from 12:30-15:00 and Monday, June 2nd from 12:30-15:00. The organisers are not responsible for any posters that have not been removed by the end of sessions on Tuesday, June 3rd.

MODERATED POSTER PRESENTATIONS EAS is proud to have moderated poster sessions that will be located in the Exhibition area, providing the unique opportunity for convivial scientific discussions and exchange. For further details please refer to the Overview of Moderated Poster Sessions on the following page.

OVERVIEW OF MODERATED POSTER SESSIONS The Presenting Author of the moderated posters will be allocated 3 minutes presentation time plus 3 minutes for discussion.

ACKNOWLEDGEMENT OF POSTER MODERATORS EAS is indebted to the distinguished scientists and clinicians who have kindly accepted the role of moderator during the Moderated Poster Sessions at the Congress.

POSTER OVERVIEW Please note that posters of Abstract presenters that were not registered to the congress by the deadline were not allocated poster boards. Such abstract presenters are requested to approach the poster help desk to be allocated an available poster board on-site.

17

Moderated Poster Session Moderated Poster Session A, Sunday, June 1, 2014 13:50-14:50 Session Session Topic

Session Chair

Board #

1

Endothelial Cell Biology and Angiogenesis

Asrar B. Malik, USA

2

Genetics and Omics

Ruth Frikke-Schmidt, Denmark

M34-M41

3

Metabolism and Function of Lipids in Vascular Cells

Bart de Geest, Belgium

M57-M64

4

Lipids and Lipoproteins Metabolism

Bo Angelin, Sweden

M72-M78

5

Nutrition, Nutraceuticals, Metabolic Syndrome And Obesity

Helena Gylling, Finland

M87-M94

M1-M8

6

CV Risk Factors in Atherogenesis I

Hans Dieplinger, Austria

M103-M110

7

Vascular Imaging

Dan O’Leary, USA

M133-M139

Moderated Poster Session B, Monday, June 2, 2014 12:45-13:45 Session Session Topic 8

Vascular Biology and Atherosclerosis

Session Chair

Board #

Roch Nofer, Germany

M9-M16

9

Inflammation and Atherosclerosis

Christoph Binder, Austria

M25-M33

10

Vascular Remodeling and Plaque Stability

Andrew Newby, UK

M42-M49

11

Lipid Metabolism/Cholesterol Efflux

Carlos Fernandez-Hernando, USA

M65-M71

12

PCSK9 from Pathophysiology to Pharmacology

Bertrand Cariou, France

13

CV Risk Factors In Atherogenesis II

Alipio Mangas, Spain

M118-M125

14

Environmental and Metabolic Stressors in CVD

Peter Arner, Sweden

M148-M155

M79-M86

Moderated Poster Session C, Monday, June 2, 2014 13:50-14:50 Session Session Topic

18

Session Chair

Board #

15

Experimental Atherosclerosis

Petri Kovanen, Finland

M17-M24

16

HDL

Anatol Kontush, France

M50-M56

17

CV Risk Factors in Atherogenesis III

Erik Stroes, Netherlands

M95-M102

18

Inherited Dyslipidemia

Jörg Heeren, Germany

M111-M117

19

Familial Hypercholesterolaemia

Miguel Pocovi, Spain

M126-M132

20

Emerging Aspects in Pharmacological Treatment of Dyslipidemia

Pedro Valdivielso, Spain

M140-M147

21

Cardiovascular Disease in Patients with Diabetes, Chronic Inflammatory and Chronic Renal Disease

Michal Vrablik, Czech Republic

M156-M163

Poster overview Track 1: VASCULAR BIOLOGY OF THE ARTERIAL WALL Session Topic

Board No.

Track 3: RISK FACTORS, EPIDEMIOLOGY, PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES

Endothelial cells and function

001 - 026

Session Topic

Board No.

Smooth muscle cells

027 - 032

Cardiovascular epidemiology

328 - 356

Monocytes/Macrophages

033 - 048

Woman and cardiovascular risk

357 - 366

Epigenetics and microRNA

049 - 070

Biomarkers

367 - 397

Gene expression

071 - 085

Endothelial dysfunction clinical assessment

398 - 408

Imaging

409 - 420 421 - 428

Extracellular matrix and calcification

086

Inflammation

087 - 123

Intima media thickness

Coagulation and Thrombosis

124 - 132

Obesity and fat distribution

429 - 441

Innate immunity

133 - 140

Metabolic syndrome

442 - 462

Adaptive immunity

141 - 144

NASH and related disorders

463 - 464

Infection and atherosclerosis

145 - 148

Sub inflammatory states

Hormones and atherosclerosis

149 - 160

Diabetes macroangiopathy

466 - 485

Miscellaneous

161 - 184

Nephropathy

486 - 492

Track 2: LIPIDS AND LIPOPROTEIN METABOLISM Session Topic

Board No.

ApoB-containing lipoproteins

185 - 190

Lp(a)

191 - 198

TG rich lipoproteins

199 - 204

Post prandial lipoproteins

205 - 208

Lipases and lipoprotein metabolism

209 - 227

HDL function

228 - 243

HDL metabolism

244 - 260

Familial hypercholesterolaemia

261 - 279

Primary hyperlipidaemia

280 - 281

Secondary dyslipidaemia

282 - 283

Genetics

284 - 299

Microbiota

Aneurysms

465

493

Lifestyle and CV risk

494 - 507

Nutrition and CV risk

508 - 537

Lipid-lowering therapy

538 - 587

Emerging therapies

588 - 616

Intravascular procedures

617 - 619

Miscellaneous

620 - 692

NON REGISTERED ABSTRACTS (700 – 876). Please approach the poster helpdesk to receive your board number.

300

Native and modified LDL

301 - 312

Miscellaneous

313 - 327 19

HALL NAME EULOGY OF DISTINGUISHED SCIENTISTS Nikolai N. Anitschkow (1885-1964) Professor of the Department of Pathological Physiology of the Military Medical Academy St. Petersburg, Russia In 1913, experimental pathologist Dr. Nikolai N. Anitschkow showed that simply feeding to rabbits purified cholesterol dissolved in sunflower oil induced vascular lesions closely resembling those of human atherosclerosis, both grossly and microscopically. Controls fed with only the sunflower oil showed no lesions. It is fair to say that this paper marked the beginning of the modern era of atherosclerosis research. Dr. Anitschkow was not only a keen-eyed structural pathologist and a careful experimentalist; he thought in terms of function and time-related pathogenesis. However, the landmark studies by Dr. Anitschkow were largely rejected at the time. An important reason for this was that the findings were inconsistent with the prevailing view of atherosclerosis. It was generally accepted to be an inevitable accompaniment of aging (the “senescence hypothesis”). If the full significance of his findings had been appreciated at the time, we might have saved more than 30 years in the long struggle to settle the cholesterol controversy. In honor of Dr. Nikolai N. Anitschkow, the “Anitschkow Prize in Atherosclerosis Research” awarded annually by the EAS recognizes outstanding research in the field of atherosclerosis and linked metabolic disturbances.

Francisco Grande-Covian (1909-1995) PROFESSOR OF PHYSIOLOGY. UNIVERSIDAD DE ZARAGOZA, SPAIN Prof Grande-Covian was a spanish physiologist who, along with Ancel Keys and Joseph T. Anderson, was the first to demonstrate specific quantitative effects of different dietary fatty acids on blood serum cholesterol levels. They developed their equation to predict the average change in serum cholesterol level from the percentage of total calories consumed daily from polyunsaturated, monounsaturated, and saturated fats and dietary cholesterol. He became an avid promoter and defender of the Mediterranean diet. Grande played a specific role in developing specially engineered foods for the controlled diets, and is a Member of Honour of Spanish Society of Atherosclerosis. “Man first ate to survive, then to eat well, and so incorporated gastronomy into his culture. Now, moreover, he eats for health.” .F Grande-Covián. 20

Manuel de Oya (1941-2006) PROFESSOR OF MEDICINE. UNIVERSIDAD AUTONOMA, MADRID, SPAIN Specialist in Internal Medicine and Endocrinology. Training at Jay Phillips Laboratory of Mount Sinai Hospital (1969) and University of Minnesota (1970), where he worked with Professor Grande Covian. In 1985, at the Jiménez Díaz Foundation, he created one of the first Lipid Units in Spain. Full Professor of Internal Medicine at the Autonoma University Medical School (1987) and Chairman of the Department of Medicine (1990-1999). Founding member of the Spanish Arteriosclerosis Society and its President from 1992 to 1996. Advisor to The European Society for Clinical Investigation (1992-1994) and its Vice-president (1994-1996). Head of the Internal Medicine Department at the Jiménez Díaz Foundation and he was the center’s Medical Director (2003-2004). More than 150 national and international publications and 50 chapters in books reflect his pioneering work in Spain studying genetically conditioned dislipemias, the relationship between diet and atherosclerosis and metabolic disorders in children (Four Provinces Study-4P). Member of Honour of Spanish Society of Atherosclerosis.

Amador Schüller (1921-2010) PROFESSOR OF MEDICINE. UNIVERSIDAD COMPLUTENSE, MADRID, SPAIN Specialist of Internal Medicine, with special dedication to Lipid Metabolism and Clinical Medicine. Master and inexhaustible researcher, held the most notable positions within the medical profession: Magnificent Rector of the Complutense University of Madrid and President of the Royal National Academy of Medicine. He deserved all type of mentions and honors and advised the highest Spanish levels, from centers of research, universities, ministries, to the Royal House. But his greatest merit, what made him most comfortable, was being a professor of medicine, close to his students and his patients. Member of Honour of Spanish Society of Atherosclerosis.

21

CONGRESS FLOOR PLAN

Press Room

N117/N118

Amador Schuller Hall N101/N102

N115/N116

Manuel de Oya Hall

Over Flow Hall N114

Executive Lounge

N103/N104

N113

Speakers' Ready Room Nicholas Anitschkow Hall

N112

N111

Meeting Room & Hospitality N110

Meeting Room & Hospitality N109

President Office

N105/N106

Francisco Grande Covian Hall

N108

EAS Office & Meeting Room N107

Meeting Room & Hospitality ENTRANCE

22

Programme at a Glance Saturday, May 31, 2014 Nicholas Anitschkow Hall


10:30-20:30

Registration Desk Open

12:00-13:30

Educational Symposium Supported Session Not included in the CME/CPD programme

13:30-14:00

Break

14:00-15:30

Educational Symposium- Joint Sesion Supported Session Not included in the CME/CPD programme

15:30-16:00

Coffee Break

16:00-17:30

Educational Symposium Supported Session Not included in the CME/CPD programme

17:30-18:00

Break, Exhibition

18:00-19:45 19:45-20:45

Exhibition & Posters Area (Hall 9)

Opening Ceremony, including the Anitschkow Lecture Welcome Reception

For details of the Educational Symposia not included in the CME/CPD programme, please refer to the industry supported sessions section of the programme book.

23

Sunday, June 1, 2014 Nicholas Anitschkow Hall 08:30-10:30

Manuel de Oya Hall

Amador Schuller Hall


Plenary Session Microbiota, Immunity and Regulation

10:30-11:00

11:00-12:30


Coffee Break, Exhibition and Poster Viewing 11:00-11:45 Advanced Clinical Seminar: Ectopic Fat as a Cardiovascular Risk Factor 11:45-12:30 Advanced Clinical Seminar: New Targets for Lipid Lowering Therapy

Workshop: The LiverIntestine Axis in Lipid Metabolism

Workshop: Gene-Environment Interactions and Epigenetics

Workshop: Immunology of Atherosclerosis

Lunch Break, Exhibition and Poster Viewing

12:30-15:00 14:00 – 15:00 Educational Symposium Supported Session Not included in the CME/CPD programme 15:00-16:30 16:30-17:00

17:00-18:30

24

Joint EAS-ESC Symposium

13:00 – 14:30 Mixed Hyperlipidemia and Triglycerides In Cardiovascular Prevention Accredited Educational Program Supported by an Unrestricted Educational Grant by Astra Zeneca

Workshop: Endothelial Cell Biology

12:45-13:45 EAS General Assembly (Members Only)

13:50 – 14:50 Moderated Poster Session A

15:45-16:30 Clinical & Late Breaking Session I

Coffee Break, Exhibition and Poster Viewing Educational Symposium Supported Session Not included in the CME/CPD programme

17:00-17:45 Meet the Expert Supported Session Not included in the CME/CPD programme

17:00-17:45 Special Lecture Supported Session Not included in the CME/CPD programme

Monday, June 2, 2014 Nicholas Anitschkow Hall 08:30-10:30

Manuel de Oya Hall



Plenary Session: Energy, Metabolism and Diabetes

10:30-11:00 11:00-12:30


Coffee Break, Exhibition and Poster Viewing Workshop: Nutrition and Nutraceuticals

Workshop: Regulation of Depot Fat

Workshop: Environmental and METABOLIC Stressors in Cardiovascular Disease

Workshop: Metabolism and Functions of Lipids in Vascular Cells

Lunch Break, Exhibition and Poster Viewing 13:00-14:30 Educational Symposium Supported Session Not included in the CME/CPD programme

12:30-15:00

15:00-16:30

16:30-17:00

17:00-18:30

Joint ICCR/EAS Workshop: Targeting Lifestyle in CVD Risk Management / Prevention

Workshop: Novel Protective Effects of HDL

EAS Initiatives Update session (open to all)

12:45 – 13:45 Moderated Poster Session B 14:00 – 15:00 Educational Symposium Supported Session Not included in the CME/CPD programme 15:00-15:45 Young Investigator Award Session 15:45-16:30 Clinical & Late Breaking Session II

13:50 – 14:50 Moderated Poster Session C

Poster Award Competition

Coffee Break, Exhibition and Poster Viewing Educational Symposium Supported Session Not included in the CME/CPD programme

17:00-17:45 Special Lecture Supported Session Not included in the CME/CPD programme

25

Tuesday, June 3, 2014 Nicholas Anitschkow Hall 08:30-10:30

26

Manuel de Oya Hall


Plenary Session: Risk Factors and Interventions

10:30-11:00

11.00-12.30


Coffee Break, Exhibition and Poster Viewing 11.00-11:45 Advanced Clinical Seminar: Imaging of Atherosclerosis and Cardiovascular Disease 11:45-12:30 Advanced Clinical Seminar: Optimizing Treatment of Familial Hypercholesterolemia

Workshop: Genomics and Proteomics of Lipid Metabolism

Workshop: Hypolidaemic Drugs Present and Future

Workshop: Plasticity of Atherosclerotic Lesions


Scientific Programme

Saturday, May 31, 2014

Saturday, May 31, 2014 11:00-12:00Amador Schuller Hall Spanish Society of Atherosclerosis - Secondary Prevention Working Group

Welcome J. Ascaso, Spain J. Millán Núñez-Cortés, Spain A.L. Catapano, Italy

Presentation F. Civiera, Spain

Presarv-SEA Study. Methodology and data file C. Brotons, Spain X. Pintó, Spain

Project 70 C. Guijarro, Spain

Document: Aortic aneurysm C. Lahoz, Spain

Educational projects F. Civiera, Spain

Global comments

Close up

12:00 - 13:30


INDUSTRY SPONSORED SESSION Supported Session. Not included in the CME/CPD programme. For Programme details please refer to the Recognition, Acknowledgements & Commercial Support Section in the Final Programme

13:30 Break 14:00 - 15:30


INDUSTRY SPONSORED SESSION Supported Session. Not included in the CME/CPD programme. For Programme details please refer to the Recognition, Acknowledgements & Commercial Support Section in the Final Programme 29

Saturday, May 31, 2014 orals

15:30 Coffee Break 16:00 - 17:30



17:30 Break 18:00 - 19:40Anitschkow Hall PLENARY: OPENING CEREMONY INCLUDING THE ANITSCHKOW LECTURE Chairpersons: A. Catapano (Italy) J. Millan Nuñez-Cortes (Spain) J. Pedro-Botet (Spain)

1 2 2A

18:00

Welcome from EAS President A. Catapano (Italy)

3

18:05

Welcome from SEA President J. Ascaso (Spain)

4

18:10

Welcome from the Congress Chairperson J. Millan Nuñez-Cortes (Spain)

5

18:15

Welcome from the Spanish Authorities

18:20

Orchestra de Pulso y Pua de la Universidad Complutense

18:35

Introduction of the Anitschkow Prize Recipient A. Catapano (Italy)

6

18:40

The Anitschkow Lecture J. Kastelein (Netherlands)

7

19:25

Orchestra de Pulso y Pua de la Universidad Complutense

19:45 - 20:30Exhibition Area WELCOME RECEPTION

30



Sunday, June 1, 2014

A source of current research, new methods and state-of-the-art reviews in vascular biology and microcirculation

Official Journal of the ‘European Society for Microcirculation’

Main Editor

U. Pohl Munich

Co-Editor

G.A. Meininger

KI14673

Co lumb ia , M o.

www.karger.com/jvr

IF 2.434

Sunday, June 1, 2014 8:30 - 10:30Anitschkow Hall PLENARY SESSION: MICROBIOTA, IMMUNITY AND REGULATION Chairpersons: A. Catapano (Italy) J.Millan Núñez-Cortés (Spain)

8 9

8:30

ROLE OF MICROBIOTA IN ATHEROSCLEROSIS F. Bäckhed (Sweden)

10

9:00

IMMUNITY IN ATHEROSCLEROSIS I. Tabas (USA)

11

9:30

VACCINATION AGAINST ATHEROSCLEROSIS J. Kuiper (Netherlands)

12

10:00

ROLE OF microRNAs IN ATHEROSCLEROSIS C. Fernández-Hernando (USA)

13

10:30 Coffee Break, Exhibition & Poster viewing

exhibition area

11:00 - 11:45Anitschkow Hall WORKSHOP: ADVANCED CLINICAL SEMINAR: ECTOPIC FAT AS A CARDIOVASCULAR RISK FACTOR Chairpersons:

V. Lahera (Spain) P. Moulin (France)

14 15

11:00

THE ROLE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN CARDIOVASCULAR DISEASE S. Francque (Belgium)

16

11:20

OBESITY AND CARDIOVASCULAR RISK J.P. Després (Canada)

17

11:40 Discussion

33

Sunday, June 1, 2014 orals

11:45 - 12:30Anitschkow Hall WORKSHOP: ADVANCED CLINICAL SEMINAR: NEW TARGETS FOR LIPID LOWERING THERAPY Chairpersons:

J. Pedro-Botet (Spain) C. Packard (United Kingdom)

18 19

11:45

ANTISENSE NUCLEOTIDES M. Graham (USA)

20

12:05

TRANSCRIPTIONAL REGULATORS B. Staels (France)

21

12:25 Discussion

11:00 - 12:30


WORKSHOP: THE LIVER-INTESTINE AXIS IN LIPID METABOLISM Chairpersons: G. Kostner (Austria) C. Ehnholm (Finland)

22 23

11:00

INTESTINAL TRANSPORTERS, TICE B. Groen (Netherlands)

24

11:25

CHOLINE AND CARNITINE METABOLISM M. Nieuwdorp (Netherlands)

25

11:50

INDUCTION OF LDL RECEPTOR MRNA DEGRADATION FACTOR HNRNPD CONTRIBUTES TO THE CHOLESTEROL-MEDIATED SUPPRESSION OF LIVER LDL RECEPTOR EXPRESSION J. Liu, A. Singh (USA)

26

HEPATIC DE NOVO LIPOGENESIS AND FAT OXIDATION PREDICT THE POSTPRANDIAL RESPONSE OF TRIGLYCERIDE-RICH LIPOPROTEIN PARTICLES IN HEALTHY SUBJECTS N. Matikainen, M. Adiels, S. Söderlund, A. Hakkarainen, J. Borén, M.R. Taskinen (Finland)

27

12:03

12:16

RNF20 IS A KEY PLAYER IN PKA-DEPENDENT SREBP1C DEGRADATION IN HEPATIC LIPID METABOLISM28 J. Lee, G. Lee, H. Jang, J. KIM (Korea)

12:30 Lunch Break, Exhibition & Poster Presentations

34

Sunday, June 1, 2014 11:00 - 12:30

Manuel de Oya Hall

WORKSHOP: GENE-ENVIRONMENT INTERACTIONS AND EPIGENETICS Chairpersons: F. Civeira (Spain) R. Frikke-Schmidt (Denmark) 11:00

GENETIC AND ENVIRONMENTAL FACTORS INFLUENCING NON-TRADITIONAL CARDIOVASCULAR RISK FACTORS F. Kronenberg (Austria)

11:25

MicroRNAs IN HEART DISEASE T. Thum (Germany)

11:50

TARGETING HDAC3 LIMITS FOAM CELL FORMATION AND IMPROVES ATHEROSCLEROTIC PLAQUE STABILITY J. Van den Bossche, M.A. Hoeksema, M.J.J. Gijbels, S. Van der Velden, A. Sijm, A.E. Neele, T. Seijkens, S. Meiler, M.C.S. Boshuizen, L. Boon, S.E. Mullican, N.J. Spann, G.M. Dallinga-Thie, J.P. Cleutjens, M.A. Lazar, C.J. De Vries, E.A.L. Biessen, M.J.A.P. Daemen, E. Lutgens, M.P.J. De Winther (Netherlands)

12:03

12:16

SIX-YEAR TELOMERE SHORTENING IS ASSOCIATED WITH INCREASED INCIDENCE OF SUBCLINICAL CAROTID VASCULAR DAMAGE AND CARDIOVASCULAR PROGNOSIS A. Baragetti, J. Palmen, K. Garlaschelli, L. Grigore, S. Humpries, A. Catapano, P. Talmud, G.D. Norata (Italy) IRON AS A RISK FACTOR FOR ATHEROSCLEROSIS: CONFIRMING THE IRON HYPOTHESIS IN A MOUSE MODEL OF HEMOCHROMATOSIS F. Vinchi, S. Altamura, M. Costa da Silva, B. Galy, M.W. Hentze, M.U. Muckenthaler (Germany)

29 30 31 32

33

34

35

12:30 Lunch Break, Exhibition & Poster Presentations

35


11:00 - 12:30Amador Schuller Hall WORKSHOP: IMMUNOLOGY OF ATHEROSCLEROSIS Chairpersons: J. Egido (Spain) G.D. Norata (Italy)

36 37

11:00

B CELLS AND HUMORAL IMMUNITY IN ATHEROSCLEROSIS C. Binder (Austria)

38

11:25

DENDRITIC CELLS A. Zernecke (Germany)

39

11:50

THE ROLE OF INNATE IMMUNE RECEPTOR NOD2 IN ATHEROSCLEROSIS X.Y. Zhang, M. Johansson, A. Lundberg, M. Levin, X. Yuan, L. Folkersen, P. Eriksson, U. Hedin, J. Boren, G.K. Hansson, Z.Q. Yan (Sweden)

40

12:03

MACROPHAGE-SPECIFIC INACTIVATION OF THE NUCLEAR RECEPTOR ROR-ALPHA LEADS TO INCREASED ATHEROSCLEROSIS IN MOUSE O. Molendi-Coste, S. Fleury, E. Bouchaert, L. Pineau, B. Staels, D. Dombrowicz (France)

12:16

NON-INVASIVE IN VIVO IMAGING OF PERIPHERAL MONONUCLEAR CELL MIGRATION TO ATHEROSCLEROSIS IN HUMANS F. Van der Valk, J. Kroon, R. Thurlings, H. Verberne, A. Nederveen, J. Van Buul, M. Nieuwdorp, W. Mulder, Z. Fayad, E. Stroes (Netherlands)

41

42

12:30 Lunch Break, Exhibition & Poster Presentations 12:45 - 13:45Amador Schuller Hall EAS GENERAL ASSEMBLY Members Only

13:50 – 14:50 Moderated Poster Session A Exhibition Area

36

Sunday, June 1, 2014 13:00 - 14:30

Manuel de Oya Hall

EDUCATIONAL SYMPOSIUM: MIXED HYPERLIPIDEMI AND TRIGLYCERIDES IN CARDIOVASCULAR PREVENTION? Accredited Educational Program Supported by an Unrestricted Educational Grant from AstraZeneca Programme created in collaboration with Sahlgrenska Academy, University of Gothenburg This educational programme is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit(s); Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS). Chairpersons: R. Carmena (Spain) O. Wiklund (Sweden)

43 44

13:00

TRIGLYCERIDES, CHOLESTEROL AND HDL IN CVD – LESSONS FROM GENETICS B. Nordestgaard (Denmark)

45

13:25

MECHANISTIC BASES FOR THE ORIGIN AND THERAPY OF ELEVATED TRIGLYCERIDES AND MIXED HYPERLIPIDEMIA G. Watts (Australia)

46

13:50

MIXED HYPERLIPIDEMIA AND TRIGLYCERIDES IN CURRENT GUIDELINES FOR TREATMENT O. Wiklund (Sweden)

47

14:15

CONCLUDING REMARKS AND DISCUSSION R. Carmena (Spain)

48

14:00 - 15:00


SPONSORED SESSION: INDUSTRY SPONSORED SYMPOSIUM Supported Session. Not included in the CME/CPD programme. For Programme details please refer to the Recognition, Acknowledgements & Commercial Support Section in the Final Programme

37


15:00 - 16:30Anitschkow Hall WORKSHOP: JOINT ESC/EAS SYMPOSIUM: LIPID LOWERING IN CARDIOVASCULAR PREVENTION; WHERE DO WE STAND AND WHERE ARE WE GOING? Chairpersons: I. Graham (Ireland) L. Tokgözoglu (Turkey) 15:00

49 50

REVIEW OF CURRENT STATUS FOR THE GUIDELINES ON DYSLIPIDEMIA – COMPARING EUROPEAN AND US GUIDELINES O. Wiklund (Sweden)

15:22

CHALLENGES FOR FUTURE GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION G. de Backer (Belgium)

52

15:45

RISK ESTIMATION AND RISK CALCULATION I. Graham (Ireland)

53

16:07

LOOKING TO THE FUTURE – GUIDANCE ON LIPIDS AND OTHER TARGETS B. Nordestgaard (Denmark)

54

15:00 - 16:30


WORKSHOP: ENDOTHELIAL CELL BIOLOGY Chairpersons:

T. Tejerina (Spain) P. Kovanen (Finland)

55 56

15:00

REGULATION OF ENDOTHELIAL BARRIER INTEGRITY A.B. Malik (USA)

57

15:25

LYMPHATIC VESSELS AND LYMPHANGIOGENESIS M. Detmar (Switzerland)

58

15:50

P27 PHOSPHORYLATION AT SERINE 10 PROTECTS AGAINST EARLY ATHEROSCLEROSIS MODULATING ENDOTHELIUM-LEUKOCYTE INTERACTION P. Molina Sánchez, R. Chèvre, J.J. Fuster, A. Hidalgo, V. Andrés (Spain)

16:03

THE ROLE OF ENDOTHELIAL DICER IN ATHEROSCLEROSIS P. Hartmann, Z. Zhou, Y. Wei, M.L. Iruela-Arispe, C. Weber, A. Schober (Germany)

16:16

THE ADIPOKINE VISFATIN/NAMPT INDUCES PREMATURE SENESCENCE AND TELOMERE DAMAGE IN HUMAN ENDOTHELIAL CELLS C. Peiro, L.A. Villalobos, A.K. Uryga, T. Romacho, C.F. Sánchez-Ferrer, J.D. Erusalimsky (Spain)

16:30 Coffee Break, Exhibition & Poster Viewing 38

51

59 60

61

exhibition area

Sunday, June 1, 2014 15:45 - 16:30Amador Schuller Hall CLINICAL AND LATE BREAKING SESSION I

Chairpersons: A.M. Gotto, Jr. (USA) G. Assmann (Germany) 15:45

62 63

ATTAINMENT OF THE ANTICIPATED >=50% REDUCTION IN LDL-C IN THE FOUR ACC/AHA GUIDELINES STATIN BENEFIT GROUPS: A VOYAGER META-ANALYSIS B. Karlson (Sweden)

15:58

EFFICACY OF EVOLOCUMAB (AMG 145) IN PATIENTS WITH PCSK9 GAIN-OF-FUNCTION MUTATIONS M. Harada-Shiba (Japan)

16:11

TRIAL EVALUATING EVOLOCUMAB, A PCSK9 ANTIBODY, IN PATIENTS WITH HOMOZYGOUS FH (TESLA): RESULTS OF THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL F. Raal (South Africa)

16:24

THERAPY WITH THE THYROID HORMONE RECEPTOR AGONIST EPROTIROME IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA: A RANDOMISED, DOUBLE BLIND, PLACEBOCONTROLLED STUDY B. Sjouke (Netherlands)

16:30 Coffee Break, Exhibition & Poster Viewing 17:00 - 18:30

64 65

66

67

exhibition area


INDUSTRY SPONSORED SESSION Suppported Session. Not included in the CME/CPD programme. For Programme details please refer to the Recognition, Acknowledgements & Commercial Support Section in the Final Programme

17:00 - 17:45

Manuel de Oya Hall


17:00 - 17:45Amador Schuller Hall INDUSTRY SPONSORED SESSION Supported Session. Not included in the CME/CPD programme. For Programme details please refer to the Recognition, Acknowledgements & Commercial Support Section in the Final Programme

39

40

orals



Monday, June 2, 2014

Discover quality cardiology content from the prestigious journals of the European Society of Cardiology

Stay alert: Sign up for a My Account to receive electronic email Table of Contents and Advance Access article alerts

Read on the move: Download the ESC Journals App

Monday, June 2, 2014 8:30 - 10:30Anitschkow Hall PLENARY SESSION: ENERGY METABOLISM AND DIABETES Chairpersons: J. Borén (Sweden) A.M. Gotto, Jr. (USA)

68 69

8:30

DIABETIC DYSLIPIDEMIA M. Taskinen (Finland)

70

9:00

REGULATION OF ADIPOGENESIS U. Smith (Sweden)

71

9:30

NAFLD and NASH P. Newsome (United Kingdom)

72

10:00

LIPOTOXIC HEART DISEASE I.J. Goldberg (USA)

73

10:30 Coffee Break, Exhibition & Poster Viewing

exhibition area

43

Monday, June 2, 2014 orals

11:00 - 12:30Anitschkow Hall WORKSHOP: NUTRITION AND NUTRACEUTICALS Chairpersons: E. Ros (Spain) P. Nestel (Australia)

74 75

11:00

MEDITERRANEAN DIET E. Ros (Spain)

76

11:25

NUTRIGENOMICS AND FUNCTIONAL FOODS H. Gylling (Finland)

77

11:50

EFFECT OF A MEDITERRANEAN DIET INTERVENTION ON 3T MRI-MONITORED CAROTID PLAQUE PROGRESSION AND VULNERABILITY. A SUB-STUDY OF THE PREDIMED TRIAL. A. Sala-Vila, N. Bargalló, R. Gilabert, E.S. Romero-Mamani, R. Estruch, E. Ros (Spain)

12:03

12:16

IS COMPLYING WITH THE RECOMMENDATIONS OF SODIUM INTAKE BENEFICIAL FOR HEALTH? EVIDENCE FROM THE PREDIMED STUDY J. Merino, M. Guasch-Ferré, M. Martínez-González, D. Corella, R. Estruch, M. Fitó, E. Ros, L. Masana, J. Salas-Salvadó (Spain) CHILDHOOD 25-OH-VITAMIN D LEVELS AND CAROTID INTIMA-MEDIA THICKNESS IN ADULTHOOD: THE CARDIOVASCULAR RISK IN YOUNG FINNS STUDY M. Juonala, MD, K. Pahkala, MD, J.S.A. Viikari, MD, N. Hutri-Kähönen, MD, C.G. Magnussen, MD, O.T. Raitakari, MD (Finland)

12:30 lunch break

44

78

79

80

Monday, June 2, 2014 11:00 - 12:30


WORKSHOP: REGULATION OF DEPOT FAT

Chairpersons: G. Dallinga-Thie (Netherlands) P. Gonzalez Santos (Spain)

81 82

11:00

ABDOMINAL FAT P. Arner (Sweden)

83

11:25

BROWN ADIPOSE TISSUE J. Heeren (Germany)

84

11:50

NON-CANONICAL WNT SIGNALING PROMOTES OBESITY-INDUCED ADIPOSE TISSUE INFLAMMATION AND METABOLIC DYSFUNCTION 85 J. Fuster, M.A. Zuriaga, D. Ngo, M.G. Farb, T. Aprahamian, T.P. Yamaguchi, N. Gokce, K. Walsh (USA)

12:03

THE INHIBITION OF LYSYL OXIDASE IMPROVES METABOLIC ALTERATIONS AND ADIPOSE TISSUE DISTURBANCES IN OBESE ANIMALS E. Martínez-Martínez, M. Galán, M. Miana, S. Varona, R. Jurado-López, J. Martínez-González, C. Rodríguez, V. Cachofeiro (Spain)

12:16

THE LOW-EXPRESSION VARIANT OF FATTY ACID-BINDING PROTEIN 4 FAVORS REDUCED MANIFESTATIONS OF ATHEROSCLEROTIC DISEASE AND INCREASED PLAQUE STABILITY J. Saksi, P. Ijäs, M.I. Mäyränpää, K. Nuotio, P.M. Isoviita, J. Tuimala, E. Lehtonen-Smeds, M. Kaste, A. Jula, J. Sinisalo, M.S. Nieminen, M.L. Lokki, M. Perola, J. Kettunen, M. Jauhiainen, P.T. Kovanen, P.J. Lindsberg (Finland)

86

87

12:30 lunch break

45

orals

11:00 - 12:30

Manuel de Oya Hall

WORKSHOP: ENVIRONMENTAL AND METABOLIC STRESSORS IN CARDIOVASCULAR DISEASE

Chairpersons: 11:00

F. Rodriguez Artalejo (Spain) M. Vrablik (Czech Republic)

STRESS, SOCIOECONOMIC STATUS AND CARDIOVASCULAR DISEASE RISK: AN UPDATE ON CURRENT KNOWLEDGE M. Kivimäki (United Kingdom)

90

11:25

ENVIRONMENTAL AND BEHAVIOURAL RISK FACTORS F. Rodríguez-Artalejo (Spain)

11:50

CIRCULATING PLASMA FIBROBLAST GROWTH FACTOR-23 IS ASSOCIATED WITH HEMORRHAGIC BUT NOT WITH ISCHEMIC STROKE: RESULTS FROM A GERMAN POPULATION STUDY R. Di Giuseppe, T. Kühn, F. Hirche, B. Buijsse, J. Dierkes, A. Fritsche, R. Kaaks, H. Boeing, G.I. Stangl, C. Weikert (Germany)

92

LACK OF LDL-RECEPTORS PROTECTS AGAINST NEW ONSET TYPE 2 DIABETES - RESULTS OF A COHORT OF 38,000 INDIVIDUALS ANALYZED FOR FH MUTATIONS J. Besseling, B.A. Hutten, J.J.P. Kastelein, G.K. Hovingh (Netherlands)

93

PLASMA SPHINGOLIPID PROFILING REVEALS NOVEL DISTINCT BIOMARKERS FOR PREDICTING CARDIOVASCULAR DISEASE AND TYPE 2 DIABETES MELLITUS A. Othman, C. Saely, H. Drexel, A. Von Eckardstein, T. Hornemann (Switzerland)

94

12:03

12:16

12:30 lunch break

46

88 89

91

Monday, June 2, 2014 11:00 - 12:30Amador Schuller Hall WORKSHOP: METABOLISM AND FUNCTIONS OF LIPIDS IN VASCULAR CELLS Chairpersons: J.A. Páramo (Spain) B. Staels (France)

95 96

11:00

CELLULAR LIPID TRAFFICKING E. Ikonen (Finland)

97

11:30

SPHINGOSINE-1-PHOSPHATE R. Nofer (Germany)

98

11:50

LIPOPROTEIN METABOLISM AND TRANSENDOTHELIAL APOLIPOPROTEIN A-I TRANSPORT IN MICE WITH AN ENDOTHELIUM SPECIFIC KNOCK-OUT OF ATP BINDING CASSETTE TRANSPORTER A1 R. Hasballa, L. Rohrer, P. Fotakis, V.I. Zannis, J.S. Parks, A. Von Eckardstein (Switzerland)

12:03

12:16

99

HIV-1 PROTEIN NEF IMPAIRS CELLULAR CHOLESTEROL EFFLUX BY DISRUPTING THE INTERACTION BETWEEN ABCA1 AND CALNEXIN M. Bukrinsky, L. Jennelle, B. Brichacek, D. Sviridov (USA)

100

PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 DEFICIENT MICE ARE PROTECTED FROM NEOINTIMA FORMATION IN CAROTID ARTERY INJURY MODEL N. Ferri, G. Tibolla, R. Baetta, A. Corsini, A. Catapano (Italy)

101

12:30 Lunch Break, Exhibition and Poster PresentationsExhibition Area 12:45 - 13:45 Moderated Poster Session BExhibition Area 13:50 - 14:50 Moderated Poster Session CExhibition Area 13:00 - 14:30

Manuel de Oya Hall


47


14:00 - 15:00Amador Schuller Hall INDUSTRY SPONSORED SESSION Supported Session. Not included in the CME/CPD programme

15.00 - 16:30 Poster Award CompetitionExhibition Area 15:00 - 16:30Anitschkow Hall WORKSHOP: JOINT ICCR/EAS WORKSHOP: TARGETING LIFESTYLE IN CVD RISK MANAGEMENT / PREVENTION

48

Chairpersons: G. Riccardi (Italy) F.B. Hu (USA)

102 103

OPENING REMARKS G. Riccardi (Italy)

104

FROM NUTRIENTS TO FOOD: KEY FEATURES OF OUR DIET PROVIDING CARDIO PREVENTION F.B. Hu (USA)

105

LESSONS FROM THE PREDIMED TRIAL E. Ros (Spain)

106

LESSONS FROM LOOK AHEAD J.P. Després (Canada)

107

PHYSICAL ACTIVITY AND CVD RISK R. Rauramaa (Finland)

108

Monday, June 2, 2014 15:00 - 16:30


WORKSHOP: NOVEL PROTECTIVE EFFECTS OF HDL

Chairpersons: A. von Eckardstein (Switzerland) M. van Eck (Netherlands) 15:00

109 110

THERAPEUTIC POTENTIAL OF HDL IN CARDIOPROTECTION, CARDIAC REMODELLING, AND HEART FAILURE B. de Geest (Belgium)

15:25

HDL AND ABCA1 IN THE BRAIN C. Wellington (Canada)

15:50

A LOSS-OF-FUNCTION MUTATION IN SCARB1 SEVERELY IMPAIRS SR-BI PROCESSING AND ACTIVITY IN HUMANS P. Zanoni, D.B. Larach, S.A. Khetarpal, W.F. Hancock-Cerutti, G.M. Peloso, A. Rodrigues, J. Tohyama, J.T. Billheimer, S. Kathiresan, M. Cuchel, D.J. Rader (USA)

16:03

16:16

112

NOVEL HDL FUNCTIONS ASSOCIATED WITH INTERCELLULAR COMMUNICATION, ATHEROSCLEROSIS, AND CHRONIC KIDNEY DISEASE C.B. Weise, C.L. Toth, S.R. Landstreet, R.C. Taylor, F. Tabet, K.A. Rye, L.H. Hofmeister, D.G. Harrison, V. Kon, K. Vickers (USA) APOLIPOPROTEIN A-I MIMETIC PEPTIDE 4F BLOCKS SPHINGOMYELINASE-INDUCED LDL AGGREGATION: INTERACTION OF THE AMPHIPATHIC HELICAL PEPTIDE WITH LDL PARTICLES S. Nguyen, P. Tero, M. Navab, A. Fogelman, P. Kovanen, O. Katariina (Finland)

16:30 Coffee Break, Exhibition & Poster Viewing

111

113

114

115

exhibition area

49


15:00 - 15:45Amador Schuller Hall YOUNG INVESTIGATORS: AWARD SESSION Chairpersons:

P. Kovanen (Finland) J. Millan Nuñez-Cortes (Spain)

116 117

15:00

WINNER IN CLINICAL RESEARCH NOVEL FUNCTIONAL APOB MUTATIONS OUTSIDE LDL-BINDING REGION CAUSING FAMILIAL HYPERCHOLESTEROLAEMIA Ana Catarina Alves (Portugal) 117A

15:20

WINNER IN BASIC RESEARCH MICRORNA-30C REDUCES HYPERLIPIDEMIA AND ATHEROSCLEROSIS IN MICE BY DECREASING LIPID SYNTHESIS AND LIPOPROTEIN SECRETION James Soh (USA)

15:00 - 16:30

Manuel de Oya Hall

EAS INITIATIVES UPDATE SESSION

Chairpersons: A. Catapano (Italy) O. Wiklund (Sweden)

118 119

INTRODUCTION/ GENERAL OVERVIEW A. Catapano (Italy)

120

EDUCATIONAL ACTIVITIES * ACCREDITED DIPLOMA COURSE, * EAS ACADEMY * ADVANCED COURSES121 L. Tokgözoglu (Turkey)

CONSENSUS POSITION PAPERS* PLANT STANOLS AND PLANT STEROLS* TRIGLYCERIDES* HOMOZYGOUS FH* STATIN INTOLERANCE J. Chapman (France)

16:30 COFFEE BREAK, EXHIBITION & POSTER VIEWING

50

117B

122

15:45 - 16:30Amador Schuller Hall CLINICAL AND LATE BREAKING SESSION II Chairpersons:

J. Shepherd (United Kingdom) J. Fruchart (France)

15:45

RECOMBINANT HUMAN APOLIPOPROTEIN-A-I PREBETA-HDL (CER-001) PROMOTES REVERSE CHOLESTEROL TRANSPORT AND REDUCES CAROTID WALL THICKNESS IN PATIENTS WITH GENETICALLY-DETERMINED LOW HDL R.S. Kootte (Netherlands)

15:58

EFFECTS OF CER-001 ON CAROTID ATHEROSCLEROSIS BY 3TMRI IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH): THE MODIFYING ORPHAN DISEASE EVALUATION (MODE) STUDY E. Stroes (Netherlands)

16:11

MUTATIONS IN ABCA1 ARE ASSOCIATED WITH ENHANCED BETA-CELL SECRETORY CAPACITY IN HUMANS M. Cuchel (USA)

16:24

GENE THERAPY WITH ALIPOGENE TIPARVOVEC (GLYBERA®) FOR THE PREVENTION OF LPLD INDUCED PANCREATITIS: FOLLOW-UP DATA SUGGESTS LONG-TERM CLINICAL BENEFIT D. Gaudet (Canada)

16:30 Coffee Break, Exhibition and Poster ViewingExhibition Area 17:00 - 18:30



17:00 - 17:45Amador Schuller Hall INDUSTRY SPONSORED special lecture Supported Session. Not included in the CME/CPD programme

20:30 - 22:00

Palacio de Cibeles. City Hall (Plaza de Cibeles)

EAS 50th Anniversary Networking Event (ticket required)

51

52

orals



Tuesday, June 3, 2014

Tuesday, June 3, 2014 8:30 - 10:30Anitschkow Hall PLENARY SESSION: RISK FACTORS AND INTERVENTION Chairpersons:

J. Chapman (France) O. Wiklund (Sweden)

129 129A

8:30

CLASSICAL AND NOVEL RISK FACTORS N. Sattar (United Kingdom)

130

9:00

GENETIC RISK FACTORS AND MENDELIAN RANDOMIZATION A. Tybjaerg-Hansen (Denmark)

131

9:30

RESIDUAL CARDIOVASCULAR RISK: MANAGEMENT BEYOND STATINS J.M. Armitage (United Kingdom)

132

10:00

PCSK9 INHIBITION B. Cariou (France)

133

10:30 Coffee Break, Exhibition & Poster ViewingExhibition Area 11:00 - 11:45Anitschkow Hall WORKSHOP: ADVANCED CLINICAL SEMINAR: IMAGING OF ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE Chairpersons: X. Pinto (Spain) G. Thompson (United Kingdom) 11:00

11:20

EPIDEMIOLOGICAL AND CLINCIAL EVIDENCE IN FAVOUR OR AGAINST CLINICAL UTILITY OF DIFFERENT PROCEDURES D. O'Leary (USA) NOVEL METHODS E. Stroes (Netherlands)

134 135 136 137

11:40 Discussion

55

Tuesday, June 3, 2014 orals

11:45 - 12:30Anitschkow Hall WORKSHOP: ADVANCED CLINICAL SEMINAR: OPTIMIZING TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIA Chairpersons: B. Nordestgaard (Denmark) L. Masana (Spain)

138 139

11:45

TREATMENT OF ADULTS L. Masana (Spain)

140

12:05

TREATMENT OF CHILDREN AND ADOLESCENTS A. Wiegman (Netherlands)

141

12:25 Discussion

11:00 - 12:30

Manuel de Oya Hall

WORKSHOP: HYPOLIDAEMIC DRUGS PRESENT AND FUTURE Chairpersons: R. Carmena (Spain) A. Olsson (Sweden)

142 143

11:00

STATE OF THE ART IN LIPID LOWERING THERAPY R. Carmena (Spain)

144

11:25

FUTURE DEVELOPMENTS OF LIPID LOWERING DRUGS A. Corsini (Italy)

145

11:50

EFFECT OF ROSUVASTATIN THERAPY ON CAROTID INTIMA MEDIA THICKNESS IN CHILDREN WITH FAMILIAL HYPERCHOLESTEROLEMIA: FINDINGS FROM THE CHARON STUDY M.J.A.M. Braamskamp, G. Langslet, B.W. McCrindle, D. Cassiman, G.A. Francis, C. Gagné, D. Gaudet, K.M. Morrison, A. Wiegman, T. Turner, E. Miller, J.S. Raichlen, P.G. Martin, E.A. Stein, J.J.P. Kastelein (Netherlands)

12:03

12:16

56

ALIROCUMAB, MONOCLONAL ANTIBODY TO PCSK9, DOSE-DEPENDENTLY DECREASES ATHEROSCLEROSIS, IMPROVES PLAQUE STABILITY AND SHOWS ADDITIVE EFFECTS WITH ATORVASTATIN IN APOE*3LEIDEN.CETP MICE J.W.A. Van der Hoorn, S. Kühnast, E.J. Pieterman, A.M. Van den Hoek, W.J. Sasiela, V. Gusarova, A. Peyman, H.L. Schaefer, U. Schwahn, J.W. Jukema, H.M.G. Princen (Netherlands)

146

147

EFFECT OF SEBELIPASE ALFA AFTER 90 WEEKS IN ADULTS WITH LYSOSOMAL ACID LIPASE DEFICIENCY148 V. Valayannopoulos, V.E.R.A. Malinová, R. Sharma, C. Bourdon, S. Boyadjiev, B. Kessler, C. Whitley, C. Twelves, R. Tripuraneni, S. Eckert, A. Quinn (France)

Tuesday, June 3, 2014 11:00 - 12:30


WORKSHOP: GENOMICS AND PROTEOMICS OF LIPID METABOLISM Chairpersons: A. Kontush (France) S. Humphries (United Kingdom)

149 150

11:00

GENOMICS (GWAS) M. Arca (Italy)

151

11:25

STRUCTURE-FUNCTION RELATIONSHIPS ACROSS HDL PARTICLES AS REVEALED BY PROTEOMICS AND LIPIDOMICS A. Kontush (France)

152

11:50

MUTATIONS IN STAP1 ARE ASSOCIATED WITH AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA 153 S.W. Fouchier, N.O. Stitziel, G.M. Dallinga-Thie, J.C.M. Meijers, N. Zelcer, J.J.P. Kastelein, J.C. Defesche, S. Kathiresan, G.K. Hovingh (Netherlands)

12:03

LOSS-OF-FUNCTION MUTATIONS IN APOC3 AND REDUCED RISK OF ISCHEMIC VASCULAR DISEASE 154 A. Jørgensen, R. Frikke-Schmidt, B.G. Nordestgaard, A. Tybjærg-Hansen (Denmark)

12:16

GENETIC DEFECTS IN PROTEIN GLYCOSYLATION AS A CAUSE OF DYSLIPIDEMIA M.A.W. Van den Boogert, S.D. Kuil, G.K. Hovingh, M.M. Motazacker, J.H.M. Levels, G. Dallinga-Thie, J.A. Kuivenhoven, R. Wevers, E.S.G. Stroes, D.J. Lefeber, A.G. Holleboom (Netherlands)

155

57

Tuesday, June 3, 2014 orals

11:00 - 12:30Amador Schuller Hall WORKSHOP: PLASTICITY OF ATHEROSCLEROTIC LESIONS Chairpersons: L. Badimón (Spain) A. Newby (United Kingdom)

156 157

11:00 METALLOPROTEINASES A. Newby (United Kingdom)

158

11:25

MACROPHAGE TRAFFICKING G. Randolph (USA)

159

11:50

FORKHEAD TRANSCRIPTION FACTOR FOXO3A POTENTLY INDUCES SMOOTH MUSCLE CELL APOPTOSIS AND PROMOTES EXTRACELLULAR MATRIX DEGRADATION THROUGH ACTIVATION OF MATRIX METALLOPROTEINASES H. Yu, T. Littlewood, M. Bennett (United Kingdom)

160

HEAT SHOCK PROTEIN 27 IS A NOVEL ATHERO-BIOMARKER THAT HALTS ATHEROSCLEROTIC LESION PROGRESSION AND ENHANCES LESION REMODELING E. O'Brien, MD, T. Seibert, P. Deb-Rinker, X. Zhao, C. Shi, Y.X. Chen (Canada)

161

LINCRNA-P21 REGULATES NEOINTIMA FORMATION AND ATHEROSCLEROSIS BY ENHANCING P53 ACTIVITY G.Z. Wu, Y. Cai, Y.J. Yang, Z.C. Xu, W.E. Wang, K. Chen, C. Zeng (China)

162

12:03

12:16

58


Moderated poster presentations

Board No.

Sunday, June 1, 2014 13:50 - 14:50Exhibition Area MODERATED POSTER SESSION A: ENDOTHELIAL CELL BIOLOGY AND ANGIOGENESIS M001

M002

M003

M004

M005

M006

M007

Chair: A.B. Malik (USA)

163

IDENTIFICATION OF CYTOKERATIN 1 AS A BINDING PROTEIN OF CIRCULANT FABP4 IN ENDOTHELIAL CELLS P. Saavedra, A. Bosquet, S. Guaita, M. Heras, J. Girona, L. Masana (Spain)

164

THE ATYPICAL MECHANOSENSITIVE MICRORNA-712 DERIVED FROM PRE-RIBOSOMAL RNA INDUCES ENDOTHELIAL INFLAMMATION AND ATHEROSCLEROSIS H. Jo, D. Son, S. Kumar (USA)

165

SERUM OF PERIPHERAL ARTERIAL DISEASE PATIENTS WITH POOR FLOW-MEDIATEDARTERIAL-DILATION VALUES TRIGGERS A GENOMIC OVER-EXPRESSION OF TOLL-LIKERECEPTOR 4 BY ENDOTHELIAL CELLS C. Varela, J. De Haro, S. Bleda, A. Ferruelo, F. Acin (Spain)

166

SYNDECAN-4 INTRACELLULAR DOMAIN ORCHESTRATES RANTES/CCL5-INDUCED MONOCYTE ARREST ON ENDOTHELIAL CELL MONOLAYER UNDER FLOW L. Maillard, V. Friand, N. Suffee, H. Hlawaty, O. Haddad, F. Chmilewsky, S. Backhouche, E. Desbois, O. Oudar, D. Letourneur, N. Saito, T. Ueyama, N. Charnaux, A. Sutton (France) EFFECT OF LATE-OUTGROWTH ENDOTHELIAL PROGENITOR CELLS ON PLATELET ACTIVATION IN VITRO V. Chantzichristos, A. Tselepis (University of Ioannina) AUGMENTED NEOVASCULARIZATION CAPACITIES OF ENDOTHELIAL PROGENITOR CELLS VIA ANTI-APOPTOTIC EFFECT BY FOXO4 SIRNA TRANSFECTION IN RATS T. Nakayoshi, K. Sasaki, T. Imaizumi, T. Ueno, M. Ohtsuka, N. Itaya, H. Chibana, Y. Fukumoto (Japan) HYDROGEN-SULFIDE RELEASING MOLECULES INHIBIT INTRAPLAQUE HEMORRHAGEASSOCIATED OXIDATIVE BURST IN THE HUMAN ATHEROMA AND SUBSEQUENT ENDOTHELIAL REACTIONS V. Jeney, L. Potor, D. Petho, M. Whiteman, M.E. Wood, G. Balla, J. Balla (Hungary)

167

168

169

170

61

Board No.

M008

Sunday, June 1, 2014 FUCOIDAN, A LIGAND OF SCAVENGER RECEPTOR CLASS A, CAUSES VASCULAR RELAXATION THROUGH A NITRIC OXIDE/CGMP-MEDIATED PATHWAY IN RAT AORTA T. Iesaki, T. Takeuchi, M. Okano, R. Hashimoto, R. Kakigi, Y. Ishii, T. Okada (Japan)

171

13:50 - 14:50Exhibition Area MODERATED POSTER SESSION A: GENETICS AND OMICS Chair: R. Frikke-Schmidt (Denmark)

MODERATED POSTERS

M034

M035

M036

M037

M038

M039

62

RARE LOSS-OF-FUNCTION MUTATIONS IN THE APOC3 GENE, PLASMA TRIGLYCERIDES, AND RISK FOR CORONARY HEART DISEASEMP01E S. Kathiresan, On behalf of the NHLBI Exome Sequencing Project HDL/TG Study Group (USA) COMMON VARIANTS CONTRIBUTE TO HYPERTRIGLYCERIDEMIA WITHOUT DIFFERENCES BETWEEN FAMILIAL COMBINED HYPERLIPIDEMIA AND ISOLATED HYPERTRIGLYCERIDEMIA I. De Castro-Orós, A. Cenarro, M.T. Tejedor, L. Baila-Rueda, R. Mateo-Gallego, I. Lamíquiz-Moneo, M. Pocoví, F. Civeira (Spain)

172

173

174

VARIATION IN CHOLESTEROL ABSORPTION IN HEALTHY MALE ADULTS CAN BE EXPLAINED BY A COMBINATION OF SNPS IN CHOLESTEROL METABOLISM GENES C. Desmarchelier, E. Wolff, M. Nowicki, A. Nicolay, D. Lairon, P. Borel (France)

175

IMPORTANCE OF NON-SYNONYMOUS GENETIC VARIATION IN WRN ON RISK OF ISCHEMIC VASCULAR DISEASE AND MORTALITY IN THE GENERAL POPULATION M. Christoffersen, R. Frikke-Schmidt, B.G. Nordestgaard, A. Tybjærg-Hansen (Denmark)

176

ASSOCIATION OF MT2A GENE POLYMORPHISM -209 A/G, RS1610216, WITH DIABETES MELLITUS RELATED TO SMOKING STATUS IN THAI SUBJECT WITH CAD R. Rattanatham, N. Settasatian, C. Settasatian, N. Komanasin, U. Kukongwiriyapan, P. Intharapetch, V. Senthong (Thailand) SIGNIFICANT ASSOCIATION BETWEEN GENETIC POLYMORPHISMS OF GCKR AND GLUT1, AND ISCHEMIC STROKE Y. Chen, F. Hsieh, Y. Hsieh, J. Jeng, L. Lien, H. Lin, C. Hu, G. Peng, C. Chern, C. Chen, S. Tang, N. Chi, Y. Sung, H. Chiou (Taiwan)

177

178


Board No.

M040

M041

GENETICALLY REDUCED 25-HYDROXYVITAMIN D AND RISK OF ISCHEMIC HEART DISEASE AND MYOCARDIAL INFARCTION: A MENDELIAN RANDOMIZATION STUDY P. Jacobsen, M. Benn, S. Afzal, B. Nordestgaard (Denmark) MATRIX ASSISTED LASER DESORPTION/IONIZATION MASS SPECTROMETRY IMAGING (MALDI-MSI) REVEALS AND LOCALIZES DIFFERENT LIPIDS CLASSES INVOLVED IN ATHEROSCLEROSIS DEVELOPMENT M. Martin-Lorenzo, B. Balluff, A.S. Maroto, R.J. Carreira, R.J.M. Van Zeijl, F. De la Cuesta, L.F. Lopez-Almodovar, L.R. Padial, M.G. Barderas, L.A. McDonnell, G. Alvarez-Llamas, F. Vivanco (Spain)

179

180

13:50 - 14:50Exhibition Area MODERATED POSTER SESSION A: METABOLISM AND FUNCTION OF LIPIDS IN VASCULAR CELLS M057

M058

M059

M060

M061

Chair: B. de Geest (Belgium)

181

MATERNAL SUPRAPHYSIOLOGICAL HYPERCHOLESTEROLEMIA LEADS TO REDUCED NITRIC OXIDE SYNTHASE ACTIVITY ASSOCIATED WITH REDUCED LEVELS OF TETRAHYDROBIOPTERIN IN HUVEC A. Leiva, B. Fuenzalida, B. Sobrevia, F. Pardo, L. Sobrevia (Chile)

182

SULFATION OF 25-HYDROXYCHOLESTEROL REGULATES LIPID METABOLISM AND INFLAMMATORY RESPONSES IN HUMAN AORTIC ENDOTHELIAL CELLS, MACROPHAGES, AND HEPATOCYTES S. Ren (USA)

183

AT1 DIRECTLY INTERACTING WITH LOX-1 MEDIATES SIGNAL TRANSDUCTION INDUCED BY OXIDIZED LDL A. Kakino, K. Yamamoto, A. Nakano, L. Li, Y. Fujita, H. Rakugi, T. Sawamura (Japan)

184

ACTIVATION OF LIVER X RECEPTORS PROMOTES POLYUNSATURATED FATTY ACID SYNTHESIS AND EICOSANOID SECRETION IN HUMAN MACROPHAGES A. Varin, M. Ishibashi, L. Ménégaut, C. Thomas, M. Narce, L. Lagrost, D. Masson (France)

185

PHOSPHATIDYLSERINE: A KEY PLAYER IN MULTIPLE BIOLOGICAL ACTIVITIES OF HDL A. Kontush, L. Camont, M. Lhomme, F. Rached, W. Le Goff, C. Dauteuille, I. Guillas Baudouin, A. Nègre-Salvayre, R. Salvayre, C. Calzada, M. Lagarde, K.A. Rye, M.J. Chapman (France)

186

63

Board No.

M062

PLASMA CHOLESTEROL-INDUCED REGRESSION OF EARLY, MATURE, AND ADVANCED ATHEROSCLEROSIS187 J.L.M. Björkegren, S. Hägg, H.A. Talukdar, H. Foroughi Asl, R.K. Jain, C. Cedergren, M.M. Shang, A. Rossignoli, R. Takolander, O. Melander, A. Hamsten, T. Michoel, J. Skogsberg (Sweden)

M063

A DIETARY TRANS FAT SUBSTITUTE ALSO INDUCES ATHEROSCLEROSIS DEVELOPMENT IN LDLR-KO MICE M.S. Afonso, M.S.F. Lavrador, M.K. Koike, R.P. Bombo, V.S. Nunes, S. Catanozi, E.R. Nakandakare, A.M. Lottenberg (Brazil)

M064 MODERATED POSTERS


MYOCARDIAL TRIGLYCERIDE CONTENT IN PATIENTS WITH DILATED CARDIOMYOPATHY M. Granér, MD, M. Pentikäinen, MD, K. Nyman, MD, R. Siren, MD, J. Lundbom, MD, A. Hakkarainen, MD, K. Lauerma, MD, N. Lundbom, MD, M.S. Nieminen, MD, M.R. Taskinen, MD (Finland)

188

189

13:50 - 14:50Exhibition Area MODERATED POSTER SESSION A: LIPIDS AND LIPOPROTEINS METABOLISM Chair: B. Angelin (Sweden)

M072

191

M073

INDUCTION OF NPC1L1 MEMBRANE TRANSLOCATION AND CHOLESTEROL ABSORPTION BY CHOLECYSTOKININ192 H. Yang, L. Zhou, E. Okoro, Z.M. Guo (USA)

M074

TANGIER DISEASE IPSC-DERIVED HEPATOCYTES RECAPITULATE HDL BIOGENESIS DEFECTS AND DISPLAY ELEVATED TRIGLYCERIDE SECRETION E. Pashos, N.N. Lyssenko, A. Picataggi, M. Hernandez, Y. Liu, R. Yan, W. Yang, E.E. Morrisey, S.A. Duncan, D.J. Rader (USA)

M075

64

LIVER X RECEPTOR ACTIVATION DECREASES CHYLOMICRON ASSEMBLY AND IMPROVES POST-PRANDIAL TRIGLYCERIDEMIA VIA INTESTINAL SR-BI DOWNREGULATION O. Briand, V. Touche, S. Colin, C. Dugardin, A. Davalos, A. Tailleux, A. Moschetta, G. Brufau, A.K. Groen, V. Clavey, B. Staels, S. Lestavel (France)

190

CHOLESTEROL BIOSYNTHESIS UP-REGULATION PLAYS A CRUCIAL ROLE IN HFD-INDUCED HEPATIC ER STRESS AND HEPATOCELLULAR INFLAMMASOMES ACTIVATION A. Bashiri, M. Menard, G. Tavallaee, D.S. Ng (Canada)

193

194


Board No.

M076

M077

M078

HUMAN LOW DENSITY LIPOPROTEIN-METABOLISM IN SILICO: MODELING THE CHANGE OF LIPID-COMPOSITION IN THE LIPOPROTEIN PARTICLE M. Jansen, K. Winkler (Germany) APOLIPOPROTEIN A5-DEFICIENCY PROMOTES CARDIAC GLUCOSE METABOLISM AND PROTECTS AGAINST ACUTE MYOCARDIAL STRESSES F. Lalloyer, R. Neviere, E. Bauge, D. Montaigne, S. Lancel, L. Ravasi, X. Marechal, B. Staels (France) LINKING WHITE-TO-BROWN FAT REMODELING TO FATTY ACID AND LIPOPROTEIN METABOLISM L. Scheja, A. Bartelt, C. John, L. Cherradi, C. Schlein, A. Worthmann, F. Rinninger, J. Heeren (Germany)

195

196

197

13:50 - 14:50Exhibition Area MODERATED POSTER SESSION A: NUTRITION, NUTRACEUTICALS, METABOLIC SYNDROME AND OBESITY Chair: H. Gylling (Finland)

M087

M088

M089

M090

DIETS NATURALLY-RICH IN POLYPHENOLS IMPROVE GLUCOSE METABOLISM IN PEOPLE AT HIGH CARDIOVASCULAR RISK: A CONTROLLED RANDOMIZED TRIAL. L. Bozzetto, G. Annuzzi, G. Pacini, C. Vetrani, G. Costabile, A. Mangione, G. Della Pepa, S. Cocozza, E. Griffo, G. Anniballi, A. Tura, A. Giacco, G. Riccardi, A.A. Rivellese (Italy) PHYTOSTEROL AND OXYPHYTOSTEROL LEVELS IN PLASMA AND AORTIC VALVE CUSPS IN PATIENTS WITH SEVERE AORTIC STENOSIS O. Weingärtner, H.F. Schött, A. Luister, C. Husche, H.J. Schäfers, M. Böhm, U. Laufs, D. Lütjohann (Germany) PLEIOTROPIC EFFECTS OF PLANT STEROLS COMPARED WITH EZETIMIBE ON ATHEROSCLEROSIS BIOMARKERS IN TYPE 2 DIABETIC PATIENTS TREATED WITH STATINS A. Bertolami, MD, P.B. Botelho, MD, L.F.L. Macedo, MD, D.S.P. Abdalla, MD, A.A. Faludi, MD, M. Galasso, MD, I. Castro, MD (Brazil) SUPPLEMENTATION OF OLIVE AND GRAPE SEED EXTRACTS IMPROVES VASCULAR FUNCTION IN HEALTHY HUMANS: A RANDOMIZED CONTROLLED STUDY M. Kominami, Y. Yasutake, Y. Ono, H. Shibata (Japan)

198

199

200

201

202

65

Board No.

M091

M092

M093

MODERATED POSTERS

M094

Sunday, June 1, 2014 PREHYPERTENSION AND CARDIOVASCULAR RISK FACTORS IN 10 841 YOUTHS: THE PEP FAMILY HEART STUDY T. Bertsch, J.E. Scholze, E. Liepold, G.M. Haas

203

SHOULD BODY MASS INDEX (BMI) BE INCLUDED IN ADDITION TO HEIGHT IN PEDIATRIC BLOOD PRESSURE PERCENTILES? G. Haas, T. Bertsch, J.E. Scholze, P. Schwandt (Germany)

204

OXIDATIVE STRESS STATUS AND ADIPOKINES IN OBESE TYPE 2 DIABETES MELLITUS PATIENTS FROM BARIATRIC SURGERY D. Lixandru, M. Mitu, J. Tudosoiu, I. Stoian, L. Gaman, A. Rosca, B. Smeu, C. Copaescu, C. Ionescu-Tirgoviste (Romania) HIGHER INSULIN RESISTANCE IS ASSOCIATED WITH REDUCED CEREBRAL GLUCOSE METABOLISM IN THE TEMPORAL LOBE WITH F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY N. García-Casares, J.A. García-Arnes, A. Gutiérrez Cardo, J. Rioja-Villodres, M.J. Ariza-Corbo, A. Nabrozidis, P. González-Santos (Spain)

205

206

13:50 - 14:50Exhibition Area MODERATED POSTER SESSION A: CV RISK FACTORS IN ATHEROGENESIS I Chair: H. Dieplinger (Austria)

M103

M104

M105

66

ARACHIDONATE 15-LIPOXYGENASE ENZYME PRODUCTS INCREASE PLATELET AGGREGATION AND THROMBIN GENERATION A. Lundqvist, C. Vijil, C. Hermansson, A. Jeppsson, G. Bergström, L. Mattsson Hultén (Sweden) CIRCULATING BIOMARKERS FOR EXPRESSION OF PRO-INFLAMMATORY CYTOKINES IN CAROTID PLAQUES A. Edsfeldt, H. Grufman, M. Nitulescu, A. Persson, M. Nilsson, J. Nilsson, I. Goncalves (Sweden) THE VALUE OF SERUM MMP-9 AS A DIAGNOSTIC AND PROGNOSTIC MARKER IN ACUTE CORONARY SYNDROME AND ITS RECURRENCE L. Lahdentausta, P. Pussinen, E. Pesonen, T. Sorsa (Finland)

207

208

209

210


Board No.

M106

THE PROGNOSTIC VALUE OF MEAN PLATELET VOLUME FOR CLINICAL OUTCOMES IN PATIENTS WITH CORONARY ARTERY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION211 S. Han, P.C. Oh, T.H. Ahn, W.C. Kang, K.H. Lee, S.Y. Seo, E.K. Shin (Korea)

M107

THE LONGITUDINAL DISTRIBUTION OF EXCESSIVE EXPANSIVE REMODELING AND LOW ENDOTHELIAL SHEAR STRESS AFFECTS THE NATURAL HISTORY OF ATHEROSCLEROSIS IN HUMANS212 A.P. Antoniadis, M.I. Papafaklis, S. Takahashi, M. Tsuda, S. Mizuno, K. Shishido, Y. Makita, T. Domei, T. Ikemoto, A.U. Coskun, J. Honye, S. Nakamura, S. Saito, C.L. Feldman, P.H. Stone (USA)

M108

PRESENCE OF ANGINA PECTORIS IS RELATED WITH EXTENSIVE CORONARY ARTERY DISEASE IN DIABETIC PATIENTS A. Celik, M. Karayakali, U. Erkorkmaz, F. Altunkas, K. Karaman, F. Koc, K. Ceyhan, H. Kadi, A. Avsar (Turkey)

M109

M110

213

STATIN TREATED PATIENTS AT VERY HIGH CARDIOVASCULAR RISK IN EUROPE: ARE THE MAJORITY CLOSE TO LDL-C T SNP IN APOLIPOPROTEIN A-I GENE IN A HEALTHY BRAZILIAN POPULATION E. Soler Parra, V.H. Souza Zago, D. Zanetti Scherrer, F. Alexandre, N. Baratella Panzoldo, V. Sutti Nunes, E. R. Nakandakare, E.C. R. Quintão, E. Cotta de Faria (Brazil)

8:30 - 18:30 300

122

644

645

Microbiota

CHANGING DIETARY CONTENT OF GLUTEN - AND POTENTIALLY THE GUT MICROBIOTA, DID NOT RESULT IN INCREASED ATHEROSCLEROSIS IN THE APOE-/- MOUSE I. Rune, B. Rolin, J. Lykkesfeldt, B. Chistoffersen, R.K. Kirk, A.K. Hansen (Denmark)

646

Board No.

Saturday, May 31 – Tuesday, June 3, 2014

8:30 - 18:30Native and modified LDL 301

302

303

OMEGA-6 POLYUNSATURATED FATTY ACIDS AND MDA-LDL ARE HIGHER IN BRANCH ATHEROMATOUS DISEASE IN COMPARISON TO SMALL VESSEL DISEASE N. Amioka, U. Masayuki, M. Takuro, K. Yuji, Y. Daisuke, O. Nobuhiko, T. Atsushi, H. Satoshi, I.T.O. Hiroshi (Japan) RELATION BETWEEN OXIDIZED LOW DENSITY LIPOPROTEINS AND CHRONIC LIVER INFLAMMATION PROCESS L. Bagdonaite, V. Banys (Lithuania) MINIMALLY MODIFIED LOW-DENSITY LIPOPROTEIN TRIGGERS THE INFLAMMATORY RESPONSE IN HUMAN MONOCYTES SUBSETS L. Chávez-Sánchez, J.E. Espinosa-Luna, K. Chávez-Rueda, M.V. Legorreta-Haquet, F. Blanco-Favela (Mexico)

647

648

649

304

SMALL DENSE LDL CARRIES ACTIVE PARAOXONASE 1 A. Gugliucci, MD, K. Kotani, MD, S. Kimura, MD, T. Menini, MD (USA)

305

RELATIONSHIP OF CAROTID INTIMA-MEDIA THICKNESS WITH LDL PHENOTYPE IN ELITE RUNNERS 651 H.A. Fonseca, C.R. Bittencourt, F.A. Fonseca, A.M. Monteiro, P.R. Santos, A.M. Figueiredo Neto, L.M. Camargo, M. IZAR, M.A. Gidlund (Brazil)

306

HUMAN LDL STRUCTURAL DIVERSITY STUDIED BY IR SPECTROSCOPY J.A. Fernández-Higuero, A. Benito-Vicente, A.M. Salvador, J.C.G. Milicua, J.L.R. Arrondo, C. Martin (Spain)

307

OXLDL – THE MOLECULE LINKING HYPERCOAGULABILITY WITH THE PRESENCE OF CARDIOVASCULAR DISEASE IN HEMODIALYZED URAEMIC PATIENTS K. Pawlak, M. Mysliwiec, D. Pawlak (Poland)

653

OXIDIZED LOW-DENSITY LIPOPROTEINS (OXLDL) PLASMA LEVELS AND OXLDL TO LDL RATIO – ARE THEY REAL OXIDATIVE STRESS MARKERS IN DIALYSED PATIENTS? D. Pawlak, M. Mysliwiec, K. Pawlak (Poland)

654

EVALUATION OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL AS AN INDICATOR TO REDUCE ATHEROSCLEROSIS CARDIOVASCULAR RISK A. Sato, H. Kanno, M. Tomoda (Japan)

655

308

309

650

652

123

Board No.

310

311

312

Saturday, May 31 – Tuesday, June 3, 2014 NITRIC OXIDE AND MITOCHONDRIAL PERMEABILITY TRANSITION IN HYPERCHOLESTEROLEMIC MICE A. Vercesi, A. Moraes, A.C. Marques, H.C.F. Oliveira (Brazil)

656

PLURONIC BLOCK COPOLYMERS REDUCE INTRACELLULAR CHOLESTEROL ACCUMULATION CAUSED BY LDL A. Melnichenko, N. Pervushina, N. Nikiforov, A.N. Orekhov (Russia)

657

THE IMPORTANCE OF CONSIDERING LDL-C RESPONSE AS WELL AS CARDIOVASCULAR RISK IN DECIDING WHO CAN BENEFIT FROM STATIN THERAPY. H. Soran, P. Durrington (United Kingdom)

658

8:30 - 18:30 313

POSTERS

314

124

Miscellaneous

APOA-I DEFICIENCY IN APOE-KO MICE SEVERELY ALTERS LYMPH NODES AND MODULATES T LYMPHOCYTE SUBSETS M. Busnelli, F. Sala, S. Manzini, G.S. Ganzetti, C. Parolini, F. Dellera, E. Scanziani, L. Arnaboldi, C.R. Sirtori, G.D. Norata, G. Chiesa (Italy) GENETIC RISK SCORE DOES NOT EXPLAIN HYPERCHOLESTEROLAEMIC PHENOTYPE IN CHILDREN WITH HYPERCHOLESTEROLEMIA OF UNKNOWN GENETIC ORIGIN B. Sjouke, S.W. Fouchier, A. Wiegman, J.J.P. Kastelein, G.K. Hovingh (Netherlands)

315

LDL PARTICLE SIZE AND DISTRIBUTION IN CHILDREN WITH TYPE 1 DIABETES S. Alabakovska, MD, D. Labudovic, MD, K. Tosheska Trajkovska, MD (Macedonia)

316

LIPOPROTEINS SUBFRACTIONS DISTRIBUTION IN MEN WITH CORONARY ATHEROSCLEROSIS TAKING STATIN THERAPY N. Artemeva, E. Utkina, O. Afanasieva, Y. Matchin, A. Burdeynaya, I. Adamova, M. Ezhov, S. Pokrovsky (Russia)

317

APOLIPOPROTEIN D PRODUCTION IN CELL LINES S. Braesch-Andersen, L. Persson, S. Paulie, M. Kumagai (Sweden)

318

ENCAPSULATION OF HUMAN GROWTH HORMONE AND APOA-I IN HDL EXERTED STRONGER ANTIOXIDANT ACTIVITY AND ANTI-ATHEROSCLEROTIC ACTIVITY E.Y. Lee, K.H. Cho (Korea)

659

660

661

662

663

664

Board No.

319

320

Saturday, May 31 – Tuesday, June 3, 2014 IDOL N342S GENE VARIANT IS NOT ASSOCIATED WITH PLASMA LIPID PROFILE AND PRECLINICAL CAROTID ATHEROSCLEROSIS IN ITALIAN FREE LIVING POPULATION A. DHYANI, MD, G. Tibolla, MD, A. Baragetti, MD, K. Garlaschelli, MD, L. Grigore, MD, G. Norata, MD, A. Catapano, MD (Italy) EFFECTS OF SILICON INCLUSION IN RESTRUCTURED MEAT-ENRICHED DIET ON LIPOPROTEIN PROFILE AND COMPOSITION IN AGED WISTAR RATS A. Garcimartín, J.A. Santos-López, J. Benedí, S. Bastida, F.J. Sánchez-Muniz (Spain)

665

666

321

LPPLA2 AS SURROGATE MARKER FOR SMALL DENSE LDL: FACT OR ARTEFACT? M.M. Hoffmann, G. Pütz, K. Winkler (Germany)

322

PIOGLITAZONE TREATMENT MAY LEAD TO ANTI-ATHEROGENIC ALTERATIONS OF LIPOPROTEINS THROUGH INCREASING SERUM ADIPONECTIN IN STATIN-TREATED DIABETES PATIENTS K. Kanno, M. Matsuda, T. Segawa, R. Tamura, T. Kawamoto (Japan)

668

IMPACT OF TRIGLYCERIDES, HIGH-DENSITY LIPOPROTEIN, ADIPONECTIN, AND ANTIDIABETES MEDICATIONS ON OXIDIZED LOW-DENSITY LIPOPROTEIN LEVELS IN STATINTREATED DIABETES PATIENTS M. Matsuda, R. Tamura, K. Kanno, T. Segawa, T. Kawamoto (Japan)

669

RELATIONSHIP OF SMALL DENSE LDL PARTICLES WITH PARAMETERS OF OXIDATIVE STRESS IN PATIENTS WITH CORONARY HEART DISEASE V. Metelskaya, I. Ozerova, N. Perova, V. Lankin, N. Gavrilova, T. Vlasik (Russia)

670

ANALYSIS OF THE ASSOCIATIONS BETWEEN LIPOPROTEIN PROFILE PARAMETERS AND CORONARY ARTERY DISEASE SEVERITY ESTIMATED BY GENSINI SCORE V. Metelskaya, N. Gavrilova, E. Yarovaya, N. Gomyranova, S. Boytsov (Russia)

671

323

324

325

326

327

APOLIPOPROTEIN J DISTRIBUTION AMONG LIPOPROTEIN FRACTIONS IN NORMOLIPEMIA AND HYPERLIPEMIA A. Rull, M. Martínez-Bujidos, M. Pérez-Cuellar, A. Pérez, J. Ordóñez-Llanos, J.L. Sanchez-Quesada (Spain) DIFFERENT ASSOCIATION OF SERUM DOCOSAHEXAENOIC ACID AND EICOSAPENTAENOIC ACID LEVELS WITH ATHEROGENIC AND ANTI-ATHEROGENIC LIPOPROTEINS IN STATINTREATED DIABETES PATIENTS T. Segawa, M. Matsuda, K. Kanno, R. Tamura, T. Kawamoto (Japan)

667

672

673 125

Board No.


8:30 - 18:30

328

329

330

POSTERS

331

ESTABLISHMENT OF REFERENCE RANGE FOR HDL SUBFRACTIONS IN JAPANESE POPULATION WITH A NEW AUTOMATED ASSAY Y. Ito, N. Satoh, T. Ishii, J. Kumakura (Japan)

674

LDL-C TREATMENT GAPS IN STATIN-TREATED PATIENTS AT HIGH AND VERY HIGH CARDIOVASCULAR RISK IN EUROPE A.K. Gitt, B. Ambegaonkar, P. Brudi, D. Lautsch (Austria)

675

IMPACT OF LOSS OF FUNCTION VARIANT OF BETATROPHIN ON ADVANCED CORONARY ARTERY DISEASE AMONG DIABETIC PATIENTS IN JAPAN A. Nohara, K. Yagi, J. Liu, S. Okazaki, M. Yoshida, M. Mori, C. Nakanishi, M.A. Kawashiri, A. Inazu, M.A. Yamagishi, H. Mabuchi (Japan) CORRELATION BETWEEN APOA-1, APOB-100 AND PARAMETERS OF LIPID PROFILE IN PATIENTS WITH LOW AND MODERATE CARDIOVASCULAR RISK BY SCORE SCALE S. Boytsov, S. Urazalina, V. Kucharchuk, I. Sergienko (National Research Center for Preventive Medicine Ru)

676

677

332

LIPID PROFILE IN PREHYPERTENSIVE ADOLESCENTS E. Silva, G. Bermudez, J.J. Villasmil, M. Bracho, C. Esis, M. Villamizar (Venezuela)

678

333

IMPACT OF PLANT-BASED DIET ON LIPID RISK FACTORS FOR ATHEROSCLEROSIS A. Kuchta, A. Lebiedzinska, E. Kreft, J. Czaja, A. Kozlowska, M. Fijalkowski, A. Cwiklinska, A. Wolska, B. Kortas-Stempak, M. Wróblewska (Poland)

679

334

ATHEROGENIC RATIOS IN PATIENTS WITH RECURRENT ACUTE CORONARY SYNDROME AND RECEIVING STATIN THERAPY: CLINICAL USEFULLNESS AS CARDIOVASCULAR PREDICTORS J. Millan, X. Pinto, M. Zuñiga, A. Mangas, A. Hernandez Mijares, E. Corbella, J.U.A.N. Pedro-Botet (Spain)

335

126

Track 3: RISK FACTORS, EPIDEMIOLOGY, PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES Cardiovascular epidemiology

ANTHROPOMETRIC INDICES AND CARDIOVASCULAR RISK: SPANISH PERSPECTIVES J. Millan, T. Mantila, S. Monereo, B. Moreno, C. Perez Rodrigo, J. Aranceta (Spain)

680

681

Board No.

336

337

338

Saturday, May 31 – Tuesday, June 3, 2014 TRENDS FOR CLINICAL PRACTICE IN THE MANAGEMENT OF DIABETIC AND HYPERTENSIVE PATIENTS IN PRIMARY CARE IN SPAIN. ATENCION STUDY J. Millan, M. Rodriguez de Miguel, M. Orera Peña, M. De la Figuera, M. Jesus (Spain)

682

PREVALENCE OF DYSLIPIDAEMIA: A COMPARISON OF CAUCASIAN AND SOUTH ASIAN SUBPOPULATIONS POST-ACS P.A. Patel, J.R.J. Foley, Y. Zheng, C. Yau, Y. Blackburn, S. Bulugahapitiya (United Kingdom)

683

ETHICAL SURVEY OF HIGH CHOLESTEROL AND RISK ESTIMATION FOR FAMILIAL HYPERCHOLESTEROLEMIA IN 6320 STUDENTS OF AGES FROM 6 TO 19 YEARS A. Pereira, T.P. Camargo, S.S.M. Ihara, M.C. Elias, L.E.S. Almeida Pinto, C.A. Machado, R.D. Santos Filho, S. Fernandes, T.L.R. Martinez (Brazil)

684

339

OVERVIEW OF THE BASELINE METABOLIC STATUS IN LIPID-NAIVE TYPE 2 DIABETIC PATIENTS R. Fabregate, J. Rodriguez-Encinar, A. Duque, M. Fabregate, S. Tello, A. Reyes, B. Castejon, A. Andres, J. Saban-Ruiz (Spain)

685

340

UNDER-PRESCRIBING CARDIOVASCULAR DRUGS AS CAUSES OF HOSPITALISATION A. Benavente Fernández, A. Escudero Brocal, A. Salmerón-García, F. Nieto Cobo (Spain)

686

341

THYROID DISEASE SEEN IN HYPERTENSIVE PATIENTS S.B. Denizeri, M.H. Bektas, S. Erden (Turkey)

687

342

FIVE YEAR PROGNOSIS IN PATIENTS WITH ANGIOGRAPHICALLY PROVEN STABLE CORONARY HEART DISEASE: RESULTS OF PROSPECTIVE OBSERVATIONAL STUDY IN RUSSIA E. Gofman, S. Martsevitch, S. Tolpygina, A. Malysheva, Y. Polyanskaya, A. Deev (Russia)

688

THE EFFECTS OF HOME BLOOD PRESSURE MONITORING ON HIGH BLOOD PRESSURE AND THE TREATMENT PLAN S. Erden, M.H. Bektas, S.B. Denizeri, E. Karabacak (Turkey)

689

VARIATIONS IN PREVALENCE AND MANAGEMENT OF HYPERTENSION BETWEEN CAUCASIAN AND SOUTH ASIAN SUBGROUPS WITH ACS: A RETROSPECTIVE STUDY J.R.J. Foley, P.A. Patel, Y. Zheng, C. Yau, Y. Blackburn, S. Bulugahapitiya (United Kingdom)

690

343

344

345

VITAMIN D DEFICIENCY AND OBESITY I. Gonzalez Molero, G. Rojo, S. Morcillo, C. Gutierrez-Repiso, E. Rubio, F. Soriguer, F. Soriguer (Spain)

691

346

CORRELATION BETWEEN ESTIMATED CARDIOVASCULAR RISK AND ANTHROPOMETRIC DATA M. Olmedo, R. Garcia, M. Barrientos, P. Chisholm, J. Millan (Spain)

692 127

Board No.

347

THE INCIDENCE OF METABOLIC SYNDROME IN A GROUP OF OBESE CHILDREN IN CZECH REPUBLIC 693 D. Pastucha, J. Hyjanek, D. Horakova (Czech Republic)

348

BEHAVIOURAL ASPECTS OF SMOKING (BOTH PASSIVE AND ACTIVE) AND ALCOHOL CONSUMPTION ON THE RISK OF MYOCARDIAL INFARCTION R. Attard, P. Dingli, K. Cassar, C. Doggen, R. Farrugia, S. Bezzina Wettinger (Malta)

349

350

351

POSTERS

352

353

354

355

128


STUDY OF SEDENTARY TIME DEFINITIONS AND RISK OF METABOLIC SYNDROME IN A MIDDLE-AGED WORKING POPULATION: THE AWHS COHORT B. Moreno-Franco, E.M. Andrés-Esteban, M. Ledesma, M. Laclaustra, J.L. Peñalvo, M. Pocoví, J.M. Ordovás, J.A. Casasnovas, M. León-Latre (Spain)

694

695

THE EFFECT OF FAMILY STRESS ON RISK OF MYOCARDIAL INFARCTION IN FEMALE POPULATION AGED 25-64 YEARS IN RUSSIA V. Gafarov, D. Panov, E. Gromova, I. Gagulin, A. Gafarova (Russia)

696

IMPACT OF THE POLITICAL REVOLUTION ON CORONARY HEART DISEASE BURDEN ON YOUNG POPULATION A.M. Saleh, H.A.N.Y. Negm, M. Shalaby, M. Haykal, M. Fayez, N. ElMahdy (Germany)

697

COLT, MULTICENTER CAPRE OPEN LABEL RANDOMIZED DOSE-RANGING PHASE II TRIAL TO ASSESS EFFICACY/SAFETY IN PATIENTS WITH MILD-TO-HIGH HYPERTRIGLYCERIDEMIA T. Sampalis, Y. Pesant, T. Elliott, J. Pouliot, G. Tsoukas, Y. Gonzalez, R. Dufour, J. Sampalis, P. Lemieux, F. Amiri, H. Waksal, J. Davignon (Canada)

698

HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA IN GREECE: EPIDEMIOLOGICAL DATA FROM 29 PATIENTS E. Drogari, N. Mavroidis, E. Laios, P. Proyas, V. Mollaki (Greece)

699

COMPARISON NON-PHARMACOLOGICAL AND PHARMACOLOGICAL TREATMENT OF FH/FDB IN CHILDREN (CHILDREN´S LIPID CLINIC AT THE UNIVERSITY HOSPITAL OLOMOUC) J. Hyjanek, D. Pastucha (Czech Republic)

700

DIFFERENCES BETWEEN RURAL AND URBAN POPULATION CONSIDERING PREVALENCE OF CHRONIC COMPLICATIONS AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS A. Koutsovasilis, A. Papazafiropoulou, A. Sotiropoulos, T. Peppas, A. Grozou, M. Bachlitzanaki, E. Tamvakos, S. Bousboulas (Greece)

701

Board No.

356

Saturday, May 31 – Tuesday, June 3, 2014 MULTIVESSEL CORONARY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME AND GENETICS-IS THERE A CONNECTION? N. Lozhkina, V. Maksimov, P. P. Orlov, A. Kuimov, M. M. Voevoda (Russia)

702

8:30 - 18:30Woman and cardiovascular risk 357

GENDER DISPARITIES OF NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND BODY FAT DISTRIBUTION703 T. Bertsch, G.M. Haas, P. Schwandt (Germany)

358

MALE PATIENTS HAD MORE VULNERABLE CORONARY PLAQUE THAN IN FEMALES, ESPECIALLY IN PATIENTS WITH STABLE ANGINA AND YOUNG PATIENTS S. Han, P. Oh, K. Koh, K. Lee, W. Kang, S. Suh, E. Shin (Korea)

359

360

361

362

363

364

PREDICTORS OF OBSTRUCTIVE CORONARY ARTERY DISEASE IN SYMPTOMATIC WOMEN: CHEST PAIN IN KOREAN WOMEN’S REGISTRY H. Kim, M. Kim, W. Shim, S. Park, Y. Kim, J. Na, M. Shin, Y. Kim, K. Kim, H. Yoon, G. Shin, Y. Cho, S. Kim, K. Hong, H. Kim, K. Cho (Korea)

704

705

THE EFFECTS OF METABOLIC SYNDROME AND ITS COMPONENTS ON ARTERIAL STIFFNESS IN RELATION TO GENDER H. Kim, J. Seo, W. Chung, S. Kim, J. Zo, M. Kim (Korea)

706

THE ASSOCIATION BETWEEN AMBULATORY BLOOD PRESSURE PROFILE AND BRACHIALANKLE PULSE WAVE VELOCITY IN UNTREATED HYPERTENSIVE SUBJECTS H. Kim, J. Seo, W. Chung, S. Kim, J. Zo, M. Kim (Korea)

707

GENDER DOES NOT SIGNIFICANTLY AFFECT THE ASSOCIATION BETWEEN INFLAMMATION AND THE METABOLIC SYNDROME AMONG PATIENTS WITH STABLE CORONARY ARTERY DISEASE C.H. Saely, A. Vonbank, P. Rein, A. Leiherer, D. Zanolin, H. Drexel (Austria)

708

GENDER DIFFERENCES ON OXIDATIVE STRESS MARKERS AND COMPLEMENT COMPONENT C3 PLASMA VALUES AFTER AN ORAL UNSATURATED FAT LOAD TEST A. Artero, S. Martinez-Hervas, M.A. Priego, J. Martinez-Ibañez, J.F. Martinez-Valls, J.T. Real, J.F. Ascaso (Spain) ICAM-1 AS AN EARLY CVD RISK MARKER IN NAFLD? I. Skuja, I. Stukena, G. Krievina, D. Vanagele, A. Lajnieks (Latvia)

709

710

129

Board No.


365

DO GENDER DIFFERENCES EXIST IN TOTAL UNTIOXIDANT CAPACITY IN YOUNG POPULATION? M. Stojanov, A. Stefanovic, J. Ivanisevic (Serbia)

366

PREVALENCE AND GENDER DIFFERENCES OF STATINS MYOPATHY IN CLINICAL PRACTICE IN DYSLIPIDEMIC PATIENTS G. Mombelli, C. Pavanello, S. Castelnuovo, R. Bosisio, L. Morandi, C.R. Sirtori (Italy)

711

712

8:30 - 18:30Biomarkers

POSTERS

367

368

LOW SERUM TRYPTOPHAN PREDICTS HIGHER MORTALITY IN CARDIOVASCULAR DISEASE C. Murr, T. Grammer, M. Kleber, A. Meinitzer, W. März, D. Fuchs (Austria)

369

MOLECULAR ALTERATIONS IN HUMAN URINE REVEAL ATHEROSCLEROSIS DEVELOPMENT, CARDIOVASCULAR EVENT AT ONSET AND FOLLOW-UP M. Martin-Lorenzo, I. Zubiri, A.S. Maroto, M. Posada-Ayala, L. Gonzalez-Calero, F. De la Cuesta, L.F. Lopez-Almodovar, L.R. Padial, M.G. Barderas, F. Vivanco, G. Alvarez-Llamas (Spain)

370

371

372

130

PLASMA LEVELS OF IGG ANTI OXIDIZED LDL PREDICT THE OCCURRENCE OF CV DEATH IN PATIENTS WHO UNDERWENT CAROTID ENDARTERECTOMY G. Asciutto, N. Dias, G. Fredrikson, R. Alm, I. Gonçalves, J. Nilsson (Sweden)

HDL AS A BIOMARKER OF REJECTED HEART PRODUCING SEVERE ATHEROSCLEROSIS OF THE TRANSPLANTED HEART W. González, P. Altieri, H.L. Banchs, D. Iravedra, I.F. González-Cancel, R. Calderón, C. Gurrea, N. Escobales, M. Crespo (Puerto Rico) THE POSSIBLE PREDICTIVE ROLE OF LABORATORY BIOMARKERS FOR ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH METABOLIC SYNDROME L. Merkovska, L. Jedlickova, J.A.N. Fedacko, M. Janicko, L. Jackova, M. Vachalcova, M. Sajty, T. Lopuchovsky, B. Novakova, P. Jarcuska, D. Pella (Slovakia) 1H-NMR SPECTROMETRIC IDENTIFICATION OF BIOMARKERS OF ATHEROSCLEROSIS IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE P. Abdulhannan, MD, M. Twigg, MD, N. Mughal, MD, D. Russell, MD, S. Homer-Vanniasinkam, MD, J. Fisher, MD (United Kingdom)

713

714

715

716

717

718

Board No.

373

Saturday, May 31 – Tuesday, June 3, 2014 THE ROLE OF VEGF IN THE ELDERLY DIABETIC PATIENTS UNDERGOING ENDOVASCULAR THERAPY OF ADVANCED ATHEROSCLEROTIC AORTIC VALVE STENOSIS V. Bláha, J. Stásek, J. Bis, C. Andrys, J. Vojácek, L. Sobotka, P. Polansky, M. Brtko (Czech Republic)

719

374

LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 MASS LEVEL IS ELEVATED AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION OR BALLON ANGIOPLASTY IN ELDERLY PATIENTS 720 J. Fortunato, V. Bláha, J. Bis, J. ?tásek, C. Andr?s, J. Vojácek, L. Sobotka, P. Polansk?, M. Brtko (Czech Republic)

375

CORONARY SLOW FLOW PHENOMENON AND NEUTROPHIL-TO-LYMPHOCYTE RATIO F. Altunkas, F. Koç, A. Celik, K. Kayihan, M. Karayakali, K. Ceyhan (Turkey)

376

EFFECT OF SWITCH TO THE HIGHEST DOSE OF ROSUVASTATIN VS ADD-ON NICOTINIC ACID VS ADD-ON FENOFIBRATE ON SERUM VITAMIN D LEVELS S. Makariou, E. Liberopoulos, A. Kei, A. Challa, M. Elisaf (Greece)

377

MICROPARTICLES AND HYPERTENSIVE CARDIOVASCULAR DISEASE:EFFECTS OF ANTIHYPERTENSIVE AND LIPID-LOWERING THERAPY ON CIRCULATING MICROPARTICLES M. IZAR, C.N. França, N.D. Matsunaga, C.E. Ferreira, H.T. Bianco, J. Kato, J.B. Amaral, F.A. Fonseca (Brazil)

721

722

723

378

IPS CELL DERIVED HEPATOCYTES AS A MODEL TO IDENTIFY NEW BIOMARKERS FOR ATHEROSCLEROSIS724 M. Kiamehr, L. Viiri, K. Aalto-Setälä (Finland)

379

BIOCHEMICAL MARKERS OF ENDOTHELIAL DYSFUNCTION DURING EXPERIMENTAL ATHEROSCLEROSIS IN RABBITS S. Kryvorot, T. Vladimirskaya, I. Shved, N. Moskaleva (Belarus)

725

CLINICAL IMPLICATION OF CRITICAL SHEAR STRESS IN PATIENTS WITH ADVANCED CORONARY ARTERY DISEASE B. Lee, H. Kwon, M. Cho, Y. Yoon (Korea)

726

A NEW RISK CHART WITH GENETIC AND PHENOTYPIC VARIABLES FOR DETECTION OF ACUTE MYOCARDIAL INFARCTION SUSCEPTIBILITY F. Licastro, M. Ianni, G. Campo, R. Ferrari, E. Porcellini, M. Buscema, E. Grossi (Italy)

727

380

381

131

Board No.

382

383

384

POSTERS

385

COMPARISON OF SERUM TIMP-2, NGAL AND ANGIOPOIETIN-2 LEVELS TO IDENTIFY CORONARY ARTERY STENOSIS H. Joo, Y. Han, H. Seo, S. Choi, J. Park, C. Yu, S. Hong, D. Lim (Korea) CIRCULATING PRO-ATHEROGENIC OXIDIZED-LDL/B2-GLYCOPROTEIN I COMPLEXES ARE DETECTED IN ARTERIAL AND VENOUS DISEASES AND ARE INDEPENDENT PREDICTORS OF CAROTID ARTERIAL DISEASE L.R. Lopez, E. Matsuura, K.E. Guyer, C.B. Rockman, J.S. Berger (USA) LIPOSCALE: A NOVEL ADVANCED LIPOPROTEIN TEST BASED ON 2D DIFFUSION-ORDERED 1H NMR SPECTROSCOPY R. Mallol, N. Amigó, A. Cabré, M.A. Rodríguez, M. Heras, M. Vinaixa, N. Plana, E. Rock, J. Ribalta, L. Masana, X. Correig (Spain) RATIOS OF SERUM EICOSAPENTAENOIC (EPA) AND DOCOSAHEXAENOIC (DHA) ACID TO ARACHIDONIC ACID (AA) AND CORONARY AND AORTIC PLAQUE INSTABILITY Y. Momiyama, R. Ohmori, R. Kato, H. Taniguchi, F. Ohsuzu (Japan)

728

729

730

731

386

NUMBER OF CORONARY RISK FACTORS IS ASSOCIATED WITH BLOOD THROMBOGENICITY T. Nemoto, Y. Ueda (Japan)

387

FOCUS ON RELEASED EXTRACELLULAR MATRIX COMPONENTS FROM CAROTID PLAQUE CORE: INTACT PROTEINS OR FRAGMENTS? S. Rocchiccioli, G. Pelosi, S. Rosini, N. Ucciferri, M. Marconi, M. Ferrari, A. Cecchettini (Italy)

733

LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 SERUM LEVELS IN PATIENTS FROM DIFFERENT CATEGORIES OF CARDIOVASCULAR RISK A. Semenova, D. Nozadze, I. Sergienko, T. Vlasik, V. Kukharchuk (Russia)

734

ASSOCIATIONS OF CHEMERIN LEVELS AND LIPID SUBFRACTIONS IN NON-DIABETIC OBESE AND LEAN SUBJECTS I. Seres, H. Lorincz, M. Katkó, M. Harangi, S. Somodi, K. Gaál, P. Fülöp, G. Paragh (Hungary)

735

HETEROPLASMY LEVEL OF FIVE MITOCHONDRIAL MUTATIONS IN DIFFERENT TYPES OF LEUCOCYTES IN HUMAN BLOOD V.V. Sinyov, M.A. Sazonova, A.I. Ryzhkova, A.Y. Postnov, A.N. Orekhov, I.A. Sobenin (Russia)

736

388

389

390

132


732

Board No.

391

392

393

394

395

396

397

Saturday, May 31 – Tuesday, June 3, 2014 ELECTROCARDIOGRAPHIC BIOMARKERS OF METABOLIC CARDIOMYOPATHY AND THEIR ASSOCIATION WITH LONG-TERM RESULTS OF MYOCARDIAL REVASCULARIZATION IN MEN WITH CORONARY ATHEROSCLEROSIS N. Timoshenko, Y. Ragino, A. Chernjavskyi, S. Tcimbal, L. Scherbakova, M. Voevoda (Russia) INFLAMMATORY AND OXIDATIVE STRESS MARKERS IN PLASMA OF CRITICAL LIMB ISCHEMIA PATIENTS E. Wysocka, W. Walczak, S. Michalak, M. Nowicki, J. Tomczak, L. Kruszyna, G. Oszkinis (Poland)

737

738

EXTENSIVE CORONARY CALCIFICATION COMPROMISES MYOCARDIAL PERFUSION IN THE ABSENCE OF HIGH GRADE STENOSIS M.Y. Henein, T. Bengrid, N. Rachel, Y. Zhao, B. Johansson, A. Schmermund (Sweden)

739

MUTATIONS C3256T, G13513A, G14846A, G12315A OF MITOCHONDRIAL GENOME AND ATHEROSCLEROSIS OF CORONARY AND CAROTID ARTERIES L. Egorova, Z. Khasanova, A. Postnov, M. Ezhov (Russia)

740

LIPOPROTEIN(A) AND CELL ADHESION MOLECULES AS PREDICTORS OF VEIN GRAFT OCCLUSION IN POST-CABG PATIENTS RECEIVING LIPOPROTEIN APHERESIS R. Adzhiev, M. Ezhov, M. Safarova, M. Afanasieva, Y. Berestetskaya, G. Konovalov, S. Pokrovsky (Russia) GDF-15 LEVELS WITH PRESENCE BUT NOT PROGRESSION OF ATHEROSCLEROSIS IN STABLE CHD PATIENTS D. Soboleva, M. Afanasieva, O. Dmitrieva, Y. Matchin, M. Ezhov (Russia) HIGHER INSULIN RESISTANCE IS ASSOCIATED WITH CEREBRAL ATROPHY IN TEMPORAL LOBE N. García-Casares, J. Rioja-Villodres, J.A. García-Arnes, M.J. Ariza-Corbo, A. Nabrozidis, F. Alfaro-Rubio, A. Gutiérrez Cardo, P. González-Santos (Spain)

741

742

743

8:30 - 18:30Endothelial dysfunction clinical assessment 398

ARTERIAL STIFFNESS IN RELATION TO AGE AND FRAILTY S.M. Aurelian, A. Capisizu, A. Zamfirescu, D. Cheta (Romania)

744

399

INCREASED AORTIC PULSE WAVE VELOCITY IN OBESE CHILDREN A. Celik, M. Ozcetin, Y. Yerli, I.H. Damar, H. Kadi, F. Koc, K. Ceyhan (Turkey)

745

133

Board No.

400

401

402

403

POSTERS

404

405

406

407

134

Saturday, May 31 – Tuesday, June 3, 2014 EVALUATION OF POSSIBLE SUBCLINICAL ATHEROSCLEROSIS IN ADOLESCENTS WITH A FAMILY HISTORY OF PREMATURE ATHEROSCLEROSIS A. Celik, M. Ozcetin, Z.R.Y. Celikyay, E. Sogut, Y. Yerli, H. Kadi, F. Koc, I.H. Damar, K. Ceyhan, U. Erkorkmaz (Turkey) ENDOTHELIAL DYSFUNCTION IS ASSOCIATED WITH ELEVATED ASYMMETRIC DIMETHYLARGININE LEVELS IN PATIENTS WITH AMI AND ABNORMAL GLUCOSE TOLERANCE L. David, A. Grosu (Moldova) IMPACT OF Q192R OF PON1 POLYMORPHISM ON THE ENDOTHELIAL FUNCTION AND OXIDATIVE STRESS MARKERS IN THE SIMVASTATIN-TREATED CHD PATIENTS T.B. Domagala, R. Januszek, K. Kotula-Horowitz, J. Zagajewski, M. Janczura, J. Musial (Poland) ENDOTHELIAL FUNCTION IN YOUNG HEALTHY SUBJECTS ASSESSED BY LASER DOPPLER FLOWMETRY POORLY CORRESPONDS WITH FLOW-MEDIATED VASODILATION MEASURED BY ENDOPAT 2000 M. Jakubowski, A. Turek, E. Szahidewicz-Krupska, J. Gawrys, K. Rdzanek (Poland) INNER MICROVASCULAR FUNCTION ASSESSMENT THROUGH AN OPTO-MECHANICAL POLYDIMETHYLSILOXANE CHIP R. Rodriguez-Rodriguez, J. Nyvad, J.A. Plaza, U. Simonsen, A. Llobera, V. Matchkov, X. Muñoz-Berbel (Spain)

746

747

748

749

750

THE EFFECT OF PERIODONTAL THERAPY ON ENDOTHELIAL FUNCTION AND PROINFLAMMATORY BIOMARKERS IN PATIENTS WITH STABLE CORONARY DISEASE:PROTOCOL FOR A RCT M. Saffi, M.V. Furtado, M.M. Montenegro, I.W.J. Ribeiro, C. Kampits, E.R. Rabelo-Silva, C.A. Polanczyk, C.K. Rösing, A.N. Haas (Brazil)

751

CORRELATION BETWEEN ENDOTHELIAL DYSFUNCTION AND REDOX-POTENTIAL DECREASING IN PATIENTS WITH SEVERE FORM OF CONGESTIVE HEART FAILURE O. Donetskaya, B. Krugly, V. Tulupova, N. Shuldeshova (Russia)

752

ENDOTHELIAL DYSFUNCTION, ACTIVITY OF RENIN-ANGIOTENSIN SYSTEM IN PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS AFTER CARDIAC SURGICAL REVASCULARIZATION S. Kovalev, A. Bulinin, V. Malutin, V. Malikov, M. Arzumanyan (Russia)

753

Board No.

408

Saturday, May 31 – Tuesday, June 3, 2014 COMPARISON OF COMBINED ANTIHYPERTENSIVE AND HYPOLIPIDEMIC THERAPY ACCORDING TO THE INFLUENCE ON ENDOTHELIAL FUNCTION Y. Balandina, Y. Tarlovskaya, N. Maksimchuk-Kolobova (Russia)

754

8:30 - 18:30Imaging 409

EVOLUTION OF SYMPTOMATIC INTRACRANIAL ATHEROSCLEROTIC DISEASE UNDER AGGRESSIVE RISK FACTOR CONTROL: A PROSPECTIVE STUDY BY SERIAL 3D-ROTATIONAL ANGIOGRAPHY755 T.W. Leung, L. Wang, S. Yu, Y. Soo, L. Wong (Hong Kong China)

410

A QUANTITATIVE LIPIDOMIC ANALYSIS OF PLASMA AND PLASMA LIPOPROTEINS BY MALDI-TOF MASS SPECTROMETRY J. Serna, A. Arroyo, R. Busto, M.A. Lasuncion, A. Alcazar, O. Pastor (Spain)

756

DISTURBED RIGHT VENTRICULAR FUNCTION RESPONSE TO DOBUTAMINE STRESS IN SYNDROME X PATIENTS: A POTENTIAL EFFECT OF CORONARY CALCIFICATION T.M. Bengrid, MD, Y. Zhao, MD, M.Y. Henein, MD (Sweden)

757

411

412

DIXON IMAGING ALLOWS QUANTIFICATION OF MURINE PLAQUE LIPIDS BY EX VIVO MRI B. Dietel, L. Budinsky, C. Garlichs, S. Achenbach, A. Hess (Germany)

413

CORRELATION BETWEEN CORONARY ARTERY CALCIFICATION AND GLOMERULAR FILTRATION RATE IN HIGH-COMPLIANCED PATIENTS WITH UNCOMPLICATED ARTERIAL HYPERTENSION759 N. Koziolova, I. Shatunova, I.G.O.R. Lazarev (Russia)

414

TARGETING THE IMMUNE CO-STIMULATORY MOLECULE CD80 FOR THE IMAGING OF VULNERABLE ATHEROSCLEROTIC PLAQUES BY PET R. Meletta, A. Müller, L. Mu, A. Chiotellis, N. Borel, Z. Rancic, P.A. Kaufmann, S.M. Ametamey, R. Schibli, S.D. Krämer (Switzerland)

415

416

758

760

PROGNOSIS OF DETECTION OF SILENT CORONARY ARTERY DISEASE BY COMPUTED TOMOGRAPHIC SCAN C. Morcillo, Y. López Perna, C. Vericat, J. Masip (Spain)

761

THE FEATURES OF THE MYOCARDIAL DEFORMATION CHARACTERISTICS IN PATIENTS WITH CORONARY ARTERY DISEASE, DEFINED BY THE TECHNOLOGY X-STRAIN V. Oleynikov, V. Galimskaya, I. Donchenko, E. Romanovskaya (Russia)

762 135

Board No.

417

Saturday, May 31 – Tuesday, June 3, 2014 ATHEROSCLEROTIC LESIONS OF THE CORONARY ARTERIES IN PATIENTS WITH MITRAL HEART DISEASE WITH OR WITHOUT TYPE 2 DIABETES MELLITUS E. Shalaeva, N. Dadabaeva, A. Shalaeva, K. Zakirov, B. Babajanov, B. Janabaev (Uzbekistan)

763

418

VASCULAR CHANGES IN DIABETIC PATIENTS UNDERGOING PERITONEAL DIALYSIS P. Miarka, M. Krzanowski, M. Walus-Miarka, A. Pietrzycka, K. Janda, B. Idzior-Walus, W. Sulowicz (Poland)

764

419

ROLE OF IN VIVO IMAGING IN CARDIVASCULAR RESEARCH, DIAGNOSIS AND TREATMENT M. Semjeni, G. Foldes, K. Szigeti, N. Kovacs, D. Mathe (Hungary)

765

420

PROBNP STRONGLY PREDICTS VASCULAR EVENTS INDEPENDENTLY FROM THE ANGIOGRAPHICALLY DETERMINED CORONARY ARTERY STATE P. Rein, C.H. Saely, A. Vonbank, A. Leiherer, H. Drexel (Austria)

766

POSTERS

8:30 - 18:30Intima media thickness 421

INTRAVASCULAR ULTRASOUND MODIFIES PERIPHERAL ARTERIAL ENDOVASCULAR INTERVENTIONS767 R.B. Allan, Y.T. Wong, P.J. Puckridge, J.I. Spark (Australia)

422

POSSIBLE IMPACT ON THE TOTAL CAROTID PLAQUE AREA IN PATIENT WITH ARTERIAL HYPERTENSION768 N. Balashenko, V. Podpalov, O. Zhurova, O. Podpalova (Belarus)

423

PSYCHOLOGICAL STRESS AND CAROTID THICKNESS MEASURED IN ADOLESCENTS V. Romero, MD, G. Bermudez (Venezuela)

424

RISK FACTORS FOR THE PREVALENCE AND PROGRESSION OF ATHEROSCLEROTIC PLAQUE IN CHRONIC KIDNEY DISEASE M. Gracia, D. Arroyo, A. Betriu, E.D. Fernández (Spain)

770

PARAMETERS OF LOCAL VASCULAR STIFFNESS IN HEALTHY SUBJECTS AND PATIENTS WITH CORONARY ARTERY DISEASE COMBINED WITH HYPERTENSION 1-2 DEGREES V. Oleynikov, I. Matrosova, E. Melnikova, J. Tomashevskaya (Russia)

771

425

136

769


Board No.

426

427

428

SUBCLINICAL CAROTID ATHEROSCLEROSIS CORRELATES WITH CHRONOTROPIC INCOMPETENCE IN ASYMPTOMATIC MIDDLE-AGE SUBJECTS A. Liontou, C. Pitsavos, J. Skoumas, C. Chrysohoou, C. Stefanadis (Greece) THE COMPARATIVE STUDY OF COMMON CAROTID INTIMA-MEDIA THICKNESS IN RUSSIAN AND ITALIAN HIGH-RISK INDIVIDUALS I. Sobenin, V. Orekhova, Y. Bobryshev, A. Orekhov, V. Myasoedova, A. Ravani, E. Tremoli, D. Baldassarre (Russia) NEW INDEX OF ATRIAL-ARTERIAL COUPLING FOR PHYSICAL FITNESS IN ELDERLY MEN W. Tsai, J. Shih, J. Chen, P. Liu, L. Tsai (Taiwan)

8:30 - 18:30

772

773

774

Obesity and fat distribution

429

ECTOPIC VISCERAL FAT AND DIFFERENCES BETWEEN RISK FACTORS AND CORONARY SYNDROMES 775 R. Leonardo, E.S. Resende, N. Penha-Silva, A.S. Roerver-Borges, A. Casella-Filho, A.L.D. Diniz, P.M.M. Dourado, C. Denardi, F. Veloso, M. Silva, A.C.P. Chagas (Brazil)

430

IMPROVING ARTERIAL STIFFNESS IN OVERWEIGHT AND OBESE SUBJECTS AFTER WEIGHT LOSS INTERVENTION V. Elian, L. Dragomirescu, D.M. Cheta, C. Serafinceanu (Romania)

776

431

EFFECTS OF METFORMIN IN PARAOXONASE-1 DEFICIENT MICE I. Fort, M. Riera-Borrull, E. Rodríguez-Gallego, A. Hernández-Aguilera, F. Luciano, S. Fernández-Arroyo, A. Abengochea, R. Mariné, M. Guirro, J. Camps, A. García Heredia (Spain)

432

THE ACTION OF METFORMIN IN HYPERLIPEMIC MICE IS MODULATED BY THE METABOLIC CONTEXT 778 M. Riera-Borrull, A. Hernández-Aguilera, E. Rodríguez-Gallego, A. Abengochea, S. Fernández-Arroyo, A. García-Heredia, F. Luciano, R. Mariné, M. Guirro, J. Joven (Spain)

433

ULTRASONOGRAPHIC STEATOSIS EVALUATION AND CARDIO-METABOLIC RISK PROFILE IN HEALTHY SUBJECTS L. Ballerini, A. Milia, L. Giannini, A. Berni, C. Fiorillo, M. Becatti, L. Poggesi, M. Boddi (Italy)

434

CARDIO-RENAL ECTOPIC FAT AND ORGAN DAMAGE IN HEALTHY SUBJECTS L. Giannini, L. Ballerini, A. Milia, A. Berni, L. Poggesi, M. Boddi (Italy)

777

779

780

137

Board No.

435

Saturday, May 31 – Tuesday, June 3, 2014 ULTRASONOGRAPHIC ABDOMINAL FAT ASSESSMENT IN CARDIOMETABOLIC RISK EVALUATION OF HEALTHY SUBJECTS A. Milia, L. Giannini, L. Ballerini, A. Berni, C. Fiorillo, M. Becatti, L. Poggesi, M. Boddi (Italy)

436

EFFECTS OF LEPTIN ON MACROPHAGES IN VIVO A. Hoffmann, S. Kralisch, S. Duhring, T. Ebert, F. Jeromin, N. Kloting, M. Bluher, R. Burckhardt, M. Fasshauer (Germany)

437

CIRCULATING ADHESION MOLECULE SERUM CONCENTRATIONS IN INDIVIDUALS WITH INSULIN SENSITIVE OBESITY V. Richter, M. Blüher (Germany)

438

OVERWEIGHT, OBESITY, AND DIABETES AFTER A GROUP MOTIVATIONAL INTERVENTION IN PRIMARY CARE HEALTH J. Rodriguez Cristobal, C. Alonso-Villaverde Grote, J. Panisello Royo, E. Quillama Torres, L. Illamola Martin, O. Linares Cerro (Spain) WAIST-TO HEIGHT RATIO AS A METABOLIC RISK FACTOR IN HEMODIALYSIS PATIENTS M. Ruperto, G. Barril, F.J. Sánchez-Muniz (Spain)

440

CONTINUOUS POSITIVE AIRWAY PRESSURE INDUCES ABDOMINAL FAT REDISTRIBUTION IN OBSTRUCTIVE SLEEP APNEA PATIENTS D. Ibarretxe, R. Català, R. Ferré, A. Cabré, S. Sangenís, N. Plana, L. Masana (Spain)

POSTERS

439

441

FASTING AND POSTPRANDIAL LEVELS OF GIP IN HEALTHY AND OBESE SUBJECTS (THE BIOCLAIMS STUDY) M. Malczewska-Malec, J. Goralska, U. Razny, D. Wnek, J. Stancel-Mozwllo, A. Polus, M. KiecKlimczak, A. Zdzienicka, A. Gruca, A. Hubalewska-Dydejczyk, A. Dembinska-Kiec (Poland)

8:30 - 18:30 442

138

781

782

783

784

785

786

787

Metabolic syndrome

PROTEOMIC CHANGES IN PERIPHERAL BLOOD MONONUCLEAR CELLS FROM METABOLIC SYNDROME PATIENTS AFTER LONG TERM INTAKE OF DIFFERENT DIETARY FAT MODELS. O. Rangel-Zuñiga, C. Marin-Hinojosa, A. Ortiz-Morales, A. Camargo-Garcia, L. Gonzalez-de la Guardia, F. Fuentes-Jimenez, J. Lopez-Miranda (Spain)

788

Board No.

443

Saturday, May 31 – Tuesday, June 3, 2014 INFLUENCE OF ENDOTHELIAL DYSFUNCTION ON TELOMERE LENGTH IN SUBJECTS WITH METABOLIC SYNDROME: LIPGENE STUDY L. Gonzalez-Guardia, E.M. Yubero-Serrano, C. Cruz-Teno, O. Rangel-Zuñiga, J.F. Alcala-Diaz, F. Perez-Jimenez, J. Lopez-Miranda (Spain)

789

444

FREE FATTY ACIDS AND ADIPONECTIN IN TUNISIAN PATIENTS WITH METABOLIC SYNDROME H. Chahed, N. Gammoudi, S. Ferchichi, A. Miled (Tunisia)

445

GENISTEIN AGLYCONE A NUTRACEUTICAL APPROACH TO METABOLIC SYNDROME: RESULTS FROM A RANDOMIZED CLINICAL TRIAL IN POSTMENOPAUSAL WOMEN A. Bitto, D. Altavilla, A. Di Benedetto, D. Cucinotta, F. Squadrito (Italy)

791

PROGNOSIS VALUE OF BIOMARKERS IN PATIENTS WITH NON ST ELEVATION ACUTE CORONARY SYNDROME AND METABOLIC SYNDROME OR DIABETES MELLITUS A. Covaciu, N. Aldulea, C. Strempel, E. Bobescu (Romania)

792

446

447

VITAMIN D DEFICIENCY AND METABOLIC SYNDROME I. Gonzalez Molero, S. Morcillo, G. Rojo, E. Rubio, C. Gutierrez-Repiso, F. Soriguer (Spain)

448

EFFECT OF RESVERATROL ADMINISTRATION ON METABOLIC SYNDROME, INSULIN SENSITIVITY AND INSULIN SECRETION M. González, MD, M. Méndez, MD, E. Martínez, MD, K.G. Pérez, MD, J.R. Lizárraga, MD (Mexico)

790

793

794

449

GELATINASES AND THEIR TISSUE INHIBITORS IN METABOLIC SYNDROME E. Hopps, B. Canino, M. Montana, D. Noto, M.R. Averna, R. Lo Presti, G. Caimi (Italy)

795

450

OXIDATIVE STATUS IN METABOLIC SYNDROME E. Hopps, B. Canino, M. Montana, D. Noto, M.R. Averna, R. Lo Presti, G. Caimi (Italy)

796

451

METABOLIC PREDICTORS OF CARDIOVASCULAR EVENTS IN DIABETIC INDIVIDUALS: 5.5-YEAR SURVEY OF CARDIOVASCULAR EVENTS K. Ina, T. Hayashi, M. Kuzuya (Japan)

452

INCREASED LIPID LEVELS AND INSULIN RESISTANCE IN PREHYPERTENSIVE SUBJECTS P. Kokkoris, K. Chantziara, C. Maniotis, E. Kassi (Greece)

797

798

139

Board No.

453

454

455

456

POSTERS

457

458

459

460

461

140

Saturday, May 31 – Tuesday, June 3, 2014 EFFECT OF MILD STREPTOZOTOCIN/NICOTINAMIDE-INDUCED DIABETES ON AORTIC PLAQUE AREA IN NEW MINIPIG MODEL OF ATHEROSCLEROSIS T.P. Ludvigsen, R.K. Kirk, B.O. Christoffersen, H.D. Pedersen, P. Heegaard, J. Lykkesfeldt, L.H. Olsen (Denmark) ENHANCED LEVELS OF THE LIGHT/LYMPHOTOXIN-BETA RECEPTOR INFLAMMATORY AXIS IN METABOLIC SYNDROME PATIENTS S. Martínez-Hervás, I. Andrés-Blasco, A. Vinué, A. Herrero, L. Piqueras, J.F. Ascaso, M.J. Sanz, H. González-Navarro (Spain)

799

800

EXPRESSION OF FRACTALKINE AND ITS RECEPTOR (CX3CR1) IN SUBCUTANOUS ADIPOSE TISSUE FROM PATIENTS WITH CORONARY ARTERY DISEASE AND TYPE 2 DIABETES I. Njerve, R. Byrkjeland, H. Arnesen, S. Akra, S. Solheim, I. Seljeflot (Norway)

801

CARDIOMETABOLIC RISK ASSOCIATED WITH METABOLIC SYNDROME IN TYPE 2 DIABETES PATIENTS M. Torrea, N. Aladeazabal, O.L.G.A. Lopez Berastegui, B. Pinilla, A. Muiño, J. Millan (Spain)

802

MMP-9-1562 C/T POLYMORPHISM INCREASES THE RISK OF CV EVENTS IN PATIENTS WITH METS, PARTLY MEDIATED THROUGH CIRCULATING MMP-9 AND EMMPRIN T. Opstad, A.A. Pettersen, H. Arnesen, I. Seljeflot (Norway)

803

FATTY FISH, BILBERRIES AND WHOLE GRAIN PRODUCTS AFFECT THE METABOLOMIC PROFILE IN SUBJECTS OF THE SYSDIMET STUDY: A NON-TARGETED METABOLOMIC APPROACH A. Pedret Figuerola, M. Lankinen, M. Kolehmainen, J. Paananen, U. Schwab, V. De Mello, R. Solà, M. Lehtonen, K. Poutanen, M. Uusitupa, H. Mykkänen, K. Hanhineva (Spain)

804

THE SIGNIFICANCE OF LIPIDS AND INFLAMMATION PARAMETERS AFTER CORONARY STENTING IN PATIENTS WITH STABLE ANGINA AND DIABETES T. Petelina, L. Gapon, N. Musikhina, O. Belosludseva, I. Osipova, V. Kuznetsov (Russia)

805

RELATIONSHIP BETWEEN TNF ALPHA, IL-6 AND CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES AND METABOLIC SYNDROME R. Dragut, E. Rusu, R. Nan, C. Parpala, F. Rusu, M. Jinga, G. Tocaci, G. Radulian (Romania)

806

EVALUATION OF THE MODERATELY OBESE APOE GENE KNOCKOUT RAT AS A NEW MODEL FOR IMPAIRED GLUCOSE TOLERANCE AND ATHEROSCLEROSIS I. Rune, B. Rolin, J. Lykkesfeldt, B. Chistoffersen, R.K. Kirk, A.K. Hansen (Denmark)

807

Board No.

462

Saturday, May 31 – Tuesday, June 3, 2014 DNA-APTAMER RAISED AGAINST RAGE BLOCKS THE PROGRESSION OF EXPERIMENTAL DIABETIC NEPHROPATHY K. Taguchi, K. Fukami, S. Yamagishi, Y. Higashimoto, M. Yokoro, N. Obara, R. Ando, Y. Nakayama, T. Matsui, M. Takeuchi, S. Ueda, S. Okuda (Japan)

808

8:30 - 18:30NASH and related disorders 463

464

CARDIOVASCULAR RISK FACTORS IN NONALCOHOLIC FATTY LIVER DISEASE/ NONALCOHOLIC STEATOHEPATITIS R. Ivanova, M. Gospodinova, J. Petrova, A. Alexiev, S. Denchev, L. Mateva (Bulgaria) SERUM TRIGLYCERIDE LEVELS ARE ASSOCIATED WITH CYTOKERATIN -18 CONCENTRATION IN PATIENTS WITH TYPE 2 DIABETES AND NON-ALCOHOLIC FATTY LIVER DISEASE M. Walus-Miarka, A. Trojak, B. Idzior-Walus, E. Wozniakiewicz, J. Gastol, L. Pawlinski, M.T. Malecki (Poland)

809

810

8:30 - 18:30Sub inflammatory states 465

ANAEMIA AND IRON METABOLISM AS RISK FACTORS FOR GLUCOSE INTOLERANCE AMONGST MEN AND WOMEN ORIGINATING FROM THE INDIAN SUBCONTINENT E.S. Agaoglu, J.V. Patel, J. Chackathayil, M. Allam, A. Vyas, P.N. Durrington, J.K. Cruickshank, P.S. Gill, E.A. Hughes (United Kingdom)

811

8:30 - 18:30Diabetes macroangiopathy 466

467

THE EFFECT OF INSULIN ANALOG INITIATION THERAPY ON PLASMA POLYUNSATURATED FATTY ACIDS DURING EARLY PHASE I. Aslan, MD, M. Aslan, MD (Turkey) EFFECT OF MAGNESIUM SUPPLEMENTATION ON METABOLIC CONTROL AND INSULIN SENSITIVITY IN TYPE 2 DIABETIC PATIENTS J.L. Ble-Castillo, A. Navarrete-Cortes, F. Guerrero-Romero, R. Cordova-Uscanga, I.E. JuarezRojop, H. Aguilar-Mariscal, C.A. Tovilla-Zarate, M.R. López-Guevara, J.C. Diaz-Zagoya (Mexico)

812

813

141

Board No.

468

EFFECTS OF HYPOLIPIDEMIC DRUGS (ATORVASTATIN, FENOFIBRATE AND COMBINED TREATMENT) ON INSULIN RESISTANCE INDEX, ADIPOKINES AND INFLAMMATORY MARKERS IN DYSLIPIDEMIC SUBJECTS L. Buldak, MD, B. Okopien, MD, R. Krysiak, MD, K. Labuzek, MD, A. Dulawa-Buldak, MD (Poland)

814

469

IMPACT OF DIFFERENT CRITERIA ON TYPE 2 DIABETES REMISSION RATE AFTER BARIATRIC SURGERY815 M. Antonio, P. Juan, B. David, F. Juana, R. Jose Manuel, C. Juan José, P. Alejandra, V. Montserrat, P.E.R.A. Manuel, G. Albert (Spain)

470

THE LONG TERM EFFICACY OF INSULIN TREATMENT IN TYPE 2 DIABETIC PATIENTS, 36-MONTHS OBSERVATION PERIOD E. Farcasiu (Romania)

471

POSTERS

472

473

142


INSULIN RESISTANCE, HYPERINSULINEMIA, HYPERALDOSTERONISM AND ENDOTHELIAL DYSFUNCTION IN YOUNG HEALTHY MEN – BYSTANDERS OR TEAM PLAYERS? A. Janus, A. Doroszko, E. Szahidewicz-Krupska, M. Jakubowski, G. Mazur, A. Derkacz (Poland) CORRELATIONS BETWEEN RESTING METABOLIC RATE AND ANTHROPOMETRIC PARAMETERS IN NEWLY DIAGNOSED TYPE 2 DIABETIC PATIENTS M. Mitu, L. Petcu, J. Tudosoiu, A. Mihai, S. Carniciu, P. Gagniuc, D. Lixandru, C. Ionescu-Tirgoviste (Romania) THE EFFECT OF HYPERTRIGLYCERIDEMIA ON CARBONYL AND OXIDATIVE STRESS IN AN EXPERIMENTAL MODEL OF INSULIN RESISTANCE H. Malinska, O. Oliyarnyk, L. Kazdova (Czech Republic)

816

817

818

819

474

EFFECT OF MICRONIZED EXTRACT AND PHYTOSOMES CONTAINING EXTRACT FROM SILYBUM MARIANUM ON METABOLIC DISORDERS IN NONOBESE MODEL OF INSULIN RESISTANCE 820 O. Oliyarnyk, H. Malinska, J. Trnovska, V. Skop, R. Vecera (Czech Republic)

475

PREVALENCE AND MANAGEMENT OF TYPE II DIABETES IN CAUCASIAN AND ASIAN SUBPOPULATIONS WITH ACS J.R.J. Foley, P.A. Patel, C. Yau, Y. Zheng, Y. Blackburn, S. Bulugahapitiya (United Kingdom)

821

Board No.

476

477

478

479

480

481

482

483

Saturday, May 31 – Tuesday, June 3, 2014 THE EFFECT OF N-3 PUFA SUPPLEMENTATION ON POSTPRANDIAL TRIGLYCERIDES AND INSULIN IN PREDIABETES: THE BIOCLAIMS STUDY U. Razny, MD, A. Polus, MD, D. Wnek, MD, B. Kiec-Wilk, MD, A. Sliwa, MD, A. Zdzienicka, MD, A. Gruca, MD, M. Malecki, MD, M. Malczewska-Malec, MD (Poland) IS LONG-ACTING RESVERATROL EFFECTIVE ON THE RESIDUAL DYSLIPIDEMIA IN STATINTREATED TYPE 2 DIABETIC PATIENTS? B. Vergès, M.C. Brindisi, B. Bouillet, E. Crevisy, P. Buffier, S. Baillot-Rudoni, G. Vaillant, V. Grivet, J.M. Petit (France) TYPE 2 DIABETIC PATIENTS WITH DIABETIC RETINOPATHY WITHOUT PREVIOUS CARDIOVASCULAR DISEASE SHOW AN INCREASED CAROTID PLAQUE BURDEN N. Alonso, A. Traveset, E. Rubinat, M.V. Arcidiacono, E. Ortega, A. Betriu, M. Hernández, E. Fernández, D. Mauricio (Spain) CAROTID ATHEROSCLEROSIS IN ASYMPTOMATIC NEWLY DIAGNOSED TYPE 2 DIABETIC SUBJECTS (NEWDM) E. Ortega, M. Catalán, Z. Herreras, M. Pinyol, A. Sala-Vila, R. Gilabert (Spain) EFFECT OF EXENATIDE ADMINISTERED IN DIFFERENT TIMES OF FOOD INTAKE ON GLUCOSE VARIABILITY IN PATIENTS WITH DIABETES MELLITUS TYPE 2 E. Martínez-Abundis, MD, T. González-Heredia, MD, M. González-Ortiz, MD, K. Pérez-Rubio, MD (Mexico) RESVERATROL, WINE POLYPHENOL INDUCES RELAXATION OF RAT RENAL ARTERY IN DIABETIC RATS L. Gojkovic-Bukarica, R. Novakovic, S. Cirovic, V. Kanjuh, H. Heinle, J. Markovic-Lipkovski (Serbia) DIABETIC RETINOPATHY IS AN INDEPENDENT RISK FACTOR OF AORTIC VALVE CALCIFICATION IN TYPE 2 DIABETES WITHOUT CHRONIC KIDNEY DISEASE T. Kasuga, A. Sato, K. Matsukawa, K. Okamoto, Y. Uchigata (Japan) CRITICAL LIMB ISCHEMIA = CRITICAL STENOSIS OF THE CORONARY ARTERIES? POSTOPERATIVE PROGNOSIS E. Shalaeva, N. Dadabaeva, A. Shalaeva, B. Babajanov, K.H. Safarov, U. Kasimov (Uzbekistan)

822

823

824

825

826

827

828

829

143

Board No.

484

485

Saturday, May 31 – Tuesday, June 3, 2014 ENDOTHELIAL DYSFUNCTION AND INTIMA-MEDIA THICKNESS IN GCK AND HNF1A MODY PATIENTS M. Szopa, G. Osmenda, G. Wilk, B. Matejko, T. Guzik, M.T. Malecki (Poland) THE INFLUENCE OF DIABETES MELLITUS ON SEVERITY AND SHORT TERM OUTCOME OF ACUTE ISCHEMIC STROKE. A. Koutsovasilis, A. Papazafiropoulou, A. Sotiropoulos, V. Vergidou, T. Peppas, O. Apostolou, M. Bachlitzanaki, E. Tamvakos, S. Bousboulas (Greece)

830

831

8:30 - 18:30Nephropathy 486

POSTERS

487

144

CONTRIBUTION OF CHRONIC KIDNEY FAILURE TO SUBCLINICAL PERIPHERAL ARTERIAL DISEASE IN PATIENTS WITH DIABETES MELLITUS J. Ena, C.R. Argente, T. Lozano, C.E. Alvarez (Spain)

832

ARTERIAL STIFFNESS AND CHRONIC KIDNEY DISEASE IN MIDDLE-AGED PATIENTS WITH TYPE 2 DIABETES MELLITUS O. Georgescu, S. Craciun, C. Nica, L. Banu, C. Ion Toader, S. Fica (Romania)

833

488

INVOLVEMENT OF DDAH-ADMA AXIS IN AKI N. Obara, S. Ueda, S. Yamagishi, Y. Nakayama, K. Taguchi, M. Yokoro, K. Fukami, S. Okuda (Japan)

489

MOLECULAR CHARACTERIZATION OF THREE ITALIAN CASES OF LIPOPROTEIN GLOMERULOPATHY 835 L. Pisciotta, A. Pasquariello, T. Sampietro, R. Miccoli, S. Calandra, S. Bertolini (Italy)

490

PREVALENCE OF PROTEIN ENERGY WASTING IN HEMODIALYSIS PATIENTS. CHARACTERIZATION OF NUTRITIONAL INDICATORS AND INFLAMMATORY MARKERS M. Ruperto, G. Barril, F.J. Sánchez-Muniz (Spain)

491

LDL APHERESIS IN LIPOPROTEIN GLOMERULOPATHY: A NEW INDICATION F. Sbrana, M. Puntoni, F. Bigazzi, P. Lorusso, R. Luciani, M. Pianelli, A. Pasquariello, T. Sampietro (Italy)

492

ASSOCIATION OF PARAOXONASE ACTIVITY WITH NUTRITIONAL STATUS IN PATIENTS WITH CHRONIC KIDNEY DISEASE G. Paragh, F. Sztanek, M. Harangi, L. Locsey, P. Koncsos, P. Fülöp, I. Seres (Hungary)

834

836

837

838

Board No.


8:30 - 18:30Aneurysms 493

EXPRESSION OF ADAMTS-1 IN AAA T. Gustafsson, E. Vorkapic, P. Eriksson, D. Wågsäter (Sweden)

839

8:30 - 18:30Lifestyle and CV risk 494

495

496

497

498

499

500

ASSOCIATION OF INCREASED LARGE HDL PARTICLES WITH IMPROVED CARDIOPULMONARY FITNESS IN ACUTE CORONARY SYNDROME PATIENTS PARTICIPATED WITH EXERCISE-BASED CARDIAC REHABILITATION Y. Ito, S. Koba, Y. Yokota, T. Hirano, M. Shoji, Y. Kobayashi (Japan)

840

IMPACT OF PSYCHOSOCIAL STRESS AND OTHER RISK FACTORS ON CARDIOVASCULAR MORBIDITY IN LITHUANIAN POPULATION D. Karciauskaite, A. Ma?eikiene, N. Burokiene, Z.A. Kucinskiene (Lithuania)

841

EFFECT OF MENTAL STRESS ON ATHEROSCLEROTIC PLAQUE VULNERABILITY, MYOCARDIAL INFARCTION AND SURVIVAL IN MICE L. Roth, D.M. Schrijvers, G.W. De Keulenaer, W. Martinet, G.R.Y. De Meyer (Belgium)

842

ASSOCIATION OF ATHEROGENIC DYSLIPIDEMIA WITH CARDIOVASCULAR RISK IN SPANISH WORKING POPULATION: RESULTS FROM THE ICARIA STUDY P. González-Santos, P. Valdivielso, M. Cabrera, L. Quevedo-Aguado, M.A. Sánchez-Chaparro, E. Calvo-Bonacho (Spain) ASSOCIATION BETWEEN CARDIOVASCULAR RISK LEVEL AND THE INCIDENCE OF STROKE AMONG SPANISH WORKING POPULATION: RESULTS FROM THE ICARIA STUDY P. Valdivielso, C. Catalina-Romero, M.A. Sánchez-Chaparro, P. González-Santos, M. Cabrera, E. Calvo-Bonacho (Spain)

843

844

THE EFFECT OF MODERATE EXERCISE ON THE AFFINITY OF TRIGLYCERIDE-RICH LIPOPROTEINS FOR LIPOPROTEIN LIPASE K. Ghafouri, M. Caslake, J.M. Gill (United Kingdom)

845

SIGNIFICANT IMPACT OF ECCENTRIC ENDURANCE EXERCISE ON LIVER ENZYMES IN OVERWEIGHT AND OBESE INDIVIDUALS P. Rein, A. Vonbank, C.H. Saely, A. Leiherer, H. Drexel (Austria)

846

145

Board No.

501

METABOLIC BENEFITS OF ECCENTRIC ENDURANCE EXERCISE IN OVERWEIGHT AND OBESE INDIVIDUALS847 P. Rein, C.H. Saely, A. Vonbank, S. Geller-Rhomberg, A. Leiherer, H. Drexel (Austria)

502

VOLUNTARY EXERCISE SLOWS THE PROGRESSION OF ESTABLISHED ANGIOTENSIN IIDEPENDENT ADVANCED ATHEROSCLEROTIC LESIONS M. Pellegrin, J.F. Aubert, K. Bouzourene, C. Amstutz, L. Mazzolai (Switzerland)

POSTERS

503

THE INFLUENCE OF EXCERCISE AND DIET ON GASTROINTESTINAL PEPTIDES CIRCULATING LEVELS: APPETITTE AND ENERGY HOMEOSTASIS V. Aragon, R. Toro, M. Quezada-Feijoo, C. Rodriguez-Leal, I. Tinoco, M. Garcia Del Rio, A. Mangas (Spain)

504

TGF BETA AND DIFFERENT DIETS: THE KEY TO THE CARDIOVASCULAR HEALTH? B. Ruiz, R. Toro, M. Quezada-Feijoo, C. Rodriguez-Leal, I. Tinoco, V. Aragon, M. Monsalvo, A. Mangas (Spain)

505

RESTING HEART RATE PLAYS A MAJOR ROLE IN CARDIORESPIRATORY FITNESS: AN USEFUL PREDICTOR OF ALL-CAUSE MORTALITY RISK S. Tello-Blasco, C. Fernández, A. Miguel, R. Fabregate, M. Fabregate, C. Gómez, D. Barrio, J. Sabán-Ruiz (Spain)

506

507

146


EFFECT OF VOLUNTARY RUNNING ON FATTY ACID COMPOSITION IN MEMBRANE PHOSPHOLIPIDS AND AMOUNT OF LIPOTOXIC INTERMEDIATES IN HEREDITARY HYPERTRIGLYCERIDEMIC RATS V. Skop, H. Malínská, J. Trnovská, M. Huttl, A. Blachnio-Zabielska, M. Baranowski, L. Kazdová (Czech Republic) USEFULNESS OF ATHEROGENIC DYSLIPIDEMIA INDEX TO ASSESS THE CARDIOVASCULAR RISK OF PRIMARY CARE PATIENTS – RESULTS FROM LIPIDOGRAM2004 AND LIPIDOGRAM2006 STUDIES K. Rygiel, J. Jozwiak, N. Mathers, W. Lukas, J. Jasik-Slezak, A. Slezak, A. Windak, T. Tomasik, M. Mastej, W.H. Smithson, M. Tomaszewski, B.M. Kaess, D. Nowak, W. Grzeszczak, A. Tykarski, E. Mizgala, M. Banach (Poland)

848

849

850

851

852

853

Board No.


8:30 - 18:30Nutrition and CV risk 508

509

EFFECT OF HIGH-FAT DIET AND ITS REVERSAL ON ARTERIAL WALL NOGO-B EXPRESSION IN EXPERIMENTAL PIGS I. Grzegorek, A. Gomulkiewicz, K. Jablonska, M. Chmielewska, A. Piotrowska, K. Drozdz, D. Janczak, R. Paslawski, U. Paslawska, P. Dziegiel, A. Szuba (Poland) CAN DIETARY POLYPHENOLS PREVENT CARDIOVASCULAR DISEASE BY INHIBITING VEGFDEPENDENT ANGIOGENESIS IN ATHEROSCLEROSIS? R.L. Edwards, P. Needs, S. Robinson, F.A. Tomás Barberán, P.A. Kroon (United Kingdom)

854

855

510

DIETARY SODIUM INTAKE RELATED WITH CYSTEINE AND METHIONINE IN TYPE 2 DIABETIC PATIENTS856 A. Valente, M. Bicho, R. Duarte, J.F. Raposo, H. Soares Costa (Portugal)

511

EFFECTS OF ACUTE INGESTION OF NATIVE BANANA STARCH ON POSTPRANDIAL GLUCOSE METABOLISM IN OBESE AND NORMAL-WEIGHT SUBJECTS J.L. Ble-Castillo, G. Jimenez-Dominguez, I.E. Juarez-Rojop, C.A. Tovilla-Zarate, M.A. Aparicio-Trapala, V. Olvera-Hernandez, S. Aguilar-Barojas, C. Garcia-Vazquez, J.C. Diaz-Zagoya (Mexico)

512

EXERCISE AND QUERCETIN INTAKE REDUCES BODY WEIGHT IN C57BL6 MICE H. Mahini, G. Ainsworth, M. Garelnabi (USA)

513

WEIGHT LOSS EFFECT ON SERUM LIPIDS AND CHOLESTEROL METABOLISM IN OVERWEIGHT AND OBESE SUBJECTS WITH GENETIC HYPERCHOLESTEROLEMIA R. Mateo-Gallego, S. Perez-Calahorra, M. Cofán, L. Baila-Rueda, A. Cenarro, E. Ros, J. Puzo, F. Civeira (Spain)

514

515

OLIVE OIL POLYPHENOLS PROTECT ENDOTHELIAL DYSFUNCTION INDUCED BY HIGH GLUCOSE AND FREE FATTY ACIDS BY MODULATING NITRIC OXIDE AND ENDOTHELIN-1 M.T. Mitjavila, C.E. Storniolo, J.J. Moreno (Spain) MODULATION OF 12-HETE BY EXTRA VIRGIN OLIVE OIL OR NUTS SUPPLEMENTATION IN NON ALCOHOLIC-HEPATIC STEATOSIS M.T. Mitjavila, C.E. Storniolo, E. Corbella, A. Galera, E. De la Cruz, J.J. Moreno, X. Pinto (Spain)

857

858

859

860

861

147

Board No.

516

CARDIOPROTECTIVE EFFECT OF (-) EPICATECHIN A. Novakovic, A. Vranic, G. Jankovic, I. Stojanovic, P. Milojevic, N. Ugresic, V. Kanjuh, Q. Yang, H. Guo-Wei (Serbia)

517

EFFECTS OF A NUTRACEUTICAL COMBINATION OF BERBERINE, POLICOSANOL, RED YEAST RICE AND ANTIOXIDANTS, ON LIPID PROFILE IN HYPERCHOLESTEROLEMIC PATIENTS: A META-ANALYSIS863 J. Millan, G. Casanovas, A Anguera (Spain)

518

DIETARY PATTERNS AND ATHEROMETABOLIC CARDIOVASCULAR RISK J. Aranceta, C. Perez Rodrigo, T. Mantilla, S. Monereo, B. Moreno, J. Millan (Spain)

519

NATURAL PRODUCTS INHIBIT ATHEROGENIC MODIFICATION (DESIALYLATION) OF LOW DENSITY LIPOPROTEIN I. Azarova, A. Feoktistov, A. Radukhin, O. Gorlova, V. Orekhova, N. Pervushina, I. Sobenin, N. Nikiforov, S. Kotyashova, V. Aladinsky, A. Temchenko, Y. Bobryshev, A. Orekhov (Russia)

520

POSTERS

521

522

523

148


THE COMBINED EFFECT ON BLOOD LIPIDS OF PLANT STEROLS AND DIFFERENT LOW DOSES OF OMEGA-3 FATTY ACIDS R. Ras, I. Demonty, Y. Zebregs, F. Quadt, J. Olsson, E. Trautwein (Netherlands) VIRGIN OLIVE OIL RESTORES STRUCTURAL, MYOGENIC AND FUNCTIONAL ALTERATIONS OF SMALL MESENTERIC ARTERIES FROM APOE KO MICE R. Rodriguez-Rodriguez, E. Ogalla, C. Claro, M. Alvarez de Sotomayor, M.D. Herrera (Spain) FENUGREEK SEEDS DECREASE OXIDATIVE STRESS AND BLOOD LIPIDS AND INCREASE NITRIC OXIDE IN PATIENTS WITH HYPERLIPIDEMIA M. Sajty, L. Jackova, L. Merkovska, L. Jedlickova, J. Fedacko, M. Janicko, M. Vachalcova, R.B. Singh (Slovakia) EFFECTS OF EZETIMIBE ON OXIDIZED CHOLESTEROL COMPONENTS IN EPICARDIAL FAT AND MYOCARDIUM: A GAS CHROMATOGRAPHY-MASS SPECTROMETRY ANALYSIS M. Shimabukuro, C. Okawa, X.F. Lei, J.R. Kim-Kaneyama, H. Yamada, H. Kurobe, D. Fukuda, M. Sato, T. Kitagawa, M. Sata (Japan)

862

864

865

866

867

868

869

Board No.

524

525

526

527

528

Saturday, May 31 – Tuesday, June 3, 2014 EVALUATION OF ANTIATHEROSCLEROTIC EFFECTS OF ELLAGIC ACID METABOLITES IN CULTURED MACROPHAGES I. Zanotti, A. Piemontese, F. Bernini, D. Del Rio (Italy) IMPACT OF DIETARY TREATMENTS ON THE LIPIDOMIC PROFILE OF PLASMA, AORTA AND LIVER FROM LDLR-KO AND PCSK9-KO MICE M. Busnelli, C. Parolini, S. Manzini, G.S. Ganzetti, F. Dellera, R. Katainen, M. Suoniemi, K. Tarasov, R. Hurme, K. Ekroos, C.R. Sirtori, R. Laaksonen, G. Chiesa (Italy) CONNECTIONS BETWEEN DARK FISH INTAKE, LIPIDOMICS AND PLASMA TRIGLYCERIDES IN THE FRAMINGHAM HEART STUDY P. Casas-Agustench, S. Sloan, P. Jacques, C. Willinger, X. Yin, P. Courchesne, V. Ramachandran, S. Robin, M. Larson, B. Chen, M. Mendelson, D. Levy, J.M. Ordovás (Spain)

871

872

FIRST PROSPECTIVE STUDY EVALUATING THE ROLE OF GENETIC TESTING IN WEIGHT MANAGEMENT PROGRAMS I. Croux, MD, R. Gallina, MD (Switzerland)

873

FLAVONOIDS AND EXERCISE BUT NOT THE COMBINATION ENHANCES PLASMA CATALASE LEVELS IN C57BL MICE M. Garelnabi, H. Mahini, G. Ainsworth (USA)

874

529

EFFECTS OF BARIATRIC SURGERY IN LIPIDS LEVELS I. Gonzalez Molero, M. Gonzalo Marin, J. García Arnes, C. Maldonado, S. Valdes, G. Olveira, F. Tinahones (Spain)

530

EFFECT OF BARIATRIC SURGERY IN MORBIDLY OBESE PATIENTS ON THE QUANTITATIVE AND QUALITATIVE CHARACTERISTICS OF PLASMA LIPOPROTEINS J. Julve, E. Pardina, M. Pérez-Cuéllar, R. Ferrer, J. Rossell, J.A. Baena-Fustegueras, J.M. Fort, A. Lecube, F. Blanco-Vaca, J.L. Sánchez-Quesada, J. Peinado-Onsurbe (Spain)

531

870

SHORT-TERM MEDITERRANEAN STYLE BREAKFAST IS SUFFICIENT TO IMPROVE HDLCHOLESTEROL IN A BRAZILIAN SAMPLE M. Monfort-Pires, L.D. Folchetti, C.M. Marton, A.A. El Orra, B. Almeida-Pittito, A. Cezzareto, S.R.G. Ferreira (Brazil)

875

876

877

149

Board No.

532

533

534

535

Saturday, May 31 – Tuesday, June 3, 2014 CORRELATION BETWEEN FOOD CONSUMPTION , BODY MASS INDEX AND WAIST CIRCUMFERENCE IN PRESCHOOL AND SCHOOL CHILDREN IN PUBLIC SCHOOLS A. Pereira, T.P. Camargo, M.C. Elias, S.S.M. Ihara, C.A. Machado, R.D. Santos Filho, T.L.R. Martinez (Brazil) COMPARISON BETWEEN TOTAL DIETARY INTAKE AND SERUM CHOLESTEROL LEVELS IN ELEMENTARY AND MIDDLE SCHOOL STUDENTS A. Pereira, F.O.C. Pereira, T.C. Pereira, M.C. Elias, S.S.M. Ihara, C.A. Machado, R.D. Santos Filho, T.L.R. Martinez (Brazil) RICE BRAN ENZYMATIC EXTRACT REDUCES OXIDATIVE STRESS AND RESTORES MESENTERIC ENDOTHELIUM DEPENDANT DILATATION IN APO E (-/-) MICE C. Perez Ternero, C. Claro, R. Rodriguez-Rodriguez, M. Alvarez de Sotomayor, M.D. Herrera (Spain) EVALUATION OF DIETARY HABITS AND THE NUTRITIONAL CONTENT OF THE INTAKE FOOD TO OVERWEIGHT AND OBESE PATIENTS M. Posea, A. Dragomir, E. Rusu, R. Nan, R. Dragut, H. Popescu, F. Stoicescu, I. Teodoru, A. Hancu, M. Stoian, G. Radulian (Romania) FUNCTIONAL OLIVE OILS FUNCTIONS R. Sola, R.M. Valls, M. Farras, M. Suarez, S. Fernandez-Castillejo, M. Fito, V. Konstantinidou, A. Pedret, F. Fuentes, J. Lopez-Miranda, M. Giralt, M.I. Covas, M.J. Motilva (Spain)

537

CARDIOPROTECTIVE EFFECT OF FLAX LIGNAN CONCENTRATE AND OMEGA-3-FATTY ACID ALONE AND IN COMBINATION IN ISCHEMIA/REPERFUSION INJURY IN ISOLATED RAT HEART A. Zanwar, M. Hegde, S. Bodhankar (India)

POSTERS

536

878

879

880

881

882

883

8:30 - 18:30Lipid-lowering therapy 538

539

150

SHORT-TERM ROSUVASTATIN THERAPY INFLUENCE ON RESTORED ENDOTHELIAL FUNCTION IN HYPERTENSIVE PATIENTS M. Andor, M. Suciu, C. Cristescu, L. Dragan, M. Tomescu (Romania)

884

PROTECTIVE EFFECT ON CARDIOVASCULAR EVENTS OF BOSENTAN IN CLAU TRIAL (CLINICAL AND ENDOTHELIAL FUNCTION ASSESSMENT AFTER ENDOTHELIN RECEPTOR ANTAGONIST)885 J. De Haro, S. Bleda, C. Gonzalez-Hidalgo, C. Varela, F. Acin (Spain)

Board No.

540

541

542

543

544

545

Saturday, May 31 – Tuesday, June 3, 2014 ROSUVASTATIN INDUCED CAROTID PLAQUE REGRESSION IN PATIENTS WITH INFLAMMATORY JOINT DISEASES S. Rollefstad, E. Ikdahl, J. Hisdal, I. Holme, I.C. Olsen, K.T. Smerud, T.R. Pedersen, T.K. Kvien, A.G. Semb (Norway) ERYTHROCYTE MEMBRANE CHOLESTEROL AND LIPID CORE GROWTH IN A RABBIT MODEL OF ATHEROSCLEROSIS: MODULATORY EFFECTS OF ROSUVASTATIN D. Tziakas, G. Chalikias, A. Kapelouzou, I. Tentes, K. Schäfer, P. Karayannakos, A. Kostakis, H. Boudoulas, S. Konstantinides (Greece) ROSUVASTATIN SIGNIFICANTLY IMPROVES ARTERIAL STIFFNESS PARAMETERS BY PULSEWAVE ANALYSIS IN HIGH RISK PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA O. Drapkina (Russia) NEW INSIGHTS INTO STATIN ACTION ON THE DYSLIPIDEMIA OF TYPE 2 DIABETES: NORMALISATION OF THE PLASMA LIPID PROFILE P.J. Meikle, G. Wong, R. Tan, B.A. Kingwell, A. Orsoni, N. Hounslow, P. Giral, M.J. Chapman (Australia) CHANGES IN FASTING GLUCOSE LEVELS FOLLOWING LONGER-TERM TREATMENT WITH SIMVASTATIN MONOTHERAPY AND COMBINED EZETIMIBE+SIMVASTATIN P.P. Toth, A. Catapano, M. Farnier, J. Foody, J.E. Tomassini, E. Jensen, A.B. Polis, T. Musliner, A.M. Tershalovec (USA) SIMVASTATIN AND EZETIMIBE HAVE OPPOSING REGULATION ON INTESTINAL CHOLESTEROL ABSORPTION AND TRANS INTESTINAL CHOLESTEROL EXCRETION (TICE) DURING METABOLIC SYNDROME R. Mangat, F. Borthwick, S. Warnakula, M. Jacome-Sosa, D. Vine, S. Proctor (Canada)

886

887

888

889

890

891

546

EFFECT OF ROSUVASTATIN THERAPY IN PATIENTS WITH Atherosclerosis892 V.I.K. Kapetivadze Vera, R.I.T. Tabukashvili Revaz, K.M.T. Tchaava Khatuna, N.D.G. Gegeshidze Nino, Z.V.M. Maghlaperidze Zviad, T.T.L. Lazashvili Tamar, Z.G.G. Grigorashvili Zurab (Georgia)

547

CONFORMITY OF PRESCRIBING PRACTICES WITH NATIONAL CHOLESTEROL EDUCATION PROGRAM (NCEP) GUIDELINES AT SAUDI ARABIA CARDIAC HOSPITAL A. Albisher (Saudi Arabia)

893

151

Board No.

548

549

550

IS THERE DIFFERENCE IN THE LIPID PROFILE BETWEEN DIABETIC AND NON DIABETIC PATIENTS AT THE MOMENT OF THE STATIN INTRODUCTION? R.J. ALVES, G.C. Paranhos, A.H. Abe, A.C.M. Carvalho, D.G. Strabelli, H. Kim, P.L. Yokomizo, J.E.N. Salles (Brazil) THE HYPOLIPIDEMIC AND HEPATOPROTECTIVE EFFICACIES OF A ESSENTIAL PHOSPHOLIPIDS WITH METHIONINE AND ATORVASTATIN IN PATIENTS WITH CARDIOVASCULAR DISEASES AND DIABETES MELLITUS M. Bubnova, D. Aronov (Russia) UK CONSENSUS POSITION ON THE MANAGEMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA AND THE INTRODUCTION OF NEW AGENTS R. Cramb, H. Soran, N. Capps, A. Rees, K. Ray, W. Madira, J. Deanfield, G. Thompson (United Kingdom) LDLR DETERMINANTS TO ARMOLIPID PLUS LDL CHOLESTEROL RESPONSE I. De Castro-Orós, M.J. Pueyo, R. Solà, R.M. Valls, J. Millán, A. Brea, J.R. Calabuig, J. Villar, A. Anguera, J. Puzo, M. Pocoví (Spain)

552

THE IMPACT OF CIGARETTE SMOKING ON THE PLEIOTROPIC EFFECTS OF SIMVASTATIN IN THE CORONARY HEART DISEASE PATIENTS T.B. Domagala, K. Kotula-Horowitz, M. Janczura, R. Januszek, J. Zagajewski, J. Musial (Poland)

POSTERS

551

553

152


HYPERCHOLESTEROLEMIC DIET WORST LEFT VENTRICULAR FUNCTION DESPITE REDUCTION OF MMP-2 EVALUATED BY ECHOCARDIOGRAPHY IN AN EXPERIMENTAL RAT INFARCT MODEL P. Dourado, M.B.P. Landim, A. Casella Filho, J.M. Tsutsui, L. Roever, V.D. Aiello, W. Mathias Jr, P. Da Luz, A.C.P. Chagas (Brazil)

894

895

896

897

898

899

554

EFFECT OF HYPOLIPIDEMIC TREATMENT ON GLYCEMIC PROFILE IN PATIENTS WITH MIXED DYSLIPIDEMIA900 A. Kei, E. Liberopoulos, M. Elisaf (Greece)

555

THE EFFECT OF ROSUVASTATIN ON LOW-DENSITY LIPOPROTEIN SUBFRACTIONS IN PATIENTS WITH IMPAIRED FASTING GLUCOSE C.V. Rizos, M.S. Kostapanos, E.C. Rizos, A.D. Tselepis, M.S. Elisaf (Greece)

901

Board No.


556

FAMILIAR HYPERCHOLESTEROLEMIA: EFFECTS OF TREATMENT WITH ROSUVASTIN I. Gonzalez Molero, M. Gonzalo Marin, M. Dominguez Lopez, G. Olveira, F. Tinahones (Spain)

557

LONG TERM EFFECT OF BRIDGED NUCLEIC ACID (BNA)-BASED ANTISENSE TARGETING PCSK9 ON METABOLISM AND INFLAMMATION M. Harada-Shiba, T. Yamamoto, H. Yasuhara, F. Wada, S. Wada, M. Shibata, S. Obika (Japan)

558

559

560

561

562

563

564

THYROID HORMONE STATUS AND CONCOMITANT MEDICATION IN HYPERLIPIDEMIC PATIENTS WITH STATIN INDUCED ADVERSE EFFECTS M. Harangi, E. Berta, N. Zsíros, G. Paragh, E.V. Nagy, M. Bodor (Hungary) DOWNREGULATION OF MONOCYTE ADHESION MOLECULES BY INHIBITION OF SYNTHESIS AND ABSORPTION OF CHOLESTEROL A. Cerda, A.C. Rodrigues, C. Alves, F.D.V. Genvigir, C.M. Fajardo, E.L. Dorea, M.C. Gusukuma, G.A. Pinto, M.H. Hirata, R.D.C. Hirata (Brazil)

902

903

904

905

DGAT1 AND DGAT2 POLYMORPHISMS HAD NO EFFECT ON THE LIPID RESPONSES TO NIACIN IN CHINESE PATIENTS WITH DYSLIPIDAEMIA M. Hu, Y. Yang, C. Ng, C. Lee, V. Lee, B. Tomlinson (Hong Kong China)

906

EFFECT OF NIACIN ON OXIDIZED LOW-DENSITY LIPOPROTEIN LEVELS IN CHINESE PATIENTS WITH DYSLIPIDAEMIA M. HU, Y. Yang, S. Yamashita, D. Masuda, B. Tomlinson (Hong Kong China)

907

SLCO1B1 TRANSPORTER POLYMORPHISM IS NOT ASSOCIATED WITH RISK OF MYOPATHY IN CZECH POPULATION J.A. Hubacek, D. Dlouha, V. Adamkova, R. Ceska, M. Vrablik (Czech Republic)

908

SIGNIFICANT DIFFERENCES IN LIPID PROFILE ASSOCIATED WITH MACE BETWEEN HEMODIALYSIS (HD) AND NON-HD PATIENTS: FU-REGISTRY A. Ike, K. Shirai, I. Nagata, M. Sugihara, H. Nishikawa, A. Kawamura, K. Mori, K. Saku (Japan) EFFECT OF STATIN ON FASTING BLOOD GLUCOSE LEVELS IN ASIAN HYPERCHOLESTEROLEMIC PATIENTS C. Kim, M. Kim (Korea)

909

910

153

Board No.

565

566

567

568

569

POSTERS

570

571

572

573

154

Saturday, May 31 – Tuesday, June 3, 2014 LIPID AND PLEOTROPIC EFFECTS OF ATORVASTATIN THERAPY AND ITS COMBINATION WITH EZETIMIBE IN PATIENTS WITH CORONARY ARTERY DISEASE AND DIABETES O. Koshelskaya, A. Sushkova, T. Suslova, R. Karpov (Russia)

911

MANAGEMENT OF DYSLIPIDEMIA USING TEMPORAL ‘FLAVOCITRIN’ INCLUSION IN COURSE OF LONG-TERM STATIN THERAPY OF PATIENTS WITH CHD AND METABOLIC SYNDROME T. Kvantaliani, M. Sikharulidze, M. Akhvlediani (Georgia)

912

MANAGEMENT OF DYSLIPIDEMIA USING TEMPORAL "FLAVOCITRIN" INCLUSION IN COURSE OF LONG-TERM STATIN THERAPY OF PATIENTS WITH CHD AND METABOLIC SYNDROME T. Kvantaliani, M. Sikharulidze, M. Akhvlediani (Georgia)

913

EFFECTS OF STEARIDONIC ACID ON SERUM TRIACYLGLYCEROL CONCENTRATIONS IN OVERWEIGHT AND OBESE SUBJECTS D.J.M. Pieters, R.P. Mensink (Netherlands)

914

PCSK9 INHIBITION AUGMENTS THE THERAPEUTIC EFFECT OF EZETIMIBE IN LOWERING INTESTINAL APOLIPOPROTEIN B LIPOPROTEIN PRODUCTION S. Rashid, MD, M. Melone, MD, H. Tavori, MD, I. Guinzioni, MD, D. Neff, MD, S. Fazio, MD (Canada) EVALUATION OF CARDIOVASCULAR EVENTS WITH ADMINISTRATION OF MIPOMERSEN, AN ANTISENSE APO B-100 SYNTHESIS INHIBITOR: RESULTS FROM THE PHASE 3 PROGRAM R. Santos, A. Mahmood, W. Chin, M. McGowan (Brazil) COMBINATION REGIMEN OF STATIN/EZETIMIBE AND REDUCTION OF SD-LDL-C FOR JAPANESE PATIENTS WITH TYPE 2 DIABETES (RESEARCH, A MULTICENTER RCT) T. Shiba, M. Kawamura, T. Kouro, A. Tanaka, M. Tagami, T. Yamazaki, K. Sakamoto, Y. Mori, The RESEARCH Study Group (Japan) EFFECTIVE STATIN DOSE AND PLASMA VITAMIN E ARE INDEPENDENTLY AND OPPOSITELY ASSOCIATED WITH SERUM ARACHIDONIC ACID E. Skeie, MD, E. Stand, MD, E.R. Pedersen, MD, B. Bjørndal, MD, P. Bohov, MD, R.K. Berge, MD, P.M. Ueland, MD, O. Midttun, MD, C. Drevon, MD, O. Nygård, MD (Norway) HYPOLIPIDEMIC THERAPY IN PATIENTS WITH A VERY HIGH CARDIOVASCULAR RISK Y. Balandina, Y. Tarlovskaya, N. Maksimchuk-Kolobova (Russia)

915

916

917

918

919

Board No.

574

575

Saturday, May 31 – Tuesday, June 3, 2014 EFFECCY AND SALETY OF HIGH DOSES OF GENERIC STATINS IN PATIENTS AFTER ACUTE CORONARY SYNDROME E. Tarlovskaya, T. Chudinovskikh, V. Dvoeglazov (Russia)

920

COMPARISON OF ‘SIMVASTATIN’ MEDICATIONS ACCORDING TO HYPOLIPIDEMIC EFFECTS AND FROM PHARMACOECONOMIC POINT OF VIEW Y. Balandina, Y. Tarlovskaya, N. Maksimchuk-Kolobova (Russia)

921

576

EFFECTIVENESS OF STATIN THERAPY IN PATIENTS UNDERGOING MEDITERRANEAN DIET I. Terzis, MD, T. Bitsis, MD, C. Brinias, MD, M. Banter, MD, C. Dilanas, MD, D. Tousoulis, MD (Greece)

922

577

STATINS AND HEART FAILURE L. Tikhomirova, MD, R. Ramírez Montesinos, MD, M. Mas Puig, MD, J. Marquez Gomez, MD, O. Araujo Loperena, MD, E. Pedrol, MD (Spain)

923

578

PITAVASTATIN 4 MG PROVIDES SIGNIFICANTLY GREATER REDUCTION IN REMNANT LIPOPROTEIN CHOLESTEROL COMPARED TO PRAVASTATIN 40 MG: RESULTS FROM THE PREVAIL TRIAL P. Toth, S.S. Martin, P. Joshi, S. Jones, J. Massaro, R. D'Agostino, C. Sponseller (USA)

579

580

581

582

LACK OF IMPROVEMENT IN NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS IN THE UNITED STATES: A TIME-SENSITIVITY ANALYSIS FROM NHANES 2003–2010 P. Toth, C. Doyle, K. Henriksson (USA) LESS AGGRESSIVE COMPARED WITH MORE AGGRESSIVE STATIN TREATMENT IN PATIENTS WITH ACUTE ISCHEMIC STROKE K. Tziomalos, S. Bouziana, M. Spanou, M. Papadopoulou, V. Giampatzis, P. Kazantzidou, V. Dourliou, S. Kostaki, C. Savopoulos, A. Hatzitolios (Greece)

924

925

926

POPULATION PHARMACOKINETIC AND PHARMACODYNAMIC MODELING OF BOCOCIZUMAB (RN316/PF-04950615) IN HYPERCHOLESTEROLEMIC SUBJECTS E. Wang, D. Plowchalk, L. Gibiansky, K. Sweeney, N. Kaila (USA)

927

VASCULAR EFFECTS OF STEROLS, OXYSTEROLS, PHYTOSTEROLS, AND OXYPHYTOSTEROLS IN APOE-/-MICE O. Weingärtner, D. Lüthjohann, H.F. Schött, T. Speer, F. McCarthy, U. Laufs (Germany)

928

155

Board No.

583

584

POSTERS

585

Saturday, May 31 – Tuesday, June 3, 2014 TREATMENT OF A COMPOUND HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA PATIENT WITH LOMITAPIDE R. Yahya, E. Favari, S. Bos, R. Vongpromek, L. Van der Zee, A. Touw, F. Zimetti, M.P. Adorn, F. Bernini, A. Verhoeven, E.J.G. Sijbrands, M.T. Mulder, J.E. Roeters van Lennep (Netherlands) EFFECTS OF ROSUVASTATIN AND PRAVASTATIN ON HIGH-DENSITY LIPOPROTEIN SUBFRACTIONS IN HIV-1-INFECTED PATIENTS RECEIVING PROTEASE INHIBITORS R. Bittar, E. Aslangul, P. Giral, L. Assoumou, M.A. Valantin, M.C. Federspiel, C. Cherfils, D. Costagliola, D. Bonnefont-Rousselot (France) VARIABILITY OF LDL-C RESPONSE WITH DIFFERENT DOSES OF SIMVASTATIN, ATORVASTATIN AND ROSUVASTATIN: RESULTS FROM VOYAGER B.W. Karlson, M.K. Palmer, S.J. Nicholls, P. Lundman, P.J. Barter (Sweden)

929

930

931

586

TREATMENTS USED IN RHEUMATOID ARTHRITIS AND THEIR INFLUENCE ON SUBCLINICAL ATHEROSCLEROSIS932 M. Parvu, L. Fit, S. Voidazan (Romania)

587

LIPID TARGET ACHIEVEMENT AMONG VERY HIGH AND HIGH CARDIOVASCULAR RISK PATIENTS IN A LIPID CLINIC F. Barkas, E. Liberopoulos, M. Kostapanos, G. Liamis, D. Tzialas, M. Elisaf (Greece)

933

8:30 - 18:30Emerging therapies 588

589

590

156

EFFECT OF TETRANECTIN-APOA-I INFUSIONS ON ATHEROSCLEROSIS PROGRESSION/ REGRESSION IN RABBIT CAROTID ARTERIES G. Chiesa, J. Fingerle, J.L. Mary, M. Bader, R. Falkenstein, S. Mohl, P. Lorenzon, M. Busnelli, G.S. Ganzetti, S. Manzini, F. Dellera, C.R. Sirtori, C. Parolini (Italy)

934

EXTRACORPOREAL LIPOPROTEIN(A) ELIMINATION IS ASSOCIATED WITH CAROTID ATHEROSCLEROSIS REGRESSION IN CHD PATIENTS WITH HIGH LIPOPROTEIN(A) LEVELS M. Safarova, M. Ezhov, O. Afanasieva, T. Balakhonova, G. Konovalov, S. Pokrovsky (Russia)

935

SYNERGISTIC ANTIANGIOGENIC ACTIVITY OF BEXAROTENE IN COMBINATION WITH ROSUVASTATIN BY TARGETING ANG-II-MEDIATED AKT/MTOR/P70S6K SIGNALING PATHWAY M.J. Sanz, E. Furio, C. Ferrando, P. Escudero, A. Navarro, L. Piqueras (Spain)

936

Board No.

591

592

593

594

595

596

597

598

Saturday, May 31 – Tuesday, June 3, 2014 CHRONIC PERIPHERAL ARTERIAL DISEASE - PROSTAGLANDINS LIKE A NEW ERA IN NONINTERVENTIONAL THERAPEUTIC APPROACH - A 976 CASES REVIEW D. Tesloianu, M. Spiridon (Romania) DIOSGENIN INDUCES TRANS-INTESTINAL CHOLESTEROL EXCRETION IN LDL RECEPTOR DEFICIENT FEMALES. J.M. Berger, F. Moreau, X. Prieur, P. Costet, F. Lasserre, H. Guillou, B. Cariou, C. Le May (France) PROPROTEIN CONVERTASE SUBTILISIN/KEXIN 9 MONOCLONAL ANTIBODY THERAPY SIGNIFICANTLY REDUCED APOPROTEIN CII AND CIII LEVELS IN SERUM IN PHASE 2 STUDIES P.P. Toth, S. Hamon, S.R. Jones, S.S. Martin, P.H. Joshi, K. Kulkarni, P. Banerjee, C. Hanotin (USA) A NOVEL POTENT AND SELECTIVE PPARALPHA AGONIST, K-877, AMERIOLATES BOTH FASTING AND POSTPRANDIAL HYPERTRIGLYCERIDEMIA D. Masuda, T. Kobayashi, T. Okada, H. Nakaoka, R. Kawase, K. Nakatani, M. Koseki, T. Ohama, M. Nishida, Y. Sakata, S. Yamashita (Japan) COMBINATION TREATMENT OF THE NOVEL PHARMACOLOGICAL FXR-COMPOUND PX20606 AND EZETIMIBE LEADS TO MASSIVELY INCREASED NEUTRAL STEROLS EXCRETION IN MICE M. Schonewille, J.F. De Boer, M. Boesjes, H. Wolters, H. Verkade, U. Tietge, C. Kremoser, A.K. Groen (Netherlands)

937

938

939

940

941

EVALUATION OF THE HEMODYNAMIC PROFILE IN HOSPITALIZED HYPERTENSIVE OLD AGE PATIENTS, USING HOTMAN® INTEGRATED HEMODYNAMIC MANAGEMENT SYSTEM A. Capisizu, T. Movileanu, S. Aurelian, A. Zamfirescu, L. Vlad, R. Dascalescu (Romania)

942

EFFECT OF VALSARTAN/HYDROCHLOROTHIAZIDE COMBINATION ON LOW-DENSITYLIPOPROTEIN PARTICLE SIZE AND PLASMA LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 ACTIVITY IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME L. Christogiannis, M. Kostapanos, A. Agouridis, F. Barkas, E. Klouras, C. Tellis, A. Tselepis, M. Elisaf (Greece)

943

EFFECTS OF COMBINATIONS OF VALSARTAN WITH AMLODIPINE OR HYDROCHLOROTHIAZIDE ON RENAL FUNCTION AND PROTEINURIA IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME L. Christogiannis, M. Kostapanos, C. Kostara, F. Barkas, A. Liontos, T. Panagiotopoulou, E. Bairaktari, M. Elisaf (Greece)

944

157

Board No.

599

600

EFFICACY AND SAFETY OF FIXED-DOSE COMBINATION OF ROSUVASTATIN AND IRBESARTAN IN PATIENTS WITH DYSLIPIDEMIA AND HYPERTENSION S.H. Kim, H.L. Lee, H.L. Kim, J.B. Seo, W.Y. Chung, J.H. Zo, M.A. Kim, B.H. Oh (Korea)

945

INDICATORS OF CENTRAL PRESSURE AND RIGIDITY DURING THE LONG-TERM THERAPY OF CALCIUM ANTAGONISTS IN PATIENTS WITH METABOLIC SYNDROME AND HYPERTENSION V. Oleynikov, L. Gusakovskaya, I. Matrosova, N. Sergatskaya (Russia)

946

601

CILOSTAZOL NO IMPROVES STRESS OXIDATIVE IN PERIPHERAL ARTERIAL DISEASE M. Bernal Lopez, D. Peña, P. Gomez-Martin, F.J. Tinahones, R. Gomez Huelgas (Spain)

602

INHIBITION OF HUMAN PLATELET AGGREGATION USING AIIB DERIVED PEPTIDES THAT MAINTAIN AIIBB3 IN ITS LOW AFFINITY STATE P. Trypou, W.H. Lee, E. Schaffner-Reckinger, D.C. Tsoukatos, K. Aylward, V. Moussis, V. Tsikaris, E. Malisiova, A. Gkourogianni, S. Papadaki, M. Egot, D. Baruch, N. Kieffer, C. Bachelot-Loza (Greece) ANTI-INFLAMMATORY ACTIONS OF STATINS IN HUMAN MACROPHAGES M. Alkorashy (United Kingdom)

604

FULLY HUMAN MONOCLONAL ANTIBODIES TO PHOSPHORYLCHOLINE INHIBIT TNFINDUCED IL-6 AND VCAM-1 IN HUMAN UMBILICAL VENOUS ENDOTHELIAL CELLS D. Thiagarajan, R. Fiskesund, J. Steen, J. Su, V. Malmström, J. Frostegård, A. Frostegård (Sweden)

POSTERS

603

605

606

607

158


947

948

949

950

PROBIOTICS SUPPLEMENTATION AND ANTIOXIDANT ACTIVITY IN CHILDREN AFFECTED BY PRIMARY HYPERLIPIDEMIA P. Cagliero, E. Marini, C. Cena, F. Veglia, O. Guardamagna (Italy)

951

INTERVENTION WITH ANTI-INFLAMMATORY RVE1 ATTENUATES ATHEROSCLEROSIS WITHOUT DECREASING PLASMA CHOLESTEROL AND ADDS TO THE ANTI-ATHEROGENIC EFFECT OF ATORVASTATIN K. Salic, P.Y. Wielinga, L. Verschuren, P. Gjorstrup, R. Kleemann, T. Kooistra (Netherlands)

952

THE CELLULAR AND MOLECULAR BASIS FOR THERAPEUTIC EFFECTIVENESS OF ?-ESCIN K. Koziak, M. Kowalewska, O. Zegrocka-Stendel, M. Dutkiewicz, D. Maciejko, D. Domanski, A. Perzanowska, A. Fogtman, I. Grabowska (Poland)

953

Board No.


608

MULTIMODAL MELDONIUM’S INFLUENCE ON FUNCTIONAL BRAIN STATE S.M. Kuznetsova, V.V. Kuznetsov, M.S. Iegorova, F.V. Yurchenko (Ukraine)

609

FUMARIC ACID ESTERS CAN BLOCK PRO-INFLAMMATORY ACTIONS OF HUMAN CRP AND AMELIORATE METABOLIC DISTURBANCES IN TRANSGENIC SPONTANEOUSLY HYPERTENSIVE RATS 955 M. Pravenec, J. Silhavy, V. Zidek, P. Mlejnek, V. Landa, M. Simakova, H. Strnad, O. Oliyarnyk, L. Kazdova, T.W. Kurtz (Czech Republic)

610

NATURAL BIFLAVONOIDS FROM THE TROPICAL FRUIT TREE GARCINIA MADRUNO ARE ATEROPROTECTIVE IN VITRO AND IN VIVO J. Tabares-Guevara, O. Lara-Guzman, E. Osorio-Durango, J. Londoño-Londoño, J. Sierra-Restrepo, R. Alvarez-Quintero, Y. Leon-Varela, J. Ramirez-Pineda (Colombia)

611

THE ANGIOTENSIN (1-7)/MAS RECEPTOR AXIS AND VASCULAR CELL INFLAMMATION C.F. Sanchez-Ferrer, L. Villalobos, T. Romacho, S. Vallejo, E. Cercas, M.J. Sanz, C. Peiró (Spain)

612

DIETARY OMEGA-3 POLYUNSATURATED FATTY ACIDS PLUS ASPIRIN DECREASES PLASMA LIPIDS AND INCREASES PRO-RESOLVING LIPID MEDIATORS IN APOE-DEFICIENT MICE A.V. Sorokin, MD, B.L. Vaisman, MD, S. Thacker, MD, Z.X. Yu, MD, J.M. Fitzgerald, MD, C.N. Serhan, MD, A.T. Remaley, MD (USA)

613

MYELOPEROXIDASE INHIBITORS ENHANCE AORTIC ATHEROSCLEROSIS IN AN ANIMAL MODEL I. Marczell, J. Stark, H. Heinle, T. Pazmany, D. Szombath, M. Dinya, Z. Tulassay, K. Racz, B. Szekacs, A. Farkas, G. Illyes, G. Bekesi (Hungary)

614

IMPACT OF ANTIPLATELET THERAPY ON EXTRACELLULAR VESICLES IN PATIENTS WITH ACUTE CORONARY SYNDROMES A. Arakelyan, O. Ivanova, A. Lebedeva, M. Vagida, E. Nikitskaya, N. Ryazankina, J.C. Grivel, A. Shpektor, L. Margolis, E. Vasilieva (Russia)

615

BIOAVAILABILITY OF BERBERINE AND MONACOLIN AFTER ORAL ADMINISTRATION OF A PROPRIETARY NUTRACEUTICAL COMBINATION IN HEALTHY MALE VOLUNTEERS S. Persiani, F. Sala, C. Manzotti, Y. Donazzolo, C. Benvenuti, L.C. Rovati (Italy)

954

956

957

958

959

960

961

159

Board No.

616

Saturday, May 31 – Tuesday, June 3, 2014 AN ORAL COCKTAIL STUDY ON POTENTIAL DRUG INTERACTIONS OF A PROPRIETARY NUTRACEUTICAL COMBINATION CONTAINING BERBERINE AND MONACOLIN IN HEALTHY VOLUNTEERS962 S. Persiani, F. Sala, C. Manzotti, Y. Donazzolo, B. Barbetta, C. Vitalini, G. Giacovelli, C. Benvenuti, L.C. Rovati (Italy)

8:30 - 18:30Intravascular procedures 617

PROGNOSTIC DETERMINANTS OF INTERMEDIATE-TERM OUTCOME IN PERIPHERAL ARTERY DISEASE UNDERGOING PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY IN TAIWAN - A SINGLE CENTER EXPERIENCE I.C. Chen, T.H. Chao, C.C. Fang, I.H. Wu, C.L. Yu, C.Y. Lam (Taiwan)

618

HYBRID THERAPY FOR PERIPHERAL ARTERIAL DISEASE S. Ito, H. Suesada, T. Amemiya, N. Katayama, M. Hashimoto, H. Tsuchida (Japan)

619

IN-HOSPITAL AND LONG-TERM CLINICAL OUTCOMES OF LEFT MAIN CORONARY ARTERY DISEASE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION T. Sato, Y. Kashihara, Y. Namba, M. Tanaka, S. Fuke, H. Saito (Japan)

POSTERS

8:30 - 18:30

160

963

964

965

Miscellaneous

620

WINE CONSUMPTION AND BLOOD LIPIDS IN A PORTUGUESE POPULATION M. Siopa, C. Alves, Q. Rato, P. Aguiar, M. Bourbon (Portugal)

966

621

DETERMINATION OF THE ATHEROGENIC PROFILE IMPROVES PATIENT STRATIFICATION A.R. Manaças, S. Jamal, A.C. Alves, Q. Rato, M. Bourbon (Portugal)

967

622

CARDIOVASCULAR RISK FACTORS IN A YOUNG ADULT POPULATION J. Canilho, A.C. Alves, Q. Rato, M. Bourbon (Portugal)

968

623

INVESTIGATING THE RELATIONSHIP BETWEEN RS10911021 AND OXIDATIVE STRESS K.E. Beaney, K. Li, J.A. Cooper, J.W. Stephens, S.E. Humphries (United Kingdom)

969

624

FUNCTIONAL ANALYSIS OF THE BCAR1-CFDP1-TMEM170A LOCUS ASSOCIATED WITH CAROTID INTIMA-MEDIA THICKNESS AND PLAQUE F.A. Boardman-Pretty, A.J.P. Smith, P. Frankel, I.M. Evans, I.C. Zachary, A. Hamsten, K. Gertow, S.E. Humphries (United Kingdom)

970

Board No.


625

ACOUSTIC LOCALISATION OF CORONARY ARTERY STENOSIS E.J. Cantor, B. Khera, J. Reeves, M. Birch, S. Shaw, H.T. Banks, M. Brewin, C. Kruse, J. Whiteman, S. Hu, Z. Kenz, A.K. Jain, S. Greenwald (United Kingdom)

626

ASSOCIATION OF AORTIC VALVE SCLEROSIS AND ATHEROSCLEROSIS IN DIFFERENT VASCULAR TERRITORIES G. Giunta, E. Gennero, P. Mendez, N. Rodriguez, P. Bobadilla Jacob, R. Skorka, E. Guevara, L. Cuniberti, R. Sanchez (Argentina)

627

ROSUVASTATIN PREVENTS HYPERTENSION INDUCED-LEFT VENTRICULAR HYPERTROPHY BY ENHANCING CATALASE ACTIVITY N. Pacienza, G. Duaip, G. Giunta, E. Gennero, E. Guevara, R. Favaloro, G. Yannarelli, L. Cuniberti (Argentina)

628

LIPIDS AND VITAMIN D LEVELS I. Gonzalez Molero, S. Morcillo, G. Rojo, E. Rubio, C. Gutierrez-Repiso, F. Soriguer (Spain)

629

YOUNG HEALTHY ASPIRIN POOR RESPONDERS ARE CHARACTERIZED BY WORSE ENDOTHELIAL FUNCTION MEASURED BY LASER DOPPLER, BUT NOT BY ENDOPAT M. Jakubowski, A. Turek, E. Szahidewicz-Krupska, J. Gawrys, K. Rdzanek, A. Doroszko (Poland)

971

972

973

974

975

630

ULTRA DISTAL BYPASS SURGERY PREVENTS AMPUTATION IN PATIENTS WITH SEVERE ATHEROSCLEROSIS976 T. Joergensen, J.M. Jepsen, C. Hallenberg, K.C. Houlind (Denmark)

631

MEDITERRANEAN DIET SEEMS TO DETERIORATE AORTIC FUNCTIONAL CAPACITY IN ELDERLY DIABETIC INDIVIDUALS: IKARIA STUDY C. Chrysohoou, C. Pitsavos, J. Skoumas, V. Metaxa, M. Zaromytidou, C. Zisimos, G. Lazaros, D. Panagiotakos, C. Stefanadis (Greece)

977

632

ABNORMAL LIPIDS IN CHILDREN WITH PARENTAL EARLY CORONARY ARTERY DISEASE: ASSOCIATIONS WITH CHARACTERISTICS OF THEIR PARENTS WITHOUT CORONARY ARTERY DISEASE978 M.V. Konnov, A.D. Deev, N.A. Gratsiansky (Russia)

633

SHORT-TERM EFFECTS OF PITAVASTATIN TREATMENT ON ISCHEMIA-MODIFIED ALBUMIN AND MODIFIED LIPOPROTEINS IN PATIENTS WITH HYPERCHOLESTEROLEMIA K. Kotani, R. Caccavello, K. Tsuzaki, N. Sakane, A. Gugliucci (Japan)

979

161

Board No.

634

635

636

POSTERS

637

HBA1C IS A SIGNIFICANTLY STRONGER PREDICTOR OF CARDIOVASCULAR EVENT RISK IN WOMEN THAN IN MEN AMONG PATIENTS UNDERGOING CORONARY ANGIOGRAPHY C.H. Saely, A. Vonbank, P. Rein, D. Zanolin, K. Geiger, A. Leiherer, H. Drexel (Austria)

980

ALBUMINURIA SIGINIFICANTLY PREDICTS CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES INDEPENDENTLY FROM THE BASELINE CORONARY ARTERY STATE P. Rein, A. Vonbank, D. Zanolin, A. Leiherer, C.H. Saely, H. Drexel (Austria)

981

GENETIC FACTORS IN 15-YEAR SURVIVAL OF THE PATIENTS WITH CHRONIC THREE VESSEL DISEASE J. Machal, O. Hlinomaz, M. Pavkova Goldbergova, A. Vasku, L. Groch (Czech Republic)

982

COMPARISON OF PATIENTS’ ADHERENCE AND LDL-CHOLESTEROL GOAL ATTAINMENT IN 2010 AND 2013 IN THE HUNGARIAN MULTI GAP 2012 STUDY L. Mark, I. Reiber, G. Paragh, I. Karadi, G. Pados, R.G. Kiss, Z. Kiss (Hungary)

983

638

THE RISK FACTORS OF TRANS FATTY ACIDS IN JAPANESE SCHOOL GIRLS M. Mori, H. Mori, Y. Yamori (Japan)

639

CARDIOTOXICITY OF CHRONIC SUNITINIB TREATMENT IN NORMOTENSIVE AND HYPERTENSIVE RATS I. Nemeckova, O. Lencova, M. Sterba, P. Nachtigal (Czech Republic)

985

SINGLE AND TRIPLE VESSEL DISEASE AMONGST CAUCASIAN AND SOUTH ASIAN POPULATIONS WITH ACS: A RETROSPECTIVE ANALYSIS P.A. Patel, J.R.J. Foley, C. Yau, Y. Zheng, Y. Blackburn, S. Bulugahapitiya (United Kingdom)

986

640

641

642

162


IMPACT OF A DECADE OF ACTION ON PREVENTION OF HYPERTENSION AND ANTHROPOMETRY OF SCHOOL STUDENTS A. Pereira, T.P. Camargo, M.C. Elias, S.S.M. Ihara, C.A. Machado, R.D. Santos Filho, T.L.R. Martinez (Brazil) BASELINE MEAN PLATELET VOLUME AS A SHORT TERM PROGNOSTIC FACTOR FOR ACUTE MYOCARDIAL INFARCTION M.P. Ranjith, V. Haridasan, B. George, K.F. Rajesh, G. Rajesh, C.G. Sajeev, M.N. Krishnan (India)

984

987

988

Board No.

643

644

645

646

Saturday, May 31 – Tuesday, June 3, 2014 THE ASSOCIATION OF PON1 AND SOD3 GENE POLYMORPHISMS WITH SMOKING RELATED CAD RISK IN THAI SUBJECTS C. Settasatian, N. Decharatchakul, N. Settasatian, N. Komanasin, U. Kukongwiriyapan, P. Intharapetch, V. Senthong (Thailand) BREATH CARBON MONOXIDE AND CARBOXYHEMOGLOBIN ARE RELATED TO ABNORMAL BLOOD LIPID PROFILE IN SMOKER N. Settasatian, C. Settasatian, P. Yongsakulchai, I. Sarutipaiboon, P. Pitivejthurakit, N. Decharatchakul, S. Khaichaiyaphum, R. Rattanatham (Thailand)

989

990

LIPID MANAGEMENT AND PHYSICIAN VISIT PATTERNS IN A REAL-WORLD SAMPLE OF PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA P. Toth, K. Higuchi, N. Ramey, M. Grabner (USA)

991

INCIDENCE AND CHARACTERISTICS OF ACUTE PANCREATITIS IN A REAL-WORLD SAMPLE OF PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA P. Toth, M. Grabner, N. Ramey, K. Higuchi (USA)

992

647

DIAGNOSIS AND TREATMENT PATTERNS OF REAL-WORLD PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA993 P. Toth, N. Ramey, M. Grabner, K. Higuchi (USA)

648

PREVALENCE OF GILBERT SYNDROME AND UGT1A1*28 STATUS IN THE CZECH POPULATION, AND THEIR RELATIONSHIP TO ISCHEMIC HEART DISEASE L. Kadlckova, V. Danzig, R. Cifkova, A. Linhart, J.A. Hubacek, M. Galovcova, J. Belohoubek, V. Adamkova, A. Jiraskova, L. Vitek (Czech Republic)

649

650

CARDIAC RISK FACTORS REDUCTION BY MODIFICATION OF LIFESTYLE IN CARDIAC REHABILITATION IN PATIENTS WITH CHD S. Aminpour, M. Shahamfar, A. Gavidel Sardsahra, J. Shahamfar (Iran) SELF-REPORTED ADHERENCE TO CARDIOVASCULAR RISK REDUCTION INTERVENTION OF PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS OF THE FRANCIS STUDY D.F. Van Breukelen-van der Stoep, J. Zijlmans, D. Van Zeben, N. Van der Meulen, B. Klop, M.A. De Vries, J. Van der Arend, C. Van Casteren-Messidoro, G.J.M. Van de Geijn, H.W. Janssen, E. Birnie, J.M.W. Hazes, M. Castro Cabezas (Netherlands)

994

995

996

163

Board No.

651

OMEGA-3 FATTY ACIDS AFFECT THE EXPRESSION OF CX40 IN RAT AORTA DURING INFLAMMATION 997 K. Frimmel, R. Sotnikova, J. Navarova, I. Bernatova, L. Okruhlicova (Slovakia)

652

PREDICTORS OF THE COMBINED ADOPTION OF HEALTHY EATING AND PHYSICAL ACTIVITY AMONG HYPERCHOLESTEROLEMIC ADULTS P. Gomez, E. Bruckert, S. Boesen-Mariani (France)

POSTERS

998

653

INFLUENCE OF PHYSICAL ACTIVITIES NECESSARY FOT LIPID STATUS AND OBESITY IN ADOLESCENTS999 G. Grujic Ilic, M. Jerkan, L.J. Pejcic, J. Rankovic (Serbia)

654

OXIDATIVE STRESS IN CHILDREN AFFECTED BY PRIMARY HYPERCHOLESTEROLEMIA P. Cagliero, O. Guardamagna (Italy)

655

TPP1 RS2555173 A ALLELE SIGNIFICANTLY ASSOCIATED WITH THE RISK OF EARLY-ONSET ISCHEMIC STROKE F. Hsieh, S. Chiu, H. Chiou, H. Lin, J. Jeng, L. Lien, G. Peng (Taiwan)

656

657

658

659

660

164


REMOTE ISCHEMIC PRECONDITIONING ALLEVIATES MYOCARDIAL ISCHEMIA BY RECRUITABLE COLLATERAL CIRCULATION N. Itaya, T. Ueno, K. Sasaki, S. Yokoyama, M. Ohtsuka, T. Nakayoshi, H. Chibana, M. Sasaki (Japan) THE IMPACT OF ANKLE BRACHIAL INDEX ON TARGET LESION REVASCULARIZATION AFTER DRUG-ELUTING STENT IMPLANTATION M. Sasaki, T. Ueno, K. Sasaki, S. Yokoyama, M. Ohtsuka, T. Nakayoshi, N. Itaya, H. Chibana, Y. Fukumoto (Japan)

1000

1001

1002

1003

LONG-TERM EFFECTS OF CPAP THERAPY FOR SUPPRESSING CAROTID ATHEROSCLEROSIS IN HYPERTENSIVE PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME Y. Sawayama, A. Hatashima, T. Koga (Japan)

1004

PREDICTION OF SURGICAL PROGNOSIS WITH DOBUTAMINE STRESS ECHOCARDIOGRAM IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY K. Lee, C. Chang, Y. Chuang, J. Wei (Taiwan)

1005

LIPID TARGET ACHIEVEMENT AMONG PATIENTS ACCORDING TO ESC/EAS AND ACC/AHA GUIDELINES IN A LIPID CLINIC H. Milionis, F. Barkas, E. Liberopoulos, M. Kostapanos, E. Klouras, M. Elisaf (Greece)

1006

Board No.


661

MISSING TEETH PREDICT FUTURE CARDIOVASCULAR EVENTS, DIABETES AND DEATH J.M. Liljestrand, V. Salomaa, A.S. Havulinna, S. Paju, P.J. Pussinen (Finland)

1007

662

PHARMACOLOGICAL TREATMENT OF DYSLIPIDEMIA IN POLAND E. Gwiazda, A. Mastalerz-Migas, B. Sapilak, D. Pokorna-Kalwak, P. Szyber (Poland)

1008

663

THE USE OF FINDRISC QUESTIONNAIRE IN ASSESSMENT OF RISK OF THE TYPE 2 DIABETES DEVELOPMENT IN PATIENTS WITH HYPERTENSION A. Mastalerz-Migas, D. Pokorna-Kalwak, B. Sapilak (Poland)

664

665

666

667

668

669

670

IMPACT OF PHOSPHATIDYLINOSITIDE 3-KINASE SIGNALING PATHWAY ON THE CARDIOPROTECTION INDUCED BY INTERMITTENT HYPOXIA G. Milano, P.M. Abruzzo, A. Bolotta, M. Marini, L. Terraneo, B. Ravara, L. Gorza, L.K. Von Segesser, M. Samaja (Switzerland) SOLUBLE AND INSOLUBLE DIETARY FIBRE INTAKE AND RISK FACTORS FOR CVD AND METABOLIC SYNDROME IN MIDDLE-AGED ADULTS: THE AWHS COHORT B. Moreno-Franco, M. León-Latre, E.M. Andrés-Esteban, J.M. Ordovás, J.A. Casasnovas, J.L. Peñalvo (Spain)

1009

1010

1011

THE EFFECT OF LIPOPOLYSACCHARIDE ON CONNEXIN43 EXPRESSION IN SPONTANEOUSLY HYPERTENSIVE RAT HEART L. Okruhlicova, Z. Cicakova, K. Frimmel (Slovakia)

1012

FACTORS AFFECTING TOO LOW EFFECTIVENESS OF HYPERTENSION TREATMENT - THE ROLE OF THERAPEUTIC INERTIA D. Pokorna-Kalwak, A. Mastalerz-Migas, B. Sapilak (Poland)

1013

THE TYPES OF LIPID DISORDERS IN ADULT POPULATION DIAGNOSED WITH DYSLIPIDEMIA IN POLAND E. Gwiazda, A. Mastalerz-Migas, D. Pokorna-Kalwak, B. Sapilak, P. Szyber (Poland)

1014

COMMON CAROTID ARTERY INTIMA-MEDIA THICKNESS IS PREDICTIVE FOR MAJOR CARDIOVASCULAR EVENTS, IRRESPECTIVE OF GLUCOSE TOLERANCE IN 64-YEAR-OLD WOMEN C. Schmidt, G.M. Bergström (Sweden)

1015

HIGH DOSE STATINES SLOW PROGRESION CAROTID INTIMA-MEDIA THICKNESS (IMT) AND DECREASE THE RISK FOR CARDIAC ARRHYTMIAS AND CORONARY ARTERY DISEASE I. Sikharulidse, I. Bakhlishvili, I. Bakhlishvili (Georgia)

1016 165

Board No.

671

POSTERS

CORRELATION OF NOCTURNAL HYPERTENSION AND CAROTID INTIMA-MEDIA THICKNESS IN ASYMPTOMATIC PATIENTS I. Terzis, MD, T. Bitsis, MD, C. Brinias, MD, M. Banter, MD, C. Dilanas, MD, D. Tousoulis, MD (Greece)

1017

672

MUSCLE WASTING FOLLOWING TREADMILL TRAINING OF PATIENTS WITH INTERMITTENT CLAUDICATION1018 S. Vun, C.L. Delaney, M.D. Miller, J.I. Spark (Australia)

673

UNDERUTILIZATION OF STATINS IN ELDERLY PATIENTS HOSPITALIZED WITH CARDIOVASCULAR EVENTS A. Benavente Fernández, A. Escudero Brocal, A. Salmerón-García (Spain)

1019

674

CARDIOVASCULAR AND RENAL PROTECTION IN CORONARY ARTERY DISEASE E. Bobescu, D. Dobreanu, L. Rogozea, A. Pascu, C. Strempel, N. Aldulea, A. Covaciu (Romania)

675

TERC POLYMORPHISM, LEUKOCYTE TELOMERE LENGTH AND THE SURVIVAL LENGTH IN PATIENTS AFTER HEART TRANSPLANTATION D. Dlouha, J. Hubacek, Y. Vymetalova, V. Vancura, I. Malek (Czech Republic)

1021

ASYMPTOMATIC PERIPHERAL ARTERY DISEASE IN PATIENTS WITH A PREVIOUS SINGLE CORONARY OR CEREBOVASCULAR EVENT: A MULTICENTER CROSS-SECTIONAL STUDY FROM THE MIDDLE EAST A. El-Menyar, H. Al-Thani, A.M.I.T. Kumar, M. Al-Bader, J. Al Suwaidi, I. Al-Zakwani, D.I.R.K. Deleu, M. Ismail (Qatar)

1022

BRACHIAL ANKLE PULSE WAVE VELOCITY IS AN INDEPENDENT RISK FACTOR FOR CORONARY ARTERY DISEASE S. Hong, H. Joo, D. Lim (Korea)

1023

A NEW POINT-OF-CARE ANALYZER FOR RAPID AND PRECISE DETERMINATION OF LIPID PROFILE AND HBA1C B. Joergensen, A. Sais Zidek (Denmark)

1024

676

677

678

679

166


LIPID RATIOS AS PREDICTORS OF SUBCLINICAL ATHEROSCLEROSIS S. Novo, F. Macaione, F.P. Guarneri, E. Corrado, S. Evola, G. Novo (Italy)

1020

1025

Board No.

680

Saturday, May 31 – Tuesday, June 3, 2014 PROGNOSTIC VALUE OF LDL/HDL CHOLESTEROL RATIO IN PATIENTS UNDERGOING CORONARY STENTING S. Novo, F. Macaione, F.P. Guarneri, E. Corrado, S. Evola, G. Novo (Italy)

681

CARDIOVASCULAR LIFESTYLE PROFILE IN UNDERGRADUATES UNIVERSITARY STUDENTS J. Millan, C. Recarte Garcia-Andrade, L. Alvarez-Sala Walther (Spain)

682

AGREEMENTS TO CALCULATE CARDIOVASCULAR RISK BY STANDARDIZED MODELS IN SPANISH POPULATION M. Artacho, M. Olmedo, J. Millan (Spain)

683

TOTAL FAT INTAKE MODIFIES THE ASSOCIATION BETWEEN APOLIPOPROTEIN B AND RISK OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH STABLE ANGINA PECTORIS O. Nygård, G.F.T. Svingen, E. Skeie, N. Puaschitz, E. Strand, C.A. Drevon, V. Lysne, T. Olsen, H. Schartum-Hansen, T. Karlsson, E.R. Pedersen (Norway)

684

SODIUM INTAKE AND PREVALENCE OF HYPERTENSION IN ELEMENTARY SCHOOL STUDENTS A. Pereira, T.C. Pereira, M.C. Elias, S.S.M. Ihara, C.A. Machado, R.D. Santos Filho, F.O.C. Pereira, T.L.R. Martinez (Brazil)

685

THE EFFECT OF ABCG5/G8 GENE POLYMORPHISMS ON BLOOD LIPID PROFILE RELATED TO SMOKING STATUS IN THAIS S. Khaichaiyaphum, N. Settasatian, C. Settasatian, P. Yongsakulchai, N. Decharatchakul, I. Sarutipaiboon, R. Rattanatham, P. Pitivejthurakit (Thailand)

1026

1027

1028

1029

1030

1031

686

SYNERGISTIC BAD EFFECTS OF HYPERTENSION AND OBESITY ON METABOLIC COMPONENTS M.S. Shin, B.R. Kim, M.Y. Baek, Y.M. Park, I.S. Choi (Korea)

1032

687

COMPLIANCE-RELATED PROBLEMS OF MEDICINES IN THE PHARMACEUTICAL PRACTISE I. Urtane, K. Pukite, S. Berzina, A.S. Stokmane, D. Bandere (Latvia)

1033

688

EFFECTS OF A DIET SUPPLEMENTATION WITH PLANT STEROLS ON CIRCULATING MONOCYTES IN HUMANS: A PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED, PLACEBOCONTROLLED, CROSS-OVER STUDY O. Weingärtner, I. Bogeski, C. Kummerow, S. Schirmer, T. Vanmierlo, M. Hoth, D. Lütjohann, U. Laufs (Germany)

1034

167

Board No.

689

APOD MEDIATES BINDING OF HDL TO LDL AND TO GROWING T24 CARCINOMA S. Braesch-Andersen, L. Beckman, S. Paulie, M. Kumagai-Braesch (Sweden)

690

EFFECT OF PHYSICAL TRAINING ON PLATELET AGGREGATION AND FIBRINOGEN CONCENTRATION IN PATIENTS WITH CHRONIC HEART FAILURE A. Mongirdiene, R. Kubilius (Lithuania)

691

POSTERS

692

168


ANGIOTENSIN-1-CONVERTING ENZYME (ACE) POLYMORPHISMS ARE ASSOCIATED WITH CORONARY ARTERY DISEASE BUT NOT WITH RESTENOSIS AFTER CORONARY STENTING G. Vargas-Alarcon, E. Alvarez-León, A. Totomoch, J. Angeles-Martínez, H. Delgadillo, H. Delgadillo, J.M. Fragoso, M.A. Peña-Duque, M.A. Martínez-Ríos (Mexico) VARIABILITY OF SOME MITOCHONDRIAL DNA POINT MUTATIONS IN BUCCAL AND WHOLE BLOOD HUMAN CELLS V.V. Sinyov, M.A. Sazonova, S.A. Kosogorova, Y.V. Bobryshev, A.Y. Postnov, A.N. Orekhov, I.A. Sobenin (Russia)

1035

1036

1037

1038

Board No.

700

701

702

703

704

705

706

707


NON REGISTERED ABSTRACTS ULTRAVIOLET-VISIBLE AND FLUORESCENCE SPECTROSCOPY TECHNIQUES ARE IMPORTANT DIAGNOSTIC TOOLS DURING THE PROGRESSION OF ATHEROSCLEROSIS M. Abdelhalim, M. Abdelhalim (Saudi Arabia)

1039

THE ROLE OF ZN-SUPPLEMENTED WITH HIGH CHOLESTEROL DIET ON SERUM AND WHOLE BLOOD RHEOLOGICAL PROPERTIES OF RABBITS FED HCD M. Abdelhalim, M. Abdelhalim (Saudi Arabia)

1040

THE BENEFIT OF ARGAN OIL IN THE NUTRITIONAL PREVENTION AFTER ACUTE MYOCARDIAL INFARCTION A. Adlouni, R. Safa, R. Habbal, M. Messal (Morocco)

1041

ASSOCIATION OF THE NEUTROPHIL–LYMPHOCYTE RATIO (NLR) WITH OUTCOMES IN PATIENTS ADMITTED FOR AN ACUTE CORONARY SYNDROME J. Aherrera, L. Chiong, F. Reganit, F. Punzalan (Philippines)

1042

CLINICAL PROFILE AND PREDICTORS OF OUTCOMES OF PATIENTS WITH MITRAL STENOSIS UNDERGOING PERCUTANEOUS TRANSSEPTAL MITRAL COMMISSUROTOMY E.W. Timbol, J. Aherrera, Q. Gino, D.E.E. Wilfred, D.E.E. Wilfred (Philippines)

1043

A COMPARISON OF 12 LEAD ELECTROCARDIOGRAM AND 2D-ECHOCARDIOGRAPHY DERIVED EJECTION FRACTION AMONG PATIENTS WITH DEPRESSED EJECTION FRACTION J. Aherrera, P. Reganit, R. Jara, R. Abarquez (Philippines)

1044

INFLUENCE OF INITIAL GLYCOSYLATED HEMOGLOBIN LEVEL ON CLINICAL OUTCOMES IN NON-DIABETIC PATIENTS WITH NON ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION H.O.N.G. Taek Jong, J. Ahn, P.A.R.K. Jin Sup, L.E.E. Hye Won, O.H. Jun-Hyok, C.H.O.I. Jung Hyun, L.E.E. Han Cheol, C.H.A. Kwang Soo, L.E.E. Hyo Seon (Korea) COMPARISON OF CLINICAL OUTCOMES BETWEEN BARE METAL VERSUS DIFFERENT TYPES OF DRUG ELUTING STENTS FOR TREATMENT OF ACUTE MYOCARDIAL INFARCTION H.O.N.G. Taek Jong, J. Ahn, P.A.R.K. Jin Sup, L.E.E. Hye Won, O.H. Jun-Hyok, C.H.O.I. Jung Hyun, C.H.A. Kwang Soo, L.E.E. Han Cheol (Korea)

1045

1046

169

Board No.

708

709

710

711

712

713

714

unallocated abstracts

715

716

170

EFFECT OF PRETREATMENT WITH POLYALTHIA LONGIFOLIA VAR (ANNONACEAE) ON DOXORUBICIN INDUCED CARDIOTOXICITY IN RATS R. Alluri, R. Perusomula (India)

1047

EFFECTS OF NIGHT SHIFT ON 24 HOURS CHRONOMICS OF BLOOD PRESSURE/HEART RATE AND ITS RELATION WITH MELATONIN SULPHATE LEVEL B. Anjum, MD, N. Verma, MD, S. Tiwari, MD, R. Singh, MD, A.A. Mahdi, MD (India)

1048

CLINICAL EVALUATION OF THE EFFECTS OF CORNUS MAS L .ON BIOCHEMICAL FACTOR IN ADULT PATIENTS WITH TYPE2 DIABETES S. Asgary, M. Keshvari, A. Sahebkar, R. Soltani, A. Gorji, N. Sarrafzadegan1 (Iran)

1049

THE EFFECTS OF HIBISCUS SABDARIFFA FRUIT EXTRACT ON SERUM LIPID LEVELS IN PATIENTS WITH METABOLIC SYNDROME S. Asgary, M. Keshvari, A. Sahebkar, R. Soltani, M. Zolghadr, N. Sarrafzadegan (Iran)

1050

HYDROCORTISONE REDUCES TOLL-LIKE RECEPTOR 4 EXPRESSION ON PERIPHERAL CD14+ MONOCYTES IN PATIENTS UNDERGOING PERCUTANOUES CORONARY INTERVENTION B. Bagheri, A. Garjani, B. Sohrabi, M. Shokri, B. Taherkhanchi (Iran)

1051

EVEROLIMUS-ELUTING STENTS REDUCE MONOCYTE EXPRESSION OF TOLL-LIKE RECEPTOR 4 COMPARED WITH BARE STENTS B. Bagheri, M. Shokri, A. Garjani, B. Sohrabi, B. Taherkhanchi (Iran)

1052

ATHEROPROTECTIVE POTENTIAL OF BOOPS BOOPS' MUSCLE PROTEINS: MITIGATION HYPERCHOLESTEROLEMIA AND OXIDATIVE STRESS INDUCED BY HIGH CHOLESTEROL DIET. A. Barkia, I. Lassoued, M. Trigui, R. Nasri, M. Nasri (Tunisia)

1053

THE STRUCTURAL EFFECTS OF SIMVASTATIN ON LIVER RAT TISSUE: FTIR AND RAMAN IMAGING STUDIES S. Bayari, S. Garip, I. Lednev, M. Severcan, F. Severcan (Turkey)

1054

ANTICARDIOLIPIN ANTIBODIES OF THE IGG ISOTYPE: ASSOCIATION WITH POLYNEUROPATHY AND HYPERFIBRINOGENEMIA IN PATIENTS WITH DIABETIC NEPHROPATHY M. Becarevic, V. Cabarkapa, M. Djeric, S. Ignjatovic (Serbia)

1055

Board No.

717

718

719

CIRCULATING OSTEOPONTIN AS A MARKER OF EARLY ATHEROSCLEROTIC DAMAGE IN TYPE TWO DIABETES MELLITUS PATIENTS WITH KNOWN ASYMPTOMATIC CORONARY ARTERY DISEASE A. Berezin, MD, A.A. Kremzer, MD, T.A. Samura, MD, Y.U.V. Martovitskaya, MD (Ukraine)

1056

INDEPENDENT PREDICTED VALUE OF SERUM URIC ACID DECREASED NUMBER OF CIRCULATING PROANGIOGENIC PROGENITOR CELLS IN ASYMPTOMATIC CORONARY ARTERY DISEASE PATIENTS A. Berezin, MD, A.A. Kremzer, MD, Y.U.V. Martovitskaya, MD, T.A. Samura, MD (Ukraine)

1057

ASSOCIATION CIRCULATING GALECTIN-3 WITH CIRCULATING PROANGIOGENIC MONONUCLEAR PROGENITOR CELLS IN PATIENTS WITH ISCHEMIC CHRONIC HEART FAILURE A. Berezin, A. Kremzer, Y. Martovitskaya (Ukraine)

1058

720

FLOW MEDIATED DILATION IN POLYCYSTIC OVARY SYNDROME: A CASE CONTROL STUDY F. Bilora, A. Zanella, L. Sarolo, F. Pomerri (Italy)

721

COMPARISON OF THE EFFECT OF AEROBIC EXERCISE WITH DIFFERENT INTENSITIES ON CHANGES IN BLOOD PRESSURE AMONG MIDDLE-AGED WOMEN V. Boghrabadi, S. Kashefi, B. Pouladi (Iran)

1060

COMPARISON OF CONTINUOUS AND INTERVAL MODERATE AEROBIC EXERCISE TRAINING ON BLOOD PRESSURE AND ENDOTHELIN_1 ON HYPERTENSION PATIENTS V. Boghrabadi, S. Kashefi, V. Boghrabadi (Iran)

1061

ATORVASTATIN ADDITION TO ANTIHYPERTENSIVE THERAPY REDUCED BLOOD LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN HYPERCHOLESTEROLEMIC PATIENTS WITH ESSENTIAL HYPERTENSION V. Bozhko, S. Koval, O. Mysnichenko, M. Penkova, E. Shenyavskaya, I. Snegurskaya (Ukraine)

1062

LIPID METABOLISM DISORDERS AND URIC ACID BLOOD LEVELS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND METABOLIC SYNDROME V. Bozhko, I. Snegurskaya, D. Miloslavsky, O. Mysnichenko, E. Shenyavskaya (Ukraine)

1063

BLOOD ADIPONECTIN LEVELS CHANGES IN PATIENTS WITH ESSENTIAL HYPERTENSION, DYSLIPIDEMIA AND GLUCOSE TOLERANSE DISTURBANCES V. Bozhko, M. Penkova, S. Koval, I. Snegurskaya, L. Groznaya, O. Mysnichenko (Ukraine)

1064

722

723

724

725

1059

171

Board No.


726

172

HISTOMORPHOMETRIC CHANGES IN THE AORTA OF MICE WITH CHRONIC CHAGAS DISEASE UNDERGOING MILD EXERCISE L. Brianezi, N. Lima, F. Fonseca, L. Maifrino (Brazil)

727

HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH): ONE DISEASE, MULTIPLE FACES P. Buonuomo, M. Macchiaiolo, M.V. Gonfiantini, A. Bartuli (Italy)

728

IMPROVING BAROREFLEX SENSITIVITY AS A THERAPEUTIC TARGET FOR ATHEROSCLEROSIS DEPENDS ON CHOLINERGIC ANTI-INFLAMMATORY PATHWAY. G. Cai (China)

1065

1066

1067

729

THE PREDICTIVE VALUE OF ELEVATED NEUTROPHIL TO LYMPHOCYTE RATIO FOR LONG TERM CARDIOVASCULAR MORTALITY IN PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE 1068 M. Erturk, H. Cakmak, O. Surgit, O. Celik, H. Aksu, O. Akgul, M. Gurdogan, U. Bulut, B. Ozalp, E. Akbay, A. Yildirim (Turkey)

730

IMMUNISATION WITH KLEBSIELLA PNEUMONIAE OMPK36 SHAPES COLON MICROBIOME COMPOSITION, AND MODIFIES LOCAL AND SYSTEMIC INFLAMMATORY PROFILES IN APOE-/- MICE. 1069 F. Canducci, S. Saita, R. Ferrarese, E. Ceresola, C. Sorini, M. Falcone, R. Burioni, M. Clementi (Italy)

731

THE ASSESSMENT OF RELATIONSHIP BETWEEN GGT LEVELS AND CORONARY PLAQUE BURDEN AND PLAQUE STRUCTURE IN PATIENTS WITH SUBCLINICAL CORONARY ATHEROSCLEROSIS1070 O. Celik, S. Satilmis, H.A. Cakmak, M. Erturk, D. Ozturk, F. Akin, A.A. Yalcin, M.M. Atasoy, B. Gungor, N. Uslu (Turkey)

732

DETECTION OF ARTERIAL HYPERTENSION AND HYPERTENSION-RELATED CARDIOMETABOLIC RISK FACTORS IN SURGICAL CARE STAFF K. Chagunava, G. Lomtatidze (Georgia)

1071

733

THE EFFECT OF LPS AND CPG ON ENDOTHELIAL BARRIER FUNCTIONS AND TOLEROGENIC PROFILE OF DENDRITIC CELLS IN RESPONSE TO APOB100 1072 M. Chalubinski, K. Gebicka, K. Wojdan, M. Borowiec, M. Mikolajczyk-Chmiela, M. Broncel (Poland)

734

THE ASSOCIATION OF INCREASED SERUM IL-35 LEVELS WITH CHOLESTEROL CONCENTRATIONS IN PATIENTS WITH CORONARY ARTERY DISEASE M. Chalubinski, P. Gorzelak, K. Wojdan, E. Luczak, I. Duraj, M. Mozdzan, M. Broncel (Poland)

1073

Board No.

735

SYSTEMIC APPROACH OF SERUM MICRORNAS AS BIOMARKERS FOR MYOCARDIAL INFARCTION P. Chu, S.J. Chen, H.J. Chen (Taiwan)

736

THROMBOMODULIN AND ANGIOPOIETIN-2 PREDICT THE DEVELOPMENT OF ACUTE KIDNEY INJURY IN PATIENTS WITH MYOCARDIAL INFARCTION P. Chu (Taiwan)

1075

ASSESSMENT OF VASCULAR FUNCTION IN SIXTY HEALTHY MALES: SOCCERS SHOW IMPAIRED FEMORAL COMPLIANCE AND ENDOTHELIAL DYSFUNCTION G. Cioni, A. Berni, G.F. Gensini, A. Abbate, M. Boddi (Italy)

1076

737

1074

738

NON-ALCHOLIC FATTY LIVER DISEASE AND SUBCLINICAL ORGAN DAMAGE: A NEW PREDICTOR OF ASYMPTOMATIC EXTRACORONARY ATHEROSCLEROSIS AND ENDOTHELIAL DYSFUNCTION1077 G. Cioni, R. Marcucci, L. Mannini, M. Pazzi, S. Valente, C. Giglioli, G.F. Gensini, R. Abbate, M. Boddi (Italy)

739

IMPAIRMENT OF PERIPHERAL VASCULAR FUNCTION IN SLE PATIENTS. DIFFERENCES FROM THE VASCULAR PATTERN OF PATIENTS AT HIGH CARDIOVASCULAR RISK G. Cioni, E. Silvestri, C. Cenci, M. Pazzi, G. Degl'Innocenti, G. Emmi, R. Marcucci, M.M. D'Elios, L. Emmi, D. Prisco, R. Abbate, M. Boddi (Italy)

1078

740

OMEGA-3 FATTY ACID MODIFIES HDL SIZE AND CONCENTRATION IN BRAZILIANS SUBJECTS N. Teixeira Damasceno, F. De Conti Cartolano, M. Nunez Aldin (Brazil)

741

PHOSPHOLIPID MEMBRANE SPECTRUM IN DYNAMICS OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH CHRONIC RENOCARDIAC SYNDROME O. Smiianova, MD, L. Vynnychenko, MD

1080

VILDAGLIPTIN COMPARED TO GLIMEPIRIDE ON POST-PRANDIAL LIPEMIA AND ON INSULIN RESISTANCE IN TYPE 2 DIABETIC PATIENTS G. Derosa, A. Bonaventura, L. Bianchi, D. Romano, E. Fogari, A. D'Angelo, P. Maffioli (Italy)

1081

COMPUTATIONAL IDENTIFICATION OF POTENTIAL TRANSCRIPTIONAL REGULATORS OF TGF-ß1 IN HUMAN ATHEROSCLEROTIC ARTERIES N. Dhaouadi, J.Y. Li, P. Feugier, K. Kacem, G. Bricca, C. Cerutti (France)

1082

742

743

1079

173

Board No.

744

VASCULAR AGEING IS APPARENT DURING AN ORAL GLUCOSE CHALLENGE IN HEALTHY HUMANS 1083 H. Dominguez, O.B. Abdullah, J. Raunsø, A. Major-Pedersen, T.S. Hermann, B. Falskov, B. Christiansen, N. Ihlemann, L. Køber, C.T. Torp-Pedersen (Denmark)

745

DYSLIPEDEMIA CONTROL IN TYPE 2 DIABETIC PATIENTS J. Duarte, C. Bello, R. Ferreira, F. Serra, C. Roque, J. Azinheira, A. Saraiva (Portugal)

746

THE CONTROL OF DYSLIPIDEMIA IN PATIENTS WITH HIV INFECTION / AIDS. EXPERIENCE A CENTRAL HOSPITAL FROM 2008 TO 2012 J. Duarte, R. Fonseca, K. Mansinho, H. Farinha, J. Azinheira (Portugal)


1085

747

EFFICIENCY OF COENZYME Q10 IN PROTECTING HEPATOCYTES AGAINST STATIN-INDUCED TOXICITY1086 M. Eghbal, N. Abdoli, Y. Azarmi (Iran)

748

SERUM LEVELS OF VISFATIN IN PATIENTS WITH CORONARY ARTERY DISEASE (CAD) AND TYPE 2 DIABETES IN COMPARISON WITH CONTROL GROUP R. Fadaei, E. Parvaz (Iran)

1087

749

ASSESSMENT OF THE GENETIC EFFECTS OF POLYMORPHISMS IN THE OSTEOPROTEGERIN GENE, TNFRSF11B, ON SERUM OSTEOPROTEGERIN LEVELS AND CAROTID PLAQUE VULNERABILITY1088 A. Flex, F. Biscetti, G. Straface, D. Pitocco, A. Santoliquido, C. Porreca, F. Bertucci, E. Stigliano, F. Angelini, A. Gasbarrini (Italy)

750

ALTERED HIGH-DENSITY LIPOPROTEIN (HDL) ANTIOXIDANT ACTIVITY AND SUBPOPULATION DISTRIBUTION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS K. Gaál, H. Lorincz, I. Seres, K. Rimár, M. Harangi, V. Borbás, T. Tarr, G. Paragh (Hungary)

751

752

174

1084

RELATIONSHIP BETWEEN POLYMORPHISMS OF UNCOUPLING PROTEIN (UCP) AND THEIR EXPRESSION IN EPICARDIAL AND SUBCUTANEOUS ADIPOSE TISSUE WITH CARDIOVASCULAR DISEASE R. Gamboa, S. Cabello, C. Huesca-Gomez (Mexico) RELATIONSHIP BETWEEN AORTIC STIFFNESS AND INTRARENAL HEMODYNAMICS IN HYPERTENSIVE PATIENTS G. Mulè, G. Geraci, C. Geraci, M. Mogavero, F. D'Ignoto, S. Cottone (Italy)

1089

1090

1091

Board No.

753

SUBCLINIKAL ATHEROSKLEROSIS, TRIGLICERID LEVEL AND INFLAMMATION IN PATIENT WITH CORONARY HEART DISEASE IN COMBINATION WITH NONALCOHOLIC FATTY LIVER DISEASE 1092 M. Grechanyk, O. Kuryata (Ukraine)

754

PON1 GENE POLYMORPHISMS AS GENETIC MARKERS OF OXIDATIVE STRESS IN PATIENTS WITH MANIFESTED DIABETES TYPE 2 AND ATHEROSCLEROSIS I. Grubisa, P. Otasevic, B. Toljic, J. Milasin (Serbia)

1093

ASSOCIATION OF ADIPONECTIN/ENDOTHELIN AND LEPTIN/INSULIN RATIOS WITH EARLY CORONARY LESIONS N. Gumanova, N. Gavrilova, A. Gorshkov, O. Alexandrovich, V. Metelskaya (Russia)

1094

755

756

EPICARDIAL ADIPOSE TISSUE THICKNESS IS INCREASED IN PREMENOPAUSAL WOMEN WITH VITAMIN-D DEFICIENCY AND DOES NOT RESPOND TO SHORT-TERM REPLACEMENT THERAPY1095 K. Gürses, L. Tokgözoglu, U. Yalçin, M. Dural, D. Koçyigit, H. Yorgun, B. Kaya, G. Kabakçi, N. Ozer, K. Aytemir (Turkey)

757

VITAMIN-D REPLACEMENT IMPROVES ENDOTHELIAL FUNCTION AND ENDOTHELIAL PROGENITOR CELL COUNT IN HEALTHY PREMENOPAUSAL WOMEN WITH VITAMIN-D DEFICIENCY 1096 K. Gürses, L. Tokgözoglu, U. Yalçin, D. Koçyigit, H. Yorgun, H. Canpinar, D. Güç, A. Gürlek, B. Kaya, K. Aytemir (Turkey)

758

HYPERTENSION PROBLEMS AND THOSE RELATED TO DIABETIC FOOT IN BRAZIL: A PROGRAM FOR THEIR TREATMENT. M. Gutierrez Cordova, A. Daige, S. Daige, D. Clajus Gutierrez, A. Sales, D. Ivanovic (Brazil)

1097

A HEALTH PROMOTION PROGRAM TO PREVENT PROBLEMS RELATED TO DIABETIC FOOT (HPPDF) IN BRAZIL. M. Gutierrez Cordova, A. Daige, S. Daige, D. Clajus Gutierrez, A. Sales, D. Ivanovic (Brazil)

1098

759

760

NOREPINEPHRINE INDUCES APOPTOSIS IN SMOOTH MUSCLE CELLS DERIVED FROM RAT BALLOON-INJURED ARTERY: INVOLVEMENT OF CALPAIN AS A TARGET FOR PKADEPENDENT APOPTOSIS 1099 R. Hachani, MD, H. Dab, MD, A. Feriani, MD, S. Saber, MD, M. Sakly, MD, R. Sercombe, MD (Tunisia)

175

Board No.

761

762

CHARACTERIZATION OF LIPID HYDROPEROXIDES IN HUMAN LDL BY LC/MS S.P. Hui, R. Shrestha, Y.U.J.I. Takahashi, A. Yagi, S. Takeda, H. Fuda, H. Chiba (Japan)

763

IN VITRO PIV EXPERIMENT FOR EVALUATING PREFERRED SITES OF ATHEROSCLEROSIS IN LEFT CORONARY ARTERY K. Hyoung-Ho, S.U.H. Sang-Ho, C.H.O.I. Young Ho, R. Md. Rakibuzzaman, K.I.M. Kyung-Wuk, K.A.N.G. Min Woo (Korea)

1101

1102

CARDIOVASCULAR AND CARDIOMETABOLIC RISK IN WOMEN WITH POSTSURGICAL MENOPAUSE 1103 A. Ilyushina, O. Mitchenko, V. Romanov, T. Belyaeva, I. Chulayevska (Ukraine)

765

THE RELATIONSHIP OF APELIN-12 LEVELS WITH THE PARAMETERS OF LIPID METABOLISM IN PATIENTS WITH ESSENTIAL HYPERTENSION S. Koval, K. Iushko, T. Starchenko, I. Shut’ (Ukraine)

1104

COMPARE THE STRESSFUL LIFE EVENTS AND MENTAL HEALTH AMONG CORONARY HEART DISEASE PATIENTS AND NON-PATIENTS H. Jahangiri (Iran)

1105

THE PREVALENCE OF CARDIOVASCULAR DISEASE RISK FACTORS AND LIFE STYLE AMONG RETIRED TEACHERS H. Jahangiri, G. Sarabi, F. Jahangiri, H. Davidian, A. Norouzi (Iran)

1106

DETERMINE THE PREVALENCE OF ANXIETY AND DEPRESSION IN HOSPITALIZED WOMEN PATIENTS WITH CAD H. Jahangiri, F. Jahangiri, G. Sarabi (Iran)

1107

CAROTID GSM OF THE IMT IS MORE ACCURATE, THAN CONVENTIONAL IMT, IN IDENTIFYING PATIENTS WITH PRIOR CARDIOVASCULAR EVENT F. Jashari, P. Ibrahimi, M.Y. Henein (Sweden)

1108

767

768


1100

764

766

769

770

176

THE EFFECTIVENESS OF COMMERCIAL GAMING-BASED VIRTUAL REALITY MOVEMENT THERAPY ON FUNCTIONAL RECOVERY OF THE UPPER EXTREMITY IN SUBACUTE STROKE E. Han, S.H. I.M., J.W. Choi (Korea)

FARNESOID X RECEPTOR UP-REGULATES EXPRESSION OF LIPID TRANSFER INHIBITOR PROTEIN IN LIVER CELLS AND MICE Y. Jiang, MD, L. Li, MD, H.O.N.G. Liu, MD, J. Peng, MD, Y. Wang, MD, Y.A.N. Zhang, MD, J. Dong, MD, X. Liu, MD, D. Guo, MD (China)

1109

Board No.

771

772

ACTIVATION OF FARNESOID X RECEPTOR DOWNREGULATES MONOCYTE CHEMOATTRACTANT PROTEIN-1 IN MURINE MACROPHAGE Y. Jiang, MD, Q.I.A.N. Zhang, MD, L. Li, MD, L.I.U. Hong, MD, J. Peng, MD, Y.A.N. Zhang, MD, L.I.L.I. Shen, MD, J. Dong, MD, Y. Wang, MD (China) ANTIATHEROSCLEROTIC AND ANTIOXIDANT ACTIVITY OF CORIANDRUM SATIVUM IN CHOLESTEROL FED RABBITS S. Joshi (India)

773

EXPOSURE TO BIODIESEL EXHAUST TRIGGERS ATHEROSCLEROTIC PLAQUE DESTABILIZATION E. Kilinc, J.I. Borissoff, A. Haegens, I. Kooter, A. Jedynska, D.J.T.H. TJWA, H.M.H. Spronk, H. Ten Cate (Turkey)

774

CAROTID ENDARTERECTOMY AND MEDICAL TREATMENT IN PATIENTS WITH ASYMPTOMATIC CAROTID ATHEROSCLEROSIS: RANDOMIZED CLINICAL TRIAL I. Kolos, S. Boytsov, A. Deev, T. Tvorogova (Russia)

1110

1111

1112

1113

775

EVALUATION OF THE VASCULAR WALL PERIPHERAL VASCULAR WOMEN WITH CHD N. Koriagina, L.M. Vasilets, A.V. Petrischeva (Russia)

776

LEFT VENTRICULAR DIASTOLIC FUNCTION IN NAFLD HYPERTENSIVE PATIENTS USING DIFFERENT ACE INHIBITOR-BASED REGIMENS O. Korneeva, O. Drapkina, V. Ivashkin (Russia)

1115

CORRECTIVE EFFECT OF SYSTEMIC ENZYME THERAPY ON COMPONENTS OF METABOLIC SYNDROME IN EXPERIMENTAL CONDITIONS A. Kozliuk, T. Talaeva (Ukraine)

1116

LEPTIN LEVELS AND SOLUBLE LEPTIN RECEPTOR AT PATIENTS WITH HYPERTENSION DEPENDING ON BODY MASS INDEX AND CARBOHYDRATE DISORDERS O. Kulyk, O. Mitchenko, V. Romanov, I. Chulaevskaya, T. Belyaeva (Ukraine)

1117

COMPARABLE EFFECTS ON HDL CHOLESTEROL BETWEEN EZETIMIBE AND PRAVASTATIN: RESULTS FROM A PILOT CROSS-OVER STUDY N. Kume (Japan)

1118

777

778

779

780

OXIDATIVE STRESS IN PATIENTS WITH DIABETES MELLITUS B. Kundalic, J. Kundalic (Serbia)

1114

1119

177

Board No.

781

PHENOTYPIC MANIFESTATIONS OF GENETIC SUSCEPTIBILITY TO ISCHEMIC STROKE S. Kuznetzova, N. Larina (Ukraine)

782

THE ASSOCIATION BETWEEN ACETYLCHOLINE-INDUCED CORONARY SPASM, BLOOD PRESSURE AND HEART RATE E. Lee, K. Yun, H. Seo, M. Choi, B. Choi, J. Na, C. Choi, H. Lim, J. Kim, E. Kim, S. Rha, C. Park, D. Oh (Korea)


1121

783

ACETYLCHOLINE INDUCED CORONARY ARTERY SPASM IS ASSOCIATED WITH VASCULAR SMOOTH MUSCLE HYPERREACTIVITY RATHER THAN ENDOTHELIAL DYSFUNCTION 1122 E. Lee, H. Seo, M. Choi, D. Kang, J. Na, C. Choi, H. Lim, J. Kim, E. Kim, S. Rha, C. Park, D. Oh (Korea)

784

COMPARISON THE EFFECT ON FASTING BLOOD SUGAR BETWEEN ATORVASTATIN AND PITAVASTATIN IN KOREAN POPULATION : LONG TERM FOLLOW-UP 1123 Y.S. Lee, K.R. Bae, Y.W. Park, S.W. Jun, S.P. Hong, J.B. Lee, J.K. Ryu, J.Y. Choi, S.K. Kim, M.W. Bae (Korea)

785

HIGH-DEFINITION CT IMAGING FOR CORONARY ARTERY STENTS: INITIAL RESULTS OF SELECTING OPTIMAL RECONSTRUCTION ALGORITHM T.A.O. Li, X. Cui (China)

1124

ASPRIN AND CLOPIDOGREL DUAL ANTI-PLATELETS THERAPY IS ENOUGH FOR ACUTE CORONARY SYNDROME WITH HYPERTENSION PATIENTS: A COHORT STUDY X. Li (China)

1125

786

178

1120

787

A RTK-BASED FUNCTIONAL RNAI SCREEN REVEALS DETERMINANTS OF PTX-3 EXPRESSION H. Liu, X. Qu (China)

1126

788

METABOLIC SYNDROME IN PATIENTS WITH HYPERTENSION AND HYPOTHYROIDISM A.A. Logvinenko, E.I. Mitchenko, T.V. Belayeva (Ukraine)

1127

789

ANKLE BRACHIAL INDEX (ABI) IN CHILDREN WITH STEROID RESISTANT NEPHROTIC SYNDROME 1128 S. Maher (Egypt)

790

MYOCARDIAL INFARCTION RISK IN THE FEMALE OCCUPATIONAL CATEGORIES IN RESPECT TO PSYCHOSOCIAL JOB CHARACTERISTICS IN KAUNAS, LITHUANIA V. Malinauskiene (Lithuania)

1129

Board No.

791

SHORT-TERM NITROGEN DIOXIDE POLLUTION EXPOSURE AND EMERGENCY HOSPITAL ADMISSION FOR ACUTE CORONARY SYNDROMES V. Malinauskiene (Lithuania)

1130

792

LOSS OF EXCESS THICKNESS OF THE CAROTID INTIMA-MEDIA AFTER BARIATRIC SURGERY 1131 J. Matos-Souza, MD, B. Geloneze, MD, J.C. Pareja, MD, W.J.R. Nadruz, MD, O.R. Coelho, MD (Brazil)

793

CIRCULATING UNDECARBOXYLATED MATRIX GLA PROTEIN AS MORTALITY PREDICTOR IN STABLE PATIENTS WITH VASCULAR DISEASE O. Mayer, J. Seidlerová, J. Bruthans, K. Timoracka, J. Vanek, J. Filipovsky (Czech Republic)

1132

STATIN THERAPY IN THE REDUCTION OF CARDIAC EVENTS IN PATIENTS UNDERGOING VASCULAR OPERATIONS E. Medvedeva, Y. Shchukin (Russia)

1133

794

795

796

OSTEOPROTEGERIN, FIBROBLAST GROWTH FACTOR 23 AND VITAMIN D3 LEVELS IN MALE PATIENTS WITH HYPOGONADISM C. Meric, A. Sonmez, A. Aydogdu, S. Tapan, C. Haymana, Y. Basaran, K. Baskoy, E. Sertoglu, A. Taslipinar, E. Bolu, O. Azal (Turkey) EFFECTS OF VALSARTAN TREATMENT ON SERUM GHRELIN LEVEL AND LEFT VENTRICULAR MASS INDEX IN PATIENTS WITH UNTREATED PRIMARY HYPERTENSION C. Meric, A. Aydogdu, I. Tasci, F. Deniz, O. Baysan, M. Serdar, K. Saglam, O. Azal (Turkey)

1134

1135

797

THE METABOLIC SYNDROME AND PRESENCE OF SUBCLINICAL ATHEROSCLEROSIS IN ADOLESCENTS1136 V. Negrean, O. Mislea, I. Cheta, T. Alexescu, V. Ruta, I. Para, I. Chisalita (Romania)

798

A DUAL-NOX ACTIVATION INDUCED BY ANGIOTENSIN II MODULATES VASCULAR SMOOTH MUSCLE CELLS FUNCTIONS: ROLE OF ALPHA1BETA1 INTEGRIN AND ILK J.A. Moraes, A.C. Frony, A.V. Dias, M. Renovato-Martins, G. Rodrigues, C. Marcinkiewicz, J. Assreuy, C. Barja-Fidalgo (Brazil)

799

FLK-1 MEDIATES ETHANOL-STIMULATED ENDOTHELIAL CELL ANGIOGENESIS VIA A NOTCH-DEPENDENT PATHWAY D. Morrow, E.K. Hatch, K. Hamm, P.A. Cahill, E.M. Redmond (USA)

1137

1138

179

Board No.

800


801

1139

THE ROLE OF ENDOTHELIAL FUNCTION, SUBCLINICAL FORMS OF ATHEROSCLEROSIS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASE IN PATIENTS WITH SYSTEMIC DISEASE O. Mytrokhina (Ukraine)

1140

802

ASSOCIATION BETWEEN AMPD1 GENE POLYMORPHISM AND ESSENTIAL HYPERTENSION R. Nemati, M. Heidari, R. Vasudevan, P. Ismail, R. Roozafzoon, M. Yahya, Z. Rabiei, M. Shahrzad, M. Arasthe (Malaysia)

803

RENAL VASCULAR DOPPLER ULTRASONOGRAPHIC INDICES CORRELATION WITH CAROTID ARTERY INTIMA-MEDIA THICKNESS IN DIABETIC NEPHROPATHY S. Ghorashi, B. Salari, N. Nezami (USA)

804

20-YEARS TRENDS OF BLOOD LIPID PARAMETERS FOR INHABITANTS OF NOVOSIBIRSK Y. Nikitin, S. Malyutina, K. Makarenkova (Russia)

805

FASTING AND POSTPRANDIAL LIPID PROFILES MANAGEMENT IN LIPOPROTEIN LIPASE DEFICIENCY: EVALUATION OF DIFFERENT LIPID-LOWERING TREATMENTS IN ADDITION TO LOW-FAT DIET J.P. Nogueira, M. Marie, R. Valero (Argentina)

1141

1142

1143

1144

806

LIPIDOMICS OF HUMAN SKIN FIBROBLASTS IN NEIMANN-PICK DISEASE TYPE C D. Noto, S. Indelicato, O. Palesano, M. Fontana, F. Fayer, I. Altieri, R. Spina, V. Valenti, M. Greco, E. Di Leo, L. Magnolo, P. Tarugi, F. Di Gaudio, M. Averna (Italy)

807

DIABETES MELLITUS IN PATIENTS WITH KLINEFELTER'S SYNDROME OF DIFFERENT CHROMOSOME CONSTITUTIONS AND THE XYY SYNDROME E. Nwabugwu (Nigeria)

1146

PLATELET ACTIVATION: A LINK BETWEEN PSORIASIS PER SE AND SUBCLINICAL ATHEROSCLEROSIS – A CASE-CONTROL STUDY A.M. Onsy, E.A.S. Attia, H.M.A. Saleh, A.A. Saad, M.M.M. Abd Ellah (Egypt)

1147

COMPARISON OF PHOSPHOLIPID TRANSFER PROTEIN (PLTP) GENE EXPRESSION IN PBMCS OF PATIENTS WITH ATHEROSCLEROSIS AND NORMAL CASES E. Parvaz, R. Fadaei (Iran)

1148

808

809

180

DIFFERENTIAL EXPRESSION OF HEDGEHOG/NOTCH AND TRANSFORMING GROWTH FACTOR-BETA IN HUMAN ABDOMINAL AORTIC ANEURYSMS A.J. Doyle, E.M. Redmond, D.L. Gillespie, P.A. Knight, J.P. Cullen, P.A. Cahill, D. Morrow (USA)

1145

Board No.

810

LIPID PROFILE IN HYPERTENSIVE AND NORMOTENSIVE PATIENTS E. Pello, S. Malyutina, G. Simonova, Y. Nikitin, T. Kuznetsova, J. Staessen (Russia)

1149

811

LIPID - LOWERING PROPERTIES OF ACTIVE ANTIHYPOXANT 3,5-DIAMINO-1,2,4-TIDIAZOL D. Pen'kov, P. Shabanov, I. Okunevich, L. Khnychenko (Russia)

1150

812

RESTING METABOLIC RATE AND ADIPOCYTOKINES IN OBESE NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS PATIENTS 1151 A. Mihai, L. Petcu, A. Picu, P. Gagniuc, C. Guja, I. Stoian, D. Lixandru, C. Ionescu-Tirgoviste (Romania)

813

ROSIGLITAZONE AMELIORATES BIOMARKERS ON VASCULAR REMODELING AMONG SUBJECTS WITH PRE-DIABETES AND CORONARY ARTERY DISEASE P. Liu, MD, Y. Lee, MD, C. Lee, MD, T. Chao, MD, L. Tsai, MD, L. Ping-Yen, MD (Taiwan)

814

815

SYSTEMIC INFLAMMATION IN PATIENTS WITH PSORIASIS IS ASSOCIATED WITH INCREASED EMPS/EPCS RATIO AND CAROTID INTIMA-MEDIA THICKNESS M. Pirro, L. Stingeni, M.R. Mannarino, M. Vonella, K. Hansel, F. Bagaglia, A. Alaeddin, P. Lisi, E. Mannarino (Italy) LIPID PARAMETERS AND CARDIOVASCULAR MORTALITY IN PATIENTS WITH ARTERIAL HYPERTENSION IN THE EASTERN EUROPEAN REGION V. Podpalov, N. Prakoshyna, A. Deev, A. Stchastlivenko, O. Podpalova (Belarus)

1152

1153

1154

816

MIRNA AND ANTI-INFLAMMATORY EFFECT OF N-3 PUFA (DHA/EPA) IN PREDIABETES A. Polus, U. Razny, J. Goralska, M. Malczewska-Malec, B. Kiec-Wilk, A. Zdzienicka, A. Gruca, D. Wnek, A. Dembinska-Kiec (Poland)

817

LIPOPROTEIN (A) AS PREDICTOR OF PERIPHERAL ARTERIAL DISEASE IN PATIENTS WITH DIABETES TYPE 2 L. Popovic, K. Lalic, D. Draskovic Radojkovic, N. Rajkovic, S. Singh, L. Stosic (Serbia)

1156

LEUKOCYTE CLEARANCE OF LIPIDS IN ALLOGENEIC TRANSPLANTATION OF CRYOPRESERVED PLACENTA IN RABBITS WITH EXPERIMENTAL ATHEROSCLEROSIS I. Topchii, I. Kondakov, A. Kirienko, D. Kirienko, A. Popovich (Ukraine)

1157

INFLUENCE OF CO-EXISTING NAFLD UPON CORONARY ATHEROSCLEROSIS DEPENDING ON LEFT VENTRICLE SYSTOLIC FUNCTION M. Dolzhenko, S. Potashev, L. Konoplyanik (Ukraine)

1158

818

819

1155

181

Board No.

820

ELECTROCARDIOGRAPHIC BIOMARKERS OF METABOLIC CARDIOMYOPATHY AND THEIR ASSOCIATIONS WITH COMPONENTS OF METABOLIC SYNDROME IN MEN WITH CORONARY ATHEROSCLEROSIS1159 Y. Ragino, N. Timoshenko, A. Chernjavskyi, S. Tcimbal, L. Scherbakova, M. Voevoda (Russia)

821

STUDING OF THE EFFECTS OF SIMVAGLYZIN AND ATORVAGLYZIN ON THE EXPRESSION OF 3-HYDROXY-3-METHYL-GLUTARYL-COA REDUCTASE IN RAT LIVER Y. Ragino, V. Vavilin, E. Stakhneva, O. Safronova, A. Shintyapina (Russia)

822


823

182

INFLUENCE OF OBESITY ON RELATIONSHIP BETWEEN ADIPOCITOKINES AND MARKERS OF ENDOTHELIAL DYSPHUNCTION IN TYPE 2 DIABETES N. Rajkovic, K. Lalic, N.M. Lalic, E. Colak, L. Lukic, S. Singh, L. Stosic, L. Popovic, D. Draskovic Radojkovic, A. Jotic, T. Milicic (Serbia) INCRESED INFLAMMATORY RESPONSE IN PATIENTS WITH FIRST MYOCARDIAL INFARCTION AND NON SIGNIFICANT STENOSIS INFARCT RELATED ARTERY N. Ratkovic, S. Obradovic, D. Dincic (Serbia)

1160

1161

1162

824

ALCOHOL CONSUMPTION AND PREMATURE CARDIOVASCULAR MORTALITY IN BELARUS Y. Razvodovsky, Y. Razvodovsky (Belarus)

1163

825

CONTRIBUTION OF ALCOHOL TO HYPERTENSION MORTALITY IN RUSSIA Y. Razvodovsky (Belarus)

1164

826

ALCOHOL ATTRIBUTABLE FRACTION OF ISHEMIC HEART DISEASE MORTALITY IN BELARUS Y. Razvodovsky (Belarus)

1165

827

OBESE ADIPOSE TISSUE INCREASES LY6C LOW CIRCULATING MONOCYTES AND INDUCES M1 MACROPHAGE POLARIZATION IN MICE M. Renovato-Martins, I. Ramos de Andrade, S. Vargas da Silva, M. Citelli dos Reis, E. Bouskela, T. Barja-Fidalgo (Brazil)

1166

828

THE IMPACT OF LP(A) ON CAROTID ARTERY DISEASE 1167 F. Resta, M. Benigno, P. Suppressa, I. Garzia, A. Noia, V. Triggiani, E. Guastamacchia, C. Sabbà (Italy)

829

ANTI-DIABETIC EFFECT OF FISH OIL ON ALLOXAN INDUCED DIABETIC MICE (MUS MUSCULUS) R. Roy, S. Kamat (India)

1168

Board No.

830

831

POSTPRANDIAL CHANGES OF LIPOPROTEIN PROFILE BY LINEAR ELECTROPHORESIS IN HEALTHY SUBJECTS AND SUBJECTS WITH ABDOMINAL OBESITY P. Sabaka, M. Caprnda, M. Bend?ala, D. Balá?, S. Oravec, A. Dukát, L. Ga?par (Slovakia) USEFULNESS OF LIPID RATIOS AND ATHEROGENIC INDEX OF PLASMA IN OBESE MOROCCAN WOMEN WITH OR WITHOUT METABOLIC SYNDROME R. Saile, MD, F. Essiarab, MD, H. Taki, MD, H. Lebrazi, MD, A. Kettani, MD, M. Sabri, MD, A. Derouiche, MD (Morocco)

832

STATINS DEREGULATE MICRORNA EXPRESSION SIGNATURE IN HEPG2 CELLS T. Zambrano, R.D.C. Hirata, M.H. Hirata, A. Cerda, L.A. Salazar (Chile)

833

CHARACTERIZATION OF GENE EXPRESSION ASSOCIATED WITH INTRACELLULAR CHOLESTEROL METABOLISM IN HEPG2 CELLS TREATED WITH STATINS J. Lagos, R.D.C. Hirata, M.H. Hirata, L.A. Salazar (Chile)

834

835

ANALYSIS OF HETEROPLASMY LEVEL IN MITOCHONDRIAL GENOME MUTATIONS OF MORPHOLOGOCALLY MAPPED AORTIC WALL M.A. Sazonova, V.V. Sinyov, K.Y. Mitrofanov, Y.V. Bobryshev, A.Y. Postnov, I.A. Sobenin, A.N. Orekhov (Russia) STUDY OF BLOOD CELL MITOCHONDRIAL GENOME MUTATIONS IN SYMPTOMLESS ATHEROSCLEROSIS AMONG WOMEN M.A. Sazonova, M.M. Chicheva, Y.V. Bobryshev, A.Y. Postnov, A.N. Orekhov, I.A. Sobenin (Russia)

1169

1170

1171

1172

1173

1174

836

COULD ENDOTHELIAL MICROPARTICLES ACT AS POTENTIAL BIOMARKERS OF PLAQUE INSTABILITY IN PATIENTS WITH CAROTID DISEASE? 1175 A. Schiro, D. Murray, J. Smyth, A.J.M. Boulton, F. Serracino-Inglott, M.Y. Alexander (United Kingdom)

837

SERUM MONOCYTE CHEMOATTRACTANT PROTEIN-1 AND CD16+ MONOCYTES IN TYPE 2 DIABETIC PATIENTS WITH CORONARY HEART DISEASE I. Topchii, P. Semenovykh, V. Galchiskaya, N. Efimova, T. Scherban (Ukraine)

838

1176

C-REACTIVE PROTEIN CHARACTERISTICS IN DIFFERENT REGIONS OF THE RUSSIAN FEDERATION 1177 S. Shalnova, A. Deev, G. Muromtseva, M. Mamedov, I. Medvedeva, S. Romanchuk, O. Rotar, Z. Toguzova (Russia)

183

Board No.

839

840

METABOLIC EFFECTS OF BARIATRIC SURGERY IN PATIENTS WITH MORBID OBESITY AND ARTERIAL HYPERTENSION A. Shkroba, O. Mitchenko, A. Lavrik, V. Romanov (Ukraine)

1179

THE RELATION OF PLASMA GLUCOSE LEVELS AND HBA1C WITH MORTALITY IN PATIENTS WITH ACUTE HEART FAILURE. 1180 A. Sianni, A. Ganotopoulou, I. Matsoukis, P. Paraskevas, E. Gova, N. Tsivilis, A. Asimis, I. Liouris (Greece)

842

THE ROLE OF OMEGA-3 FATTY ACIDS IN PATIENTS WITH CARDIOVASCULAR DISEASE AND DIABETES MELLITUS TYPE II 1181 A. Sianni, I. Matsoukis, A. Ganotopoulou, P. Paraskevas, A. Asimis, N. Tsivilis, E. Gova, I. Liouris (Greece)

843

ADHERENCE AND PERSISTENCE OF FIBRATE THERAPY G. Simonyi, M. Molnar, M. Palosi (Hungary)

844

P-SELECTIN EXPRESSION ON PLATELET-LYMPHOCYTE COAGGREGATES SURFACE IN PATIENTS WITH STABLE ANGINA PECTORIS A. Solpov, P. Tereshkov, M. Avetisyan, O. Bolshakova, Y. Vitkovsky (Russia)

1183

DIASTOLIC WALL STRAIN IN COMORBID PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE O. Soya, O. Kuryata (Ukraine)

1184

RECEPTOR CHARACTERIZATION OF SEROTONIN AND BRADYKININ ACTION ON ISOLATED PERIPHERAL RAT ARTERIES M. Stojanovic, M. Radenkovic, M. Prostran (Serbia)

1185

RELATIONSHIP BETWEEN PARAMETERS OF TOTAL AND ABDOMINAL OBESITY, LEVELS OF LIPOPROTEINS AND CORONARY HEART DISEASE IN TYPE 2 DIABETES L. Stosic, K. Lalic, N. Rajkovic, L. Popovic, D. Draskovic, S. Singh, M. Zamaklar (Serbia)

1186

THE CLINICAL OUTCOME OF TARGET NON-HIGH DENSITY LIPOPROTEIN-CHOLESTEROL (NON-HDL-C) ACHIEVEMENT IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: A PROPENSITY SCORE MATCHED ANALYSIS S. Suh, P. Oh, J. Seo, K. Lee, W. Kang, S. Han, T. Ahn, E. Shin, Y. Ahn, M. Jeong (Korea)

1187

846


1178

841

845

847

848

184

ATORVASTATIN IMPROVES PLAQUE STABILITY IN APOE-KNOCKOUT MICE BY REGULATING CHEMOKINES AND CHEMOKINE RECEPTORS L. Shen, P. Nie, D. Li, L. Hu, X. Jin, X. Jin, Y. Yu, Z. Cai, Q. Shao, B. He (China)

1182

Board No.

849

ACUTE LIMB ISCHAEMIA IN PATIENTS WITH CANCER; A CHALLENGING PROBLEM Z.D.Y. Sun, MD, D.A. Russell, MD, M.A. Troxler, MD, D.J.A. Scott, MD (United Kingdom)

850

THE STUDY OF ANTI-OXLDL AUTOANTIBODY BIOMARKER ON THE PREVENTION OF ACUTE CORONARY SYNDROME T. Sumiya, MD, M. Munkhzol, MD, E. Odkhuu, MD (Mongolia)

851

RETINOL-BINDING PROTEIN IN MYOCARDIAL INFARCTION COMPLICATED WITH ACUTE HEART FAILURE O. Gruzdeva, MD, E. Uchasova, MD, E. Belik, MD, Y. Dyleva, MD, V. Karetnikova, MD, E. Shurygina, MD, O. Barbarash, MD (Russia)

852

ADIPOKINES, GHRELIN AND MARKERS OF INSULIN RESISTANCE IN MYOCARDIAL INFARCTION O. Gruzdeva, MD, E. Uchasova, MD, E. Belik, MD, Y. Dyleva, MD, V. Karetnikova, MD, E. Shurygina, MD, O. Barbarash, MD (Russia)

853

GHRELIN AND INSULIN RESISTANCE MARKERS IN MYOCARDIAL INFARCTION COMPLICATED WITH ACUTE HEART FAILURE O.L.G.A. Gruzdeva, MD, E. Uchasova, MD, E. Belik, MD, Y. Dyleva, MD, V. Karetnikova, MD, E. Shurygina, MD, O. Barbarash, MD (Russia)

1188

1189

1190

1191

1192

854

CETP EXPRESSION EXERTS ANTI-INFLAMMATORY PROPERTIES IN MOUSE PERITONEAL MACROPHAGES1193 T. Venancio, MD, A. Castoldi, MD, F. Soriano, MD, E. Quintão, MD, N. Camara, MD, P. Cazita, MD (Brazil)

855

THE INFLUENCE OF LIPID PROFILE ON CLINICAL OUTCOME IN ISCHEMIC STROKE PATIENTS TREATED WITH THROMBOLYSIS S. Vidale, F. Di Palma, A. Sampietro, L. Tancredi, M. Arnaboldi (Italy)

1194

856

ASSOCIATION OF SERUM CYTOKINES, HUMAN GROWTH HORMONE, INSULIN-LIKE GROWTH FACTOR (IGF)-I, IGF-II AND IGF-BINDING PROTEIN (IGFBP)-3 WITH CORONARY ARTERY DISEASE.1195 H. Wei-Syun (Taiwan)

857

ERK1/2 MEDIATES LIPOPOLYSACCHARIDE-UPREGULATED FGF-2, UPA, MMP-2, MMP-9 AND CELLULAR MIGRATION IN PRIMARY CARDIAC FIBROBLASTS H. Wei-Syun (Taiwan)

858

PROTECTIVE ROLE OF GENISTEIN ON CARDIOMYOCYTE H. Wei-Syun (Taiwan)

1196

1197 185

Board No.

859

860

861


1198

ANTHOCYANINS INHIBIT PLATELET GRANULE SECRETION IN HYPERCHOLESTEROLEMIA VIA INHIBITION OF PHOSPHOINOSITIDE 3-KINASE SIGNALING Y. Yang, F. Song, Y. Zhu, J. Tian, X. Deng, J.I.N.G. Ren, W. Ling (China)

1199

A 4-YEAR FOLLOW-UP STUDY OF THE PATIENTS WITH CAD AND PRESERVED LEFT VENTRICLE SYSTOLIC FUNCTION AFTER REVASCULARIZATION Y. Yegorova, O.V. Kuryata (Ukraine)

1200

862

LEVELS OF TRACE ELEMENTS IN HAIR OF PATIENTS WITH CAROTID ATHEROSCLEROSIS COMPARED WITH HEALTHY INDIVIDUALS 1201 G. Rozikhodjaeva, K. Yokubov, M. Abdullahodjaeva, S. Hikmatov, S. Hudoynazarov, L. Pak (Uzbekistan)

863

DOES HDL CHOLESTEROL LEVELS PREDICT CORONARY ATHEROSCLEROSIS? L. Tokgözoglu, H. Yorgun, U. Canpolat, G. Fatihoglu, B. Kaya, L. Sahiner, B. Evranos, G. Kabakçi, K. Aytemir (Turkey)

1202

864

INTRACELLULAR APOLIPOPROTEIN O MODULATES INFLAMMATION IN ADIPOCYTES B. Yu, C. Wu, S. Zhao (China)

1203

865

MORBIDITY AND MORTALITY IN ELDERLY WITH LOW TOTAL SERUM CHOLESTEROL A. Zacharof (Greece)

1204

866

THE PREVALENCE OF THE COMPONENTS OF METABOLIC SYNDROME IN CHILDREN WITH DIFFERENT FORMS OF OBESITY A. Solntsava, O. Zagrebaeva, H. Mikhno (Belarus)

1205

MORPHOLOGICAL FEATURES OF PERIPHERAL ATHEROSCLEROSIS DISEASE IN SUBJECTS WITH ABDOMINAL AORTIC CALCIFICATION V. Zelinskiy, M. Melnikov, M. Shchur (Russia)

1206

867

868

186

ASSESSMENT OF CAROTID ARTERY INTIMA-MEDIA THICKNESS AND AORTIC PULSE WAVE VELOCITY IN DIFFUSE CORONARY ARTERY ECTASIA E. Yalcinkaya, C. Barcin (Turkey)

ROLE OF GRK4 IN THE REGULATION OF ARTERIAL AT1 RECEPTOR IN HYPERTENSION K. Chen, C.J. Fu, C.Y. Chen, L. Liu, H.M. Ren, Y. Han, J. Yang, D.F. He, L. Zhou, Z.W. Yang, L.F. Zhang, P.A. Jose, C. Zeng (China)

1207

Board No.

869

870

871

872

ASYMMETRIC DIMETHYLARGININE TRIGGERS MACROPHAGES APOPTOSIS VIA ENDOPLASMIC RETICULUM STRESS PATHWAY G. Zhang, D. Hong, Y. Bai (China)

1208

HIGH DENSITY LIPOPROTEIN INCREASES LOX-1 EXPRESSION IN HEPATIC CELLS VIA DECREASED ENDOPLASMIC RETICULUM STRESS PATHWAY G. Zhang, D. Hong, Y. Bai (China)

1209

OX-LDL INDUCES ENDOTHELIAL CELL APOPTOSIS VIA THE LOX-1-DEPENDENT ENDOPLASMIC RETICULUM STRESS PATHWAY G. Zhang, D. Hong, Y. Bai (China)

1210

RENALASE, A POTENTIAL CRUCIAL PROTEIN IN ATHEROSCLEROSIS, IS INVOLVED IN THE MECHANISM OF VALSARTAN PROMOTING THE STABILITY OF AS PLAQUE M.X. Zhou, C. Ma, W.H. Liu, H.X. Liu, N. Wang, W.F. Zhao, P. Li (China)

1211

873

THE ROLE OF MICRORNAS IN PERIPHERAL ARTERY DISEASE X. Zhou, Y. He (China)

874

MICRORNA-146A INDUCES ENDOTHELIAL PROGENITOR CELL APOPTOSIS AND SENESCENCE BY TARGETING PLK2 EXPRESSION S. Zhu, S. Deng, C. Jia, D. Zhuo, Q. Ma, J. Shi, H. Wang, P. Goldschmidt-Clermont, D. Dykxhoorn, C. Dong (USA)

875

876

LIPID PARAMETERS IN PATIENTS WITH DIFFERENT LEVELS OF BLOOD PRESSURE AMONG BELORUSSIAN URBAN POPULATION O. Zhurova, V. Podpalov, A. Stchastlivenko, N. Balashenko, N. Ogrisko, V. Sorokina (Belarus)

1212

1213

1214

THE 9P21 AS A POTENTIAL RISK FACTOR FOR CAD COMORBIDITY IN ADVANCED CAROTID ATHEROSCLEROSIS: PRELIMINARY STUDY 1215 M. Zivkovic, T. Djuric, A. Djordjevic, I. Zivotic, I. Koncar, L. Davidovic, D. Alavantic, A. Stankovic (Serbia)

187

unallocated abstracts Board No.

188


index of Authors

Presentation No. A Aalto-Setälä, K.

724

Abarquez, R.

1044

Abbate, A.

1076

Abbate, R. Abd Ellah, M.M.M.

1077, 1078 1147

Abd Muid, S.

422

Abdalla, D.S.P.

201

Abdelhalim, M.

1039, 1039, 1040, 1040

Abdoli, N.

1086

Abdulhannan, P.

718

Abdullah, O.B.

1083

Abdullahodjaeva, M.

1201

Abe, A.H.

894

Abengochea, A.

777, 778

Abramowicz, S.

226

Abruzzo, P.M.

101

Abu Ahmad, W.

595

Abualhin, M.

513

Acha, J.

611

Achenbach, S.

758

Acin, F.

166, 440, 885

Acin, S.

597

Adam, V.

398

Adamkova, V.

636, 908, 994

Adamova, I.

662

Adelman, S.

257

Adham, I.

274

Adiels, M.

27, 554

Adlouni, A.

1041

Adorn, M.P.

929

Adorni, M.P.

385, 602

Adzhiev, R.

741

Afanasieva, M.

741, 742

Presentation No. Afanasieva, O.

250, 540, 662, 935

Afonso, M.

188

Afzal, S.

179

Agaoglu, E.S.

811

Agapakis, D.

561

Agardh, H.

451

Aghamohammadzadeh, R.E.Z.A.

465

Agouridis, A.

943

Agrawal, D.

238

Aguiar, P.

319, 966

Aguilar-Barojas, S.

857

Aguilar-Mariscal, H.

813

Aherrera, J.

1042, 1043, 1044

Ahmad, R.

363, 365

Ahn, J.

1045, 1046

AHN, T.

1187, 284

Ahn, T.H.

211

AHN, Y.

1187

Aiello, V.D.

899

Ainsworth, G.

858, 874

Aizpuru, N.

328, 625

Akao, H.

608

Akbay, E.

1068

Akgul, O.

1068

Akhvlediani, M.

470, 912, 913

Akin, F.

107

Åkra, S.

801

Aksu, H.

1068

Al Suwaidi, J.

1022

Al-Bader, M.

1022

Al-Thani, H.

1022

Al-Zakwani, I.

1022

Alabakovska, S.

661

Aladeazabal, N.

802

Presentation No. Aladinsky, V.

433, 865

Alaeddin, A.

1153

Alavantic, D.

1215

Albert, G.

815

Albisher, A.

893

Alcaide, J.U.A.N.

409

Alcala-Diaz, J.F.

560, 789

Alcazar, A.

756

Aldulea, N.

792, 1020

Alejandra, P.

815

Alekseeva, G.V.

429

Alekseeva, I.

250

Alexander, M.Y. Alexandre, F. Alexandrovich, O.

1175 569, 645 1094

Alexandru, N.

437

Alexescu, T.

1136

Alexiev, A.

809

Alfaro-Rubio, F.

743

Ali, A.M.

462

Alicezah, M.K.

363

Alipour, A. Alkorashy, M.

441, 442 949

Allam, M.

811

Allan, R.

350, 767

Alloni, M.

456

Alluri, R.

1047

Alm, R.

270, 484, 713

Almagro, F.

406

Almeida Pinto, L.E.S.

684

Almeida, C.

535

Almeida-Pittito, B.

877

Alméras, N.

262

Alonso, M.

614

Alonso, N.

824 191

Presentation No. Alonso, R.

784

Altamura, S.

35

Altavilla, D.

791

Altieri, I.

1145

Altieri, P.

716

Altunkas, F. Alvarez de Sotomayor, M. Alvarez, C.E. Alvarez-Leon, E.

213, 721

Arasthe, M.

1141

434

Araujo Loperena, O.

923

Ando, R.

808

Arca, M.

151

Andor, M.

351, 436, 884

Arcidiacono, M.V.

824

Andr?s, C.

720

Ardigò, D.

602

Andrei, E.

437

Arefieva, T.I.

490

Andres, A.

600, 685

Argente, C.R.

832

Andrés, V.

59

Argimon, J.

322

564, 800

Ariza, M.J.

832

Andrés-Esteban, E.M.

180, 521, 715

Alvarez-Quintero, R.

956

Alvarez-Sala Walther, L.

1027 117A, 314, 319,557, 616, 617, 618, 619, 967, 968

Alves, C.

905, 966

Alves, R.

495, 894

Amara, K.

482

Amaral, J.B.

723

Amaral, M.

335

Ambegaonkar, B.

128

Andersson, J.

Andrés-Blasco, I.

241, 1037

214, 675

Amemiya, T.

964

Ametamey, S.M.

760

Presentation No.

Andersen, M.

867, 880, 510

Alvarez-Llamas, G.

Alves, A.C.

Andrys, C. Angeles-Martínez, J.

695, 1011 719 241, 1037

Angelin, B.

190

Angelini, F.

1088

Anguera, A.

897

Anguera, A.N.N.A.

863

Anjum, B.

1048

Annema, W.

603

Anniballi, G.

199

Annuzzi, G.

199

Antoniadis, A.P.

212

Antonio, M.

815

Antunes, R.

488

Aoki, T.

556

Aouichat Bouguerra, S.

373 857

Ariza-Corbo, M.J.

406 206, 743

Armitage, J.M.

132

Arnaboldi, L.

659

Arnaboldi, M.

1194

Arnal, C.

597

Arnautovic Torlak, V.

480

Arner, P.

83, 278

Arnesen, H.

801, 803

Aronov, D.

895

Arrondo, J.L.R.

652

Arroyo, A.

756

Arroyo, D.

770

Arsenault, B.

262

Artacho, M.

1028

Artemeva, N.

540, 662

Artero, A.

709

Arteta, D.

328, 625

Arugaslan, E.

251

Arzumanyan, M.

753

Amigó, N.

579, 730

Aminoff, A.

635

Aparicio-Trapala, M.A.

Aminpour, S.

995

Apostolou, O.

831

Ascaso, J.

4

Amioka, N.

647

Appleton, M.

572

Ascaso, J.F.

547, 709, 800

Amiri, F.

698

Aprahamian, T.

85

Asciutto, G.

713

Ammori, B.

298

Amstutz, C.

848

Anagnostopoulou, K.

402

Anders, H. 192

614

Alonso-Villaverde Grote, C.

Presentation No.

515

Aragon, V. Arakelyan, A. Aranceta, J.

528, 599, 849, 850

Asensio, E.M.

960

Ashavaid, T.

633

Ashley, S.

633

681, 864

Asgary, S.

401 1049, 1050

Presentation No.

Presentation No.

Asimis, A.

1180, 1181

Aslan, I.

812

Babajanov, B.

Aslan, M.

812

Babas, G.

502

Balen, S.

503, 504

Aslangul, E.

930

Baccara-Dinet, M.T.

267

Balla, G.

170

236, 379

Bachelot-Loza, C.

948

Balla, J.

170

451

Bachlitzanaki, M.

701, 831

Ballantyne, C.

268

Assmann, G.

63

Bäck, M.

451

Ballerini, L.

779, 780, 781

Assoumou, L.

930

Bäckhed, F.

10

Balluff, B.

180, 521

Assreuy, J.

1137

Backhouche, S.

167

Balogh, I.

336

Asztalos, B.

257

Backteman, K.

487

Banach, M.

438, 580, 853

Atasoy, M.M.

107

Bader, M.

Atsma, D.

240

Badimon, L.

Atsushi, T.

647

Attard, R.

343, 694

Attia, E.A.S.

Asmis, R. Assinger, A.

B

Presentation No.

763, 829

Balashenko, N.

768, 1214

Baldassarre, D.

773

934

Banchs, H.L.

716

559, 592, 156

Bandere, D.

1033

Bae, E.

376

Banerjee, P.

939

Bae, K.R.

1123

banks, H.T.

971

1147

Bae, M.W.

1123

Banter, M.

922, 1017

Aubert, J.F.

848

Baek, J.M.

581, 584

Banu, L.

833

Aulinger, B.A.

285

Baek, M.Y.

1032

Bañuls, C.

341

Aurelian, S.

942

876

648

744

Baena-Fustegueras, J.A.

Banys, V.

Aurelian, S.M.

Baptista, J.

535

Baetta, R.

101

Baragetti, A.

34, 263, 665

Bagaglia, F.

1153

Bagdonaite, L.

648

Austin, R.C.

354, 386, 387

Avdeeva, K.

460

Avellaneda, L.

541

Averna, M.

1145

Averna, M.R.

795, 796

Avetisyan, M.

1183

Avsar, A.

213

Aydogdu, A. Aylward, K.

499, 500, 1134, 1135 948

Aytemir, K.

1095, 1096, 1202

Azal, O.

499, 500, 1134, 1135

Bagheri, B. bai, Y.

1051, 1052

Baranowski, M.

852

Baratella Panzoldo, N.

645

1208, 1209, 1210

Barbaras, R.

125, 538

BAILA RUEDA, L.

316

Barbarash, O.

1190, 1191, 1192

Baila-Rueda, L.

174, 320, 611, 859

Barbetta, B.

962

Barcin, C.

1198

Baillot-Rudoni, S.

823

Bairaktari, E.

944

Baker, B.

333

Bakhlishvili, I.

1016, 1016

Bakker, S.

443

Azarmi, Y.

1086

Bala, A.

435

Azarova, I.

433, 865

Balá?, D.

1169

Azinheira, J.

1084, 1085

Balakhonova, T. Balandina, Y.

Barderas, M.G. Bargalló, N.

180, 715 78

Barinova, V.A.

271

Barja-Fidalgo, C.

1137

Barja-Fidalgo, T.

1166

Barkas, F.

933, 943, 944, 1006

935

Barkia, A.

1053

754, 919, 921

Barlera, S.

639 193

Presentation No.

Presentation No.

Baroni, M.

456

Bekesi, G.

959

Berg, M.

451

Barragan-Arnal, R.

401

Bekkering, S.

234

Berge, R.K.

918

Barranquero, C.

597

Bektas, M.H.

687, 689

Berger, J.M.

261, 938

Barrett, H.

545

Belayeva, T.V.

1127

Berger, J.S.

729

692

Beleyur Narayanaswamy, P.

375

Bergero, G.

541

Bergeron, J.

262

Béliard, S.

332

Barrientos, M. barril, G.

785, 836

Barrio, D.

574, 851

Bartelt, A.

197

Barter, P.

298

Barter, P.J.

64, 215, 931

Bartlett, K.

572

Bartling, B.

194

Presentation No.

382

Bartuli, A.

1066

Baruah, P.

489

Baruch, D.

948

Basaran, Y.

500, 1134

Bashiri, A.

194

Baskoy, K.

500, 1134

Bastida, S.

666

Batuca, J.

335

Bauge, E.

196

Baum, L.

399

Baumeister, S.E.

359

Belik, E.

1190, 1191, 1192

Bello, C.

1084

Belloy, L.

253

Belohoubek, J.

994

Belosludseva, O.

805

Beltrán-Debón, R.

273

Belyaeva, T.

1103, 1117

Benaiges, D.

286

Benavente Fernández, A.

686, 1019

Bend?ala, M.

1169

Benedí, J.

666

Bengrid, T.

310, 739, 757

Bengtsson, E.

270, 432, 484

Benigno, M.

1167

Benitez, S.

235, 237, 559

Benito, E.

547

Baumgartner, S.

552

BAYARI, S.

1054

Bayes-Genis, A.

559

Benlian, P.

562, 630

Bays, H.

268

Benn, M.

179

Baysan, O.

1135

Bennett, M.

160

BEA, A.M.

316, 320, 544, 611

Benvenuti, C.

961, 962

Beaney, K.E.

969

Beaver, T.

414

Becarevic, M.

1055

Becatti, M.

779, 781

Beckman, L.

1035

Benito-Vicente, A.

Beraia, G.

314, 557, 558, 652

509

Beraia, M.

509

Berciano, S.

407

Berestetskaya, J.

540

Berestetskaya, Y.

741

Berezin, A.

1056, 1057, 1058

Bergström, G.

208

Bergström, G.M.

1015

Bergström, I.

487

Bermudez, G.

222, 678, 769

Bernal Lopez, M.R.

947

Bernatova, I.

997

Bernelot Moens, S.

439

Berni, A.

779, 780, 781, 1076

Bernini, F.

307, 385, 587, 591, 602, 870, 929

Berta, E.

336, 904

Bertolami, A.

201

Bertolini, S.

835

Bertsch, T.

203, 204, 703

Bertucci, F.

1088

Berzina, S.

1033

Besseling, J. Betriu, A.

93 770, 824

Beuers, U.H.W.

305

Beylot, M.

373

Bezzina Wettinger, S.

343, 418, 634, 694

Bianchi, L.

1081

Bianco, H.T.

483, 723

Bicho, M.

856

Biessen, E.A.L.

33

Bigazzi, F. Bijl, N.

428, 837 226

Presentation No.

Presentation No.

Presentation No.

Billheimer, J.T.

113

Bobescu, E.

792, 1020

Bilora, F.

1059

Bobryshev, Y.

433, 773, 865

Binder, C.

38, 233, 395

Bobryshev, Y.V.

1038, 1173, 1174

Bosisio, R.

712

Birch, M.

971

Bosquet, A.

164, 279

Birner-Gruenberger, R.

297

779, 780, 781, 1076, 1077, 1078

Birnie, E. Bis, J.

308, 441, 996 719, 720

Biscetti, F.

1088

Bisello, A.

225

Bitsis, T.

922, 1017

Bittar, R.

930

Bittencourt, C.R.

651

Bitto, A.

507, 791

Björkbacka, H.

270, 484

Björkegren, J.L.M.

187

Bjørndal, B.

918

Blachnio-Zabielska, A. Blackburn, Y.

852 683, 690, 821, 986

Blaha, M.

471

Blaha, V.

471, 719, 720

Blanco-Favela, F. Blanco-Vaca, F.

649 254, 258, 322, 604, 876

Blazhev, A.

523, 524

Ble-Castillo, J.

813, 857

Boddi, M. Bodhankar, S.

883

Bodor, M.

336, 904

Boeing, H.

92

Boesen-Mariani, S.

998

Boesjes, M.

941

Bogeski, I.

1034

Boghrabadi, V.

1060, 1061, 1061

Böhm, M.

200

Bohov, P.

918

Boidin-Ceschini, L.

562

Bolotta, A.

101

Bolshakova, O.

1183

Bolu, E.

1134

Bombo, R.P.

188

Bonaventura, A.

1081

Bond, D.

615

Bonnefont-Rousselot, D.

930

Boon, L.

33

Borbás, V.

1089

Borel, N.

760

Borel, P.

175

Boren, J.

40, 27, 68, 554, 635

Bleda, S.

166, 440, 885

Blesa, S.

398

Blokker, B.

407

Borissoff, J.I.

1112

Blom, D.J.

66

Borowiec, M.

435, 1072

458

Borthwick, F.

Blomhoff, R. Bluher, M.

782, 783

Bos, S.

891

Boshuizen, M.C.S.

33

Bosi, C.

307

Bot, I.

288

Botelho, P.B.

201

Botham, K.M.

393

Botteri, G.

411

Bouam, M.

280

Bouchaert, E.

41

Boudoulas, H.

887

Bouillet, B.

823

Boulton, A.J.M.

1175

Bourbon, M.

314, 319, 557, 616, 617, 618, 619, 966, 967, 968

Bourdon, C.

148

Bousboulas, S.

701, 831

Bouskela, E.

1166

Boussel, L.

219

Bouziana, S.

926

Bouzourene, K.

848

Bowler, A.

127

Boyadjiev, S.

148

Boytsov, S.

640, 671, 677, 1113

Bozhko, V.

1062, 1063, 1064

Bozic Stanojevic, M.

295

Bozzetto, L.

199

Braamskamp, M.

146, 330

Bracho, M.

222, 678

Braesch-Andersen, S.

663, 1035

537, 929

Braga, A.A.

229

Boardman-Pretty, F.

970

Boschcov, P.

483

Brambilla, P.

456

Bobadilla Jacob, P.

972

Boshuizen, M.

291

Brandão, S.A.

483 195

Presentation No.

Presentation No.

Bravo-Romero, M.J.

493

Buijsse, B.

92

Cai, G.

1067

Brea, A.

897

Bujo, H.

565

Cai, Y.

162

Brea, A.J.

406

Bukrinsky, M.

100

Cai, Z.

Brégeon, J.

261

Buldak, L.

388, 814

Caimi, G.

Brewin, M.

971

Buldak, R.J.

388

Caixàs, A.

322

Briand, O.

191

Bulinin, A.

753

Cakmak, H.

1068

Brianezi, L.

1065

Cakmak, H.A.

107

Bricca, G.

1082

Calabresi, L.

587

Brichacek, B.

100

Brindisi, M.C.

823

Brinias, C.

922, 1017

Briones, A.M.

244

Brisson, D.

318

Broedl, U.C.

285

Broncel, M.

435, 1072, 1073

Brtko, M. Bruckert, E.

719, 720 998

Brudi, P.

214, 675

Brufau, G.

191, 255

Brugada, R.

427

Brügger-Andersen, T.

457

Brunatti, P.

573

Brunborg, C.

448

Brunet, A.

267

Brunner, S.

266

Bruno, M.

128

Brunssen, C.

352, 496

Brusberg, M.

239

Bulugahapitiya, S.

683, 690, 821, 986

Bulut, U.

1068

Buonuomo, P.

1066

Burckhardt, R.

782

Burdeynaya, A.

662

Burioni, R.

897

Calandra, S.

307, 602, 835

Calderón, R.

716

1069

Calmarza Calmarza, P.

627

Burks, D.J.

564

Calmarza, P.

323

Burnett Jr, J.c.

639

Calvo-Bonacho, E.

Burokiene, N.

841

Calzada, C.

186

Burton, B.

315

Camara, N.

1193

Buscema, M.

727

Camargo, A.

404

Busnelli, M.

290, 426, 659, 871, 934

Busto, R.

756

Byazrova, S.

242

Byrkjeland, R.

801

C Cabarkapa, V.

1055

Cabello, S.

109

Cabello-Moruno, R.

393

Cabre, A.

579, 279, 730, 786

1132

Cabrera, M.

843, 844

Brux, M.

352

Caccavello, R.

595, 979

Bubnova, M.

895

Cacciagiú, L.

629

Budinsky, L.

758

Cachofeiro, V.

86 311

Bueno, M.

322

Cademartiri, F.

Buerke, M.

382

Cagliero, P.

573, 951, 1000

Cahill, P.A.

1138, 1139

823

1178 795, 796

Calabuig, J.R.

Bruthans, J.

Buffier, P. 196

Presentation No.

406, 843, 844

Camargo, L.M.

651

Camargo, T.P.

684, 878, 987

Camargo-Garcia, A.

788

Camejo, G.

239

Camont, L.

186

Campo, G.

727

Camps, J.

777

Campuzano, O.

427

Canducci, F.

1069

Canet Soulas, E.

219

Canet-Soulas, E.

293

Canilho, J.

968

Canino, B.

795, 796

Cannone, V.

639

Canonne-Hergaux, F.

389

Canpinar, H.

1096

Canpolat, U.

1202

Presentation No. Cantor, E.J. Capdevila-Busquets, E. Capisizu, A.

971 411 744, 942

Presentation No. Castoldi, A. Castro Cabezas, M.

1193 308, 441, 442, 996

Castro, I.

201

Capps, N.

896

Castro-Cabezas, M.

419

Caprnda, M.

1169

Català, R.

786

Cardillo, C.

230

Catalán, M.

825

Cardona, F.

408, 409, 419, 493

Catalina-Romero, C.

844

Catanozi, S.

188

Cardoso, G.

241

Carerj, S.

507

Cariou, B.

133, 260, 261, 938

Cavichioli, D.

Carmena , R.

43, 48, 142, 144

Cazita, P.

Catapano, A.L.

1, 3, 6, 8, 34, 101, 118, 120, 263, 665, 890

Presentation No. Cezzareto, A.

877

Chacin, L.

222

Chackathayil, J.

811

Chae, J.

227

Chagas, A.C.P.

775, 899

Chagunava, K.

1071

Chahed, H.

790

Chalikias, G.

887

Challa, A.

722

Chalmers, A.

461

Chalubinski, M.

435, 1072, 1073

229

Chan, D.C.

545

1193

Chan, E.

414 411

Carniciu, S.

818

Cecchettini, A.

733

Chan, T.O.

Carrasco, P.

400

Cedergren, C.

187

Chang, C.

1005

Carreira, R.J.

180

Cekirdekci, E.

251

Chang, N.

220

Carrié, A.

630

Celada, P.

472

CHANTZIARA, K.

798

Carvalho, A.C.M.

894

213, 745, 746, 721

168

863

Celik, A.

Chantzichristos, V.

Casanovas, G.

Chao, T.

1152

Casas-Agustench, P.

872

Celik, O.

1068, 1070

Celikyay, Z.R.Y.

746

Cena, C.

951

Cenarro Lagunas, A.

627

Chao, T.H.

963

Chapman, J.

122, 129, 256, 301, 589

Chapman, M.J.

186, 549, 889, 578

Charnaux, N.

167

Charriere, S.

624

1078

Chaves, F.J.

398, 547

Cercas, E.

957

Chávez-Rueda, K.

649

374, 508

Cerda, A.

229, 905, 1171

Chávez-Sánchez, L.

649

368, 685

Ceresola, E.

1069

Chawla, P.K.

633

Cerrato, F.

614

Chebel-Dumont, S.

630

cerutti, C.

1082

Chen, B.

872

Cesana, F.

456

Chen, C.

178

408, 419

Ceska, R.

67, 620, 908

Chen, C.Y.

1207

Castello, R.

341

Ceyhan, K.

Chen, H.J.

1074

Castelnuovo, S.

712

213, 721, 745, 746

Chen, I.-C.

963

Casasnovas, J.A.

695, 1011

Casella Filho, A.

899

Casella-Filho, A.

775

Caslake, M.

845

Cassar, K.

343, 694

Cassiman, D.

146, 330

Cenci, C.

Cassorla, G.

381

Castaño, D. Castejon, B. Castellano Castillo, C.

409

Castellano, J.

559

Castellano-Castillo, D.

CENARRO, A.

316, 174, 320, 323, 324, 611, 612, 859

197

Presentation No.

Presentation No.

Chen, J.

774

Chisalita, I.

1136

Chulaevskaya, I.

1117

Chen, J.Y.

491

Chisholm, P.

692

Chulayevska, I.

1103

Chen, K.

162, 1207

Chen, S.J.

1074

Chen, X.

254, 399, 604

Chen, Y.

178, 277

Chen, Y.X.

161

Cho, K.

Cheng, M.

294

Cho, K.-H.

Chennamsetty, I.

253

Cho, K.H.

582, 584

Cherfils, C.

930

Cho, M.

726

Cifkova, R.

178

Chern, C.

Chistoffersen, B.

646, 807

Chung, E.

337

Chiu, S.

1001

Chung, W.

706, 707

Chmielewska, M.

854

Chung, W.Y.

520, 945

Chmilewsky, F.

167

Ciavarella, C.

513

705

Cicakova, Z.

1012

581, 583, 664

Cicero, A.F.G.

307, 602

Cicha, I.

353 275, 994

Cho, M.K.

376

Cimalla, P.

496

737, 1159

Cho, Y.

705

Cioni, G.

1076, 1077, 1078

Cherradi, L.

197

Choi, B.

1121

Cirovic, S.

827

Cheta, D.

744

Choi, B.G.

345

Citelli dos Reis, M.

1166

Cheta, D.M.

776

Choi, C.

Cheta, I.

1136

Choi, C.U.

Cheung, L.

283

Choi, E.

Chèvre, R.

59

Choi, I.

394

Chi, N.

178

Choi, I.S.

1032

Chiara, M.

426

Choi, J.W.

11

Chiba, H.

576, 1101

Choi, J.Y.

1123

169, 232, 1002, 1003

Choi, M.

1121, 1122

Choi, S.

728

Chou, C.

491

Christiansen, B.

1083

Christoffersen, B.O.

799

Christoffersen, M.

176

Christogiannis, L.

943, 944

Chernjavskyi, A.

Chibana, H. Chicheva, M.M.

1174

Chiesa, G.

290, 426, 659, 871, 934

Chin, W.

333, 916

Chinetti-Gbaguidi, G.

253

Chiong, L.

1042

Chiotellis, A. Chiou, H. Chiou, H.-Y.

198

Presentation No.

760 178, 1001 277

Chirackal Manavalan, A.P.

598

Chirico, E.N.

293

Chirossel, P.

624

Chroni, A. Chrysohoou, C.

1121, 1122 345 412, 412

299 312, 331, 505, 772, 977

Civeira, F.

Claderon, C. CLAJUS GUTIERREZ, D.

29, 174, 316, 320, 323, 324, 396, 544, 611, 612, 613, 627, 859 261 1097, 1098

Claro, C.

510, 867, 880

Clavey, V.

191

Clemente-Postigo, M.

409, 419

Clementi, M.

1069

Clemenza, F.

639

Cleutjens, J.P.

33

Climent, E.

613

Coca, I.

406

Cocera, L.

398

Cockcroft, N.

352

1074, 1075

Cocozza, S.

199

Chuang, Y.

1005

Coelho, O.R.

1131

Chudinovskikh, T.

920

Cofán, M.

859

414

Cokkinos, D.

402

Colak, E.

1161

Chu, P.

Chukkapalli, S.

Presentation No.

Presentation No.

Presentation No.

Colhoun, H.

302

Cramb, R.

896

Daisuke, Y.

647

Colhoun, H.M.

267

Crane, E.

354

Dalla Nora, E.

469

Colin, S.

191, 253

Crespo, M.

716

Dallinga-Thie, G.

81, 155

Collantes, M.

526

Crevisy, E.

823

Dallinga-Thie, G.M.

33, 153

Collins, H.

257

Criado-Garcia, J.

397

Damar, I.H.

745, 746

Colmenero, J.D.

493

Cristescu, C.

351, 436, 884

Damaskos, D.

402

Coltell, O.

400, 401

Cropp, A.

268

Danzig, V.

994

Contini, C.

377

Croux, I.

873

Daoued, R.

501

Coolen, B.F.

305

Cruickshank, J.K.

811

Das, S.

Cooper, J.A.

969

Cruz-Teno, C.

789

Dascalescu, R.

942

Cooper, S.

360

Dashti, M.

475

Copaescu, C.

205

Dasseux, J.

538

Dasseux, J.L.

125, 126

Dauteille, C.

578, 589

Dauteuille, C.

186, 256, 301

Davalos, A.

191, 258, 407

Corbella, E. Cordova-Uscanga, R. Corella, D. Corrado, E. Corrêa-Giannella, M.L.

680, 861 813 79, 400, 401 1025, 1026 384

Correig, X.

579, 730

Corsano, E.

428

Corsini , A.

145

Corsini, A.

101

Coskun, A.U.

212

Costa da Silva, M.

35

Costa, L.

389

Costabile, G.

199

Costagliola, D.

930

Costet, P.

261, 938

Cotta de Faria, E.

645

Cottone, S.

1091

Courchesne, P.

872

Courtney, H.

585

Covaciu, A.

792, 1020

Covas, M.i.

882

Craciun, S.

833

Cuchel, M.

113, 127, 256, 301

Cucinotta, D.

791

Cuesta Torres, L.F.

298

Cui, X.

1124

Cukier, A.

589

Cullen, J.P.

1139

Cuniberti, L.

498, 514, 541, 972, 973

Cwiklinska, A.

546, 679

Czaja, J.

679

Czarnecka, D.

607

D D’Agostino, R.

924

D’Angelo, A.

1081

D’Elios, M.M.

1078

D’Ignoto, F.

1091

da Luz, P.

899

Dab, H.

1099

Dadabaeva, N. Daemen, M.J.A.P. Dahl-Jørgensen, K.

763, 829

David, B.

448 1097, 1098

DAIGE, S.

1097, 1098

Daimiel Ruiz, L.

407

Daimiel-Ruiz, L.

410

815

David, L.

747

Davidian, H.

1106

Davidovic, L.

1215

Davidson, M.M.

411

Davignon, J.

698

Davydenko, V.

420

Dawson, N.

417

de Backer, G.

52

de Boer, J.F.

255, 603, 941

De Borst, G.J.

221

De Caridi, G.

507

DE CASTRO-ORÓS, I.

316, 174, 320, 396, 612, 897, 324, 323, 611

De Conti Cartolano, F.

1079

33

DAIGE, A.

339, 417, 539

de Diego, A.

244

de Faria, E.C.

431, 569

de Geest , B.

111, 181 199

Presentation No.

Presentation No.

de Gonzalo Calvo, D.

592

Del Core, M.

238

Deussen, A.

496

de Graaf, J.

126

Del Rio, D.

870

Devuyst, O.

601

De Haro, J.

166, 440, 885

Delaney, C.L.

350, 1018

de Herder, W.W.

442

Deleu, D.I.R.K.

1022

de Jong, R.C.

240

Delgadillo, H.

1037, 1037

de Jong, R.C.M.

527

Delgado Alves, J.

335

Di Benedetto, A.

De Keulenaer, G.W.

842

Delgado Lista, J.

397

Di Cataldo, V.

293

De Kleijn, D.P.V.

221

Delgado, M.

493

Di Filippo, M.

332, 630

de la Cruz, E.

861

Delgado, N.

404

Di Gaudio, F.

1145

de la Cuesta, F.

180, 715

Delgado-Casado, N.

403

di Giuseppe, R.

de la Figuera, M.

682

Delgado-Lista, F.J.

403

Di Leo, E.

de la Llera Moya, M.

259

Della Pepa, G.

199

Di Palma, F.

1194

De Mello, V.

804

315

842

290, 426, 659, 871, 934

Di Rocco, M.

De Meyer, G.R.Y.

Di-Filippo, M.

624

Diakoumakou, O.

402

Dias, A.V.

1137

Dias, N.

713

De Paoli, F.

253

de Vries, C.J.

33

de Vries, M.

288, 308, 441, 442

Dellera, F. Dembinska-Kiec, A.

787, 1155

Dementyeva, N.

459

Demina, E.

420

Demina, E.P.

421

de Vries, M.A.

996

Demizieux, L.

280

de Vries, M.R.

527

Demonty, I.

866

de Winther, M.

291

Den Ruijter, H.M.

221

de Winther, M.P.

395

Denardi, C.

775

de Winther, M.P.J.

33, 413

Denchev, S.

809

Deanfield, J.

896

Deng, S.

1213

Deb-Rinker, P.

161

Deng, X.

1199

989, 990, 1031

Deniz, F.

Decharatchakul, N. Deegan, P. Deetman, P. Deev, A.

200

Presentation No.

1135

315

Denizeri, S.B.

687, 689

443

Dergunov, A.

563

688, 1113, 1154, 1177

Derkacz, A.

817

Derosa, G.

1081

Derouiche, A.

117

Desbois, E.

167

Desmarchelier, C.

175

Deev, A.D.

978

deFaire, U.

302

Defesche, J.C.

153, 325

Degiovanni, A.

512

Degl’Innocenti, G.

1078

Degrace, P.

280

Després, J.P.

17, 107, 262

Detmar, M.

58

De´ Marziani, G.

629

dhaouadi, N.

1082

Dhyani, A.

263, 665 791

92 317, 1145

Diaz-Zagoya, J.C.

813, 857

Didichenko, S.A.

589

Diederichsen, A. Dieplinger, H.

311 207, 274

Dierkes, J.

92

Dietel, B.

353, 758

Dikkers, A.

255

Dilanas, C.

922, 1017

Dincic, D.

1162

Dingli, P.

343, 694

DiNicolantonio, J.J.

593

Diniz, A.L.D.

775

Dinya, M.

959

Dionizovik, M.

333

Djeric, M.

1055

Djordjevic, A.

1215

Djuric, T. Dlouha, D.

1215 281, 908, 1021

Presentation No.

Presentation No.

Dmitrieva, O.

742

Dragut, R.

Dobreanu, D.

102

Drapkina, O.

Doggen, C.

343, 418, 634, 694

Draskovic Radojkovic, D.

806, 881

Durrington, P.N.

811

511, 888, 1115

Dutkiewicz, M.

953

1156, 1161

Doliba, N.

127

Draskovic, D.

1186

Dolzhenko, M.

1158

Drazul-Schrader, D.

257

Domagala, T.

748, 898

Drechsler, C.

344

Domanski, D.

953

Drevon, C.

918

Dombrovskiy, A.

369

Drevon, C.A.

1029

Dombrowicz, D.

41

Domei, T.

212

Dominguez Lopez, M.

Drexel, H.

621, 622, 902

Dominguez, H.

1083

Donazzolo, Y.

961, 962

Donchenko, I.

762

Donetskaya, O.

752

Dong, C.

1213

Dong, J.

1109, 1110

Dongen, G.

538

Donovan, D.

333

Dorajoo, R.

637

Dorea, E.L.

905

Doroszko, A.

817, 975

Dörr, M.

359

Dostal, E.

485, 486

Douagi, I.

482

Douek, P.

624

Dourado, P.

775, 899

Dourliou, V.

926

Doyle, A.J.

1139

Doyle, C.

925

Dragan, E.

437

Dragan, L.

351, 436, 884

Dragomir, A.

881

Dragomirescu, L.

776

Presentation No.

94, 306, 342, 542, 708, 766, 846, 847, 980, 981

Dvoeglazov, V.

920

Dykxhoorn, D.

1213

Dyleva, Y.

1190, 1191, 1192

Dziegiel, P.

854

E Ebelt, H.

382

Ebert, T.

782

Eckert, S.

148, 315

Edsfeldt, A.

209, 432

Edwards, R.

855

Drogari, E.

699

Efimova, N.

1176

Drozdz, K.

854

Eghbal, M.

1086

Du, L.

283

Egorova, L.

740

Duaip, G.

498, 973

Egot, M.

948

Duarte, J.

1084, 1085

Ehnholm, C.

23

Duarte, R.

856

Ehrenborg, E.

635

Dubois-Bouchard, C.

318

Eisenhofer, G.

496

Dufour, R.

698

Ekmekçi, A.

251

Dugardin, C.

191

Ekmekci, H.

372

Duggan, W.

268

Ekroos, K.

871

Duhring, S.

782

El Khoury, P.

549

Dukát, A.

1169

El Orra, A.A.

877

Dulawa-Buldak, A.

388, 814

El-Menyar, A.

1022

Dullaart, R.

443, 603

Elbert, A.

629

Dumitriu, I.E.

488, 489

Elian, V.

776

Dumler, I.

375

Duncan, S.A.

193

Duner, P.

432, 484

Duque, A.

368, 685

Duraj, I.

1073

Dural, M.

1095

Durrington, P.

658

Durrington, P.A.U.L.

465

Elias Sanchez, T.

613

Elias, M.C.

684, 878, 879, 987, 1030

Elisaf, M.

722, 900, 901, 933, 943, 944, 1006

Elisaf, M.S.

593

Elliott, T.

698

ElMahdy, N.

697 201

Presentation No. Emmi, G.

1078

Emmi, L.

1078

Ena, J.

832

Engelbertsen, D.

270

Enns, G.

315

Erden, S.

687, 689

Eriksson, P.

Ezhov, M.

250, 540, 543, 662, 740, 741, 742, 935

F Fabia, M.J.

398

Fabregate, M.

368, 574, 600, 685, 851

Fabregate, R.

368, 574, 600, 685, 851

Presentation No. Fayer, F.

1145

Fayez, M.

697

Fazio, S.

534, 915

Fedacko, J.

355, 868

Fedacko, J.A.N.

717

Federspiel, M.C.

930

Feillet, F.

562

Feki, M.

501

Erkorkmaz, U.

213, 746

Fadaei, R.

1087, 1148

Fekih-Mrissa, N.

473

Ernerudh, J.

479, 487

Faggioli, G.

218

Feldman, A.M.

411

Errasti-Amiano, U.

613

Fajardo, C.

229

Feldman, C.L.

Errico, T.L.

604

Fajardo, C.M.

905

Felice, A.

Erridge, C.

481

Fajkusova, L.

620

Feoktistov, A.

865

Ershova, A.

640

Falcon, R.

341

Ferchaud-Roucher, V.

550

Erturk, M.

1068, 1070

Falcone, M.

1069

212 418, 634

Ferchichi, S.

790

Erusalimsky, J.D.

61

Falkenstein, R.

934

Feriani, A.

1099

Escobales, N.

716

Falskov, B.

1083

Ferin, R.

535

Escolà-Gil, J.C.

254, 258, 604

Faludi, A.A.

201

Fernandes, C.

245

Fanaee-Danesh, E.

598

Fernandes, S.

684

228, 246, 936

Fang, C.C.

963

Fernández, C.

600, 851

Esis, C.

678

Farb, M.G.

85

Fernandez, E.

295, 824

Espinosa-Luna, J.E.

649

Farcasiu, E.

816

Fernández, E.D.

770

Essiarab, F.

117

Farinha, H.

1085

Fernandez, P.

536

Esteve, E.

322

Farkas, A.

959

Fernández-Arroyo, S.

273, 777, 778

Estruch, M.

235

Farnier, M.

267, 890

Estruch, R.

78, 79

Farras, M.

882

Fernandez-Castillejo, S.

882

Fernández-Hernando, C.

13, 252, 410

Fernández-Higuero, J.A.

314, 652

Fernandez-Ruiz, I.

380 258, 614

Escudero Brocal, A. Escudero, P.

686, 1019

Estruch-Alrich, M.

237

Farrugia, R.

343, 694

Ete, M.

332

Fasshauer, M.

782

314, 557, 558

Fatihoglu, G.

1202

Eussen, S.

463

Fatorova, I.

471

Evans, I.M.

970

Fauler, G.

344

1025, 1026

Fava, C.

335

Fernandez-Suarez, M.E.

Favaloro, R.

973

Ferrando, C.

936

Favari, E.

307, 385, 573, 587, 602, 929

Ferrarese, R.

1069

Ferrari, M.

733

Fayad, Z.

42

Etxebarria, A.

Evola, S.

202

40, 247, 283, 635, 839

Presentation No.

Evranos, B.

1202

Eyer, D.

562

Presentation No.

Presentation No.

Presentation No.

Ferrari, R.

727

Fogari, E.

1081

Franzini, L.

Ferré, R.

786

Fogelman, A.

115

Franzosi, M.G.

639

Ferreira, C.E.

723

Fogtman, A.

953

Fredrikson, G.

713

Ferreira, R.

1084

Folchetti, L.D.

877

Freiberger, T.

620

Ferreira, S.R.G.

877

Foldes, G.

765

Freitas, F.R.

577

Ferrer Giménez, M.

627

Freyrie, A.

218

Ferrer, R.

876

Foley, J.R.J.

683, 690, 821, 986

Friand, V.

167

Ferri, N.

101

Folkersen, L.

40

Frick, J.

126

Fonollosa, V.

536, 626

Friedlander, Y.

637

Frigerio, L.

456

Ferruelo, A.

166

Feugier, P.

1082

Fica, S. Figueiredo Neto, A.M.

833 483, 651

Fonseca, F.

1065

Fonseca, F.A.

483, 651, 723

Fonseca, H.A.

483, 651

Frikke-Schmidt, R.

307, 602

30, 154, 172, 176, 303

Fonseca, R.

1085

Frimmel, K.

997, 1012

Figueras, R.

322

Fontana, M.

1145

Fritsche, A.

92

Fijalkowski, M.

679

Fontanez, N.

333

Froemming, G.

Filipek, A.

390

Foody, J.

890

Froemming, G.R.A.

Filipovsky, J.

1132

Foroughi Asl, H.

187

Froissard, R.

562

Fillipovsky, J.A.N.

275

Fort, I.

777

Frony, A.C.

1137

Fingerle, J.

934

Fort, J.M.

876

Frost, P.H.

567

Finucane, O.

259

Fortunato, J.

720

Frostegård, A.

950

Frostegård, A.G.

444

422 363, 365, 462

Fiorillo, C.

779, 781

Fotakis, P.

99

Fischer, J.W.

447

Fouchier, S.

153, 325

Frostegård, J.

444, 482, 950

Fisher, J.

718

Fouchier, S.W.

660

Fruchart , J.

124

Fisher, R.M.

283

Fournier, N.

588

Fu, C.J.

1207

Fiskesund, R.

482, 950

Fragoso, J.M.

1037

Fu, H.

382

Fit, L.

932

França, C.N.

723

Fuchs, D.

714

Fito, M.

882, 79

France, M.

465

Fuda, H.

576, 1101

469

Fuentes, F.

404, 882

Fittipaldi, S.

218, 512, 513

Francesconi, D.

Fitzgerald, J.M.

958

Francis, G.A.

146, 330

Fuentes-Jimenez, F.

788

Flavell, R.A.

434

Franco-Cereceda, A.

283, 635

Fuenzalida, B.

182

Fletcher, J.

381

Francque, S.

Fujii, H.

522

Fleury, S.

41

Frank, S.

253, 297, 358

Fujikawa, M.

576

Flex, A.

1088

Frankel, P.

970

Fujimoto, C.Y.

495

Flores Le-Roux, J.A.

286

Franken, R.A.

495

Fujita, Y.

184

Floriano, E.

245

Frankova, S.

281

Fukalov, Y.U.

641

16

203

Presentation No. Fukamachi, I. Fukami, K.

556 808, 834

Presentation No.

Gallina, R.

873

Garlaschelli, K.

Galovcova, M.

994

Garlichs, C.

34, 263, 665 758

Fuke, S.

965

Gálvez-Montón, C.

559

Garlichs, C.D.

Fukuda, D.

869

Galy, B.

35

Garrido-Sanchez, L.

Fukumoto, Y.

353

Garzia, I.

1167

Gasbarrini, A.

1088

409, 493

169, 232, 1003

Gaman, L.

205

Fuller, C.

127

Gamboa, R.

423, 1090

Fülöp, P.

282, 735, 838

Gammoudi, N.

790

Gaspar, L.

485, 486

Furio, E.

936

Gan, L.M.

635

Gastol, J.

810

Furtado, M.V.

751

Ganotopoulou, A.

1180, 1181

Gatti, R.

Fushimi, E.

533

Gantz, D.

Fuster, J.

85

Fuster, J.j.

59

G Ga?par, L.

1169

Gaál, K.

735, 1089

Gabbasov, Z.

242, 477

Gachechiladze, D.

470

Gafarov, V.

696

Gafarova, A.

696

Gafencu, A.

424

Gagné, C.

146, 330

Gagniuc, P.

818, 1151

Gagulin, I.

696

Gajos, G.

445, 575

Galabova, G. Galán, M.

204

Presentation No.

266 86, 244

Galasso, M.

201

Galchiskaya, V.

1176

Galenko-Iaroshevsky, P.A.

494

Galera, A.

299

Ganzetti, G.S.

290, 426, 659, 871, 934

Gapon, L.

459, 460, 805

Garces, Z.

361, 362

García Arnes, J.

875

Garcia Castañon, S.

627

Garcia Del Rio, M.

599, 849

García Heredia, A.

777

García, B.

410

Garcia, R.

692

Garcia-Aleman, J.

408

García-Arnes, J.A.

206, 743

Garcia-Carpintero, S.

397

García-Casares, N.

206, 743

Garcia-Fuster, M.j.

398

Garcia-Garcia, A.B.

547

García-Heredia, A.

273, 778

Garcia-Rios, A. Garcia-Vazquez, C.

397, 403, 404 857

Garcimartín, A.

472, 666

861

Garelnabi, M.

858, 874

Galfo, F.

507

Garev, A.

523, 524

Galiatsatos, N.

505

Gargiulo, M.

512, 513

Galimov, E.

640

Garip, S.

Galimskaya, V.

762

Garjani, A.

1054 1051, 1052

Gaudet, D. Gavidel Sardsahra, A. Gavrilova, N.

385 126, 128, 146, 318, 330 995 670, 671, 1094

Gawrys, J.

749, 975

Gazbar, S.

501

Gazzola, K.

307

Gbandi, E.

561

Gebicka, K.

1072

Gegeshidze Nino, N.D.G.

892

Geiger, K. Geller-Rhomberg, S. Geloen, A.

306, 980 847 293, 219

Geloneze, B.

1131

Gennero, E.

514, 972, 973

Genser, B. Gensini, G.F.

344 1076, 1077

Genvigir, F.D.V.

905

George, B.

988

Georgescu, A.

437

Georgescu, O.

833

Geraci, C.

1091

Geraci, G.

1091

Germano, J.F.

229

Gertow, K.

302, 970

Presentation No.

Presentation No.

Presentation No.

Ghafouri, K.

845

Gleason, T.

414

Gonzalez Santos, P.

82

Ghorashi, S.

1142

Gliwinska, A.

546

González, A.I.

629

Giacco, A.

199

Goday, A.

286

González, J.I.

400

Giacovelli, G.

962

Goeritzer, M.

568

González, M.

794

Giampatzis, V.

926

Goeser, E.

127

González, W.

716

Giannattasio, C.

456

Gofman, E.

688

Gonzalez, Y.

698

Giannini, L.

779, 780, 781

Goh, D.Y.

637

Gonzalez-Calero, L.

715

Gibiansky, L.

927

Gojkovic-Bukarica, L.

827

González-Cancel, I.F.

716

Gidlund, M.

483

Gokce, N.

85

Gidlund, M.A.

651

Göke, B.

285

Gonzalez-de la Guardia, L.

788

Giebe, S.

352

Goldberg, I.J.

73

789

Gielen, S.

382

Gierach, M.

497

GoldschmidtClermont, P.

Gonzalez-Guardia, L.

1213

González-Heredia, T.

826

Giglioli, C.

1077

Gonzalez-Hidalgo, C.

885

Gijbels, M.

291

González-Jiménez, E.

464 228, 564, 800

Gijbels, M.J.J.

33, 395

Gilabert, R.

78, 825

Gill, J.M.R.

845

Gill, P.S.

811

Gillespie, D.L.

1139

Gino, Q.

1043

Ginsberg, H.

333

Ginsberg, H.N.

267

Giral, P.

889, 930

Giralt, M.

882

Girard, E.

588

Girona, J.

164, 279

Gistera, A.

434, 451

Gitt, A.K.

214, 675

Giunta, G.

498, 514, 541, 972, 973

Giupponi, L.

456

Gjorstrup, P.

952

Gkolfinopoulou, C.

299

Gkourogianni, A.

948

Goliasch, G.

485, 486

Golovatch, V.

530

Gomaraschi, M.

587

Gomez Huelgas, R.

947

Gonzalez-Navarro, H.

Gómez, C.

574, 851

González-Ortiz, M.

826

Gomez, P.

998

González-Santos, P.

206, 406, 743, 843, 844

Gonzalo Marin, M.

621, 622, 875, 902

Goralska, J.

787, 1155, 446

Gorbach, A.V.

429

Gordon, B.

264

Gomez-Coronado, D.

614, 258

Gomez-Delgado, F.

397, 560

Gomez-Delgado, F.J.

403

Gomez-Luna, P.

560

Gomez-Martin, P.

947

Gomez-Rodriguez, V.

526

Gomulkiewicz, A.

854

Gomyranova, N.

671

Goncalves, I.

209, 432, 713

Gorji, A.

1049

Gorlova, O.

433, 865

Gorshkov, A.

1094

Gorza, L.

101

Gonfiantini, M.V.

1066

Gongadze, N.

530

Gonsalves, I.

516

Gonzalez -Navarro, H.

246 621, 622, 691, 793, 875, 902, 974

Gotto, A.M.

Gonzalez Molero, I.

Gorzelak, P.

435, 1073

Gospodinova, M.

809

Gostjeva, E.

512

Göthert, J.R.

447

Gotto, Jr., A.M. Gottrand, F.

585 62, 69 562 205

Presentation No.

Presentation No.

Goulas, A.

561

Grotevendt, A.

359

Gum, S.

376

Goumans, M.J.

527

Groznaya, L.

1064

Gumanova, N.

1094

Gova, E. Grabner, M.

1180, 1181

Grozou, A.

701

Gungor, B.

991, 992, 993

Grubisa, I.

1093

Guo, D.

1109

Gruca, A.

446, 787, 822, 1155

Guo, Z.M.

192

Guo-Wei, H.

862

Gupta, S.K.

339, 539

Grabowska, I.

953

Gracia, M.

770

Graham , M.

20

Graham, I.

49, 53

Graier, W.

253

Graier, W.F.

358

Grammer, T.

714

Grandoch, M.

447

Granér, M.

189

Gratsiansky, N.A. Grau, J.

978 322

Grechanyk, M.

1092

Greco, M.

1145

Greenstein, A.D.A.M.

465

Greenwald, S.

971

Gresti, J.

280

Griffin, M.

615

Griffo, E.

199

Grigorashvili Zurab, Z.G.G. Grigore, L.

892 34, 263, 665

Grufman, H.

209, 432

Grujic Ilic, G.

999

Grundt, H.

457

Gruzdeva, O.

1190, 1191

Gruzdeva, O.L.G.A.

1192

Grzegorek, I.

854

Grzeszczak, W.

853

Grzybczak, R.

575

Guadall, A.

244

Guaita, S.

164, 279

Guardamagna, O.

573, 951, 1000

Guardiola, M.

405

Guardmagna, O.

315

Guarneri, F.P.

1025, 1026

Gurdogan, M.

251, 1070

1068

Gurevich, V.

421

Gürlek, A.

1096

Gurrea, C.

716

Gürses, K.

1095, 1096

Gusakovskaya, L.

946

Gusarova, V.

147

Gustafsson, T.

839

Gusukuma, M.C. Gutiérrez Cardo, A. GUTIERREZ CORDOVA, M. Gutierrez-Repiso, C. Guyer, K.E.

905 206, 743 1097, 1098 691, 793, 974

Guasch-Ferré, M.

79

729

Guastamacchia, E.

1167

Guzik, T.

Güç, D.

1096

Gwiazda, E.

1008, 1014

Gueret, P.

311

Gylling, H.

77, 198

Guerin, M.

549

H

813

830

Gritli, N.

473

Guerrero-Romero, F.

Ha, J.W.

519

Grivel, J.C.

960

Guevara, E.

972, 973

Haas, A.N.

751

Grivet, V.

823

594, 595, 650, 979

204

982

Gugliucci, A.

Haas, G.-M.

Groch, L.

Haas, G.M.

203, 703

Groen, A.K.

206

Presentation No.

125, 255, 941, 191

Guillas Baudouin, I.

186

Guillem-Saiz, P.

400

Groen, B.

24

Guillén, N.

597

Gromova, E.

696

Guillou, H.

938

Grossi, E.

727

Guinzioni, I.

534, 915

Grosu, A.

747

Guirro, M.

Großmann, J.

382

Guja, C.

273, 777, 778 1151

Haase, C.L.

303

Habbal, R.

1041

Hachani, R.

1099

Hadchouel, J.

261

Haddad, O.

167

Haegegsgtröm, J.

444

Presentation No. Haegens, A.

1112

Hägg, S.

187

Haggui, A. Hakkarainen, A.

473 27, 189, 554

Hallenberg, C.

976

Haller, H.

375

Hallström, S.

297, 358

Ham, O.

412

Hama, S.

298, 465

Hamilton, S.J.

545

Hamlat Khennaf, N.

373

Hamm, K.

1138

Hamming, J.F.

527

Hamon, S.

939

Hamsten, A.

187, 302, 970

Han Cheol, L.E.E.

1045, 1046

Han, E.

11

HAN, S.

1187

Han, S.H. Han, S.J. Han, Y. Hanada, H.

211, 284, 704 519 637, 728, 1207 533, 548

Hancock-Cerutti, W.

256, 301

Hancock-Cerutti, W.F.

113

Hancu, A.

881

Hanhineva, K.

804

Hannuksela, M.L.

606

Hanotin, C.

939

Hansel, K. Hansen, A.K.

1153 646, 807

Hanssen, K.F.

448

Hansson, G.K.

40, 434, 451

Haouala, H. Harada-Shiba, M.

473 65, 903, 265

Presentation No.

Presentation No.

Harangi, M.

327, 336, 735, 838, 904, 1089

Haridasan, V.

988

Haro-Mariscal, C.

403

Harrison, D.G.

114

Hartmann, P.

60

Heng, C.

637

Hasballa, R.

99

Henriksson, K.

925

Hashimoto, M.

964

Hentze, M.W.

35

Hashimoto, R.

171

Heras, M.

Hasib, L.

479

Hermann, T.S.

1083

Hassim, F.

366, 367

Hermansson, C.

208

Hernandez Mijares, A.

680

Hatashima, A.

1004

Hatch, E.K.

1138

Hattori, H.

265

Hatzitolios, A.

926

Hatzitolios, A.I.

561

Havulinna, A.S.

Heinle, H.

827, 959

Hejlova, I.

281

Henein, M.

311, 449, 515

Henein, M.Y.

310, 739, 757, 1108

Hernandez, M.

164, 579, 730

193, 824

Hernández-Aguilera, A.

273, 777, 778

1007

Hernandez-Mijares, A.

341

Hayashi, H.

605

Herrera, M.D.

867, 880, 510

Hayashi, T.

797

Herreras, Z.

825

Haykal, M.

697

Herrero, A.

800

Hess, A.

758

Haymana, C.

499, 500, 1134

Hazes, J.

308

Heusch, G.

518

Hazes, J.M.W.

996

Hewitt, K.

352

He, B.

1178

Hidaka, Y.

533, 548

He, D.F.

1207

Hidalgo, A.

59

He, Y.

1212

Hiebl, B.

382

Hedblad, B.

270

Higashimoto, Y.

808

Hedin, U.

40

Higuchi, K.

991, 992, 993

Heegaard, P.

799

Hikmatov, S.

1201

Heeren, J.

84, 197, 313

Hirano, H.

217

Heeringa, P.

458

Hirano, T.

840

Hegde, M.

883

Hirata, M.

Hegele, R.

127

Hirata, M.H.

Heidari, M.

1141

Hirata, R.D.

229

Heier, M.

448

Hirata, R.D.C.

905, 1171, 1172

229 905, 1171, 1172

207

Presentation No.

Presentation No.

Hirche, F.

92

Horner, D.S.

426

Humphries, S.

150

Hiroshi, I.T.O.

647

Horrevoets, A.

291

Humphries, S.E.

417, 969, 970

Hisdal, J.

886

Horslen, S.

315

Humpries, S.

34

Hitos, K.

381

Hoth, M.

1034

Hunter, W.

238

Hlawaty, H.

167

Houlind, K.C.

976

Hurme, R.

871

Hlinomaz, O.

982

Hounslow, N.

889

Hurt-Camejo, E.

239

33, 413

Hovingh, G.

315

Husche, C.

200

Hussain, M.M.

632

Huth, C.

274

Hutri-Kähönen, N.

80

Hoeksema, M.A. Hoffmann, A.

782

Hoffmann, M.

667

Hofmann, A.

496

Hofmann, B.

382

Hofmeister, L.H.

114

Hollander, M.

291

Holleboom, A.G.

155

Holleran, S.

333

Holme, I.

886

Holmes, E.

449, 515

Holmgren, A.

449

Holzer, M.

297

Homer-Vanniasinkam, S.

718

Honarpour, N.

65, 66

Hong, B.

474

hong, D.

1208, 1209, 1210

Hong, K.

705

Hong, L.I.U.

111

Hong, S.

728

Hong, S.J.

1023

Hong, S.P.

1123

Honsova, E.

281

Honye, J.

212

Hopps, E.

795, 796

Horakova, D. Hori, M. Hornemann, T. 208

Presentation No.

693 265 94, 300, 601

Hovingh, G.K. Hrzenjak, A. Hsieh, F.

66, 67, 93, 125, 126, 153, 155, 660 297 178, 277

Hsieh, F.-I.

1001

Hsieh, J.

632

Hsieh, Y.

178, 277

Hu, C.

178, 277

Hu, F.B.

103, 105

Hu, L.

1178

Hu, M.

906, 907

Hu, S.

971

Hu, Y.

416

Hua, X.

444

Huang, Y.

415

Hubacek, J.

636, 908, 1021

Hutten, B.A.

93

Huttl, M.

852

Hwang, J.J.

220

Hwang, K.

412

Hye Won, L.E.E. Hyjanek, J.

1045, 1046 693, 700

Hyo Seon, L.E.E.

1045

Hyoung-Ho, K.

1102

I I.M., S.H.

11

Ianni, M.

727

Ibarretxe, D. Ibarz, M.

405, 786 295

Iborra Tallada, R.

384

Ibrahimi, P.

1108

Hubacek, J.A.

281, 994

HubalewskaDydejczyk, A.

787

Idzior-Walus, B.

607, 764, 810

Hudoynazarov, S.

1201

Iegorova, M.S.

954

Hueb, W.A.

577

Iesaki, T.

171

Huesca, C.

423

Iglseder, B.

638

Huesca-Gomez, C.

109

Ignjatovic, S.

1055

Hughes, E.A.

811

Ihara, S.S.M.

Hui, S.

576

684, 878, 879, 987, 1030

Hui, S.P.

1101

Ihlemann, N.

1083

Hultgårdh-Nilsson, A.

516

Ijäs, P.

87

Ikdahl, E.

886

Presentation No.

Presentation No.

Presentation No.

Ike, A.

909

Ito, S.

964

Ikemoto, T.

212

Ito, Y.

576, 674, 840

Ikitimur, B.

372

Iushko, K.

1104

Jara, R.

1044

Ikonen, E.

97

Ivanisevic, J.

711

Jaramillo, M.J.

423

Ilerigelen, B.

372

Ivanoshchuk, D.

532

Jaramillo.Alzate, J.

289

Illamola Martin, L.

784

Ivanova, M.

531, 532

Jarauta, E.

544

Illescas, M.J.

328

Ivanova, O.

477, 960

Jarcuska, P.

355, 717

Illyes, G.

959

Ivanova, R.

809

Jaschke, C.

382

Ilyushina, A.

1103

IVANOVIC, D.

1097, 1098

Jashari, F.

1108

Imaizumi, T.

169

Ivashkin, V.

511, 1115

Jasik-Slezak, J.

853

Imamura, S.

555

Izar, M.C.

Ina, K.

797

J

Jauhiainen, M.

87, 254, 391, 586, 590, 598, 606

Jedlickova, L.

355, 717, 868

Jedynska, A.

1112

Jemaa, R.

501

Inazu, A. Indelicato, S.

596, 609, 676 1145

Jablonska, K. Jackova, L.

854 355, 717, 868

596, 609

Jacobsen, P.B.

179

Intharapetch, P.

177, 989

Jacome-Sosa, M.

891

Ion Toader, C.

833

Jacques, P.

872

205, 818, 1151

Jahangiri, F.

1106, 1107

494, 530

Jahangiri, H.

1105, 1106, 1107

Ionov, D. Ionova, G.I.

429

Jain, A.K.

971

Iqbal, J.

632

Jain, R.K.

187

Iravedra, D.

716

Jakubowski, M.

Iruela-Arispe, M.L.

60

Jamal, S.

Isaac, B.

326

Jamaluddin, N.

422

Ishibashi, M.

185

Janabaev, B.

763

Ishida, R.

608

Janczak, D.

854

Ishii, T.

674

Janczura, M.

748, 898

Ishii, Y.

171

Janda, K.

764

Iskra, M.

466

Jang, H.

28

Ismail, M.

1022

Janicko, M.

355, 717, 868

Ismail, P.

1141

Jankovic, G.

862

87

Jansen, M.

195

Issac, G.

449, 515

Janssen, H.

308

Itaya, N.

169, 232, 1002, 1003

Janssen, H.W.

996

Janssen, J.W.

441, 442

Isoviita, P.M.

Januszek, R.

483, 651, 723

Inoue, T.

Ionescu-Tirgoviste, C.

Janus, A.

749, 817, 975 617, 967

817 748, 898

Jeney, V.

170

Jeng, J.

178, 277, 1001

Jennelle, L.

100

Jensen, E.

890

Jeon, K.H.

520

JEONG, M.

1187

Jeppsson, A.

208

Jepsen, J.M.

976

Jerkan, M.

999

Jeromin, F.

782

Jesus, M.

682

Jeyarajah, E.

257

Jeziorska, M.

465

Jezkova, K.

356, 364, 371

Jia, C. Jiang, Y.

1213 1109, 1110

Jimenez, J.

333

Jimenez, R.

404

Jiménez-Colmenero, F.

472 209

Presentation No. Jimenez-Dominguez, G.

857

Jimenez-Morales, A.I.

403

Jimenez-Oñate, F.

493

Jin Sup, P.A.R.K.

1045, 1046

Jin, J.

248

Jin, S.

576

Jin, X.

1178, 1178

Jinga, M.

806

Jiraskova, A.

994

Jirsa, M.

281

Jo, H.

165

Jo, S.H.

519

Joergensen, B.

1024

Joergensen, T.M.M.

976

Johansson, B.

739

Johansson, M.

40

John, C.

197

Jonasson, L.

Presentation No.

Jozwiak, J.

853

Kajimoto, H.

232

Juan José, C.

815

Kajinami, K.

608

Juan, P.

815

Kakigi, R.

171

Juana, F.

815

Kakino, A.

184

241

Juarez, J.G.

Kakko, S.

606

813, 857

Kalfarentzos, F.

299

Juez, M.

246

Kalil-Filho, R.

577

Juhász, I.

282

Kallaras, K.

502

Jukema, J.W.

147

Kallel, A.

501

Jula, A.

87

Kamat, S.

1168

Juliano, L.

483

Kampits, C.

751

Julius, U.

264, 334

Kandimalla, E.

288

Julve, J.

254, 604, 876

Kane, J.P.

567

Jun, S.W.

1123

Kang, D.

1122

Juarez-Rojop, I.E.

Jun-Hyok, O.H.

1045, 1046

Kang, D.O.

345

Jung Hyun, C.H.O.I.

1045, 1046

KANG, W.

1187, 704

Jung, I.H.

248

Kang, W.C.

211

Jung, L.

227

Kangas-Kontio, T.

606

Junik, R.

497

Kanjirakadavath, B.

272

Juno, C.

266

Kanjuh, V.

827, 862

Jones, D.

259

Juonala, M.

80

Kanno, H.

655

Jones, S.

924

Jurado-López, R.

86

Kanno, K.

668, 669, 673

Jones, S.R.

939

K

450

K. Lundberg, A.

450

Kaabachi, N.

501 92

Jönsson, S. Joo, H.

210

450, 455, 479, 487

Presentation No.

728, 1023

Joosten, L.A.B.

234

Kaaks, R.

Jørgensen, A.

154

Kabakçi, G.

1095, 1202

Joris, P.

357

Kacem, K.

1082

Jose Manuel, R.

815

Kachkovskii, M.

349

Jose, P.A.

1207

Kadam, P.A.

633

Joshi, P.

924

Kadi, H.

Joshi, P.H.

939

Kadlckova, L.

Joshi, S.

1111

Kaess, B.M.

853

Jotic, A.

1161

Kaijzel, E.

458

Joven, J.

273, 778

Kaila, N.

213, 745, 746 994

268, 927

Kapelouzou, A.

887

Kapetivadze Vera, V.I.K.

892

Kaplanski, G.

332

Karabacak, E.

689

Karaca, M.

251

Karadi, I.

983

Karaman, K.

213

Karamouzis, M.

502

Karayakali, M.

213, 721

Karayannakos, P.

887

Karciauskaite, D.

841

Kardassis, D.

424

Presentation No. Karetnikova, V.

Presentation No.

Presentation No.

1190, 1191, 1192

Kawamura, A.

909

Kiec-Klimczak, M.

595

Kawamura, M.

917

Kiec-Wilk, B.

Karlson, B.W.

64, 215, 931

Kawasaki, M.

Karlsson, D.

239

Kawase, R.

Karlsson, T.

1029

Kawashiri, M.

Karmally, W.

333

Kawashiri, M.A.

429

Kaya, B.

Kark, J.D.

Karpenko, M.A. Karpov, R.

453, 911

Karpov, R.S.

452

Kazantzidou, P.

Kasbi Chadli, F.

550

Kazdova, L.

Kashefi, S.

1060, 1061

Kayihan, K.

628

Kiechl, S.

274

551, 940

Kieffer, N.

948

609

Kiesslich, T.

638

596, 676

Kilinc, E.

1112

1095, 1096, 1202

Kim, B.R.

1032

721

Kim, C.

910

926

Kim, D.Y.

248

819, 955, 852

Kim, E.

1121, 1122

Kim, E.J.

345

Kim, H.

705, 705, 706, 707, 894

Kim, H.L.

520, 945

Ke, T.

637

Kashihara, Y.

965

Kedenko, I.

638

Kashtanova, E.

631

Kedenko, L.

274, 638

Kasimov, U.

829

Kei, A.

722, 900

Kaski, J.C.

488, 489

Keijserling, C.

538

KASSI, E.

798

Kempen, H.

257

Kaste, M.

87

Kenz, Z.

971

Kastelein, J.

7

Kesavalu, L.

414

Kastelein, J.J.

125

Keshvari, M.

1049, 1050

Kastelein, J.J.P.

67, 93, 146, 153, 267, 330, 660

Kastelijn, J.J.P.

126

Kastl, S.P.

485, 486

Kasuga, T.

828

Katainen, R.

871

Katano, H.

517

Katariina, O.

115

Katayama, N.

964

Kathiresan, S.

113, 153, 173

Katkó, M.

735

Kato, J.

723

Kato, R.

309, 731

Kaufmann, P.A.

760

Kawai, Y.

608

Kawamoto, T.

668, 669, 673

Kessler, B. Ketelhuth, D.F.J.

148 434, 451

Kettani, A.

117

Kettunen, J.

87

Keul, P. Keyserling, C. Kezeli, T.

787 446, 822, 1155

Kim, H.S.

236, 379, 519

KIM, J.

28, 1121, 1122

Kim, J.P.

345

Kim, J.W.

345

Kim, K.

705

Kim, M.

412, 705, 706, 707, 910

Kim, M.A. KIM, S.

520, 945 520, 227, 705, 706, 707

518

Kim, S.A.

519

125, 126

Kim, S.H.

945

530

Kim, S.K.

1123

990, 1031

Kim, S.M.

582

Khasanova, Z.

740

Kim, S.W.

345

Khasanova, Z.B.

271

Kim, W.

227

Khera, B.

971

Kim, Y.

227, 705, 705

Khetarpal, S.A.

113

Kim-Kaneyama, J.R.

869

Khmara, T.

231

Kimura, E.

241

Khnychenko, L.

115

Kimura, S.

594, 650

Khor, C.

637

Kimura, T.

556

Kiamehr, M.

724

Kingwell, B.A.

889

Khaichaiyaphum, S.

211

Presentation No. Kinugasa, E.

594

Koch, S.

Kirichenko, N.

349

Koçyigit, D.

1095, 1096

Kirienko, A.

1157

Koenig, B.

377

Kirienko, D.

1157

Koezuka, R.

265

Koga, T.

1004

Kogan-Yasny, V.

477

Kirk, R.K. Kishimoto, I.

646, 799, 807 65, 265

382

Kiss, R.G.

983

Koh, K.

284, 704

Kiss, Z.

983

Koh, W.

637

Kita, S.

217

Koike, M.K.

188

Kitagawa, T.

869

Koike, T.

529

Kitayama, M.

608

Koizumi, J.

609

Kitayama, T.Y.M.

495

KOKKORIS, P.

798

Kivimäki, M.

90

Kolehmainen, M.

804

Kiyan, Y.

375

Kolesar, I.

281

Kleber, M.

714

Kollerits, B.

274, 638

Kleemann, R. Klepp, H. Klesareva, E.

458, 952

Kologrivova, I.

453

126

Kologrivova, I.V.

452

Kolos, I.

1113

250, 540

Klett-Mingo, M.

410

Kolovou, G.

402

Kloch-Badelek, M.

607

Kolovou, V.

402

308, 441, 442, 996

Komai, H.

265

Klop, B. Kloting, N.

782

Klouras, E.

943, 1006

Knight, P.A.

1139

Ko, J.

227

Koba, S.

840

Kobayashi, J.

555, 609

Kobayashi, K.

217

Kobayashi, T.

551, 940

Kobayashi, Y.

840

Kober, A.

598

Køber, L.

1083

Koc, F. Koch, E. 212

Presentation No.

213, 745, 746, 721 496

Presentation No. Konstantinidou, V.

407, 410, 882

Kontush, A.

149, 152, 186, 256, 296, 301, 578, 589

Kooistra, T.

458, 952

Kooter, I.

1112

Kootte, R.S.

125

Koriagina, N.

1114

Kornain, N.K.

366, 367

Korneeva, O.

1115

Korneva, V. Kortas-Stempak, B. Koseki, M. Koshelskaya, O.

623 546, 679 551, 632, 940 453, 911

Koshelskaya, O.A.

452

Kosogorova, S.A.

1038

Kostaki, S.

926

Kostakis, A.

887

Kostakou, P.

402

Kostal, M.

471

Kostapanos, M.

933, 943, 944, 1006

Komanasin, N.

177, 989

Kostapanos, M.S.

901

Komarova, T.

623

Kostara, C.

944

Kominami, M.

202

Kostareva, A.A.

Kon, V.

114

Kostner, G.

22, 253

Koncar, I.

1215

Kotani, K.

650, 979

Koncsos, P.

838

Kotula-Horowitz, K.

748, 898

Kondakov, I.

1157

Kotyashova, S.

433, 865

Kondo, K.

571

Kouro, T.

Konduracka, E.

445

Koutsovasilis, A.

Konieczynska, M.

478

Kovacs, N.

765

Konnov, M.V.

978

Koval, S.

1062, 1064, 1104

Konoplyanik, L.

1158

Kovalcsik, E.

488

741, 935

Kovalev, S.

753

887

Kovanen, P.

56, 115, 116, 287

Konovalov, G. Konstantinides, S.

429

917 701, 831

Presentation No. Kovanen, P.T. Kovar, J.

87, 237, 391 553, 570

Presentation No.

Presentation No.

Krzanowski, M.

764

Kuryata, O.V.

12

Krzyminiewski, R.

466

Kusuhara, H.

605

Kowalewska, M.

953

Kubilius, R.

1036

Kuusisto, S.M.

606

Koziak, K.

953

Kucharchuk, V.

677

Kuznecova, T.

623

Kozina, A.

297, 358

Kuchta, A.

546, 679

Kuznetsov, V.

459, 805

Koziolova, N.

425, 759

Kucinskiene, Z.A.

841

Kuznetsov, V.V.

954

Kozliuk, A.

1116

Kühn, T.

92

Kuznetsova, S.M.

954

Kozlov, S.

242

Kühnast, S.

147

Kuznetsova, T.

1149

Kozlowska, A.

679

Kuil, S.D.

155

Kuznetzova, S.

112

Kozlowski, M.

388

Kuimov, A.

702

Kuzuya, M.

797

Kraal, G.

395

Kuiper, J.

12, 288

Krajcoviechova, A.

275

Kuivenhoven, J.A.

Kralisch, S.

782

Kukharchuk, V.

Krämer, S.D.

760

Kukongwiriyapan, U.

Kraml, P.

392

Kulagin, K.

Krane, V.

344

Krasnikova, T.L.

490

Kratky, D.

253, 568, 598

Kreft, E.

679

Kremoser, C.

941

Krempf, M.

550

Kremzer, A. Kremzer, A.A. Krievina, G. Krishnan, M.N. Kronenberg, F. Kroon, J.

1058 1056, 1057 710 272, 988 31, 274, 638 42

Kroon, P.A.

855

Krugly, B.

494, 752

Kruse, C.

971

Kruszyna, L.

738

Krychtiuk, K.

486

Krychtiuk, K.A.

485

Krysiak, R.

814

Kryvorot, S.

725

155 242, 543, 734 177, 989

Kvantaliani, T. Kvien, T.K. Kwang Soo, C.H.A.

470, 912, 913 886 1045, 1046

Kwok, S.

126

640

Kwok, S.E.E.

465

Kulkarni, K.

939

Kwon, H.

412, 474, 726

Kullo, I.

275

Kwon, S.

474

Kulyk, O.

1117

Kypreos, K.E.

299

Kumagai, M.

663

Kyung-Wuk, K.I.M.

1102

Kumagai-Braesch, M.

1035

Kumakura, J.

674

Kumar, A.M.I.T.

1022

Kumar, S.

165

Kume, N.

1118

Kummerow, C.

1034

Kundalic, B.

1119

Kundalic, J.

1119

Kuniyoshi, N.

529

Kunze, M.

377

Kurjanov, P.S.

421

Kurobe, H.

869

Kurtz, C.

65

Kurtz, T.W.

955

Kuryata, O.

1092, 1184

L Laaksonen, R.

290, 871

Labudovic, D.

661

Labuzek, K.

388, 814

Lacaille, F.

562

Lachaux, A.

630

Laclaustra, M.

695

Ladenson, P.W.

67

Lados, A.

478

Lagarde, M.

186

Lagos, J.

1172

Lagraauw, M.

288

Lagrost, L.

185

Laguens, R.

514

Laguna-Fernandez, A.

451

213

Presentation No.

Presentation No.

Lahdentausta, L.

210

Larson, M.

872

Lee, G.

Lahera, V.

14

Lasserre, F.

938

Lee, H.L.

Lahidheb, D.

473

Lassoued, I.

1053

Lee, J.

Lahoz, C.

613

Lasuncion, M.A.

Lai, C.

294

Latini, R.

639

Laios, E.

699

Lauerma, K.

189

Lairon, D.

175

Laufs, U.

Lajnieks, A. Lalic, K.

710 1156, 1161, 1186

Laukaitiene, J. Lautsch, D.

756, 258, 614

200, 928, 1034 476 214, 675

Lalic, N.M.

1161

Laverdy, O.G.

577

Lalloyer, F.

196

Lavrador, M.S.F.

188

Lam, C.Y.

963

Lavrik, A.

1179

Lamina, C.

274, 638

Lawson, N.

347

Lamiquiz, I. Lamiquiz-Moneo, I.

214

Presentation No.

324

Layouni, S.

473

316, 320, 612, 174, 396

Lazar, M.A.

33

Lancel, S.

196

Landa, V.

955

Landim, M.B.P.

899

Lazarev, I.G.O.R. Lazaros, G. Lazashvili Tamar, T.T.L.

759 312, 505, 977 892

Landmesser, U.

300

Le Goff, W.

186

Landstreet, S.R.

114

Le May, C.

261, 938

28 520, 945 28, 276, 276, 412

Lee, J.B.

1123

Lee, K.

284, 704, 1005, 1187

Lee, K.H. Lee, S.

211 227, 227, 412

Lee, S.K.

345

Lee, V.

906

Lee, W.H.

948

Lee, Y.

417, 1152

Lee, Y.S.

1123

Lee-Rueckert, M.

391

Lefeber, D.J.

155

Legorreta-Haquet, M.V.

649

Lehr, S.

447

Lehtonen, M.

804

Lehtonen-Smeds, E.

87

Lei, X.F.

869

Leigh, S.E.A.

417

Leiherer, A.

306, 342, 542, 708, 766, 846, 847, 980, 981

Lang, I.

598

Leander, K.

302

Langbein, H.

496

Leask, R.

360

Langlois, J.B.

293

Lebedeva, A.

960

Langslet, G.

67, 146, 330

Lebiedzinska, A.

679

Leite-Júnior, A.C.

577

Lankin, V.

670

Lebrazi, H.

117

Leiva, A.

182

Lankinen, M.

804

Lecocq, S.

256, 301, 589

Lemieux, P.

698

Lanska, M.

471

Lecube, A.

876

Lencova, O.

Lanska, V.

281

Ledesma, M.

695

León-Latre, M.

695, 1011

Lapoirie, M.

630

Lednev, I.

1054

Leon-Varela, Y.

956

Lappalainen, J.

391

Lee, B.

474, 726

Leonardo, R.

775

Lara-Guzman, O.

956

Lee, C.

412, 906, 1152

Lestavel, S.

191

Larach, D.

256

Lee, E.

1121, 1122

Letourneur, D.

167

Larach, D.B.

113

Lee, E.M.

345, 345

Leung, T.W.

755

Larina, N.

112

Lee, E.Y.

664

Levade, T.

562

985

Presentation No.

Presentation No.

Presentation No.

Levels, J.

475

Lin, H.

178, 277, 1001

Loirand, G.

261

Levels, J.H.M.

155

Lin, Y.

378

Lokki, M.L.

87

Levin, M.

40

Linares Cerro, O.

784

Løland, K.H.

346

Levkau, B.

518

Lindeman, J.H.N.

454

Lomtatidze, G.

1071

872

Lindsberg, P.J.

87

Londoño-Londoño, J.

956

Lopez Berastegui, O.L.G.A.

802

López Perna, Y.

761

López, G.I.

629

Lopez, L.R.

729

Lopez, V.

228

Levy, D. Lhomme, M. Lhotak, S.

186, 256, 301, 578, 589 387, 386

Li, D.

1178

Li, J.Y.

1082

Li, K.

969

Li, L.

184, 1110, 1109

Li, M.O.

434

Li, P.

1211

Li, T.A.O.

1124

Li, X.

1125

Li, Y.

294, 378

Liamis, G.

933

Liao, D.

416

Liberopoulos, E.

722, 900, 933, 1006

Liberopoulos, E.N.

593

Licastro, F.

727

Lieb, W.

359

Liem, A.H. Lien, L.

441, 442 178, 277, 1001

Liepold, E.

203

Liljestrand, J.M.

1007

Lim, D.

728, 1023

Lim, H.

1121, 1122

Lim, H.E.

345

Lim, S.I.

345

Lim, S.M.

581, 584

Lima, A.

535

Lima, J.

536, 626

Lima, N.

1065

Ling, W.

1199

Linhart, A.

994

Liontos, A.

944

Liontou, A.

772

Liontou, A.A. Liouris, I.

331 1180, 1181

Lisi, P.

1153

Littlewood, T.

160

Liu, A.

482

Liu, H.

1126

Liu, H.O.N.G.

1109

Liu, H.X.

1211

Liu, J.

26, 637, 676

Liu, L.

1207

Liu, P. Liu, Q.I. Liu, W.H.

1211

Liu, X.

1109

Liu, Y.

Lopez-Almodovar, L.F. López-Guevara, M.R.

180, 715 813

Lopez-Jimenez, F.

275

Lopez-Miranda, J.

404, 560, 788, 789, 882

Loppnow, H. Lopuchovsky, T.

382 355, 717

Lorbeer, R.

359

774, 1152

Lord, C.

127

467, 468

Lorenzon, P.

934

Lorincz, H.

282, 327, 735, 1089

193, 298, 465

Lorusso, P.

837

205, 818, 1151

Lottenberg, A.M.

188

794

Louzier, V.

219

Ljungcrantz, I.

484

Lozano, T.

832

Llargués, E.

322

Lozhkina, N.

750

Lu, J.

Lixandru, D. Lizárraga, J.R.

Llobera, A.

702 467, 468

559, 592

Lucas, A.

414

795, 796

Lucero, D.

629

294

Luciani, R.

837

Lobritto, S.

315

Luciano, F.

777, 778

Locsey, L.

838

Luciano-Mateo, F.

1127

Luczak, E.

Llorente-Cortés, V. Lo Presti, R. Lo, C.

Logvinenko, A.A.

273 435, 1073 215

Presentation No. Ludvigsen, T.P.

799

Machado-Lima, A.

384

Luister, A.

200

Machal, J.

982

Lukas, W.

853

Machida, T.

555

Lukic, L. Lundberg, A.

1161

Machnik, G.

388

40, 247, 487

Macias-Gonzalez, M.

408, 409

Lundberg, A.K.

455, 479

Macic Dzankovic, A.

480

Lundberg, A.M.

434

Maciejko, D.

953

Lundbom, J.

189

Madira, W.

896

Lundbom, N.

189

Maeda, I.

533

Lundgren, O.

455

Maffi, E.

311

Lundman, P.

64, 215, 931

Maffioli, P.

1081

Lundqvist, A.

208

Maggi, L.

498

Luong, S.

624

Maggioni, A.P.

639

Lupattelli, G.

587

Lutgens, E.

33

Maghlaperidze Zviad, Z.V.M.

892

Lüthjohann, D.

928

Lütjohann, D.

200, 1034

Lykkesfeldt, J.

646, 799, 807

Lynn, E.

386

Lyons, C.

259

Lysenko, A.

492

Lysne, V.

1029

Lyssenko, N.N.

193

M M. Voevoda, M.

702

Ma, C.

294, 1211

Ma, Q.

1213

Ma?eikiene, A. Mabuchi, H. Macaione, F.

841 596, 609, 676 1025, 1026

Macchiaiolo, M.

1066

Macedo, L.F.L.

201

Machado, C.A. Machado, J.T. 216

Presentation No.

684, 878, 879, 987, 1030 384

Maglio, C.

610

Magnolo, A.L.

317

Magnolo, L. Magnussen, C.G.

1145 80

Mahdi, A.A.

1048

Maher, S.

1128

Mahini, H. Mahmood, A.

858, 874 916

Mahmoudi, M.

475

Maifrino, L.

1065

Maillard, L.

167

Majd, Z.

219

Majewski, W.

466

Majnaric, L.

503, 504

Major-Pedersen, A.

1083

Majorov, N.

420

Makarenkova, K.

1143

Makariou, S.

722

Makino, H.

65, 265

Makita, Y.

212

Presentation No. MaksimchukKolobova, N. Maksimov, V. Malczewska-Malec, M. Maldonado, C.

754, 919, 921 702 446, 787, 822, 1155 875

Malecki, M.

446, 822

Malecki, M.T.

607, 810, 830

Malek, I. Malik, A.B.

1021 57, 163

Malik, R.

465

Malikov, V.

753

Malinauskiene, V. Malinova, V. Malinová, V.E.R.A.

1129, 1130 315 148

Malinska, H.

819, 820, 852

Malisiova, E.

948

Malli, R.

358

Mallol, R.

579, 730

Malloy, M.J. Malmström, V. Malutin, V.

567 482, 950 753

Malysheva, A.

688

Malyutina, S.

531, 532, 631, 1143, 1149

Mamedov, M.

1177

Manaças, A.R.

618, 967

Manchurov, V.

231

Mancina, R.M.

610

Mandelshtam, M.

623

Manfredini, M.

602

Mangas, A.

269, 427, 528, 599, 680, 849, 850

Mangat, R.

891

Mangione, A.

199

MANIOTIS, C.

798

Presentation No.

Presentation No.

Presentation No.

Mannarino, E.

1153

Maroto, A.S.

180, 521, 715

Martins, D.

535

Mannarino, M.R.

1153

Marques, A.C.

656

Marton, C.M.

877

Mannila, M.N.

635

Marques, L.

389

Martovitskaya, Y.

Mannini, L.

1077

Marquez Gomez, J.

923

Martovitskaya, Y.U.V.

Mansinho, K.

1085

Marsche, G.

297

Martsevitch, S.

688

Mantani, P.T.

484

Martí, I.

244

Mary, J.L.

934

Mantila, T.

681

Martí-Líndez, A.A.

273

Mary, S.

562

Mantilla, T.

864

Martin, A.C.R.

417

März, W.

344, 714

Manuel, P.E.R.A.

815

Martin, C.

314, 557, 558, 652

Martin, P.D.

330

Manzini, S.

290, 426, 659, 871, 934

Manzotti, C.

961, 962

Martin, P.G.

146, 330

Maranhão, R.C.

577

Martin, S.S.

924, 939

Maraninchi, M.

332

Martín-Campos, J.M.

604

Marcel Vries, M.

475

Martin-Lorenzo, M.

180, 521, 715

Marcinkiewicz, C.

1137

Martinet, W.

842

Marconi, M.

733

Martinez, A.

328, 625

Marcucci, R.

1077, 1078

Martínez, C.

574, 600

Marczell, I.

959

Martínez, E.

794

Marechal, X.

196

Margeirsdottir, H.D.

448

Margolis, L.

960

Marie, M.

1144

Marin, C.

404, 560

Marin, E.

368

Marin-Hinojosa, C.

788

Mariné, R.

777, 778

Mariné-Casadó, R.

273

Marini, E.

951

Marini, M. Marinos, G.

Martinez, R. Martinez, T.L.R.

423 684, 878, 879, 987, 1030

Martínez-Abundis, E.

826

Martínez-Beamonte, R.

597

Martínez-Botas, J.

258, 410

Martínez-Bujidos, M.

672

Martínez-González, J.

86, 244

101

Martínez-González, M.

79

505

Martinez-Hervas, S.

547, 709, 800

Mark, L.

983

Martinez-Ibañez, J.

709

Markfeld-Erol, F.

377

86

Markovic-Lipkovski, J.

Martínez-Martínez, E.

827

Martínez-Ríos, M.A.

1037

Marmash, N.

381

Martinez-Valls, J.F.

709

1058 1056, 1057

Mas Puig, M.

923

Mas, A.

286

Masana, L.

79, 139, 140, 164, 279, 405, 579, 730, 786

Masayuki, U.

647

Masenko, V.

242

Masenko, V.P.

490

Masip, J.

761

Masoura, K.

331

Massaro, J.

924

Massing, U.

377

Masson, D.

185

Masson, S.

639

Mastalerz-Migas, A.

1008, 1009, 1013, 1014

Mastej, M.

853

Masuda, D.

533, 548, 551, 907, 940

Mata, K.

245

Mata, P.

614

Matas, L.

322

Matchin, Y.

662, 742

Matchin, Y.U.

250

Matchkov, V.

750

Matejko, B.

830

Mateo Gallego, R.

612

217

Presentation No. Mateo-Gallego, R. Mateva, L.

809

Mathe, D.

765

Mathers, N.

853

Mathevet, J.L.

219

Mathew, D.

272

Mathias Jr, W.

899

Matikainen, N.

27, 554

Matos-Souza, J.

1131

Matrosova, I.

771, 946

Matsoukis, I.

1180, 1181

Matsuda, M.

668, 669, 673

Matsui, M.

548

Matsui, T.

808

Matsukawa, K.

828

Matsunaga, N.D.

723

Matsunami, Y.

217

Matsuura, E.

217, 729

Mattsson Hultén, L. Matuzok, O.

208 643, 644

Mauri, M.

322

Mauricio, D.

824

Mauro, R.

218

Mavroidis, N.

699

Mayer, O.

1132

Mayos, J.

322

Mäyränpää, M.I.

87

Mazur, G.

817

Mazzolai, L.

848

Mazzone, M.

526

McCarthy, F.

928

McCrindle, B.W. McDonald, K. McDonnell, L.A. 218

174, 324, 396, 544, 611, 613, 859

146, 330 360 180, 521

Presentation No.

Presentation No.

McGillicuddy, F.C.

259

Menuso, L.

229

McGowan, M.

916

Merckelbach, S.M.E.

221

McLeod, O.

302

Merfort, I.

377

McLin, V.

315

Meric, C.

500, 1134, 1135

Md. Rakibuzzaman, R.

1102

Meani, P.

456

Mechmeche, R.

501

Medbury, H.

381

Medeiros, A.

319

Medeiros, A.M.

616, 617, 619

Merino, J. Merkovska, L.

79 355, 717, 868

Merlet, L.

267

Meshkov, A.

640

Messal, M.

1041

Metaxa, V.

312, 505, 977

Metelskaya, V.

670, 671, 1094

Metso, J.

254, 586, 598, 606

Medina, A.

241

Medina, U.

361

Medina-Moreno, U.

362

Meyer, C.

128

Medvedeva, E.

1133

Meyer, K.

346, 463

Medvedeva, I.

1177

Miana, M.

86

Mei, H.

416

Miarka, P.

764

Meijers, J.C.M.

153

Miccoli, R.

835

Meikle, P.J.

889

Michalak, S.

738

Meiler, S.

33

Michoel, T.

187

Meinitzer, A.

714

Mickley, H.

311

Meisinger, C.

274

Micó-Moreno, V.

Melander, O.

187

Midttun, O.

Meletta, R.

760

Miguel, A.

574, 851

Melnichenko, A.

657

Mihai, A.

818, 1151

Melnikov, M.

1206

Mihas, K.

402

Melnikova, E.

771

Mihou, I.

299

Melone, M.

915

Mikhailidis, D.P.

580

Menard, M.

194

Mikhno, H.

1205

Mendelson, M.

872

Mikkola, T.

590

Méndez, M.

794

Mendez, P.

972

MikolajczykChmiela, M.

1072

Ménégaut, L.

185

Milano, G.

101

Menini, T.

650

Milasin, J.

1093

Miled, A.

790

Milia, A.

779, 780, 781

Mensink, R.P.

357, 552, 914

410 463, 918

Presentation No.

Presentation No.

Presentation No.

Milicic, T.

1161

Mogavero, M.

1091

Mores, N.

230

Milicua, J.C.G.

652

Mohl, S.

934

Moret, M.

624

1006

Mohorko, N.

469

Morey, R.

333

Molendi-Coste, O.

41

Mori, H.

984

59

Mori, K.

909

Mori, M.

596, 609, 676, 984

Mori, Y.

917

Moriarty, P.

264

Morieri, M.L.

469

Milionis, H. Millan NúñezCortés, J.

2, 5, 9, 117, 680, 681, 682, 692, 802, 863, 864, 897, 1027, 1028

Molina Sánchez, P. Moline, A.

536, 626

Millar, A.

449, 515

Moll, F.L.

221

Miller, E.

146, 330

Mollaki, V.

699

Miller, M.D.

350, 1018

Molnar, M.

1182

Millon, A.

219

Mombelli, G.

712

Milojevic, P.

862

Momiyama, Y.

309, 731

Miloslavsky, D.

1063

Monereo, S.

Min Woo, K.A.N.G.

1102

Monfort-Pires, M.

Min, P.

412

Mongirdiene, A.

Miname, M.

578

Monk, D.

Miroshnikova, V.

420

Monsalvo, M.

599, 850

Miroshnikova, V.V.

421

Montaigne, D.

196

Mislea, O.

1136

Montana, M.

795, 796

Mitchenko, E.I.

1127

Monteiro, A.M.

483, 651

Mitchenko, O.

1103, 1117, 1179

Mitjavila, M.T.

860, 861

Mitrofanov, K.Y.

681, 864 877 476, 1036 405

Montenegro, M.M.

751

Montero, E.

393

1173

Montserrat, V.

815

Mitroshkin, M.

250

Moraes, A.

656

Mitsutake, Y.

232

Moraes, J.A.

1137

Mittleman, R.

333

Morales, C.

322

205, 818

Morandi, L.

712

Mitu, M. Miyamoto, S.

609

Morawietz, H.

352, 496

Miyashita, K.

555

Morcillo, C.

Miyazaki, O.

556

Morcillo, S.

691, 793, 974

Mizgala, E.

853

Moreau, F.

938

Mizuno, S.

212

Moreno, B.

681, 864

Mizuno, T.

605

Moreno, J.J.

860, 861

Mjelva, O.R.

457

Moreno-Franco, B.

695, 1011

Mlejnek, P.

955

Moreno-Indias, I.

408, 419, 493

Mlynarski, W.

580

Moreo, A.

761

456

Morrisey, E.E.

193

Morrison, K.M.

146, 330

Morrison, M.

458

Morrow, D.

1138, 1139

Moschetta, A.

191

Moskaleva, N.

725

Mosquera, J.D.

406

Mostowik, M.

445

Motazacker, M.

475

Motazacker, M.M.

155

Motilva, M.J.

882

Motoyama, A.

608

Motta, B.M.

610

Moulin, P.

15, 332, 624, 630

Moussis, V.

948

Movileanu, T.

942

Movsesyan, I.

567

Mozdzan, M. MP, G.

1073 339, 539

Mrad, M.

473

Mu, L.

760

Muckenthaler, M.U.

35

Muendlein, A.

306

Mughal, N.

718

Mugii, S.

533 219

Presentation No. Muid, S.

462

Na, J.

Muiño, A.

802

Na, J.O.

Mulder, M.T.

537, 929

Mulder, W.

42

Mulder, W.J.

439

Mulè, G.

1091

Müller, A.

760

Müller, G.

334

Muller, T.

280

Müller-Werdan, U.

382

Mullican, S.E.

33

Muneer, K.

272

Munkhzol, M.

1189

Muñoz-Berbel, X.

750

Murakami, M.

555, 556

Murano, T.

565

Muromtseva, G.

1177

Murphy, A.

226, 259

Murr, C.

714

Murray, D.

1175

Murray, F. Musial, J. Musikas, M. Musikhina, N.

482 748, 898 562 459, 460, 805

Musio, A.

428

Musliner, T.

890

Mustafa, J.

292

Mutapcic, S.

480

Myasoedova, V.

773

Myerscough, M.

461

Mykkänen, H.

804

Mysliwiec, M.

653, 654

Mysnichenko, O.

1062, 1063, 1064

Mytrokhina, O.

114

N 220

Presentation No.

Nabrozidis, A. Nachtigal, P.

705, 1121, 1122

Navarro, A.

246, 936

345

Navarro, I.

547

206, 743 356, 364, 371, 985

Nadruz, W.J.R.

1131

Nagasaka, A.

576

Nagata, I.

909

Nagayama, D.

565

Nagy, E.V.

904

Nagy, N.

447

Nakagawa, K.

522

Nakajima, K.

555, 556

Nakamura, S. Nakandakare, E.R.

212 188, 384

Nakanishi, C.

596, 609, 676

Nakano, A.

184

Nakaoka, H.

551, 940

Nakashima, Y.

522

Nakatani, K.

551, 940

Nakayama, Y.

808, 834

Nakayoshi, T.

169, 232, 1002, 1003

Namba, Y. Nan, R.

965 806, 881

Narce, M.

185

Naruszewicz, M.

390

Nasarre, L. Naslund, U.L.F.

Presentation No.

559 449, 515

Nasri, M.

1053

Nasri, R.

1053

Nassar, H.

595

Nauck, M.

359

Navab, M.

115

Navarova, J.

997

Navarrete-Cortes, A.

813

Navarro, M.A.

244, 597

Navarro-Dorado, J.

361, 362

Navarro-Gonzalez, J.F.

295

Nawawi, H.

363, 365, 366, 367, 422, 462

Nederveen, A.

42

Nederveen, A.J.

125, 305

Needs, P. Neele, A.E.

855 33, 413

Neely, D.

572

Neff, D.

915

Neggazi, S.

373

Negm, H.A.N.Y.

697

Nègre-Salvayre, A.

186

Negrean, V.

1136

nemati, R. Nemeckova, I.

1141 356, 364, 371, 985

Nemoto, T.

732

Nessler, J.

445, 575

Nestel, P.

75

Netea, M.G.

234

Neutel, J.

268

Neves, M.Q.

384

Neviere, R.

196

Newby, A.

157, 158, 243

Newsome, P.

72

Nezami, N.

1142

Ng, C.

906

Ng, D.S.

194

Ng, H.K.

399

Ngo, D.T.

85

Nguyen, H.N.

236, 379

Presentation No.

Presentation No.

Nguyen, S.

115

Nofer, R.

Nguyen, S.D.

391

Noguchi, T.

Ni, C.

347

Nogueira, J.P.

Nica, C.

833

Nohara, A.

Nicholls, S.J.

64, 67, 215, 931

Nicolaides, A.

615

Nicolaou, G.

481

Nicolay, A.

175

Nicoll, R.

311

Nicoloff, G.

523, 524

Nicolosi, G.L.

639

Nie, P.

1178

Nieminen, M.S.

87, 189

Nieto Cobo, F.

686

Nieuwdorp, M.

25, 42, 439

Nieves, J.

625

Nijhof, W.H.

305

Nikiforov, N.

433, 657, 865

Nikitin, Y.

531, 532, 631, 1143, 1149

Nikitskaya, E. Nikolov, A.

960 523, 524

Noia, A.

98, 224

O’Leary, D.

136, 216

609

O’Reilly, M.

259

1144

Obara, N.

808, 834

596, 676

Obika, S.

903

Obradovic, S.

1162

Odkhuu, E.

1189

1167

Norata, G.D.

34, 37,263, 659, 665

Nordestgaard, B.

45, 54, 138, 179

Nordestgaard, B.G.

154, 176, 303

Nordin Fredrikson, G.

270, 484

Norouzi, A. Nossent, Y. Noto, D. Nouvel, M.

1106 288 795, 796, 1145 630

Novakova, B.

355, 717

Novakovic, A.

862

Novakovic, R.

827

Novo, G.

1025, 1026

Novo, S.

1025, 1026

Nowak, D.

853

Nowicki, M.

175, 738

Nozadze, D.

369, 734

Nunes, V.S.

188

Nunez Aldin, M.

1079

Nilsen, D.W.T.

346, 457, 525

Nilsson, J.

209, 270, 432, 484, 516, 713

Nilsson, M.

209

Nuñez Savall, E.

547

Nilsson, S.K.

434

Nuñez, L.

564

Nishida, M.

551, 940

Nuotio, K.

87

Nishikawa, H.

909

Nissen, S.E.

67

Nitulescu, M.

209, 432

Njerve, I.

801

Njo, T.L.

441, 442

Nobuhiko, O.

647

Noel, E.

562

Noeva, E.A.

490

Nwabugwu, E. Nygard, O.

1146 463, 346, 525, 918, 1029

Nygard, O.K.

340

Nyman, K.

189

Nyvad, J.

750

O O’Brien, E.

Presentation No.

161

Oestreicher Stock, E.

567

Ogalla, E.

510, 867

Ogrisko, N.

1214

Ogura, M.

65

Oh, B.H.

945

Oh, D.

1121, 1122

Oh, D.J.

345

Oh, G.T.

248

Oh, P. Oh, P.C. Ohama, T. Öhlander, M. Ohmori, R.

284, 704, 1187 211 551, 940 67 309, 731

Ohrvik, J.

302

Ohsuzu, F.

309, 731

Ohtsuka, M.

169, 232, 1002, 1003

Oikonomou, E.

312, 505

Okada, T.

171, 551, 940

Okajima, F.

556

Okamoto, K.

828

Okano, M.

171

Okawa, C.

869

Okazaki, S.

596, 676

Okopien, B.

388, 814

Okoro, E.

192

Okruhlicova, L.

997, 1012

Okubo, M.

533, 548

Okuda, L.S.

384 221

Presentation No. Okuda, S.

Orlov, P.

532

P. Orlov, P.

702

115

Orriols, M.

244

P.Szabó, G.

327

Oleynikov, V.

762, 771, 946

Orsoni, A.

889

Paananen, J.

804

405

Ortega, E.

824, 825

Paatela, H.

590

Ortega-Azorín, C.

400, 401

Paavola, T.

606

295

Pacienza, N.

498, 514, 973

Oliveira, H.C.F.

566, 656

Oliyarnyk, O.

819, 820, 955

Olmedilla-Alonso, B.

Ortiz-Morales, A.

560, 788

Pacini, G.

199

692, 1028

Osada, J.

244, 597

Packard, C.

19

Olsen, I.C.

886

Osaka, M.

571

Paczkowska, B.

Olsen, L.H.

799

Osipova, I.

805

Padial, L.R.

Olsen, T.

525, 1029

Osman, M.T.

365

Pados, G.

983

Olsson, A.

143

Osmenda, G.

830

Pahkala, K.

80

Olsson, A.G.

67

Osorio-Durango, E.

956

Paju, S.

1007

Olsson, J.

866

Ospina-Quintero, L.

289

Pak, L.

1201

Olveira, G.

621, 622, 875, 902

Ostolaza, H.

314, 558

Ostos, F.

361, 362

857

Oszkinis, G.

Omiste, A.

472

Ortiz, A.

Olmedo, M.

Olvera-Hernandez, V.

621, 622

Ono, Y.

202

Onsy, A.M.

1147

Öörni, K.

237

Opresnik, S.

297, 358

Opstad, T.

803

Oravec, S.

485, 486, 1169

Orbe, J.

526, 592

Ordoñez-Llanos, J.

237, 235, 672

Ordovás, J.M.

400, 401, 407, 410, 695, 872, 1011

Orekhov, A. Orekhov, A.N.

222

Presentation No.

Okunevich, I. Oliva, I.

808, 834

Presentation No.

433, 773, 865 223, 271, 657, 736, 1038, 1173, 1174

738

Otasevic, P.

1093

Othman, A.

94, 300, 601

Otvos, J.

257, 580

Oudar, O.

167

Ouguerram, K.

550

Ourednikova, L.

553

Ouzounian, S.

562

Ovchinnikova, O. Overhus, K.

434, 451 311

Ozalp, B.

1068

Ozcan, K.

251

Ozcetin, M.

745, 746

Ozdemir, S.

370

Özer, N.

1095

Ozerova, I.

670

Orekhova, V.

433, 773, 865

Ozturk, D.

107

Orengo, C.A.

417

Ozturk, Z.

372

Orera Peña, M.

682

P

546 180, 715

Palacios, L.

324, 328, 558, 625

Palesano, O.

1145

Palmen, J.

34

Palmer, M.K.

64, 215, 931

Palomer, X.

411

Palosi, M.

1182

Panagiotakos, D.

312, 505, 977

Panagiotopoulou, T.

944

Pang, J.

545

PANGeA Group, .

469

Panisello Royo, J.

784

Panov, D.

696

Panteleeva, A.A.

421

Panzenboeck, U.

598

Panzeri, F.

456

Panzoldo, N.B.

431, 569

Paolini, J.

125, 126

Papadaki, S.

948

Papadopoulou, M.

926

Papafaklis, M.I.

212

Presentation No. Papazafiropoulou, A.

Presentation No.

Presentation No.

701, 831

Paslawska, U.

854

Pedrol, E.

923

Paquet, C.

219

Paslawski, R.

854

Peinado-Onsurbe, J.

876

Para, I.

1136

Pasquariello, A.

835, 837

Paradowski, M.

438

Pasquinelli, G.

218, 512, 513

Peitzsch, M.

496

282, 327, 336, 735, 838, 904, 983, 1089

Passarelli, M.

384

Pejcic, L.J.

999

Paragh, G.

Passaro, A.

469

Pelicano, N.

535

Paramo, J.A.

526, 95, 592

588

Pella, D.

Paranhos, G.C.

894

Paraskevas, P.

1180, 1181

Pardina, E.

876

Pardo, F.

182

Pareja, J.C.

1131

Parhofer, K.G. Park, C. Park, C.G. Park, J.

264, 285, 549 1121, 1122 345 412, 728

Passet, M.

Peiro, C.

61, 957

355, 717

Pasterkamp, G.

221, 642

Pellegrin, M.

848

Pastor, O.

258, 756

Pastucha, D.

693, 700

Pelletier-Beaumont, E.

262

Patel, J.V.

811

Pello, E.

1149

Pelosi, G.

591, 733

Patel, N.

585

Patel, P.A.

683, 690, 821, 986

Patel, V.

381

Peña, D.

947

Patricio, P.R.

566

Peña-Duque, M.A.

1037

Patsouris, D.

219

Peñalvo, J.L.

695, 1011

Paul, J.L.

588

Pencina, M.J.

580

Paulie, S.

663, 1035

Peng, G.

178, 277, 1001

Paulweber, B.

274, 638

Peng, J.

1109, 1110

Pavanello, C.

712

Penha-Silva, N.

Pavão, M.L.

535

Penkova, M.

Park, K.A.

519

Park, K.H.

583

Park, R.

601

Park, S.

705

Park, W.J.

519

Park, Y.M.

1032

Park, Y.W.

1123

Parks, J.S.

99

Pawlak, D.

653, 654

Parodi, O.

591

Pawlak, K.

653, 654

Parolini, C.

290, 426, 659, 871, 934

Parpala, C.

806

Parra, E.S.

431, 569

Pavkova Goldbergova, M.

Pawlinski, L. Pazmany, T.

982

810

Peloso, G.M.

113

Pen’kov, D.

115

Pentikäinen, M. Peppas, T. Peppelenbosch, M. Pereira, A.

775 1062, 1064 189 701, 831 475 684, 878, 879, 987, 1030

959

Pereira, F.O.C.

879, 1030

1077, 1078

Pereira, T.C.

879, 1030

Pedersen, E.R.

340, 346, 463, 525, 918, 1029

Peretti, N.

562, 630

Perez Rodrigo, C.

681, 864

Perez Ternero, C.

880

Pérez, A.

672

Pérez, K.G.

794

Perez, S.

612

Perez-Caballero, A.

397

Pazzi, M.

Parri, A.

286

Parthasarathy, S.

380

Pedersen, H.D.

799

Parvaz, E.

1087, 1148

Pedersen, T.R.

886

Parvu, M.

932

Pedret Figuerola, A.

804

Pascu, A.

102

Pedret, A.

882

Pashos, E.

193

Pedro-Botet, J.

2A, 18, 286,680

223

Presentation No.

Presentation No.

Perez-Caballero, A.I.

560

Pettersson, K.

240

Pitivejthurakit, P.

Perez-Calahorra, S.

613, 859

Peyman, A.

147

Pitocco, D.

1088

Pérez-Cuellar, M.

672, 876

Pfaffenberger, S.

Perez-Jimenez, F.

789

Pfeffer, K.

447

Pitsavos, C.

312, 331, 772, 977

Perez-Martinez, P.

397, 403

Phillippi, J.

414

485, 486

Pérez-Rubio, K.

826

Pialoux, V.

293

Pérez-Ruiz, M.R.

544

Pianelli, M.

837

Perez-serra, A.

427

Picataggi, A.

193

Perkins, J.

276

Picon-Cesar, M.J.

408

Perola, M.

87

Picu, A.

1151

Perona, J.S.

393, 464

Piefer, L.A.

236

Perova, N.

670

Piemontese, A.

870

Persiani, S.

961, 962

Pieterman, E.J.

147

Persson, A.

209

Pieters, D.J.M.

Persson, L.

663

Pertsoulis, N. Perusomula, R. Pervushina, N.

Pitsavos, D. Plana, N.

990, 1031

505 322, 405, 613, 730, 786

Plat, J.

552

Pláteník, J.

392

Plaza, J.A.

750

Plowchalk, D.

268, 927

Pluijmert, N.J.

240

Pocovi, M.

321, 174, 396, 695, 897

914

Podpalov, V.

768, 1154, 1214

Pietrzycka, A.

764

Podpalova, O.

768, 1154

381

Pileggi, S.

639

Poggesi, L.

779, 780, 781

1047

Pilowski, C.

382

Poirier, P.

262

433, 657, 865

Pineau, L.

41

Pojskic, B.

480

Perzanowska, A.

953

Ping-Yen, L.

1152

Pojskic, L.

480

Pesant, Y.

698

Pini, R.

Pesonen, E.

210

Pinilla, B.

802

818, 1151

Pinto, G.A.

905

Petcu, L. Petelina, T.

224

Presentation No.

218, 512

459, 460, 805

Pinto, X.

134, 680, 861

Peter, K.

249

Pinyol, M.

825

Peters, A.

274

Piotrowska, A.

854

Peters, H.A.B.

527

Piotrowski, K.

285

Petho, D.

170

Pippal, J.

598

Petit, J.M.

823

Petrashevskaya, T.

460

Petriashvili, T.

430

Petrischeva, A.V.

1114

Petropoulou, P.I.

299

Petrova, J.

809

Petry, H.

128

Pettersen, A.A.

803

Piqueras, L. Pirault, J.

228, 246, 800, 936 451

Pirazzi, C.

610

Pirro, M.

587, 1153

Pisciotta, L.

835

Pisot, R.

469

Pitha, J.

636

Pokorna-Kalwak, D. Pokrovsky, S.

1008, 1009, 1013, 1014 250, 540, 662, 741, 935

Polanczyk, C.A.

751

Polansk?, P.

720

Polansky, P.

719

Poledne, R.

281

Polis, A.B.

890

Polk, D.

264

Polonskaya, Y. Polus, A.

631 446, 787, 822, 1155

Polyanskaya, E.

425

Polyanskaya, Y.

688

Polyzos, K.

451

Pomerri, F.

1059

Presentation No.

Presentation No.

Ponde, C.K.

633

Prisco, D.

1078

Pongratz, T.

485, 486

Proctor, S.

891

Pönitz, V.

457

Proempeler, H.

377

Popescu, H.

881

Prostran, M.

1185

Popovic, L.

1156, 1161, 1186

Provatorov, S.I.

490

Popovich, A.

1157

Provost, N.

219

Porcellini, E.

727

Proyas, P.

699

Pordy, R.

267

Puaschitz, N.

1029

Poreba, M.

445

Puckridge, P.J.

767

Porreca, C.

1088

Puetz, G.

377

Posada-Ayala, M.

715

Pueyo, M.J.

897

Posadas, C.

241

Pueyo-García, M.

396

Posadas, R.

241

Pugeat, M.

624

Posea, M.

881

Pukite, K.

1033

Postnov, A.

740

Pullinger, C.R.

567

Postnov, A.Y.

271, 736, 1038, 1173, 1174

Potashev, S.

1158

Potekhina, A.V.

490

Potocková, J.

392

Potor, L.

170

Pottgens, C.

395

Pouladi, B.

106

Pouliot, J.

698

Poullin, P.

332

Poutanen, K.

804

Povoa, R.M.

483

Pownall, H.

585

Prado, C.

245

Prakoshyna, N.

1154

Puntoni, M.

428, 591, 837

Punzalan, F.

1042

Pussinen, P.

210

Pussinen, P.J.

586, 1007

Pütz, G.

667

Puzo Foncillas, J.

627

Puzo, J.

613, 859, 897

Puzziferri, L.

230

Pylaeva, E.A.

490

Q Qu, X.

1126

Quadt, F.

866

Quax, P.

240, 288

Quax, P.H.A.

527

Queipo Ortuño, M.I.

408, 419

Queipo-Ortuño, M.I.

493

Quesada, H.

254 604 843

Pravenec, M.

955

Premakumari, V.

414

Priego, M.A.

709

Prieur, X.

938

Quesada-Vázquez, H.

Princen, H.M.G.

147

Quevedo-Aguado, L.

Presentation No. Quezada, M. Quezada-Feijoo, M. Quiles, L. Quillama Torres, E. Quinn, A.

528 528, 599, 849, 850, 427 400 784 148, 315

Quinn, A.G.

567

Quintão, E.

1193

Quintão, E.C.R. Quintin, J.

431, 569 234

R R. Nakandakare, E. R. Quintão, E.C. Raal, F.

645 645 66, 326

Rabelo-Silva, E.R.

751

Rabès, J.P.

630

Rabiei, Z.

1141

Rached, F.

186, 578

Rachel, N.

739

Racz, K.

959

Radenkovic, M.

1185

Rader, D.

256, 264, 301

Rader, D.J.

113, 193, 632

Radovic, B.

568

Radukhin, A.

865

Radulian, G.

806, 881

Radwan, M.

238

Ragino, Y.

631, 737, 1159, 1160

Ragusa, A.

428

Rahman, T.

363, 365, 366, 367

Raichlen, J.S.

146, 330

Raiman, J.

315

Raitakari, O.T.

80

Rajamäki, K.

237 225

Presentation No.

Presentation No.

Rajani, R.M.

633

Rau, T.

549

Ren, S.

Rajesh, G.

988

Raunsø, J.

1083

Rajesh, K.F.

988

Rauramaa, R.

108

Renovato-Martins, M.

Rajkovic, N.

1156, 1161, 1186

Ravani, A.

773

Rakugi, H.

184

Ravara, B.

101

Ramachandran, V. Ramajo, M. Ramakrishnan, S. Ramey, N.

872 361, 362

Ravasi, L.

196

Ravcukova, B.

620

333

Ray, K.

896

991, 992, 993

Ray, P.C.

539

Ramírez Montesinos, R.

923

Ramirez Pineda, J.

289

Ramirez-Pineda, J.

956

Ramirez-Pineda, J.R.

508

Ramirez-Pineda, R.

374

Ramon, J.M.

286

Ramos de Andrade, I.

1166

Ramos, S.

245

Rancic, Z.

760

Randolph, G.

159

Rangel-Zuñiga, O.

788, 789

Ranjith, M.P.

272, 988

Rankovic, J.

999

Rao, S.P.

297

Raposo, H.F.

566

Raposo, J.F.

856

Ras, R.

866

Rashid, S.

534, 915

Raskina, K.V.

490

Rastas, K.

283

Razawy, W.

288

Razny, U.

446, 787, 822, 1155

Razvodovsky, Y.

1163, 1163, 1164, 1165

Rdzanek, K.

749, 975

Real, J.T.

547, 709

Rebnord, E.

346

Recarte GarciaAndrade, C.

1027

Redmond, E.M.

1138, 1139

Redon, J. Redondo, S.

398 361, 362

Rees, A.

896

Reeves, J.

971

Reganit, F.

1042

Reganit, P.

1044

Reguillo, F.

361, 362

Reiber, I.

983

Reilly, M.P.

259

Rein, P.

306, 342, 542, 708, 766, 846, 847, 980, 981

Rentero, P.

183 1137, 1166 398

Resende, E.S.

775

Resta, F.

1167

Revuelta, E.

559

Reyes, A.

368, 685

Rezaee, F.

475

Reztsov, R.

231

Rha, S.

1121, 1122

Rha, S.W.

345

Ribalta, J.

405, 730

Ribeiro, I.W.J.

751

Riccardi, G.

102, 104, 199

Richter, V.

783

Rickels, M.

127

Riemann, D.

382

Riera-Borrull, M.

273, 777, 778

Rietveld, A.P.

442

Rieusset, J.

293

Riksen, N.P.

234

Rimár, K.

1089

Rincon-Arevalo, H. Rinninger, F. Rioja-Villodres, J.

374, 508 197 206, 743

Risko, P.

392

Rissler, J.

496

Ritz, E.

344

Rivellese, A.A.

199

Rivera, M.

414

Rathouska, J.

356, 364, 371

Reitsma, P.H.

418, 634

Rivero, M.

541

Ratkovic, N.

1162

Remaley, A.T.

958

Riwanto, M.

300

618, 966, 967, 968

Remennik, A.

641

Rizos, C.V.

593, 901

Ren, H.M.

1207

Rizos, E.C.

901

Ren, J.I.N.G.

1199

Rato, Q. Rattanatham, R. 226

Presentation No.

177, 990, 1031

Presentation No.

Presentation No.

Rizzo, M.

580

Rogozea, L.

Robertson, A.K.

434

Rohrer, L.

Robin, S.

872

Rojo, D.

498

Robinson, J.G.

267

Rojo, G.

691, 793, 974

Robinson, S.

855

Rolin, B.

646, 807

Rubio, E.

691, 793, 974

Rocchiccioli, S.

733

Rollefstad, S.

886

Ruiz, B.

427, 599, 850

Rocha, M.

341

Romacho, T.

61, 957

Roche, H.M.

259

Romanchuk, S.

Rock, E.

730

Rockman, C.B.

729

Rodionov, R.N.

334

Romanovskaya, E.

762

Ruperto, M.

785, 836

Rodrigues, A.

113

Romeo, S.

610

Russell, D.

718

Rodrigues, A.C.

905

Romero, V.

769

Russell, D.A.

Rodrigues, G.

1137

Romero-Mamani, E.S.

78

Roncal Mancho, C.

526

Rodriguez Artalejo, F.

88

Rodriguez Cristobal, J.

784

Rodriguez de Miguel, M.

682

Rodríguez, C.

86, 244

Rodriguez, J.A.

526

Rodríguez, M.A.

730

Rodriguez, N.

972

Rodríguez-Artalejo, F.

91

Rodríguez-Calvo, R.

244

Rodriguez-Encinar, J.

685

Rodríguez-Gallego, E.

273, 777, 778

Rodriguez-Leal, C. Rodriguez-Rodriguez, R.

99, 300, 601

349

Rubinat, E.

824

672

Romano, D.

1081

Rune, I.

646, 807

Romanov, V.

1103, 1117, 1179

Runge, J.

305

Ronda, N.

385, 602

Roozafzoon, R.

1141

Roque, C.

1084

Ros, E.

74, 76, 78, 79, 106, 613, 859

Rosales, C.

585

Rosca, A.

205

Rösing, C.K.

751

Rosini, S.

733

Rossell, J.

876

Rossignoli, A.

187

528, 599, 849, 850

Rotar, O.

1177

Roth, E.

267

510, 750, 867, 880

Roth, L.

842

Roura, S.

559

899

Rubanenko, O.

490

239

537, 929

1201

Rull, A.

Rosengren, B.

Roeters van Lennep, J.E.

1168

Rozikhodjaeva, G.

Ruleva, N.Y.

418, 634

775

Roy, R.

1177

Rosendaal, F.R.

Roerver-Borges, A.S.

Roever, L.

102

Presentation No.

Rovati, L.C.

961, 962

Rovella, V.

230

Rovira-Lllopis, S.

341

1188

Rusu, E.

806, 881

Rusu, F.

806

Ruta, V.

1136

Rvacheva, A.

369

Ryazankina, N. Rye, K.A. Rygiel, K.

231, 960 114, 186, 298 853

Rysz, J.

438, 580

Ryu, J.K.

1123

Ryzhkova, A.I.

736

Ryzhkova, E.

477

S Saad, A.A.

1147

Saavedra, P.

164, 279

Sabaka, P. Saban-Ruiz, J.

1169 368, 600, 685, 574, 851

Sabatino, L.

428

Sabbà, C.

1167

Saber, S.

1099

Sabri, M.

117

Saburova, O.

242 227

Presentation No. Sachdev, V.

598

Salazar, L.A.

1171, 1172

Saely, C.

94

Saleh, A.M.

697

Saleh, H.M.A.

1147

Saely, C.H.

306, 342, 542, 708, 766, 846, 847, 980, 981

Safa, R.

1041

Safarov, K.H.

829

Safarova, M.

250, 543, 741, 935

SALES, A.

1097, 1098

Salic, K.

952

Salles, J.E.N. Salmerón-García, A.

894 686, 1019

Salminen, A.

586 1007

Saffi, M.

751

Salomaa, V.

Safronova, O.

116

Salonurmi, T.

606

Saglam, K.

1135

Salvador, A.M.

652

Sahebkar, A.

1049, 1050

Salvayre, R.

186

Sahiner, L.

1202

Samaja, M.

101

Saiki, A.

565

Sampaio, M.F.

229

Saile, R.

117

Sampalis, J.

698

Sais Zidek, A.

1024

Sampalis, T.

698

Saita, S.

1069

Sampietro, A.

1194

Saito, H.

965

Sampietro, T.

428, 835, 837

Saito, N.

167

Saito, S.

212

Samson-Bouma, M.E.

Sajeev, C.G.

988

Sajty, M. Sakamoto, K.

355, 717, 868 917

Sakane, N.

979

Sakata, Y.

548, 551, 632, 940

Samura, T.A. Sánchez Hernández, R. Sanchez, R.

630 1056, 1057 544 541, 972

Sánchez-Chaparro, M.A.

406, 843, 844

Sanchez-Ferrer, C.F.

957, 61

Sánchez-Muniz, F.J.

472, 666, 785, 836

Presentation No. Santos Filho, R.D.

684, 878, 879, 987, 1030

Santos, D.

254, 604

Santos, E.

535

Santos, E.S.

229

Santos, P.R.

651

Santos, R.

916

Santos, R.D.

578

Santos-López, J.A.

666

Santra, S.

315

Sanz Molina, J.

469

Sanz, B.

625

Sanz, J. Sanz, M.J. Sanz, X.

307 228, 564, 800, 936, 957, 246 536, 626

Sapilak, B.

1008, 1009, 1013, 1014

Sarabi, G.

1106, 1107

Saraiva, A.

1084

Sarolo, L.

1059

Sarrafzadegan, N.

105

Sarrafzadegan1, N.

1049

Sarrazy, V.

226

Sarutipaiboon, I.

990, 1031

Sasaki, K.

169, 232, 1002, 1003

Sasaki, M.

232, 1002, 1003

Sakellaropoulos, G.

299

Sakly, M.

1099

Sasaki, T.

217

Saksi, J.

87

Sanchez-Niño, M.D.

295

Sasiela, W.J.

147

Saku, K.

909

235, 237, 672, 876

624, 630

576

Sanchez-Quesada, J.L.

Sassolas, A.

Sakurai, T. Sala, F. Sala-Vila, A. Salari, B. Salas-Salvadó, J. 228

Presentation No.

659, 961, 962 78, 825 1142 79

Sandberg, M.

538

Sang-Ho, S.U.H.

1102

Sangenís, S.

786

Santarino, I.B.

383

Santoliquido, A.

1088

Sata, M. Satilmis, S.

869 107

Sato, A.

655, 828

Sato, M.

869

Sato, T.

965

Presentation No.

Presentation No.

Presentation No.

Satoh, N.

674

Schlager, S.

568

Semb, A.G.

Satoshi, H.

647

Schlecht, K.

382

Semenova, A.

369, 734

Sattar, N.

130

Schlein, C.

197

Sattler, W.

598

Schmermund, A.

Savolainen, M.J.

606

SavolainenPeltonen, H.

590

Savopoulos, C.

926

Savopoulos, C.H.

561

Sawamura, T.

184

Sawayama, Y.

1004

Sazonova, M.A.

223, 271, 736, 1038, 1173, 1174

Sbaï, M.H.

501

Sbrana, F.

428, 837

Semenovykh, P.

1176

311, 739

Semjeni, M.

765

Schmidt, C.

1015

Sengupta, B.

380

Schmidt, K.

358

Senthong, V.

177, 989

Schmidt-RioValle, J.

464

Schober, A.

60

Schofield, J.

298, 465

Scholze, J.E.

203, 204

Schonewille, M.

255, 941

Schött, H.F.

200, 928

Schranz, D.

257

Schreier, L.

629

Schrijvers, D.M.

842

Seo, H. Seo, H.S. Seo, J.

Seo, S.

284

Seo, S.Y.

211

Serafinceanu, C.

776

Sercombe, R.

1099

659

Schuetz, J.D.

226

639

Schutte, C.

240

Schaefer, H.L.

147

Schwab, U.

804

Schäfer, K.

887

Schwahn, U.

147

Sergatskaya, N.

Schäfers, H.J.

200

Schwandt, P.

Schaider, H.

253

Scharnagl, H.

297, 344

Schartum-Hansen, H. Scheja, L. Scherbakova, L.

340, 346, 463, 525, 1029 197 737, 1159

Scherban, T.

1176

Scherrer, D.Z.

431, 569

Schibli, R.

760

Schinkel, A.F.L.

537

Schinzari, F.

230

Schirmer, S.

1034

Schiro, A.

1175

Schirra, J.

285

345 394, 706, 707, 1187 520, 945

Scardulla, C.

948

412, 728, 1121, 1122

Seo, J.B.

Scanziani, E.

Schaffner-Reckinger, E.

886

Serdar, M. Seres, I.

1135 282, 327, 336, 735, 838, 1089 946

204, 703

Sergeeva, E.G.

429

Schwarzman, A.

420

Sergienko, I.

369, 677, 734

Schwarzman, A.L.

421

Serhan, C.N.

958

Schweinzer, C.

598

Serna, J.

756

Scott, D.J.A.

1188

Scott, R. Seed, M.

Serra, F.

1084

66

Serracino-Inglott, F.

1175

615

Serrano, C.V.

578

Segawa, T.

668, 669, 673

Sertoglu, E.

1134

Segre, A.C.

577

Serusclat, A.

Segura, E.

528

Seibert, T.

161

Seidlerova, J.

275, 1132

Seifert, R.

340, 346, 463

Seijkens, T.

33

Seliger, B.

382

Seljeflot, I.

448, 801, 803

219

Settasatian, C.

177, 989, 990, 1031

Settasatian, N.

177, 989, 990, 1031

Seung, M.

412

Severcan, F.

1054

Severcan, M.

1054

Shabanov, P.

115 229

Presentation No.

Presentation No.

Shah, S.A.

633

Shin, E.K.

211

Simerzin, V.

349

Shahamfar, J.

995

Shin, G.

705

Simionescu, M.

424

Shahamfar, M.

995

Shin, M.

705

Simizu, T.

556

Shahrzad, M.

1141

Shin, M.S.

1032

Simm, A.

382

Shakhtshneider, E.

Shintyapina, A.

116

Simões, M.C.

566

Shalaby, M.

697

Shiomi, M.

529

Simone, M.L.

317

Shalaeva, A.

763, 829

Shirai, K.

565, 909

Simonelli, S.

587

Shalaeva, E.

763, 829

Shirakawa, T.

555

Simonova, G.

1149

Shalnova, S.

1177

Shishido, K.

212

Simons, L.

337

Shami, A.

516

Shishkova, V.

641

Simonsen, U.

750

Shang, M.M.

187

Shkroba, A.

1179

Simonyi, G.

1182

Shao, Q.

1178

Shoji, M.

840

Simunic, B.

469

148, 315

Shokri, M.

Sharma, R.

531, 532, 631

1051, 1052

Sinausia, L.

393, 464

Shatunova, I.

759

Shpektor, A.

231, 477, 960

Sinev, V.V.

271

Shaw, S.

971

Shrestha, R.

1101

Singh, A.

26

Shcherbakova, N.

640

Shuldeshova, N.

752

Singh, R.

1048

Shchukin, Y.

1133

Shurygina, E.

Singh, R.B.

868

Shchur, M.

1206

Shut’, I.

1104

Singh, S.

Shved, I.

725

Siniarski, A.

Sianni, A.

1180, 1181

Sheikh Abdul Kadir, S. SHEN, L. Shen, L.I.L.I. Shenyavskaya, E.

422 1178, 217 111 1062, 1063

Shepherd, J.

123

Shi, C.

161

Shi, G.

245, 294, 378

Shi, J.

1213

Shiba, T.

917

Shibata, H.

202

Shibata, M.

903

Shih, J.

774

Shim, W.

705

Shimabukuro, M.

869

Shimomura, Y.

555

SHIN, E. 230

Presentation No.

1187, 284, 704

1190, 1191, 1192

1156, 1161, 1186 445, 575

Sinisalo, J.

87

Siemelink, M.

642

Sinnreich, R.

595

Sierra-Restrepo, J.

956

Sinyov, V.V.

736, 1038, 1173

Signorini, S.

456

Siopa, M.

966

219

Sipahioglu, F.

372

Siren, R.

189

Sigovan, M. Sijbrands, E.J.G. Sijm, A.

537, 929 33

Sikharulidse, I.

1016

Sikharulidze, M.

912, 913

Silber, R.E.

382

Silbernagel, G.

344

Silhavy, J.

955

Silva, E.

222, 678

Silva, M.

775

Silvestri, E.

1078

Simakova, M.

955

Sirotkina, O.S.

421

Sirtori, C.R.

290, 426, 659, 712, 871, 934

Sjouke, B.

67, 660

Skeie, E.

918, 1029

Skipskis, V. Skogsberg, J. Skop, V.

476 187 820, 852

Skorka, R.

972

Skoumas, J.

312, 331, 772, 977

Presentation No.

Presentation No.

Presentation No.

Skowron, W.

435

Sola, R.

882, 804, 897

Speidl, W.

485

Skroubis, G.

299

Soler Parra, E.

645

Speidl, W.S.

486

Skuja, I.

710

Soler, C.

322

Spek, A.

418, 634

Slezak, A.

853

Solheim, S.

801

Spieler, F.

382

Sliwa, A.

822

Solntsava, A.

1205

Spina, R.

1145

Sloan, S.

872

Solovjeva, N.

492

Spiridon, M.

937

Smerud, K.T.

886

Solpov, A.

1183

Sponseller, C.

924

Smeu, B.

205

Soltani, R.

1049, 1050

Sprandel, M.C.O.

577

Smiianova, O.

108

Somers, V.

275

Spronk, H.M.H.

Smirnov, V.

242

Somodi, S.

327, 735

Squadrito, F.

507, 791

Smith, A.J.P.

970

Son, D.

165

Sreckovic, I.

297

Smith, T.

347

Song, F.

1199

Sripriya, N.

633

Smith, U.

71

Song, G.

225

Sserve, P.

588

Smithson, W.H.

853

Sonmez, A.

499, 500, 1134

Smits, L.

538

Sonmez, H.

372

Staels, B.

21, 41, 96, 191, 196, 253

Smits, L.P.

125, 305, 439

Soo, Y.

755

Smyth, J.

1175

Snegurskaya, I.

1062, 1063, 1064

Soares Costa, H.

856

Soavi, C.

469

Sobenin, I.

433, 773, 865

Sobenin, I.A.

223, 271, 736, 1038, 1173, 1174

Soran, H.

126, 298, 465, 658, 896

Soriano, F.

1193

Soriguer, F.

691, 691, 793, 974

Sorini, C.

1069

Sorli, J.V.

400, 401

Sorokin, A.

958

Sorokina, V.

1214

Soboleva, D.

742

Sobotka, L.

719, 720

Sorsa, T.

210, 586

Sobrevia, B.

182

Soska, V.

620

Sobrevia, L.

182

Sotiropoulos, A.

Sochor, O.

275

Sotnikova, R.

997

Söderberg, I.

484

Sousa, A.G.M.R.

229

Söderlund, S.

27, 554

Souza Zago, V.H.

645

Soehnlein, O.

353

Soya, O.

1184

Soffer, G.

333

Spann, N.J.

Sogut, E.

746

Spanou, M.

926

Soh, J.

117B

Spark, J.I.

350, 767, 1018

1051, 1052

Speer, T.

928

Sohrabi, B.

701, 831

33

1112

Staessen, J.

1149

Staffler, G.

266

Staines, H.

457

Stakhneva, E.

116

Stancel-Mozwillo, J.

446

Stancel-Mozwllo, J.

787

Stand, E.

918

Stanek, V.

636

Stangl, G.I.

92

Stanisic, M.

466

Stankovic, A.

1215

Starchenko, T.

1104

Stark, J.

959

Stásek, J.

719

Stchastlivenko, A.

1154, 1214

Steen, J.

482, 950

Stef, M.

323, 324, 328, 558, 625

Stefanadis, C.

312, 331, 505, 772, 977

Stefanovic, A.

711 231

Presentation No. Stefanutti, C.

Stukena, I.

Presentation No.

710

Sviridov, D.

100

Stein, E.A.

66, 146, 330

Su, J.

444, 950

Sweeney, K.

268, 927

Stella, A.

218, 512, 513

Su, T.C.

220

Swier, V.

238

Stephens, J.W.

969

Suarez, M.

882

Syed, A.

465

Stepien, A.

438

Suciu, L.

351, 351, 436

Sykut-Cegielska, J.

315

Stepien, M.

438

Suciu, M.

351, 436, 884

Sterba, M.

985

Suehisa, E.

533

SzahidewiczKrupska, E.

Stergiou-Michailidou, V.

502

Suesada, H.

964

Suffee, N.

167

Stigliano, E.

1088

Stingeni, L.

1153

Stitziel, N.O.

153

Stoffel, M.

601

Stoian, I.

205, 1151

Stoian, M.

881

Stoicescu, F.

881

Stojakovic, T.

297

Stojanov, M.

711

Stojanovic, I.

862

Stojanovic, M.

1185

Stokmane, A.S.

1033

Stone, P.H.

212

Storniolo, C.E. Stosic, L. Strabelli, D.G.

860, 861 1156, 1161, 1186 894

Straface, G.

1088

Strand, E.

346, 525, 1029

Strang, A.C.

439

Strempel, C.

792, 1020

Striggou, M.

312

Strnad, H.

955

Stroes, E.

42, 128, 137, 304, 538

Stroes, E.S.

125, 126, 305

Stroes, E.S.G. Stucchi, M. 232

126

Presentation No.

155, 439 456

Sugihara, M. Suh, S.

909 704, 1187

Sukoyan, G.

494, 530

Sulowicz, W.

764

Sumino, H.

555, 556

Sumiya, T.

1189

Sun, Z.D.Y.

1188

Sundius, L.

484

Sung, J.

276

Sung, Y.

178

Suoniemi, M.

871

Suppressa, P.

1167

Surgit, O.

1068

Surra, J.

597

Sushkova, A. Suslova, T. Suslova, T.E. Sutter, I.

911 453, 911 452 300, 601

Sutti Nunes, V.

645

Sutton, A.

167

Suvorova, A.

640

Suwa, J.

506

Svardal, A.

525

Svedlund, S.

635

Svingen, G.

340, 463

Svingen, G.F.T.

346, 525, 1029

749, 817, 975

Szekacs, B.

959

Szigeti, K.

765

Szilagyi, K.

395

Szombath, D.

959

Szopa, M.

830

Sztanek, F.

838

Szuba, A.

854

Szwajda, A. Szyber, P.

482 1008, 1014

T Tabares-Guevara, J.

289, 956

Tabas, I.

11

Tabet, F.

114, 298

Tabukashvili Revaz, R.I.T. Tada, H. Taek Jong, H.O.N.G.

892 609 1045, 1046

Tagami, M.

917

Taguchi, K.

808, 834

Taherkhanchi, B.

1051, 1052

Tai, E.

637

Tailleux, A.

191

Tak, P.P.

439

Takahashi, S.

212

Takahashi, Y.

576

Takahashi, Y.U.J.I.

1101

Takeda, K.

608

Takeda, S.

576, 1101

Takegoshi, T.

609

Presentation No.

Presentation No.

Presentation No.

Takehashi, M.

533

TATLISU, M.

251

Tesauro, M.

230

Takenaka, F.

217

Tatsuno, I.

565

Tesloianu, D.

937

Takeuchi, M.

808

Tavakoli, S.

236

Teunissen, P.

291

Takeuchi, T.

171

Tavallaee, G.

194

Thacker, S.

958

Taki, H.

117

Tavartkiladze, A.

430

Takiguchi, S.

632

Tavazzi, L.

639

the RESEARCH Study Group, .

917

Takkand, A.

459

Tavori, H.

534, 915

Therond, P.

589

Thiagarajan, D.

950

Thilly, W.

512

Thomas, C.

185

Takolander, R.

187

Taylor, R.C.

114

Takuro, M.

647

TBA,

36

Talaeva, T.

1116

Tall, A.R.

632

Talmud, P.

34

Talukdar, H.A.

187

Tamanaha, T. Tamura, R. Tamura, S. Tamvakos, E.

265 668, 669, 673 529 701, 831

Tan, R.

889

Tanaka, A.

917

Tanaka, M.

965

Tancredi, L.

1194

Tang, L.

238

Tang, S. Taniguchi, H.

178 309, 731

Tchaava Khatuna, K.M.T. Tcimbal, S. Teixeira Damasceno, N.

892 737, 1159 1079

Tejedor, D.

328, 625

Tejedor, M.T.

174

Tejedor, T.

323, 324

Tejerina, T.

55, 361, 362

Tellis, C.

943

Tellis, C.C.

593

Tello, S. Tello-Blasco, S. Temchenko, A.

685 368, 574, 600, 851 433, 865

Ten Cate, H.

1112

Teng, B.

292

Tapan, S.

499, 500, 1134

Tarasov, K.

871

Tengryd, C.

516

Tarlovskaya, E.

920

Tenneti, V.S.

545

Tarlovskaya, Y.

754, 919, 921

Tentes, I.

887

Teo, Y.

637

Tarr, T. Tarugi, P.

1089 317, 1145

Teodoru, I.

881

Tasatargil, A.

370

Tereshkov, P.

1183

Tasci, I.

1135

Tero, P.

115

Taskinen, M. Taskinen, M.R. Taslipinar, A.

70 27, 189, 267, 554 500, 1134

Terraneo, L.

101

Tershalovec, A.M.

890

Terzis, I.

922, 1017

Thompson, G.

135, 615, 896

Thorand, B.

274

Thum, T.

32

Thurlings, R.

42

Tian, B.I.N.G.

467, 468

Tian, J. Tibolla, G. Tichy, L. Tietge, U. Tietge, U.J.F. Tikhomirova, L.

1199 101, 263, 665 620 941 255, 603 923

Tikkanen, M.J.

590

Timbol, E.W.

1043

Timoracka, K.

1132

Timoshenko, N.

737, 1159

Tinahones, F.

409, 621, 622, 875, 902

Tinahones, F.J.

408, 419, 493, 947

Tinoco, I.

528, 599, 849, 850

Tiwari, S.

1048

TJWA, D.J.T.H.

1112

To Viet, T.

285

To, F. Tocaci, G.

432, 484 806 233

Presentation No.

Presentation No.

Toguzova, Z.

1177

Traveset, A.

824

Tulassay, Z.

959

Tohyama, J.

113

Tremblay, A.

262

Tulupova, V.

752

50, 121, 1095, 1096, 1202

Tremblay, K.

318

Tura, A.

199

Tremoli, E.

302, 773

Turek, A.

749, 975

Triggiani, V.

1167

Trigui, M.

1053

Triolo, M.

603

Tokgözoglu, L. Toljic, B.

1093

Tolpygina, S.

688

Tomás Barberán, F.A.

855

Tomashevskaya, J.

771

Tomasik, T.

853

Tomassini, J.E.

890

Tomaszewski, M.

853

Tomczak, J.

738

Tomescu, M.

351, 436, 884

Tomlinson, B.

906, 907

Tomoda, M.

655

Topchii, I.

1157, 1176

Toprak, S.

372

Torjesen, P.A.

448

Toro, R.

427, 528, 599, 849, 850

Torp-Pedersen, C.T.

1083

Torrea, M.

802

Tosheska Trajkovska, K.

661

Toth, C.L.

Tripuraneni, R.

148, 315, 567

Trivella, M.G.

591

Trnovska, J.

820, 852

Trojak, A.

810

Troxler, M.A.

1188

Troy-Fioramonti, S.

280

Trunecka, P.

281

Trusca, V.

424

Trypou, P. Tsai, L.

948 774, 1152

Tsai, W.

774

Tsai, W.C.

491

Tselepis, A.

168, 943

Tselepis, A.D.

593, 901

Tselmin, S.

334

Turfaner Sipahioglu, N.

372

Turner, T.

146, 330

Tuseth, N.

463

Tvorogova, T.

1113

Twelves, C.

148

Twigg, M.

718

Tybjaerg-Hansen, A.

131

Tybjærg-Hansen, A.

154, 176, 303

Tykarski, A.

853

Tziakas, D.

887

Tzialas, D.

933

Tziomalos, K.

926

U Ucciferri, N.

733

Uchasova, E.

1190, 1191, 1192

Uchigata, Y.

828

Ueda, K.

609

Ueda, S.

808, 834

Tseluyko, V.

643, 644

114

Tsikaris, V.

948

Toth, P.

924, 925, 991, 992, 993

Tsinlikov, I.

Toth, P.P.

580, 890, 939

Tsivilis, N.

1180, 1181

Totomoch, A.

1037

Tsoukas, G.

698

Ueyama, T.

167

Touche, V.

191

Tsoukatos, D.C.

948

Ugresic, N.

862

Tsuchida, H.

964

Ujfalusi, S.

282

Tsuda, M.

212

Ullevig, S.L.

379

813, 857

Tsutsui, J.M.

899

Undas, A.

478

Toyozaki, M.

571

Tsuzaki, K.

979

Unverzagt, S.

382

Trautwein, E.

866

Tudosoiu, J.

205, 818

Urazalina, S.

677

Travers, S.

588

Tuimala, J.

87

Urazgildeeva, S.A.

421

Tousoulis, D. Touw, A. Tovilla-Zarate, C.A.

234

Presentation No.

922, 1017 929

Tsinlikova, I.

523, 524

Ueda, Y.

608, 732

Ueland, P.M.

340, 346, 463, 918

Ueno, T.

169, 232, 1002, 1003

523, 524

Presentation No. Urraca, C.

361, 362

Urschel, K.

353

Urtane, I.

1033

Uryga, A.K.

61

Uslu, N.

107

usta, C.

370

Utkina, E.

662

Uusitupa, M.

804

V V.Oláh, A. Vachalcova, M.

327 355, 717, 868

Vagida, M.

960

Vaillant, G.

823

Vaillant, N.

261

Vaisman, B.L.

Presentation No. van CasterenMessidoro, C.

308, 996

Van Dam, R.M.

637

van de Geijn, G.

308

van de Geijn, G.J.M.

442, 996

van den Berg, T.K.

395

van den Boogert, M.A.W.

155

Van den Bossche, J.

33, 413

Van den Hoek, A.M.

147

van den Oord, S.C.H.

537

van der Arend, J.

308, 996

Presentation No. Vanmierlo, T.

1034

Vanneste, B.

214

Varejckova, M. Varela, C.

371 166, 440, 885

Varga, V.

336

Vargas da Silva, S.

1166

Vargas-Alarcon, G.

241, 1037

Varin, A.

185

Varona, S.

86, 244

Vasan, R.S.

359

Vasilets, L.M.

1114

Vasilieva, E.

231, 477, 960

van der Heijden, R.

458

van der Hoeven, N.

291

958

Van der Hoorn, J.W.A.

147

Vakhtangadze, T.

470

van der Laan, S.W.L.

642

Vasudevan, R.

Valantin, M.a.

930

van der Meer, J.W.M.

234

Vasuri, F.

218, 512, 513

148, 315, 562

van der Meulen, N.

308, 996

Valayannopoulos, V. Valdes, S. Valdivielso, J.M. Valdivielso, P.

Valenti, V.

1145

Valero, R.

1144, 332

Vallejo Minguez, J.

270

Vallejo, R.

621, 622

Vallejo, S.

957

Valls, R.M.

882, 897

Vallvé, J.C.

405

Van Breukelen-van der Stoep, D.

308

van Breukelen-van der Stoep, D.F.

996

van Buul, J.

42

343 1141 116 421

van der Valk, F.M.

125, 439

Vázquez, C.

614

van der Velden, S.

33, 291

Vázquez-Carrera, M.

411

295

513, 1077

Vassallo, J.

Vavilov, V.N.

329, 406, 843, 844

Valente, S.

374, 508

Vavilin, V.

van der Valk, F.

856

982

Vasquez, G.

42

875

Valente, A.

Vasku, A.

van der Zee, L.

929

Vcev, A.

van Dijk, T.

125

Vecera, R.

820

van Eck, M.

110

Vedie, B.

588

van Gorp, P.J.

395

Veglia, F.

951

van Leuven, S.I.

439

Veloso, F.

775

van Rooyen, N.

291

Velsko, I.

414

van Vught, D.

538

Venancio, T.

1193

van Zeben, D.

996

Vendrame, F.

431

308

Verberne, H.

42, 538

van Zeben, J.

503, 504

180, 521

Vercesi, A.

656

710

Verges, B.

280, 823

Vancura, V.

1021

Vergidou, V.

831

Vanegas, D.

236

Verheij, J.

305

1132

Verhoeven, A.

929

van Zeijl, R.J.M. Vanagele, D.

Vanek, J.

235

Presentation No.

Presentation No.

Vericat, C.

761

Vinchi, F.

35

Vrijenhoek, J.E.P.

221

Verkade, H.

941

Vine, D.

891

Vujic, N.

568

1048

Vinod, M.

253

Vun, S.

1018

458, 952

Vinué, A.

564, 800

Vyas, A.

811

Verma, N. Verschuren, L. Vetrani, C.

199

Virgínio, V.W.M.

569

Vymetalova, Y.

1021

Vickers, K.

114

Vitalini, C.

962

Vynnychenko, L.

108

Vickers, K.C.

298

Vitek, L.

994

W

Victor, V.

341

Vitkovsky, Y.

1183

Wada, F.

903

Vidal, H.

293

Vivanco, F.

180, 521, 715

Wada, S.

903

Vidal, J.

626

Vlad, L.

942

Wadsack, C.H.

297

Vidale, S.

1194

Vladimirskaya, T.

725

Wågberg, M.

239

Viegas, M.S.

383

Vlaia, L.

436

Wågsäter, D.

247, 839

Vieira, I.C.

569

Vlaia, V.

436

Wakasa, M.

608

Vieira, O.V.

383

Vlasik, T.

670, 734

Waksal, H.

698

Viglione, F.

591

738

307, 602

531, 532, 631, 737, 1159

Walczak, W.

Vigna, G.B.

Voevoda, M.

Waldmann, E.

549

Vihma, V.

590

Vogiatzi, G.

505

Wallaschofski, H.

359

Voicu, M.

351

Voidazan, S.

932

Viikari, J.S.A.

80

Viiri, L.

724

Vijil, C.

208

Vila, A.

322

Vila, L.

322

Vilardell, M.

536, 626

Villa-Pulgarin, J.

374, 508

Villalobos, L.

957

Villalobos, L.A.

61

Villamizar, M.

222, 678

Vojácek, J.

719, 720

Völzke, H.

359

von Bonin, A.

266

von Eckardstein, A.

94, 99, 109, 300, 601

von Segesser, L.K.

101

Vonbank, A.

306, 342, 542, 708, 766, 846, 847, 980, 981

Walsh, K. Walus-Miarka, M.

85 607, 764, 810

Wan, M.

444

Wang, E.

268, 927

Wang, H.

1213

Wang, K.

294, 378

Wang, L.

755

Wang, L.I.

468

Wang, M.

467

Wang, N.

226, 1211

897

Vonella, M.

1153

Wang, W.E.

Villard, A.

624

Vongpromek, R.

929

Wang, Y.

1109, 1110

Villarroel Salcedo, M.T.

627

Vorkapic, E.

247, 839

Wanko, B.

266

Vorkas, P.

449, 515

Wanner, C.

344

Villar, J.

236

Presentation No.

Villasmil, J.J.

222, 678

Vorobyeva, I.

477

Want, E.

Vinaixa, M.

730

Vorobyova, E.

470

Warnakula, S.

Vinayakumar, D.

272

Vrablik, M.

89, 338, 620, 908

Vincent, J.

268

Vranic, A.

862

Wasserman, S.M. Watts, G.

162

449, 515 891 65, 66 46

Presentation No.

Presentation No.

Presentation No.

Watts, G.F.

65, 545

Williams, H.

381

Y

Weber, C.

60

Willinger, C.

872

Yadav, R.

Wei, J.

1005

Windak, A.

853

Yagi, A.

1101

Wei, Y.

60

Winkler, K.

195, 377, 667

Yagi, K.

596, 609, 676

1195, 1196, 1197

Wlazel, R.N.

Wei-Syun, H. Weikert, C. Weingärtner, O. Weise, C.B.

92 200, 928, 1034 114

Welch, C.

632

Welch, C.B.

226

Wellington, C.

112

Welten, S.

288

Wen, G.

415

Werba, J.

514

Werdan, K.

382

Westein, E.

249

Westerterp, M.

226

Wevers, R.

155

Wezel, A.

288

Whiteman, J.

971

Whiteman, M.

170

Whitley, C.

148, 315

Whittall, R.A.

417

Widynski, K.

285

Wnek, D.

438

Yahya, M.

1141

446, 787, 822, 1155

Yahya, R.

929

Wohlfahrt, P.

275

Wojciechowska, W.

607

Wojdan, K.

435, 1072, 1073

Wojta, J.

485, 486

Wolff, E.

175

Wolska, A.

546, 679

Wolters, H.

255, 941

Wong, G.

889

Wong, K.S.

399

Wong, L.

755

Wong, T.

637

Wong, Y.T.

767

Wood, M.E.

170

Worm, J.

348

Worthmann, A.

197

Wozniakiewicz, E. Wright, S.D. Wróblewska, M.

298, 465

Yakovleva, L.

643, 644

Yakushiji, E.

632

Yalcin, A.A. Yalçin, U.

107 1095, 1096

Yalcinkaya, E.

1198

Yamada, H.

869

Yamada, K.

517

Yamada, S.

529

Yamagishi, M.

609

Yamagishi, M.A.

596, 676

Yamagishi, S.

808, 834

Yamaguchi, T.P.

85

Yamamoto, K.

184

Yamamoto, T.

903

Yamashita, S.

533, 548, 551, 632, 907, 940

810

Yamazaki, T.

917

589

Yamori, Y.

984

Yan, R.

193

546, 679

Wiegman, A.

141, 146, 330, 660

Wu, C.

1203

Yan, Z.Q.

40

Wielinga, P.Y.

952

Wu, G.Z.

162

Yanagi, K.

265

274

Wu, H.

294, 378

Yang, E.

394

Wiklund, O.

44, 47, 51, 119, 129A, 610

Wu, I.H.

963

Yang, H.

192

Wysocka, E.

738

Yang, J.

1207

Wiklund, U.

311

Yang, Q.

862

Wild, J.

353

Wietzorrek, G.

Wilfred, D.E.E.

1043, 1043

Wilk, G.

830

Willefert, M.

562

Willeit, J.

274

X Xiao, Q. Xu, B.I.N.G. Xu, F. Xu, Z.C.

415

Yang, W.

193

467, 468

Yang, Y.

906, 907, 1199

65, 66

Yang, Y.J.

162

162

Yang, Z.W.

1207 237

Presentation No. Yannarelli, G. Yao, J. Yarovaya, E. Yassin-Noreña, L.

958

Zaraboukas, T.

502

Yuan, J.

637

Zaromytidou, M.

312, 505, 977

671

Yuan, X.

40

Zavaroni, I.

374, 508

Yuasa, Y.

265

Yubero-Serrano, E.M.

789

Yuji, K. Yun, H.

Yasushi, S.

533

Yasutake, Y.

202 555 683, 690, 821, 986

Zdzienicka, A.

307, 602 446, 787, 822, 1155

Zebregs, Y.

866

647

Zeegers, M.P.

357

227

Zegrocka-Stendel, O.

953

Yun, K.

1121

Zelcer, N.

153

Yurchenko, F.V.

954

Zelinskiy, V.

1206

226

Zemanek, K.

Yayha, R.

537

Yvan-Charvet, L.

Ye, S.

415

Z

12

Yegorova, Y.

Zemankova, K.

435 553, 570

Zabala, S.

613

Zemankova, L.

745, 746

Zacharof, A.

1204

Zeng, C.

Yildirim, A.

1068

Zachary, I.C.

970

Zengin, A.

251

Yilmaz, B.

370

Zagajewski, J.

748, 898

Zernecke, A.

39

Yin, X.

872

Zago, V.

Yokomizo, P.l.

894

Zago, V.H.S.

Yerli, Y.

629

zhang, G.

1208, 1209, 1210

Zhang, L.

415

Zagrebaeva, O.

1205

Zhang, L.F.

1207

Zak, P.

471

Zhang, Q.I.A.N.

111

232, 1002, 1003

Zakirov, K.

763

Zhang, X.Y.

40

808, 834

Yokota, Y.

840

Yokubov, K.

371 162, 1207

431, 569

Yokoro, M. Yokoyama, S.

1201

Zalewski, J.

575

Zhang, Y.A.N.

990, 1031

Zamaklar, M.

1186

Zhao, H.

415

Yoon, H.

705

Zambrano, T.

1171

Zhao, S.

1203

Yoon, Y.

474, 726

Zamfirescu, A.

744, 942

Zhao, W.F.

1211

Yongsakulchai, P.

1109, 1110

Yorgun, H.

1095, 1096, 1202

Zamora, A.

322

Zhao, X.

161

Yoshida, M.

571, 596, 676

Zamorano, P.

311

Zhao, Y.

310, 739, 757

Zhelankin, A.

Young Ho, C.H.O.I.

1102

Zandl, M.

598

Yu, B.

1203

Zanella, A.

1059

Yu, C.

728

Zanetti Scherrer, D.

645

Yu, C.L.

963

Zannis, V.I.

99

Yu, H.

160

Zanolin, D.

342, 708, 980, 981

Zanoni, P.

113, 256

Zhou, Z.

60

Zanotti, I.

870

Zhu, S.

1213

Zanwar, A.

883

Zhu, Y.

1199

Yu, S.

755

Yu, X.

415

Yu, Y. 238

Yu, Z.X.

249

903

Yau, C.

Presentation No.

498, 514, 973

Yasuhara, H.

Yatsuzuka, S.

Presentation No.

529, 1178

271

Zheng, Y.

683, 690, 821, 986

Zhou, L.

192, 1207

Zhou, M.X.

1211

Zhou, X.

1212

Presentation No. Zhuo, D. Zhurova, O.

1213 768, 1214

Presentation No.

Presentation No.

Zivkovic, M.

1215

Zugwurst, J.

285

Zivotic, I.

1215

Zuliani, G.

469

Zidek, V.

955

Zo, J.

706, 707

Zulkafli, N.

366, 367

Zijlmans, J.

996

Zo, J.H.

520, 945

Zuñiga, M.

680

Zimetti, F.

307, 385, 573, 587, 602, 929

Zisimos, C.

977

Zito, C.

507

Zolghadr, M.

105

Zuriaga, M.A.

85

Zschiedrich, S.

377

Zvintzou, E.

299

Zsíros, N.

336, 904

Zubiri, I.

715

239

240


Recognition, Acknowledgements and Commercial Support

242

ACKNOWLEDGEMENTS CORPORATE PARTNERS Silver Level Corporate Partners

Bronze Level Corporate Partners

243

ACKNOWLEDGEMENTS The Organising Committee and the EAS Executive Committee would like to express their gratitude and acknowledgement to the following companies for their generous support in the 82nd EAS Congress:

Platinum Sponsor

Gold Sponsors

Silver Sponsors

Sponsors

244

EXHIBITORS

245

E A S • EuropEAn AthEroSclEroSiS SociEty 3 1 M Ay – 3 J u n E 2 0 1 4 • M A d r i d , S p A i n

Comprehensive Lipid Management:

A Treatment Paradigm for Optimal Cardiovascular Risk Reduction Sunday, 1 June 2014 17:00-18:30 Satellite Symposium Sponsored by MSD

CHAIR: Alberico Catapano President EAS Director, Center for the Study of Atherosclerosis Department of Pharmacological Sciences Professor of Pharmacology University of Milan Marie Curie Training Centre for Cardiovascular Diseases University of Milan Milan, Italy

FA C U LT Y: Philip Barter President, International Atherosclerosis Society Centre for Vascular Research Faculty of Medicine University of New South Wales Sydney, Australia

Ulrich Laufs Klinik für Innere Medizin III Kardiologie, Angiologie und Internistische Intensivmedizin Universitätsklinikum des Saarlandes Homburg, Saarland, Germany

Chris Packard

IFEMA, Feria de Madrid North Convention Centre Room: Francisco Grande Hall Madrid, Spain

Chair: Alberico Catapano (Italy) AGENDA 17:00 – 17:05

Chair Welcome and Opening Remarks

Alberico Catapano

17:05 – 17:20

LDL Insights Into Genetics and Epidemiology

17:20 – 17:25

Question & Answer Session

17:25 – 17:40

Bringing More Patients to Their Individual Treatment Goal

17:40 – 17:45


17:45 – 18:00

Outcomes Studies in LDL–C Reduction: What More Can Be Achieved?

18:00 – 18:05


Faculty

18:05 – 18:25

Round Table Panel Discussion

Faculty

18:25 – 18:30

Closing Comments

Chris Packard Faculty Philip Barter Faculty Ulrich Laufs

Alberico Catapano

Professor of Vascular Biochemistry University of Glasgow United Kingdom Copyright © 2014 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ, USA. All rights reserved. CVT-180901-2

246

Industry supported sessions Saturday, May 31, 2014 12:00-13:30 Francisco Grande Covian Hall

ELEVATED LDL: NOT ALWAYS FAMILIAL HYPERCHOLESTEROLEMIA 3 MYSTERY CASES FOR YOU TO DIAGNOSE Chair: Prof. Emilio Ros, Spain • Case 1 Handrean Soran, UK • Case 2 Ornella Guardamagna, Italy • Case 3 Kees Hovingh, The Netherlands

14:00-15:30 Francisco Grande Covian Hall This educational symposium is supported by an educational grant from BASF, Danone, Raisio and Unilever DIET AT THE HEART OF CVD PREVENTION Chairs: Alberico Catapano, Italy John Chapman, France 14:00-14:05 Welcome & introduction Alberico Catapano, Italy John Chapman, France 14:05-14:35 Diet – the corner stone of cholesterol management David Jenkins, Canada 14:35-14:40 Questions 14:40-14:55 Behaviour change is possible “small steps – big difference” Louis Masana, Spain 14:55-15:05 Behaviour change is possible, behaviour change in practice Helena Gylling, Finland 15:05-15:10 Questions 15:10-15:20 Introducing the E-learning tool Simon Hackett, Pegasus 15:20-15:30 Summary & Close Alberico Catapano, Italy John Chapman, France

247

Saturday, May 31, 2014 16:00 - 17:30 Francisco Grande Covian Hall

BRIDGING THE TREATMENT GAP IN HoFH Chairs: Kausik Ray, UK Pedro Mata, Spain 16:00-16:05 Welcome Kausik Ray, UK Pedro Mata, Spain 16:05-16:25 Identifying the target - Who are we treating and to what target? Marina Cuchel, USA 16:25-16:45 When to intervene - The urgency to treat Gil Thompson, UK 16:45-17:15 Tools of the trade - New treatment options in HoFH Dirk Blom, South Africa 17:15-17:30 Question and answers Kausik Ray, UK Pedro Mata, Spain

248

Sunday, June 1, 2014 13:00-14:30 - Manuel de Oya Hall Accredited Educational Program

MIXED HYPERLIPIDEMI AND TRIGLYCERIDES IN CARDIOVASCULAR PREVENTION Chairs: Rafael Carmena, Spain Olov Wiklund, Sweden • Triglycerides, cholesterol and HDL in CVD – lessons from genetics Børge Nordestgaard, Denmark • Mechanistic bases for the origin and therapy of elevated triglycerides and mixed hyperlipidemia Gerald Watts, Australia • Mixed hyperlipidemia and triglycerides in current guidelines for treatment Olov Wiklund, Sweden • Concluding remarks and discussion Rafael Carmena, Spain

14:00 - 15:00 Francisco Grande Covian Hall

APPROACH TO MODERATE CARDIOMETABOLIC RISK SUBJECTS: WHICH ROLE FOR NUTRACEUTICALS? Chairs: Alberico Catapano, Italy Gerd Assmann, Germany Panel: Individuals at moderate cardiovascular risk: strategic considerations Gerd Assmann, Germany How to manage moderate cardiometabolic risk subjects? B. Trimarco, Italy Effect of a nutraceutical product on lipid profile in hypercholesterolemic subjects: a meta- analysis Jesús Millán Núñez-Cortés, Spain

249

Sunday, June 1, 2014 17:00-18:30 Francisco Grande Covian Hall

250

COMPREHENSIVE LIPID MANAGEMENT: A TREATMENT PARADIGM FOR OPTIMAL CARDIOVASCULAR RISK REDUCTION Chair: Alberico Catapano, Italy 17:00-17:05 Chair Welcome and Opening Remarks Alberico Catapano, Italy 17:05-17:20 LDL Insights into Genetics and Epidemiology Chris Packard, UK 17:20-17:25 Question & Answer Session 17:25-17:40 Bringing More Patients to Their Individual Treatment Goa Philip Barter, Australia 17:40-17:45 Question & Answer Session Faculty 17:45-18:00 Outcomes Studies in LDL-C Reduction: What More can be Achieved? Ulrich Laufs, Germany 18:00-18:05 Question & Answer Session 18:05-18:25 Round Table Panel Discussion Alberico Catapano, Italy Chris Packard, UK Philip Barter, Australia Ulrich Laufs, Germany 18:25-18:30 Closing Comments Alberico Catapano, Italy

17:00-17:45 - Manuel de Oya Hall

MEET THE SPEAKER SESSION: Lp-PLA2: Risk Marker or Risk Factor? Presenter: Michelle O’Donoghue, Boston, USA

17:00-17:45 - Amador Schuller Hall

REVIEWERS’ WORKSHOP Hosted by: Dr. Sarah Leigh A presentation followed by an open question and answer session about the aspects of the peer review process. If you are interested in becoming a reviewer or if you already review but feel that you would like some more guidance please join us!

Monday, June 2, 2014 13.00 – 14.30 - Manuel de Oya Hall


ADDRESSING THE NEEDS OF HIGH-RISK PATIENTS IN HYPERLIPIDEMIA MANAGEMENT: THE THERAPEUTIC HORIZON Chairs: Alberico Catapano, Italy Luis Masana, Spain 13:00-13:05 Welcome and introduction Alberico Catapano, Italy Luis Masana, Spain 13:05-13:25 Hyperlipidemia management in high-risk patients: what we have and what we need John Kastelein, The Netherlands 13:25-13:55 Management of hyperlipidemia: what does the future hold? Evan Stein, USA 13:55-14:25 Monoclonal antibodies targeting PCSK9: gaining insight into their potential in clinical practice Alberico Catapano, Italy and Evan Stein, USA 14:25-14:30 Final Q&A and meeting close Alberico Catapano, Italy Luis Masana, Spain

FROM CONCEPT TO REALITY – A NEW DAWN IN GENE THERAPY FOR SEVERE LPLD Chair: Maurizio R Averna, Italy 14:00-14:05 Welcome, introductions and opening remarks Maurizio R Averna, Italy, Chair 14:05-14:25 Genetic and clinical characteristics of lipoprotein lipase deficiency (LPLD) Maurizio R Averna, Italy 14:25-14:45 Gene therapy for severe LPLD – clinical perspective and clinical challenges Daniel Gaudet, Canada 14:45-14:55 Questions and answers Maurizio R Averna, Italy and Daniel Gaudet, Canada 14:55-15:00 Closing remarks Maurizio R Averna, Italy

251

Monday, June 2, 2014

252

17:00 - 18:30 Francisco Grande Covian Hall


PCSK9 – FROM GENOMICS TO CUSTOMIZED LIPID LOWERING APPROACHES Chair: John J. Kastelein, The Netherlands 17:00-17:05 Introduction John J. Kastelein, The Netherlands 17:05-17:25 From genomic revolution to emerging therapies Gilles Lambert, France 17:25-17:45 Monoclonal antibodies - an innovative approach for PCSK9 inhibition Alberico Catapano, Italy 17:45-18:05 PCSK9 monoclonal antibodies for a tailored LDL-C lowering approach Michel Farnier, France 18:05-18:25 Panel discussion John J. Kastelein, The Netherlands Gilles Lambert, France Alberico Catapano, Italy Michel Farnier, France 18:25-18:30 Closing Remarks John J. Kastelein, The Netherlands

ALL STATINS CAUSE DIABETES? A DEBATE Chair: Toru Kita, Japan 17:00-17:10 Chair’s welcome and introduction Toru Kita, Japan 17:10-17:20 All statins cause diabetes? The case For the motion Kausik Ray, UK 17:20-17:30 All statins cause diabetes? The case Against the motion Lluis Masana, Spain 17:30-17:35 Rebuttal Kausik Ray, UK 17:35-17:40 Rebuttal Lluis Masana, Spain 17:40-17:45 Chair’s summary and close Toru Kita, Japan

exhibition floorplan

LOUNGE AREA

POSTER AWARD WINNERS

Track 1: Vascular Biology of the Arterial Wall Track 2: Lipid and Lipoprotein Metabolism

19 19A 18

Track 3: Risk Factors, Epidemiology, Prevention, and Treatment of Cardiovascular Diseases

16 15 14 HELP DESK AREA

12 13 11 09

10

08

07

03 04 02

01

ENTRANCE

@

LOUNGE AREA

exhibitors Company

Booth

Aegerion Pharmaceuticals

13

American Heart Association

12

Amgen

7

Chiesi

8

Denka Seiken

16

diaDexus

3

Company European Atheroscherosis Society

Booth 2

Company

Booth

MSD

10

Rottapharm

9 1

Fresenius Medical Care Deutschland

4

Sanofi/Regeneron

Itamar

15

Spanish Atherosclerosis Society

18

Mabtech

14

Synageva

19A

Mercodia AB

19

Wisepress

11 253

Poorly controlled LDL-C continues to loom over millions of lives 1

To Learn More, Visit Us at Booth 01. Despite treatment with lipid-lowering therapies, many patients continue to have poorly controlled LDL-C levels and persistent cardiovascular risk.1 Sanofi and Regeneron are committed to providing resources to better understand cholesterol management and to research the unmet needs of patients with poorly controlled LDL-C. LDL-C = low-density lipoprotein cholesterol.

Reference: 1. Pöss J, Custodis F, Werner C, Weingärtner O, Böhm M, Laufs U. Cardiovascular disease and dyslipidemia: beyond LDL. Curr Pharm Des. 2011;17:861-870.

©2014, Sanofi and Regeneron Pharmaceuticals, Inc.

254

05/2014

G-ALI-0123

GLB.ALI.14.05.0006

notes

262

266

Program Book PDF Version - EAS 2014, Madrid

Program Book PDF Version - EAS 2014, Madrid

Suggest Documents

Program Book PDF Version - EAS 2014, Madrid

Program Book PDF Version - Atherosclerosis Congress - EAS 2014 ...

2014-2015 KHSAA Competitive Cheer Official Program (PDF version)

2014-2015 KHSAA Competitive Cheer Official Program (PDF version)

Calendario Laboral Madrid 2014 PDF - Calendarioslaborales.com

ECT 2014, Madrid, Sept, 23rd 2014

European Open Madrid 2014 - Judobase

PDF version - Ocean Drilling Program

PDF version - Ocean Drilling Program

PDF version - Ocean Drilling Program

Download the Program Book for 2014!

Extended version - Universidad Complutense de Madrid

2014 Formula Hybrid Program (PDF)

Program Book - PDF

Program Book - PDF

Cancer Book - PDF Version - DrLam

Book Version

Segunda Circular SEPHE MADRID 2014.pdf - Google Drive

204-12-IX-Jornadas-Comiqueras-Madrid-2014.pdf - Google Drive

Conference Program (Online Version)

Version française - CQI 2014

August 2014 version

PDF version of February 2014 Patterns - WILL

2014 FIA APRC Registration Form – PDF version